BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy15989
(363 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|2OD3|B Chain B, Human Thrombin Chimera With Human Residues 184a, 186,
186a, 186b, 186c And 222 Replaced By Murine Thrombin
Equivalents
Length = 259
Score = 98.6 bits (244), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 80/263 (30%), Positives = 123/263 (46%), Gaps = 36/263 (13%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 172
Query: 187 ARDG--LRVCDTKHYVVF----TDVANVCNGDSGGGMVFK--IDSAWYLRGIVSITVARD 238
+D +R+ D F T + C GDSGG V K ++ WY GIVS
Sbjct: 173 CKDSTRIRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG-- 230
Query: 239 GLRVCDTK-HYVVFTDVKRVHIY 260
CD K Y +T V R+ +
Sbjct: 231 ----CDRKGKYGFYTHVFRLKKW 249
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 39/117 (33%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAGF+
Sbjct: 139 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGFK 191
>pdb|1MH0|A Chain A, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1MH0|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
Length = 287
Score = 96.7 bits (239), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 31 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 88
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 89 LLVRIGKHSRTRY--EANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 146
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 147 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 202
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 203 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 256
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 111 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 168
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 169 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 221
>pdb|1TQ0|B Chain B, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ0|D Chain D, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ7|B Chain B, Crystal Structure Of The Anticoagulant Thrombin Mutant
W215aE217A Bound To Ppack
Length = 257
Score = 96.3 bits (238), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 74/243 (30%), Positives = 114/243 (46%), Gaps = 31/243 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 172
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVSITVA-- 236
+D R+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 173 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCD 232
Query: 237 RDG 239
RDG
Sbjct: 233 RDG 235
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 139 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 191
>pdb|2A0Q|B Chain B, Structure Of Thrombin In 400 Mm Potassium Chloride
pdb|2A0Q|D Chain D, Structure Of Thrombin In 400 Mm Potassium Chloride
Length = 257
Score = 96.3 bits (238), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--EANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 172
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 173 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 226
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 139 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 191
>pdb|1SFQ|B Chain B, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SFQ|E Chain E, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SG8|B Chain B, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SG8|E Chain E, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SGI|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SGI|E Chain E, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SHH|B Chain B, Slow Form Of Thrombin Bound With Ppack
pdb|1SHH|E Chain E, Slow Form Of Thrombin Bound With Ppack
pdb|2HWL|B Chain B, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|2HWL|D Chain D, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|3BV9|B Chain B, Structure Of Thrombin Bound To The Inhibitor Fm19
Length = 259
Score = 96.3 bits (238), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--EANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 172
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 173 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 226
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 139 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 191
>pdb|3EE0|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF HUMAN
Thrombin (Space Group P2(1)2(1)2(1))
pdb|3HKJ|B Chain B, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
pdb|3HKJ|E Chain E, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
Length = 259
Score = 96.3 bits (238), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 74/243 (30%), Positives = 114/243 (46%), Gaps = 31/243 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 172
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVSITVA-- 236
+D R+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 173 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCD 232
Query: 237 RDG 239
RDG
Sbjct: 233 RDG 235
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 139 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 191
>pdb|1D6W|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electrophilic Inhibitors Having Cyclohexyl Moieties
At P1
pdb|1G37|A Chain A, Crystal Structure Of Human Alpha-thrombin Complexed With
Bch-10556 And Exosite-directed Peptide
Length = 287
Score = 95.9 bits (237), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 31 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 88
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 89 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 146
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 147 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 202
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 203 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 256
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 111 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 168
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 169 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 221
>pdb|2BDY|A Chain A, Thrombin In Complex With Inhibitor
Length = 289
Score = 95.9 bits (237), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 31 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 88
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 89 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 146
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 147 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 202
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 203 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 256
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 111 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 168
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 169 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 221
>pdb|1HAG|E Chain E, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1DOJ|A Chain A, Crystal Structure Of Human Alpha-ThrombinRwj-51438 Complex
At 1.7 A
pdb|1XM1|A Chain A, Nonbasic Thrombin Inhibitor Complex
Length = 295
Score = 95.9 bits (237), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 37 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 94
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 95 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 152
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 153 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 208
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 209 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 262
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 117 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 174
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 175 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 227
>pdb|1NM6|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
At 1.8a
pdb|1NT1|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
pdb|1TA2|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 1
pdb|1TA6|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 14b
pdb|1SL3|A Chain A, Crystal Structue Of Thrombin In Complex With A Potent P1
Heterocycle- Aryl Based Inhibitor
pdb|1Z71|A Chain A, Thrombin And P2 Pyridine N-oxide Inhibitor Complex
Structure
pdb|1ZRB|A Chain A, Thrombin In Complex With An Azafluorenyl Inhibitor 23b
pdb|1ZGI|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 21
pdb|1ZGV|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 2
pdb|3C1K|A Chain A, Crystal Structure Of Thrombin In Complex With Inhibitor 15
Length = 287
Score = 95.9 bits (237), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 30 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 87
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 88 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 145
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 146 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 201
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 202 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 255
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 110 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 167
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 168 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 220
>pdb|1NU9|A Chain A, Staphylocoagulase-prethrombin-2 Complex
pdb|1NU9|D Chain D, Staphylocoagulase-prethrombin-2 Complex
Length = 291
Score = 95.9 bits (237), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 33 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 90
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 91 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 148
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 149 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 204
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 205 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 258
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 113 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 170
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 171 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 223
>pdb|1JWT|A Chain A, Crystal Structure Of Thrombin In Complex With A Novel
Bicyclic Lactam Inhibitor
Length = 305
Score = 95.9 bits (237), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 37 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 94
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 95 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 152
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 153 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 208
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 209 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 262
Score = 52.0 bits (123), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 117 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 174
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 175 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 227
>pdb|1D9I|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electophilic Inhibitors Having Cyclohexyl Moieties
At P1
Length = 288
Score = 95.9 bits (237), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 31 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 88
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 89 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 146
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 147 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 202
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 203 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 256
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 111 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 168
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 169 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 221
>pdb|1EOJ|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
pdb|1EOL|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
Length = 289
Score = 95.5 bits (236), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 33 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 90
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 91 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 148
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 149 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 204
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 205 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 258
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 113 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 170
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 171 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 223
>pdb|1THP|B Chain B, Structure Of Human Alpha-Thrombin Y225p Mutant Bound To
D-Phe-Pro-Arg- Chloromethylketone
pdb|3S7H|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|D Chain D, Structure Of Thrombin Mutant Y225p In The E Form
Length = 259
Score = 95.5 bits (236), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 172
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 173 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 226
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 139 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 191
>pdb|1QUR|H Chain H, Human Alpha-Thrombin In Complex With Bivalent,
Benzamidine-Based Synthetic Inhibitor
pdb|1D3D|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzothiophene Inhibitor 4
pdb|1EB1|H Chain H, Complex Structure Of Human Thrombin With N-Methyl-Arginine
Inhibitor
pdb|1GHV|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1YPE|H Chain H, Thrombin Inhibitor Complex
pdb|1YPG|H Chain H, Thrombin Inhibitor Complex
pdb|1YPJ|H Chain H, Thrombin Inhibitor Complex
pdb|1YPK|H Chain H, Thrombin Inhibitor Complex
pdb|1YPL|H Chain H, X-Ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1008
pdb|1YPM|H Chain H, X-ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1014
pdb|2ANM|H Chain H, Ternary Complex Of An Orally Active Thrombin Inhibitor
With Human Thrombin And A C-Terminal Hirudin Derived
Exo-Sit Inhibitor
pdb|2CF9|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|1GHX|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GHY|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2CF8|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|2CN0|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Inhibitor
pdb|3BIU|H Chain H, Human Thrombin-In Complex With Ub-Thr10
pdb|3BIV|H Chain H, Human Thrombin-In Complex With Ub-Thr11
pdb|2V3H|H Chain H, Thrombin With 3-Cycle No F
pdb|2V3O|H Chain H, Thrombin With 3-Cycle With F
pdb|4AX9|H Chain H, Human Thrombin Complexed With Napsagatran, Ro0466240
pdb|4AYV|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AYY|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AZ2|B Chain B, Human Thrombin - Inhibitor Complex
pdb|1GHW|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-centered Short Hydrogen Bonding Network At The
Active Site
Length = 257
Score = 95.5 bits (236), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 172
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 173 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 226
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 139 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 191
>pdb|3JZ1|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E:na+
Form
pdb|3JZ2|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E Form
pdb|3QGN|B Chain B, The Allosteric E-E Equilibrium Is A Key Property Of The
Trypsin Fold
Length = 259
Score = 95.5 bits (236), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGPLKETWTANVGKGQPSVLQVVNL----PIVERPV 172
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 173 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 226
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 139 TGWGPLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 191
>pdb|2THF|B Chain B, Structure Of Human Alpha-thrombin Y225f Mutant Bound To
D-phe-pro-arg- Chloromethylketone
Length = 259
Score = 95.5 bits (236), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 172
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 173 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 226
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 139 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 191
>pdb|1WBG|B Chain B, Active Site Thrombin Inhibitors
Length = 259
Score = 95.5 bits (236), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 78/262 (29%), Positives = 122/262 (46%), Gaps = 34/262 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 172
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVSITVARD 238
+D R+ T + + C GDSGG V K ++ WY GIVS +
Sbjct: 173 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWG---E 229
Query: 239 GLRVCDTKHYVVFTDVKRVHIY 260
G R D Y +T V R+ +
Sbjct: 230 GCR--DDGKYGFYTHVFRLKKW 249
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 139 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 191
>pdb|1H8D|H Chain H, X-Ray Structure Of The Human Alpha-Thrombin Complex With A
Tripeptide Phosphonate Inhibitor
Length = 260
Score = 95.5 bits (236), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 70/227 (30%), Positives = 110/227 (48%), Gaps = 22/227 (9%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSAVEGTSVCN----GDSGGGMVFKIDSAWYLRGIVSITVARDGLRV 193
PVCL D TA L A V ++G V ++ + IV V +D R+
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKETGQPSVLQVVNL----PIVERPVCKDSTRI 172
Query: 194 CDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
T + + C GDSGG V K ++ WY GIVS
Sbjct: 173 RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 219
Score = 58.5 bits (140), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 38/110 (34%), Positives = 56/110 (50%), Gaps = 7/110 (6%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWGYDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + L++ +PIV C S +D FCAG++
Sbjct: 139 TGWGNLKETGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 184
>pdb|3GIC|B Chain B, Structure Of Thrombin Mutant Delta(146-149e) In The Free
Form
Length = 250
Score = 95.5 bits (236), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 71/228 (31%), Positives = 107/228 (46%), Gaps = 26/228 (11%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-----VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLR 192
PVCL D TA L A V G G V + IV V +D R
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKGQPSVLQVVNLP-------IVERPVCKDSTR 169
Query: 193 VCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 170 IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 217
Score = 55.1 bits (131), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 38/110 (34%), Positives = 56/110 (50%), Gaps = 9/110 (8%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWGYDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + L++ +PIV C S +D FCAG++
Sbjct: 139 TGWGNLKGQ--PSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 182
>pdb|1H8I|H Chain H, X-Ray Crystal Structure Of Human Alpha-Thrombin With A
Tripeptide Phosphonate Inhibitor
Length = 253
Score = 95.1 bits (235), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 71/228 (31%), Positives = 109/228 (47%), Gaps = 23/228 (10%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-----VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLR 192
PVCL D TA L A V G G V ++ + IV V +D R
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWGQPSVLQVVNL----PIVERPVCKDSTR 172
Query: 193 VCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 173 IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 220
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 39/111 (35%), Positives = 56/111 (50%), Gaps = 8/111 (7%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWG-YDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG E L++ +PIV C S +D FCAG++
Sbjct: 139 TGWGNLKETWGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 185
>pdb|1GJ5|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190ALA190 PROTEASE, Structure-Based Drug Design
pdb|1SB1|H Chain H, Novel Non-Covalent Thrombin Inhibitors Incorporating P1
4,5,6,7- Tetrahydrobenzothiazole Arginine Side Chain
Mimetics
pdb|2PW8|H Chain H, Crystal Structure Of Sulfo-Hirudin Complexed To Thrombin
pdb|3DD2|H Chain H, Crystal Structure Of An Rna Aptamer Bound To Human
Thrombin
pdb|1GJ4|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190/ala190 Protease, Structure-based Drug Design
Length = 258
Score = 95.1 bits (235), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 172
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 173 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 226
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 139 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 191
>pdb|1B7X|B Chain B, Structure Of Human Alpha-Thrombin Y225i Mutant Bound To D-
Phe-Pro-Arg-Chloromethylketone
Length = 259
Score = 95.1 bits (235), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 172
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 173 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 226
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 139 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 191
>pdb|1TWX|B Chain B, Crystal Structure Of The Thrombin Mutant D221aD222K
Length = 259
Score = 95.1 bits (235), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 172
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 173 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 226
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 139 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 191
>pdb|1ABI|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1ABJ|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1DWB|H Chain H, Crystallographic Analysis At 3.0-angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-directed Inhibitors
pdb|1DWC|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWD|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWE|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1FPH|H Chain H, The Interaction Of Thrombin With Fibrinogen: A Structural
Basis For Its Specificity
pdb|1HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of Alpha-
Thrombin
pdb|1IHS|H Chain H, Crystal Structure Of The Complex Of Human Alpha-thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1IHT|H Chain H, Crystal Structure Of The Complex Of Human Alpha-Thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1PPB|H Chain H, The Refined 1.9 Angstroms Crystal Structure Of Human
Alpha-Thrombin: Interaction With D-Phe-Pro-Arg
Chloromethylketone And Significance Of The
Tyr-Pro-Pro-Trp Insertion Segment
pdb|1THR|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1THS|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1TMB|H Chain H, Molecular Basis For The Inhibition Of Human Alpha-thrombin
By The Macrocyclic Peptide Cyclotheonamide A
pdb|2HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of
Alpha-Thrombin
pdb|2HPP|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-Thrombin
pdb|2HPQ|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-thrombin
pdb|3HTC|H Chain H, The Structure Of A Complex Of Recombinant Hirudin And
Human Alpha-Thrombin
pdb|4HTC|H Chain H, The Refined Structure Of The Hirudin-Thrombin Complex
pdb|1HUT|H Chain H, The Structure Of Alpha-Thrombin Inhibited By A 15-Mer
Single-Stranded Dna Aptamer
pdb|1NRN|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRO|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRP|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRQ|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRR|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRS|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1TMT|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1TMU|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1HLT|H Chain H, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HLT|K Chain K, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HAH|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1HAI|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|3HAT|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1FPC|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1HBT|H Chain H, Human Alpha-Thrombin Complexed With A Peptidyl Pyridinium
Methyl Ketone Containing Bivalent Inhibitor
pdb|1HDT|H Chain H, Structure Of A Retro-Binding Peptide Inhibitor Complexed
With Human Alpha-Thrombin
pdb|1HAO|H Chain H, Complex Of Human Alpha-thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (based On Nmr Model Of
Dna)
pdb|1HAP|H Chain H, Complex Of Human Alpha-Thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (Based On X-Ray Model Of
Dna)
pdb|1AHT|H Chain H, Crystal Structure Of Human Alpha-Thrombin Complexed With
Hirugen And P-Amidinophenylpyruvate At 1.6 Angstroms
Resolution
pdb|1DIT|H Chain H, Complex Of A Divalent Inhibitor With Thrombin
pdb|1TOM|H Chain H, Alpha-Thrombin Complexed With Hirugen
pdb|1HXF|H Chain H, Human Thrombin Complex With Hirudin Variant
pdb|1BMM|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-4-[(Aminoiminomethyl)
Amino]-N-[[1-[3-Hydroxy-2-[(2-
Naphthalenylsulfonyl)amino]-1-
Oxopropyl]-2-Pyrrolidinyl] Methyl]butanamide
(Bms-186282)
pdb|1BMN|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-1-(Aminoiminomethyl)-
N-[[1-[n-[(2-Naphthalenylsulfonyl)-L-Seryl]-
Pyrrolidinyl]methyl]-3- Piperidenecarboxamide
(Bms-189090)
pdb|1UMA|H Chain H, Alpha-Thrombin (Hirugen) Complexed With
Na-(N,N-Dimethylcarbamoyl)- Alpha-Azalysine
pdb|1LHD|H Chain H, Human Alpha-thrombin Complexed With
Ac-(d)phe-pro-borolys-oh
pdb|1LHE|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-N-
Butyl-Amidino-Glycine-Oh
pdb|1LHF|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-
Homolys-Oh
pdb|1LHG|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-
Boroornithine-Oh
pdb|1LHC|H Chain H, Human Alpha-Thrombin Complexed With
Ac-(D)phe-Pro-Boroarg-Oh
pdb|1AD8|H Chain H, Complex Of Thrombin With And Inhibitor Containing A Novel
P1 Moiety
pdb|1AI8|H Chain H, Human Alpha-Thrombin Ternary Complex With The Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Borompg
pdb|1AIX|H Chain H, Human Alpha-Thrombin Ternary Complex With Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Boroval
pdb|1AE8|H Chain H, Human Alpha-Thrombin Inhibition By
Eoc-D-Phe-Pro-Azalys-Onp
pdb|1AFE|H Chain H, Human Alpha-Thrombin Inhibition By Cbz-Pro-Azalys-Onp
pdb|1UVS|H Chain H, Bovine Thrombin--Bm51.1011 Complex
pdb|5GDS|H Chain H, Hirunorms Are True Hirudin Mimetics. The Crystal Structure
Of Human Alpha-Thrombin:hirunorm V Complex
pdb|1AY6|H Chain H, Thrombin Inhibitor From Theonalla, Cyclotheanamide-Based
Macrocyclic Tripeptide Motif
pdb|1A46|H Chain H, Thrombin Complexed With Hirugen And A Beta-Strand Mimetic
Inhibitor
pdb|1A4W|H Chain H, Crystal Structures Of Thrombin With Thiazole-Containing
Inhibitors: Probes Of The S1' Binding Site
pdb|1A5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1B5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1TBZ|H Chain H, Human Thrombin With Active Site N-Methyl-D
Phenylalanyl-N-[5-
(Aminoiminomethyl)amino]-1-{{benzothiazolyl)carbonyl]
Butyl]-L- Prolinamide Trifluroacetate And
Exosite-Hirugen
pdb|1A2C|H Chain H, Structure Of Thrombin Inhibited By Aeruginosin298-A From A
Blue-Green Alga
pdb|1A61|H Chain H, Thrombin Complexed With A Beta-Mimetic Thiazole-Containing
Inhibitor
pdb|1A3B|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog1
pdb|1A3E|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog2
pdb|1AWF|H Chain H, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|B Chain B, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|D Chain D, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1BCU|H Chain H, Alpha-Thrombin Complexed With Hirugen And Proflavin
pdb|8KME|2 Chain 2, Crystal Structure Of Human Alpha-thrombin Inhibited With
Sel2770.
pdb|1BA8|B Chain B, Thrombin Inhibitor With A Rigid Tripeptidyl Aldehydes
pdb|1BB0|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1CA8|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|4THN|H Chain H, The Crystal Structure Of Alpha-Thrombin-Hirunorm Iv
Complex Reveals A Novel Specificity Site Recognition
Mode.
pdb|1QBV|H Chain H, Crystal Structure Of Thrombin Complexed With An
Guanidine-Mimetic Inhibitor
pdb|1D4P|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
5- Amidinoindole-4-benzylpiperidine Inhibitor
pdb|7KME|H Chain H, Crystal Structure Of Human Alpha-Thrombin Inhibited With
Sel2711.
pdb|1QHR|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ1|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ6|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ7|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1D3P|B Chain B, Crystal Structure Of Human Aplha-Thrombin In Complex With
Benzo[b]thiophene Inhibitor 3
pdb|1D3Q|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 2
pdb|1D3T|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 1
pdb|1C4U|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4V|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4Y|2 Chain 2, Selective Non-Electrophilic Thrombin Inhibitors
pdb|1DE7|H Chain H, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1DE7|K Chain K, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1G30|B Chain B, Thrombin Inhibitor Complex
pdb|1G32|B Chain B, Thrombin Inhibitor Complex
pdb|1KTS|B Chain B, Thrombin Inhibitor Complex
pdb|1KTT|B Chain B, Thrombin Inhibitor Complex
pdb|1K21|H Chain H, Human Thrombin-Inhibitor Complex
pdb|1K22|H Chain H, Human Thrombin-inhibitor Complex
pdb|1NY2|2 Chain 2, Human Alpha Thrombin Inhibited By Rppgf And Hirugen
pdb|1O2G|H Chain H, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1OYT|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Fluorinated Inhibitor
pdb|1NO9|H Chain H, Design Of Weakly Basic Thrombin Inhibitors Incorporating
Novel P1 Binding Functions: Molecular And X-Ray
Crystallographic Studies.
pdb|1OOK|B Chain B, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Human Alpha-thrombin
pdb|1P8V|C Chain C, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Alpha-thrombin At 2.6a
pdb|1NU7|B Chain B, Staphylocoagulase-Thrombin Complex
pdb|1NU7|F Chain F, Staphylocoagulase-Thrombin Complex
pdb|1NZQ|H Chain H, D-Phe-Pro-Arg-Type Thrombin Inhibitor
pdb|1O0D|H Chain H, Human Thrombin Complexed With A D-Phe-Pro-Arg-Type
Inhibitor And A C- Terminal Hirudin Derived Exo-Site
Inhibitor
pdb|1MU6|B Chain B, Crystal Structure Of Thrombin In Complex With L-378,622
pdb|1MU8|B Chain B, Thrombin-Hirugen_l-378,650
pdb|1MUE|B Chain B, Thrombin-Hirugen-L405,426
pdb|1SR5|C Chain C, Antithrombin-Anhydrothrombin-Heparin Ternary Complex
Structure
pdb|1O5G|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1XMN|B Chain B, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|D Chain D, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|F Chain F, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|H Chain H, Crystal Structure Of Thrombin Bound To Heparin
pdb|1WAY|B Chain B, Active Site Thrombin Inhibitors
pdb|1T4U|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|1T4V|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|2AFQ|B Chain B, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2AFQ|D Chain D, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2A45|B Chain B, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|2A45|E Chain E, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|1W7G|H Chain H, Alpha-Thrombin Complex With Sulfated Hirudin (Residues
54-65) And L- Arginine Template Inhibitor Cs107
pdb|2FES|H Chain H, Orally Active Thrombin Inhibitors
pdb|2C8W|B Chain B, Thrombin Inhibitors
pdb|2C8X|B Chain B, Thrombin Inhibitors
pdb|2C8Y|B Chain B, Thrombin Inhibitors
pdb|2C8Z|B Chain B, Thrombin Inhibitors
pdb|2C90|B Chain B, Thrombin Inhibitors
pdb|2C93|B Chain B, Thrombin Inhibitors
pdb|2FEQ|H Chain H, Orally Active Thrombin Inhibitors
pdb|2BVS|H Chain H, Human Thrombin Complexed With Fragment-Based Small
Molecules Occupying The S1 Pocket
pdb|2BVX|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-P2-Linker
pdb|2BXT|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2BXU|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2A2X|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
Inh12
pdb|2ANK|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
And An Exosite Decapeptide
pdb|2GDE|H Chain H, Thrombin In Complex With Inhibitor
pdb|2H9T|H Chain H, Crystal Structure Of Human Alpha-Thrombin In Complex With
Suramin
pdb|2JH0|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH5|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH6|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|1C1U|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1V|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1W|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5L|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5N|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5O|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1HXE|H Chain H, Serine Protease
pdb|2UUF|B Chain B, Thrombin-Hirugen Binary Complex At 1.26a Resolution
pdb|2UUJ|B Chain B, Thrombin-Hirugen-Gw473178 Ternary Complex At 1.32a
Resolution
pdb|2UUK|B Chain B, Thrombin-Hirugen-Gw420128 Ternary Complex At 1.39a
Resolution
pdb|3BF6|H Chain H, Thrombin:suramin Complex
pdb|2R2M|B Chain B, 2-(2-chloro-6-fluorophenyl)acetamides As Potent Thrombin
Inhibitors
pdb|3EGK|H Chain H, Knoble Inhibitor
pdb|2ZC9|H Chain H, Thrombin In Complex With Inhibitor
pdb|2ZDA|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZDV|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZF0|H Chain H, Exploring Thrombin S1 Pocket
pdb|3E6P|H Chain H, Crystal Structure Of Human Meizothrombin Desf1
pdb|2ZFF|H Chain H, Exploring Thrombin S1-Pocket
pdb|2ZFP|H Chain H, Thrombin Inibition
pdb|2ZGB|H Chain H, Thrombin Inhibition
pdb|2ZGX|H Chain H, Thrombin Inhibition
pdb|2ZFQ|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZFR|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHQ|H Chain H, Thrombin Inhibition
pdb|2ZI2|H Chain H, Thrombin Inhibition
pdb|2ZIQ|H Chain H, Thrombin Inhibition
pdb|2ZG0|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHE|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHF|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHW|H Chain H, Exploring Thrombin S3 Pocket
pdb|3C27|B Chain B, Cyanofluorophenylacetamides As Orally Efficacious Thrombin
Inhibitors
pdb|2ZNK|H Chain H, Thrombin Inhibition
pdb|2ZO3|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3D49|H Chain H, Thrombin Inhibition
pdb|3DA9|B Chain B, Crystal Structure Of Thrombin In Complex With Inhibitor
pdb|3DHK|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3DT0|H Chain H, Understanding Thrombin Inhibition
pdb|3DUX|H Chain H, Understanding Thrombin Inhibition
pdb|3EQ0|H Chain H, Thrombin Inhibitor
pdb|3F68|H Chain H, Thrombin Inhibition
pdb|3PMH|B Chain B, Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib
Interaction With Two Distinct Alpha-Thrombin Sites
pdb|3P6Z|B Chain B, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P6Z|H Chain H, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3LDX|H Chain H, Discovery And Clinical Evaluation Of Rwj-671818, A
Thrombin Inhibitor With An Oxyguanidine P1 Motif
pdb|3P70|B Chain B, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|D Chain D, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|F Chain F, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|H Chain H, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3TU7|H Chain H, Human Alpha-Thrombin Complexed With
N-(Methylsulfonyl)-D-Phenylalanyl-
N-((1-Carbamimidoyl-4-Piperidinyl)methyl)-L-Prolinamide
(Bms-189664)
pdb|3QLP|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And A Modified Thrombin Binding Aptamer (Mtba)
pdb|3P17|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3B23|B Chain B, Crystal Structure Of Thrombin-Variegin Complex: Insights
Of A Novel Mechanism Of Inhibition And Design Of Tunable
Thrombin Inhibitors
pdb|3QTO|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QTV|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QX5|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QWC|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3U69|H Chain H, Unliganded Wild-Type Human Thrombin
pdb|3U8T|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Cys
pdb|3RLW|H Chain H, Human Thrombin In Complex With Mi328
pdb|3RLY|H Chain H, Human Thrombin In Complex With Mi329
pdb|3RM0|H Chain H, Human Thrombin In Complex With Mi354
pdb|3RM2|H Chain H, Human Thrombin In Complex With Mi003
pdb|3RML|H Chain H, Human Thrombin In Complex With Mi331
pdb|3RMM|H Chain H, Human Thrombin In Complex With Mi332
pdb|3RMN|H Chain H, Human Thrombin In Complex With Mi341
pdb|3RMO|H Chain H, Human Thrombin In Complex With Mi004
pdb|3U8O|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-D-Thr
pdb|3U8R|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Ile
pdb|3SHA|H Chain H, Human Thrombin In Complex With Ubthr97
pdb|3SHC|H Chain H, Human Thrombin In Complex With Ubthr101
pdb|3SI3|H Chain H, Human Thrombin In Complex With Ubthr103
pdb|3SI4|H Chain H, Human Thrombin In Complex With Ubthr104
pdb|3SV2|H Chain H, Human Thrombin In Complex With Ubthr105
pdb|4E7R|H Chain H, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4E7R|G Chain G, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4DIH|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Sodium Ions
pdb|4DII|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Potassium Ions
pdb|3T5F|H Chain H, Human Thrombin In Complex With Mi340
pdb|3UTU|H Chain H, High Affinity Inhibitor Of Human Thrombin
pdb|3U98|H Chain H, Human Thrombin In Complex With Mi001
pdb|3U9A|H Chain H, Human Thrombin In Complex With Mi330
pdb|4E05|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|4E06|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|3UWJ|H Chain H, Human Thrombin In Complex With Mi353
pdb|4BAH|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAK|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAM|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAN|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAO|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAQ|B Chain B, Thrombin In Complex With Inhibitor
Length = 259
Score = 95.1 bits (235), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 172
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 173 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 226
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 139 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 191
>pdb|1RD3|B Chain B, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
pdb|1RD3|D Chain D, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
Length = 259
Score = 95.1 bits (235), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 172
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 173 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 226
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 139 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 191
>pdb|1BTH|H Chain H, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
pdb|1BTH|K Chain K, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 259
Score = 95.1 bits (235), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTTNVGKGQPSVLQVVNL----PIVERPV 172
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 173 CKDSTRIRITDNMFCAGYKPDEGKRGDACQGDSGGPFVMKSPFNNRWYQMGIVS 226
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 139 TGWGNLKETWTTNVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 191
>pdb|3EDX|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|D Chain D, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|F Chain F, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3HK3|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(ONE Molecule In The Asymmetric Unit)
pdb|3HK6|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HK6|D Chain D, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HKI|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
pdb|3HKI|E Chain E, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
Length = 258
Score = 95.1 bits (235), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 77/258 (29%), Positives = 119/258 (46%), Gaps = 32/258 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G +G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCILYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E V+ +++++++P +N N DIALL+L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D T L A + T N + V ++ + + V
Sbjct: 117 PVCLPDKQTVTSLLRAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKAS 176
Query: 187 ARDGLRVCDTKHYVVF----TDVANVCNGDSGGGMVFK--IDSAWYLRGIVSITVARDGL 240
R +R+ D F T + C GDSGG V K ++ WY GIVS
Sbjct: 177 TR--IRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAG---- 230
Query: 241 RVCDTK-HYVVFTDVKRV 257
CD K Y +T V R+
Sbjct: 231 --CDRKGKYGFYTHVFRL 246
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 39/117 (33%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++++P +N N DIALL+L V +S Y+ PVCL D T L A G G V
Sbjct: 81 LEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPVCLPDKQTVTSLLRA--GYKGRV 138
Query: 313 IGWG-------YDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + N+ L++ +PIV C S +D FCAGF+
Sbjct: 139 TGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKAST----RIRITDNMFCAGFK 191
>pdb|3NXP|A Chain A, Crystal Structure Of Human Prethrombin-1
Length = 424
Score = 95.1 bits (235), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 166 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 223
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 224 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 281
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 282 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 337
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 338 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 391
Score = 52.0 bits (123), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 246 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 303
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 304 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 356
>pdb|2BVR|H Chain H, Human Thrombin Complexed With Fragment-based Small
Molecules Occupying The S1 Pocket
Length = 252
Score = 95.1 bits (235), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 70/227 (30%), Positives = 109/227 (48%), Gaps = 22/227 (9%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSAVEGTSVCN----GDSGGGMVFKIDSAWYLRGIVSITVARDGLRV 193
PVCL D TA L A V + G V ++ + IV V +D R+
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKEKGQPSVLQVVNL----PIVERPVCKDSTRI 172
Query: 194 CDTKHYVVFT------DVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
T + + C GDSGG V K ++ WY GIVS
Sbjct: 173 RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 219
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 38/110 (34%), Positives = 56/110 (50%), Gaps = 7/110 (6%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWGYDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + L++ +PIV C S +D FCAG++
Sbjct: 139 TGWGNLKEKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 184
>pdb|3K65|B Chain B, Crystal Structure Of Prethombin-2FRAGMENT-2 Complex
Length = 308
Score = 94.7 bits (234), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 70/234 (29%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 50 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 107
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 108 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 165
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 166 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 221
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GD+GG V K ++ WY GIVS
Sbjct: 222 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVS 275
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 130 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 187
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 188 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 240
>pdb|3SQE|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The
Alternative Form
pdb|3SQH|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The The
Open Form
Length = 290
Score = 94.7 bits (234), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 70/234 (29%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 32 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 89
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 90 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 147
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 148 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 203
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GD+GG V K ++ WY GIVS
Sbjct: 204 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVS 257
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 112 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 169
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 170 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 222
>pdb|1VZQ|H Chain H, Complex Of Thrombin With Designed Inhibitor 7165
Length = 250
Score = 94.7 bits (234), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 70/227 (30%), Positives = 109/227 (48%), Gaps = 22/227 (9%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + + E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTAY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSAVEGTSVCN----GDSGGGMVFKIDSAWYLRGIVSITVARDGLRV 193
PVCL D TA L A V ++G V ++ + IV V +D R+
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKETGQPSVLQVVNL----PIVERPVCKDSTRI 172
Query: 194 CDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
T + + C GDSGG V K ++ WY GIVS
Sbjct: 173 RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 219
Score = 58.2 bits (139), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 38/110 (34%), Positives = 56/110 (50%), Gaps = 7/110 (6%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWGYDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + L++ +PIV C S +D FCAG++
Sbjct: 139 TGWGNLKETGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 184
>pdb|1DM4|B Chain B, Ser195ala Mutant Of Human Thrombin Complexed With
Fibrinopeptide A (7- 16)
pdb|1JMO|H Chain H, Crystal Structure Of The Heparin Cofactor Ii-S195a
Thrombin Complex
Length = 260
Score = 94.4 bits (233), Expect = 8e-20, Method: Compositional matrix adjust.
Identities = 70/234 (29%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 2 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 59
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 60 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 117
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 118 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 173
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GD+GG V K ++ WY GIVS
Sbjct: 174 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVS 227
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 82 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 139
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 140 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 192
>pdb|1DX5|M Chain M, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|N Chain N, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|O Chain O, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|P Chain P, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1E0F|D Chain D, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|F Chain F, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|E Chain E, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
Length = 259
Score = 94.4 bits (233), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFIEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 172
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 173 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 226
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 139 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 191
>pdb|2OCV|B Chain B, Structural Basis Of Na+ Activation Mimicry In Murine
Thrombin
Length = 259
Score = 94.4 bits (233), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 77/261 (29%), Positives = 120/261 (45%), Gaps = 32/261 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G +G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCILYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E V+ +++++++P +N N DIALL+L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D T L A + T N + V ++ + + V
Sbjct: 117 PVCLPDKQTVTSLLRAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKAS 176
Query: 187 ARDGLRVCDTKHYVVF----TDVANVCNGDSGGGMVFK--IDSAWYLRGIVSITVARDGL 240
R +R+ D F T + C GDSGG V K ++ WY GIVS
Sbjct: 177 TR--IRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG---- 230
Query: 241 RVCDTK-HYVVFTDVKRVHIY 260
CD K Y +T V R+ +
Sbjct: 231 --CDRKGKYGFYTHVFRLKAW 249
Score = 55.8 bits (133), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 39/117 (33%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++++P +N N DIALL+L V +S Y+ PVCL D T L A G G V
Sbjct: 81 LEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPVCLPDKQTVTSLLRA--GYKGRV 138
Query: 313 IGWG-------YDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + N+ L++ +PIV C S +D FCAGF+
Sbjct: 139 TGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKAST----RIRITDNMFCAGFK 191
>pdb|1JOU|B Chain B, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|D Chain D, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|F Chain F, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1TB6|H Chain H, 2.5a Crystal Structure Of The
Antithrombin-Thrombin-Heparin Ternary Complex
pdb|2B5T|B Chain B, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|2B5T|D Chain D, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|3B9F|H Chain H, 1.6 A Structure Of The Pci-Thrombin-Heparin Complex
pdb|3GIS|B Chain B, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|D Chain D, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|F Chain F, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3LU9|B Chain B, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|3LU9|E Chain E, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|4DT7|B Chain B, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DT7|D Chain D, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DY7|B Chain B, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
pdb|4DY7|E Chain E, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
Length = 259
Score = 94.4 bits (233), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 70/234 (29%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 172
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GD+GG V K ++ WY GIVS
Sbjct: 173 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVS 226
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 139 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 191
>pdb|2GP9|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A Self-
Inhibited Conformation
pdb|3BEI|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A
Self_inhibited Conformation
pdb|3BEF|B Chain B, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3BEF|E Chain E, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3QDZ|B Chain B, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4.
pdb|3QDZ|D Chain D, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4
Length = 259
Score = 93.6 bits (231), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 70/234 (29%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N +IAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRNIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 172
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 173 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 226
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 37/117 (31%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N +IAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRNIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 139 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 191
>pdb|1Z8I|B Chain B, Crystal Structure Of The Thrombin Mutant G193a Bound To
Ppack
Length = 259
Score = 93.6 bits (231), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 70/234 (29%), Positives = 110/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 172
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C DSGG V K ++ WY GIVS
Sbjct: 173 CKDSTRIRITDNMFCAGYKPDEGKRGDACEADSGGPFVMKSPFNNRWYQMGIVS 226
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 139 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 191
>pdb|2PUX|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par3
pdb|2PV9|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par4
Length = 258
Score = 92.8 bits (229), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 69/232 (29%), Positives = 110/232 (47%), Gaps = 25/232 (10%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G +G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCILYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E V+ +++++++P +N N DIALL+L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D T L A + T N + V ++ + + V
Sbjct: 117 PVCLPDKQTVTSLLRAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKAS 176
Query: 187 ARDGLRVCDTKHYVVF----TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
R +R+ D F T + C GD+GG V K ++ WY GIVS
Sbjct: 177 TR--IRITDNMFCAGFKVNDTKRGDACEGDAGGPFVMKSPFNNRWYQMGIVS 226
Score = 55.8 bits (133), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 39/117 (33%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++++P +N N DIALL+L V +S Y+ PVCL D T L A G G V
Sbjct: 81 LEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPVCLPDKQTVTSLLRA--GYKGRV 138
Query: 313 IGWG-------YDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + N+ L++ +PIV C S +D FCAGF+
Sbjct: 139 TGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKAST----RIRITDNMFCAGFK 191
>pdb|1Z8J|B Chain B, Crystal Structure Of The Thrombin Mutant G193p Bound To
Ppack
Length = 259
Score = 92.8 bits (229), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 70/234 (29%), Positives = 110/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 172
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C DSGG V K ++ WY GIVS
Sbjct: 173 CKDSTRIRITDNMFCAGYKPDEGKRGDACEPDSGGPFVMKSPFNNRWYQMGIVS 226
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 139 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 191
>pdb|3R3G|B Chain B, Structure Of Human Thrombin With Residues 145-150 Of
Murine Thrombin
Length = 259
Score = 92.8 bits (229), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 70/234 (29%), Positives = 110/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A + T N + V ++ + IV V
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNL----PIVERPV 172
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + C GDSGG V K ++ WY GIVS
Sbjct: 173 CKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 226
Score = 54.7 bits (130), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWG-------YDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + N+ L++ +PIV C S +D FCAG++
Sbjct: 139 TGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 191
>pdb|1VR1|H Chain H, Specifity For Plasminogen Activator Inhibitor-1
Length = 261
Score = 92.4 bits (228), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 71/238 (29%), Positives = 114/238 (47%), Gaps = 33/238 (13%)
Query: 20 VTYGQKTARGQWPWHVALY----RTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPV 75
+ G G PW V L+ R+ G ++CG SL+S +V+TAAHC+ P+DK
Sbjct: 1 IVEGSDAEIGMSPWQVMLFAKHRRSPG--ERFLCGASLISDRWVLTAAHCLLYPPWDKNF 58
Query: 76 DSDTLVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYS 133
+ L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S
Sbjct: 59 TENDLLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 116
Query: 134 MYVRPVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIV 182
Y+ PVCL D TA L A ++ T N G V ++ + IV
Sbjct: 117 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIV 172
Query: 183 SITVARDG--LRVCDTKHYVVFT----DVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
V +D +R+ D + + C GDSGG V K ++ WY GIVS
Sbjct: 173 ERPVCKDSTRIRITDNMFCAYYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 230
Score = 48.9 bits (115), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 37/117 (31%), Positives = 56/117 (47%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 85 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 142
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCA ++
Sbjct: 143 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAYYK 195
>pdb|2PGB|B Chain B, Inhibitor-Free Human Thrombin Mutant C191a-C220a
pdb|2PGQ|B Chain B, Human Thrombin Mutant C191a-C220a In Complex With The
Inhibitor Ppack
Length = 259
Score = 92.0 bits (227), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 70/234 (29%), Positives = 110/234 (47%), Gaps = 29/234 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-----------VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
PVCL D TA L A ++ T N G V ++ + IV V
Sbjct: 117 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNL----PIVERPV 172
Query: 187 ARDGLRVCDTKHYVVF------TDVANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+D R+ T + + GDSGG V K ++ WY GIVS
Sbjct: 173 CKDSTRIRITDNMFCAGYKPDEGKRGDAAEGDSGGPFVMKSPFNNRWYQMGIVS 226
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 14/117 (11%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWGYDENDRVSE-------ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG + + L++ +PIV C S +D FCAG++
Sbjct: 139 TGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST----RIRITDNMFCAGYK 191
>pdb|1MKW|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
Length = 308
Score = 91.7 bits (226), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 71/232 (30%), Positives = 109/232 (46%), Gaps = 25/232 (10%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ GQ G PW V L+R L +CG SL+S +V+TAAHC+ P+DK D
Sbjct: 50 IVEGQDAEVGLSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTVDD 107
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E V+ + +++I+P +N N DIALL+L ++ S Y+
Sbjct: 108 LLVRIGKHSRTRY--ERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIH 165
Query: 138 PVCLWDDSTAPLQLSA-VEGTSVCNGDSGGGMVFKIDSAW-YLRGIVSITVARDGLRVCD 195
PVCL D TA L A +G G+ + + +V++ + VC
Sbjct: 166 PVCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERP--VCK 223
Query: 196 TKHYVVFTD-------------VANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+ TD + C GDSGG V K ++ WY GIVS
Sbjct: 224 ASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVS 275
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 14/115 (12%)
Query: 256 RVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIG 314
+++I+P +N N DIALL+L ++ S Y+ PVCL D TA L A G G V G
Sbjct: 132 KIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCLPDKQTAAKLLHA--GFKGRVTG 189
Query: 315 WGYDEN---DRVSE----ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
WG V+E L++ +P+V C S +D FCAG++
Sbjct: 190 WGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKAST----RIRITDNMFCAGYK 240
>pdb|1BBR|K Chain K, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1BBR|N Chain N, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1ETR|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETS|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETT|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1HRT|H Chain H, The Structure Of A Complex Of Bovine Alpha-Thrombin And
Recombinant Hirudin At 2.8 Angstroms Resolution
pdb|1TBR|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBR|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1UCY|K Chain K, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1UCY|N Chain N, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|H Chain H, Thrombin:hirudin 51-65 Complex
pdb|1MKW|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1TOC|B Chain B, Structure Of Serine Proteinase
pdb|1TOC|D Chain D, Structure Of Serine Proteinase
pdb|1TOC|F Chain F, Structure Of Serine Proteinase
pdb|1TOC|H Chain H, Structure Of Serine Proteinase
pdb|1UVT|H Chain H, Bovine Thrombin--Bm14.1248 Complex
pdb|1UVU|H Chain H, Bovine Thrombin--Bm12.1700 Complex
pdb|1YCP|H Chain H, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
pdb|1A0H|B Chain B, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1A0H|E Chain E, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1AVG|H Chain H, Thrombin Inhibitor From Triatoma Pallidipennis
pdb|2A1D|B Chain B, Staphylocoagulase Bound To Bovine Thrombin
pdb|2A1D|F Chain F, Staphylocoagulase Bound To Bovine Thrombin
pdb|2ODY|B Chain B, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|2ODY|D Chain D, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|3PMA|B Chain B, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMA|D Chain D, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMB|B Chain B, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
pdb|3PMB|D Chain D, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
Length = 259
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 71/232 (30%), Positives = 109/232 (46%), Gaps = 25/232 (10%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ GQ G PW V L+R L +CG SL+S +V+TAAHC+ P+DK D
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTVDD 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E V+ + +++I+P +N N DIALL+L ++ S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-VEGTSVCNGDSGGGMVFKIDSAW-YLRGIVSITVARDGLRVCD 195
PVCL D TA L A +G G+ + + +V++ + VC
Sbjct: 117 PVCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERP--VCK 174
Query: 196 TKHYVVFTD-------------VANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+ TD + C GDSGG V K ++ WY GIVS
Sbjct: 175 ASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVS 226
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 14/115 (12%)
Query: 256 RVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIG 314
+++I+P +N N DIALL+L ++ S Y+ PVCL D TA L A G G V G
Sbjct: 83 KIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCLPDKQTAAKLLHA--GFKGRVTG 140
Query: 315 WGYDEN---DRVSE----ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
WG V+E L++ +P+V C S +D FCAG++
Sbjct: 141 WGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKAST----RIRITDNMFCAGYK 191
>pdb|1ID5|H Chain H, Crystal Structure Of Bovine Thrombin Complex With Protease
Inhibitor Ecotin
Length = 256
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 71/232 (30%), Positives = 109/232 (46%), Gaps = 25/232 (10%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ GQ G PW V L+R L +CG SL+S +V+TAAHC+ P+DK D
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTVDD 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E V+ + +++I+P +N N DIALL+L ++ S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA-VEGTSVCNGDSGGGMVFKIDSAW-YLRGIVSITVARDGLRVCD 195
PVCL D TA L A +G G+ + + +V++ + VC
Sbjct: 117 PVCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERP--VCK 174
Query: 196 TKHYVVFTD-------------VANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+ TD + C GDSGG V K ++ WY GIVS
Sbjct: 175 ASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVS 226
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 14/115 (12%)
Query: 256 RVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIG 314
+++I+P +N N DIALL+L ++ S Y+ PVCL D TA L A G G V G
Sbjct: 83 KIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCLPDKQTAAKLLHA--GFKGRVTG 140
Query: 315 WGYDEN---DRVSE----ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
WG V+E L++ +P+V C S +D FCAG++
Sbjct: 141 WGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKAST----RIRITDNMFCAGYK 191
>pdb|3GYL|B Chain B, Structure Of Prostasin At 1.3 Angstroms Resolution In
Complex With A Calcium Ion.
pdb|3GYM|A Chain A, Structure Of Prostasin In Complex With Aprotinin
pdb|3GYM|B Chain B, Structure Of Prostasin In Complex With Aprotinin
Length = 261
Score = 88.6 bits (218), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 36/231 (15%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+T G GQWPW V++ EG+ +VCGGSLVS +V++AAHC + + + +
Sbjct: 1 ITGGSSAVAGQWPWQVSI-TYEGV---HVCGGSLVSEQWVLSAAHCFPSEHHKEAYE--- 53
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
+ LG + +S++ V +K + +P++ GDIALLQLS + +S Y+RP+
Sbjct: 54 --VKLGAHQLDSYSEDAKVST--LKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPI 109
Query: 140 CLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDT--- 196
L P ++ C +G G V S + + + V C++
Sbjct: 110 SL------PAAQASFPNGLHCT-VTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNSLYN 162
Query: 197 -------KHYVVFTDV--------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
H+V V + C GDSGG + ++ WYL GIVS
Sbjct: 163 IDAKPEEPHFVQEDMVCAGYVEGGKDACQGDSGGPLSCPVEGLWYLTGIVS 213
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 33/118 (27%), Positives = 56/118 (47%), Gaps = 14/118 (11%)
Query: 252 TDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGT 311
+ +K + +P++ GDIALLQLS + +S Y+RP+ L Q S G T
Sbjct: 71 STLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPISL-----PAAQASFPNGLHCT 125
Query: 312 VIGWGYDEND---RVSEELKMAIMPIVSHQQC-----LWSNPQFFSQFTSDETFCAGF 361
V GWG+ + L+ +P++S + C + + P+ F ++ CAG+
Sbjct: 126 VTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNSLYNIDAKPE-EPHFVQEDMVCAGY 182
>pdb|3E0P|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With A
Covalent Benzoxazole Inhibitor
pdb|3E16|B Chain B, X-Ray Structure Of Human Prostasin In Complex With
Benzoxazole Warhead Peptidomimic, Lysine In P3
pdb|3E1X|B Chain B, The Crystal Structure Of Apo Prostasin At 1.7 Angstroms
Resolution
pdb|3FVF|B Chain B, The Crystal Structure Of Prostasin Complexed With Camostat
At 1.6 Angstroms Resolution
pdb|3E0N|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With
Dffr- Chloromethyl Ketone Inhibitor
Length = 271
Score = 88.6 bits (218), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 36/231 (15%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+T G GQWPW V++ EG+ +VCGGSLVS +V++AAHC + + + +
Sbjct: 1 ITGGSSAVAGQWPWQVSI-TYEGV---HVCGGSLVSEQWVLSAAHCFPSEHHKEAYE--- 53
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
+ LG + +S++ V +K + +P++ GDIALLQLS + +S Y+RP+
Sbjct: 54 --VKLGAHQLDSYSEDAKVST--LKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPI 109
Query: 140 CLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDT--- 196
L P ++ C +G G V S + + + V C++
Sbjct: 110 SL------PAAQASFPNGLHCT-VTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNSLYN 162
Query: 197 -------KHYVVFTDV--------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
H+V V + C GDSGG + ++ WYL GIVS
Sbjct: 163 IDAKPEEPHFVQEDMVCAGYVEGGKDACQGDSGGPLSCPVEGLWYLTGIVS 213
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 33/118 (27%), Positives = 56/118 (47%), Gaps = 14/118 (11%)
Query: 252 TDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGT 311
+ +K + +P++ GDIALLQLS + +S Y+RP+ L Q S G T
Sbjct: 71 STLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPISL-----PAAQASFPNGLHCT 125
Query: 312 VIGWGYDEND---RVSEELKMAIMPIVSHQQC-----LWSNPQFFSQFTSDETFCAGF 361
V GWG+ + L+ +P++S + C + + P+ F ++ CAG+
Sbjct: 126 VTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNSLYNIDAKPE-EPHFVQEDMVCAGY 182
>pdb|1EAW|A Chain A, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAW|C Chain C, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAX|A Chain A, Crystal Structure Of Mtsp1 (Matriptase)
pdb|2GV6|A Chain A, Crystal Structure Of Matriptase With Inhibitor Cj-730
pdb|2GV7|A Chain A, Structure Of Matriptase In Complex With Inhibitor Cj-672
Length = 241
Score = 88.2 bits (217), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 47/126 (37%), Positives = 70/126 (55%), Gaps = 4/126 (3%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
V G G+WPW V+L+ + ++CG SL+S N++++AAHC + D
Sbjct: 1 VVGGTDADEGEWPWQVSLH---ALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQ 57
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
+LG + Q Q S G VQ +++KR+ +P FN + DIALL+L +YS VRP+
Sbjct: 58 WTAFLGLHDQSQRSAPG-VQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPI 116
Query: 140 CLWDDS 145
CL D S
Sbjct: 117 CLPDAS 122
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 31/109 (28%), Positives = 47/109 (43%), Gaps = 10/109 (9%)
Query: 254 VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVI 313
+KR+ +P FN + DIALL+L +YS VRP+CL D S G+ V
Sbjct: 80 LKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPDASHV-----FPAGKAIWVT 134
Query: 314 GWGYDENDRVSEE-LKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
GWG+ + L+ + +++ C Q + C GF
Sbjct: 135 GWGHTQYGGTGALILQKGEIRVINQTTC----ENLLPQQITPRMMCVGF 179
>pdb|3P8G|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Benzamidine
pdb|3P8F|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Sfti-1
Length = 241
Score = 88.2 bits (217), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 47/126 (37%), Positives = 70/126 (55%), Gaps = 4/126 (3%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
V G G+WPW V+L+ + ++CG SL+S N++++AAHC + D
Sbjct: 1 VVGGTDADEGEWPWQVSLH---ALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQ 57
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
+LG + Q Q S G VQ +++KR+ +P FN + DIALL+L +YS VRP+
Sbjct: 58 WTAFLGLHDQSQRSAPG-VQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPI 116
Query: 140 CLWDDS 145
CL D S
Sbjct: 117 CLPDAS 122
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 31/109 (28%), Positives = 46/109 (42%), Gaps = 10/109 (9%)
Query: 254 VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVI 313
+KR+ +P FN + DIALL+L +YS VRP+CL D S G+ V
Sbjct: 80 LKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPDASHV-----FPAGKAIWVT 134
Query: 314 GWGYDENDRVSEE-LKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
GWG+ + L+ + ++ C Q + C GF
Sbjct: 135 GWGHTQYGGTGALILQKGEIRVIQQTTC----ENLLPQQITPRMMCVGF 179
>pdb|3DFJ|A Chain A, Crystal Structure Of Human Prostasin
pdb|3DFL|A Chain A, Crystal Structure Of Human Prostasin Complexed To 4-
Guanidinobenzoic Acid
Length = 263
Score = 86.7 bits (213), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 36/231 (15%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+T G GQWPW V++ EG+ +VCGGSLVS +V++AAHC + + + +
Sbjct: 1 ITGGSSAVAGQWPWQVSI-TYEGV---HVCGGSLVSEQWVLSAAHCFPSEHHKEAYE--- 53
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
+ LG + +S++ V +K + +P++ GDIALLQLS + +S Y+RP+
Sbjct: 54 --VKLGAHQLDSYSEDAKVST--LKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPI 109
Query: 140 CLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVC----- 194
L P ++ C +G G V S + + + V C
Sbjct: 110 SL------PAANASFPNGLHCT-VTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNALYN 162
Query: 195 -----DTKHYVVFTDV--------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
+ H+V V + C GDSGG + ++ WYL GIVS
Sbjct: 163 IDAKPEEPHFVQEDMVCAGYVEGGKDACQGDSGGPLSCPVEGLWYLTGIVS 213
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 32/118 (27%), Positives = 55/118 (46%), Gaps = 14/118 (11%)
Query: 252 TDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGT 311
+ +K + +P++ GDIALLQLS + +S Y+RP+ L S G T
Sbjct: 71 STLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPISL-----PAANASFPNGLHCT 125
Query: 312 VIGWGYDEND---RVSEELKMAIMPIVSHQQC-----LWSNPQFFSQFTSDETFCAGF 361
V GWG+ + L+ +P++S + C + + P+ F ++ CAG+
Sbjct: 126 VTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNALYNIDAKPE-EPHFVQEDMVCAGY 182
>pdb|1BBR|H Chain H, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|H Chain H, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|F Chain F, Thrombin:hirudin 51-65 Complex
pdb|1YCP|K Chain K, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 150
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 50/136 (36%), Positives = 76/136 (55%), Gaps = 6/136 (4%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ GQ G PW V L+R L +CG SL+S +V+TAAHC+ P+DK D
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTVDD 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E V+ + +++I+P +N N DIALL+L ++ S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA 153
PVCL D TA L A
Sbjct: 117 PVCLPDKQTAAKLLHA 132
Score = 48.1 bits (113), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 27/62 (43%), Positives = 36/62 (58%), Gaps = 3/62 (4%)
Query: 256 RVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIG 314
+++I+P +N N DIALL+L ++ S Y+ PVCL D TA L A G G V G
Sbjct: 83 KIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCLPDKQTAAKLLHA--GFKGRVTG 140
Query: 315 WG 316
WG
Sbjct: 141 WG 142
>pdb|3BN9|B Chain B, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3BN9|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3NCL|A Chain A, Crystal Structure Of Mt-Sp1 Bound To Benzamidine
Phosphonate Inhibitor
pdb|3NPS|A Chain A, Crystal Structure Of Membrane-Type Serine Protease 1
(Mt-Sp1) In Complex With The Fab Inhibitor S4
pdb|3SO3|A Chain A, Structures Of Fab-Protease Complexes Reveal A Highly
Specific Non- Canonical Mechanism Of Inhibition
Length = 241
Score = 84.7 bits (208), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 46/126 (36%), Positives = 69/126 (54%), Gaps = 4/126 (3%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
V G G+WPW V+L+ + ++CG SL+S N++++AAHC + D
Sbjct: 1 VVGGTDADEGEWPWQVSLH---ALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQ 57
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
+LG + Q Q S G VQ +++KR+ +P FN + DIALL+L +YS VRP+
Sbjct: 58 WTAFLGLHDQSQRSAPG-VQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPI 116
Query: 140 CLWDDS 145
L D S
Sbjct: 117 SLPDAS 122
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/109 (27%), Positives = 46/109 (42%), Gaps = 10/109 (9%)
Query: 254 VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVI 313
+KR+ +P FN + DIALL+L +YS VRP+ L D S G+ V
Sbjct: 80 LKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPISLPDASHV-----FPAGKAIWVT 134
Query: 314 GWGYDENDRVSEE-LKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
GWG+ + L+ + +++ C Q + C GF
Sbjct: 135 GWGHTQYGGTGALILQKGEIRVINQTTC----ENLLPQQITPRMMCVGF 179
>pdb|1BHX|B Chain B, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|B Chain B, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
pdb|2PKS|B Chain B, Thrombin In Complex With Inhibitor
pdb|3PO1|B Chain B, Thrombin In Complex With Benzothiazole Guanidine
Length = 147
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 47/136 (34%), Positives = 76/136 (55%), Gaps = 6/136 (4%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQHQFSDEGGVQN-KQVKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVR 137
L++ +GK+ + ++ E ++ +++++I+P +N N DIAL++L V +S Y+
Sbjct: 59 LLVRIGKHSRTRY--ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 116
Query: 138 PVCLWDDSTAPLQLSA 153
PVCL D TA L A
Sbjct: 117 PVCLPDRETAASLLQA 132
Score = 48.9 bits (115), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 27/64 (42%), Positives = 38/64 (59%), Gaps = 3/64 (4%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 138
Query: 313 IGWG 316
GWG
Sbjct: 139 TGWG 142
>pdb|1A0L|A Chain A, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|B Chain B, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|C Chain C, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|D Chain D, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
Length = 244
Score = 80.5 bits (197), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/229 (28%), Positives = 99/229 (43%), Gaps = 38/229 (16%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
GQ+ R +WPW V+L R G + CGGSL+ +V+TAAHCV P D +
Sbjct: 4 GQEAPRSKWPWQVSL-RVHGPYWMHFCGGSLIHPQWVLTAAHCV------GPDVKDLAAL 56
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLW 142
+ QH + + Q V R+ ++P F ++ DIALL+L V S +V V L
Sbjct: 57 RVQLREQHLYYQD---QLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLP 113
Query: 143 DDST--APLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHY- 199
S P V G + D F + V + + + +CD K++
Sbjct: 114 PASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQ-------VKVPIMEN--HICDAKYHL 164
Query: 200 ---------VVFTDV-------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
+V D+ + C GDSGG +V K++ W G+VS
Sbjct: 165 GAYTGDDVRIVRDDMLCAGNTRRDSCQGDSGGPLVCKVNGTWLQAGVVS 213
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 32/109 (29%), Positives = 50/109 (45%), Gaps = 12/109 (11%)
Query: 239 GLRVCDTKHYVVFTD----VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWD 294
LRV + ++ + D V R+ ++P F ++ DIALL+L V S +V V L
Sbjct: 55 ALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTL-- 112
Query: 295 DSTAPLQLSAVEGRDGTVIGWG-YDENDRVSE--ELKMAIMPIVSHQQC 340
P + G V GWG D ++R+ LK +PI+ + C
Sbjct: 113 ---PPASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHIC 158
>pdb|2BM2|A Chain A, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|B Chain B, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|C Chain C, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|D Chain D, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2FWW|A Chain A, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|B Chain B, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|C Chain C, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|D Chain D, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FXR|A Chain A, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|B Chain B, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|C Chain C, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|D Chain D, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FPZ|A Chain A, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|B Chain B, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|C Chain C, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|D Chain D, Human Tryptase With 2-Amino Benzimidazole
pdb|2FS8|A Chain A, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|B Chain B, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|C Chain C, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|D Chain D, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS9|A Chain A, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|B Chain B, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|C Chain C, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|D Chain D, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2GDD|A Chain A, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|B Chain B, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|C Chain C, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|D Chain D, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2ZA5|A Chain A, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|B Chain B, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|C Chain C, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|D Chain D, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|4A6L|A Chain A, Beta-Tryptase Inhibitor
pdb|4A6L|B Chain B, Beta-Tryptase Inhibitor
pdb|4A6L|C Chain C, Beta-Tryptase Inhibitor
pdb|4A6L|D Chain D, Beta-Tryptase Inhibitor
pdb|3V7T|A Chain A, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|B Chain B, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|C Chain C, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|D Chain D, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
Length = 245
Score = 80.5 bits (197), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/229 (28%), Positives = 99/229 (43%), Gaps = 38/229 (16%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
GQ+ R +WPW V+L R G + CGGSL+ +V+TAAHCV P D +
Sbjct: 4 GQEAPRSKWPWQVSL-RVHGPYWMHFCGGSLIHPQWVLTAAHCV------GPDVKDLAAL 56
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLW 142
+ QH + + Q V R+ ++P F ++ DIALL+L V S +V V L
Sbjct: 57 RVQLREQHLYYQD---QLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLP 113
Query: 143 DDST--APLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHY- 199
S P V G + D F + V + + + +CD K++
Sbjct: 114 PASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQ-------VKVPIMEN--HICDAKYHL 164
Query: 200 ---------VVFTDV-------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
+V D+ + C GDSGG +V K++ W G+VS
Sbjct: 165 GAYTGDDVRIVRDDMLCAGNTRRDSCQGDSGGPLVCKVNGTWLQAGVVS 213
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 32/109 (29%), Positives = 50/109 (45%), Gaps = 12/109 (11%)
Query: 239 GLRVCDTKHYVVFTD----VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWD 294
LRV + ++ + D V R+ ++P F ++ DIALL+L V S +V V L
Sbjct: 55 ALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTL-- 112
Query: 295 DSTAPLQLSAVEGRDGTVIGWG-YDENDRVSE--ELKMAIMPIVSHQQC 340
P + G V GWG D ++R+ LK +PI+ + C
Sbjct: 113 ---PPASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHIC 158
>pdb|2ZEB|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
Length = 243
Score = 80.5 bits (197), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/229 (28%), Positives = 99/229 (43%), Gaps = 38/229 (16%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
GQ+ R +WPW V+L R G + CGGSL+ +V+TAAHCV P D +
Sbjct: 4 GQEAPRSKWPWQVSL-RVHGPYWMHFCGGSLIHPQWVLTAAHCV------GPDVKDLAAL 56
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLW 142
+ QH + + Q V R+ ++P F ++ DIALL+L V S +V V L
Sbjct: 57 RVQLREQHLYYQD---QLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLP 113
Query: 143 DDST--APLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHY- 199
S P V G + D F + V + + + +CD K++
Sbjct: 114 PASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQ-------VKVPIMEN--HICDAKYHL 164
Query: 200 ---------VVFTDV-------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
+V D+ + C GDSGG +V K++ W G+VS
Sbjct: 165 GAYTGDDVRIVRDDMLCAGNTRRDSCQGDSGGPLVCKVNGTWLQAGVVS 213
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 32/109 (29%), Positives = 50/109 (45%), Gaps = 12/109 (11%)
Query: 239 GLRVCDTKHYVVFTD----VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWD 294
LRV + ++ + D V R+ ++P F ++ DIALL+L V S +V V L
Sbjct: 55 ALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTL-- 112
Query: 295 DSTAPLQLSAVEGRDGTVIGWG-YDENDRVSE--ELKMAIMPIVSHQQC 340
P + G V GWG D ++R+ LK +PI+ + C
Sbjct: 113 ---PPASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHIC 158
>pdb|1EKB|B Chain B, The Serine Protease Domain Of Enteropeptidase Bound To
Inhibitor Val- Asp-asp-asp-asp-lys-chloromethane
Length = 235
Score = 78.6 bits (192), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 53/219 (24%), Positives = 102/219 (46%), Gaps = 23/219 (10%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G + G WPW VALY + VCG SLVS +++++AAHCV Y + ++
Sbjct: 4 GSDSREGAWPWVVALYFDD----QQVCGASLVSRDWLVSAAHCV----YGRNMEPSKWKA 55
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLW 142
LG + + ++ + + ++ I P +N DIA++ L V+Y+ Y++P+CL
Sbjct: 56 VLGLHMASNLTSPQ-IETRLIDQIVINPHYNKRRKNNDIAMMHLEMKVNYTDYIQPICL- 113
Query: 143 DDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVF 202
P + +C+ G ++++ +A L+ ++ + + ++ +
Sbjct: 114 -----PEENQVFPPGRICSIAGWGALIYQGSTADVLQEADVPLLSNEKCQQQMPEYNITE 168
Query: 203 TDV--------ANVCNGDSGGGMVFKIDSAWYLRGIVSI 233
V + C GDSGG ++ + ++ W L G+ S
Sbjct: 169 NMVCAGYEAGGVDSCQGDSGGPLMCQENNRWLLAGVTSF 207
Score = 48.1 bits (113), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 27/110 (24%), Positives = 57/110 (51%), Gaps = 9/110 (8%)
Query: 254 VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVI 313
+ ++ I P +N DIA++ L V+Y+ Y++P+CL +++ GR ++
Sbjct: 75 IDQIVINPHYNKRRKNNDIAMMHLEMKVNYTDYIQPICLPEENQV-----FPPGRICSIA 129
Query: 314 GWG-YDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG ++ L+ A +P++S+++C P++ ++ CAG+
Sbjct: 130 GWGALIYQGSTADVLQEADVPLLSNEKCQQQMPEY---NITENMVCAGYE 176
>pdb|1AUT|C Chain C, Human Activated Protein C
Length = 250
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 67/245 (27%), Positives = 103/245 (42%), Gaps = 30/245 (12%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G+ T RG PW V L ++ CG L+ ++V+TAAHC+ +S L++
Sbjct: 4 GKMTRRGDSPWQVVLLDSKK---KLACGAVLIHPSWVLTAAHCMD--------ESKKLLV 52
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLW 142
LG+Y ++ E + +K V ++P ++ S DIALL L+ S + P+CL
Sbjct: 53 RLGEYDLRRW--EKWELDLDIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVPICLP 110
Query: 143 DDSTAPLQLSAVEGTSVCNG---DSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHY 199
D A +L+ ++ G S K + + L I V + +
Sbjct: 111 DSGLAERELNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEVMSNMV 170
Query: 200 V-------VFTDVANVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKH-YVVF 251
+ D + C GDSGG MV W+L G+VS C H Y V+
Sbjct: 171 SENMLCAGILGDRQDACEGDSGGPMVASFHGTWFLVGLVSWGEG------CGLLHNYGVY 224
Query: 252 TDVKR 256
T V R
Sbjct: 225 TKVSR 229
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 34/115 (29%), Positives = 53/115 (46%), Gaps = 11/115 (9%)
Query: 253 DVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
D+K V ++P ++ S DIALL L+ S + P+CL D A +L+ G++ V
Sbjct: 70 DIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVPICLPDSGLAERELNQA-GQETLV 128
Query: 313 IGWGYDENDRVSEE------LKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
GWGY + + L +P+V H +C + S S+ CAG
Sbjct: 129 TGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNEC----SEVMSNMVSENMLCAGI 179
>pdb|3F6U|H Chain H, Crystal Structure Of Human Activated Protein C (Apc)
Complexed With Ppack
Length = 240
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 67/245 (27%), Positives = 103/245 (42%), Gaps = 30/245 (12%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G+ T RG PW V L ++ CG L+ ++V+TAAHC+ +S L++
Sbjct: 4 GKMTRRGDSPWQVVLLDSKK---KLACGAVLIHPSWVLTAAHCMD--------ESKKLLV 52
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLW 142
LG+Y ++ E + +K V ++P ++ S DIALL L+ S + P+CL
Sbjct: 53 RLGEYDLRRW--EKWELDLDIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVPICLP 110
Query: 143 DDSTAPLQLSAVEGTSVCNG---DSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHY 199
D A +L+ ++ G S K + + L I V + +
Sbjct: 111 DSGLAERELNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEVMSNMV 170
Query: 200 V-------VFTDVANVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKH-YVVF 251
+ D + C GDSGG MV W+L G+VS C H Y V+
Sbjct: 171 SENMLCAGILGDRQDACEGDSGGPMVASFHGTWFLVGLVSWGEG------CGLLHNYGVY 224
Query: 252 TDVKR 256
T V R
Sbjct: 225 TKVSR 229
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 34/115 (29%), Positives = 53/115 (46%), Gaps = 11/115 (9%)
Query: 253 DVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
D+K V ++P ++ S DIALL L+ S + P+CL D A +L+ G++ V
Sbjct: 70 DIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVPICLPDSGLAERELNQA-GQETLV 128
Query: 313 IGWGYDENDRVSEE------LKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
GWGY + + L +P+V H +C + S S+ CAG
Sbjct: 129 TGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNEC----SEVMSNMVSENMLCAGI 179
>pdb|2CGA|A Chain A, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|2CGA|B Chain B, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|1ACB|E Chain E, Crystal And Molecular Structure Of The Bovine
Alpha-Chymotrypsin-Eglin C Complex At 2.0 Angstroms
Resolution
pdb|1CGI|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1CGJ|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1EX3|A Chain A, Crystal Structure Of Bovine Chymotrypsinogen A
(Tetragonal)
pdb|1GL1|A Chain A, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|B Chain B, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|C Chain C, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL0|E Chain E, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-D2v, An Inhibitor From The Insect Locusta
Migratoria
pdb|1K2I|1 Chain 1, Crystal Structure Of Gamma-Chymotrypsin In Complex With 7-
Hydroxycoumarin
pdb|1P2M|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2M|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OXG|A Chain A, Crystal Structure Of A Complex Formed Between Organic
Solvent Treated Bovine Alpha-Chymotrypsin And Its
Autocatalytically Produced Highly Potent 14-Residue
Peptide At 2.2 Resolution
pdb|1T7C|A Chain A, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T7C|C Chain C, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|A Chain A, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|C Chain C, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|A Chain A, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|C Chain C, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|A Chain A, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|C Chain C, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|A Chain A, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|C Chain C, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1CHG|A Chain A, Chymotrypsinogen,2.5 Angstroms Crystal Structure,
Comparison With Alpha-Chymotrypsin,And Implications For
Zymogen Activation
pdb|1GCD|A Chain A, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2Y6T|A Chain A, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|B Chain B, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|C Chain C, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|D Chain D, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|3T62|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|B Chain B, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|C Chain C, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
Length = 245
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 66/240 (27%), Positives = 97/240 (40%), Gaps = 68/240 (28%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G++ G WPW V+L G + CGGSL++ N+V+TAAHC SD
Sbjct: 16 IVNGEEAVPGSWPWQVSLQDKTGF---HFCGGSLINENWVVTAAHCGV-------TTSD- 64
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
V+ G++ Q S++ +Q ++ +V +NS DI LL+LS+ +S V V
Sbjct: 65 -VVVAGEFDQGSSSEK--IQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAV 121
Query: 140 CL----------------------WDDSTAPLQL-------------------------- 151
CL + ++ P +L
Sbjct: 122 CLPSASDDFAAGTTCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNCKKYWGTKIKDAMI 181
Query: 152 -SAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVANVCN 210
+ G S C GDSGG +V K + AW L GIVS G C T V+ V + N
Sbjct: 182 CAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSW-----GSSTCSTSTPGVYARVTALVN 236
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 31/114 (27%), Positives = 50/114 (43%), Gaps = 16/114 (14%)
Query: 254 VKRVHIYPTFNSSNYLG-----DIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGR 308
++++ I F +S Y DI LL+LS+ +S V VCL +A +A G
Sbjct: 80 IQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCL---PSASDDFAA--GT 134
Query: 309 DGTVIGWGYDE--NDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
GWG N + L+ A +P++S+ C +++ D CAG
Sbjct: 135 TCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNC----KKYWGTKIKDAMICAG 184
>pdb|1DLK|B Chain B, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
pdb|1DLK|D Chain D, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
Length = 230
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 66/240 (27%), Positives = 97/240 (40%), Gaps = 68/240 (28%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G++ G WPW V+L G + CGGSL++ N+V+TAAHC SD
Sbjct: 1 IVNGEEAVPGSWPWQVSLQDKTGF---HFCGGSLINENWVVTAAHC-------GVTTSD- 49
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
V+ G++ Q S++ +Q ++ +V +NS DI LL+LS+ +S V V
Sbjct: 50 -VVVAGEFDQGSSSEK--IQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAV 106
Query: 140 CL----------------------WDDSTAPLQL-------------------------- 151
CL + ++ P +L
Sbjct: 107 CLPSASDDFAAGTTCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNCKKYWGTKIKDAMI 166
Query: 152 -SAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVANVCN 210
+ G S C GDSGG +V K + AW L GIVS G C T V+ V + N
Sbjct: 167 CAGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSW-----GSSTCSTSTPGVYARVTALVN 221
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 31/114 (27%), Positives = 50/114 (43%), Gaps = 16/114 (14%)
Query: 254 VKRVHIYPTFNSSNYL-----GDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGR 308
++++ I F +S Y DI LL+LS+ +S V VCL +A +A G
Sbjct: 65 IQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCL---PSASDDFAA--GT 119
Query: 309 DGTVIGWGYDE--NDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
GWG N + L+ A +P++S+ C +++ D CAG
Sbjct: 120 TCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNC----KKYWGTKIKDAMICAG 169
>pdb|1A5I|A Chain A, Catalytic Domain Of Vampire Bat (Desmodus Rotundus) Saliva
Plasminogen Activator In Complex With Egr-Cmk
(Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 69/244 (28%), Positives = 110/244 (45%), Gaps = 27/244 (11%)
Query: 7 SCGTVVYNKAQPLVTYGQKTARGQWPWHVALY----RTEGINLSYVCGGSLVSVNYVITA 62
+CG Y + Q T G T PW A++ R+ G ++CGG L+S +V+TA
Sbjct: 1 TCGLRKYKEPQLHSTGGLFTDITSHPWQAAIFAQNRRSSGER--FLCGGILISSCWVLTA 58
Query: 63 AHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIA 122
AHC + + D L + LG+ ++ + +E Q +VK+ ++ F+ Y DIA
Sbjct: 59 AHC-----FQESYLPDQLKVVLGRTYRVKPGEE--EQTFKVKKYIVHKEFDDDTYNNDIA 111
Query: 123 LLQLSSD----VDYSMYVRPVCLWDDSTAPLQLSAVEGTSVCNGDSG----------GGM 168
LLQL SD S VR +CL + + + E + S G +
Sbjct: 112 LLQLKSDSPQCAQESDSVRAICLPEANLQLPDWTECELSGYGKHKSSSPFYSEQLKEGHV 171
Query: 169 VFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVANVCNGDSGGGMVFKIDSAWYLR 228
S + + + TV + L DT+ ++ +V + C GDSGG +V D+ L
Sbjct: 172 RLYPSSRCAPKFLFNKTVTNNMLCAGDTRSGEIYPNVHDACQGDSGGPLVCMNDNHMTLL 231
Query: 229 GIVS 232
GI+S
Sbjct: 232 GIIS 235
Score = 37.4 bits (85), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 35/114 (30%), Positives = 55/114 (48%), Gaps = 15/114 (13%)
Query: 254 VKRVHIYPTFNSSNYLGDIALLQLSSD----VDYSMYVRPVCLWDDSTAPLQLSAVEGRD 309
VK+ ++ F+ Y DIALLQL SD S VR +CL A LQL + +
Sbjct: 92 VKKYIVHKEFDDDTYNNDIALLQLKSDSPQCAQESDSVRAICL---PEANLQLP--DWTE 146
Query: 310 GTVIGWGYDENDR--VSEELKMAIMPIVSHQQCLWSNPQF-FSQFTSDETFCAG 360
+ G+G ++ SE+LK + + +C P+F F++ ++ CAG
Sbjct: 147 CELSGYGKHKSSSPFYSEQLKEGHVRLYPSSRCA---PKFLFNKTVTNNMLCAG 197
>pdb|1PYT|D Chain D, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 251
Score = 75.5 bits (184), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 69/252 (27%), Positives = 111/252 (44%), Gaps = 19/252 (7%)
Query: 8 CGTVVYN-KAQPLVTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCV 66
CG ++ V G+ WPW ++L + CGG+L++ N+V+TAAHC+
Sbjct: 1 CGAPIFQPNLSARVVGGEDAIPHSWPWQISLQYLRDNTWRHTCGGTLITPNHVLTAAHCI 60
Query: 67 TKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQL 126
+ ++ T + LGK + + DE G V + ++ +NS DIAL++L
Sbjct: 61 S--------NTLTYRVALGK-NNLEVEDEAGSLYVGVDTIFVHEKWNSFLVRNDIALIKL 111
Query: 127 SSDVDYSMYVRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIV--SI 184
+ V+ ++ CL + + Q T + G + ++ L+ +V +
Sbjct: 112 AETVELGDTIQVACLPSEGSLLPQDYPCFVTGWGRLYTNGPIAAELQQG--LQPVVDYAT 169
Query: 185 TVARD--GLRVCDTKHYVVFTDVANVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRV 242
RD G V +T V + CNGDSGG + + D W +RGIVS GL
Sbjct: 170 CSQRDWWGTTVKETMVCAGGDGVISACNGDSGGPLNCQADGQWDVRGIVSFG---SGLSC 226
Query: 243 CDTKHYVVFTDV 254
K VFT V
Sbjct: 227 NTFKKPTVFTRV 238
Score = 35.4 bits (80), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 30/130 (23%), Positives = 57/130 (43%), Gaps = 11/130 (8%)
Query: 233 ITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 292
+ + ++ L V D + ++ V + ++ +NS DIAL++L+ V+ ++ CL
Sbjct: 68 VALGKNNLEVED-EAGSLYVGVDTIFVHEKWNSFLVRNDIALIKLAETVELGDTIQVACL 126
Query: 293 WDD-STAPLQLSAVEGRDGTVIGWG-YDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQ 350
+ S P V GWG N ++ EL+ + P+V + C S ++
Sbjct: 127 PSEGSLLPQDYPCF------VTGWGRLYTNGPIAAELQQGLQPVVDYATC--SQRDWWGT 178
Query: 351 FTSDETFCAG 360
+ CAG
Sbjct: 179 TVKETMVCAG 188
>pdb|2F83|A Chain A, Crystal Structure At 2.9 Angstroms Resolution Of Human
Plasma Coagulation Factor Xi Zymogen
Length = 625
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 62/234 (26%), Positives = 91/234 (38%), Gaps = 63/234 (26%)
Query: 1 MCYRDVSCGTVVYNKAQPLVTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVI 60
+C D C T K +P + G + RG+WPW V L+ T ++CGGS++ +++
Sbjct: 373 LCKMDNECTT----KIKPRIVGGTASVRGEWPWQVTLHTTSPTQ-RHLCGGSIIGNQWIL 427
Query: 61 TAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGD 120
TAAHC K L +Y G +Q + ++ Q +H S Y D
Sbjct: 428 TAAHCFYGVESPK-----ILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGY--D 480
Query: 121 IALLQLSSDVDYSMYVRPVCL-------------W----------DDSTAPLQLSAVE-- 155
IALL+L + V+Y+ RP+CL W D LQ + +
Sbjct: 481 IALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLV 540
Query: 156 --------------------------GTSVCNGDSGGGMVFKIDSAWYLRGIVS 183
G C GDSGG + K + W+L GI S
Sbjct: 541 TNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITS 594
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 32/121 (26%), Positives = 60/121 (49%), Gaps = 9/121 (7%)
Query: 244 DTKHYVVFTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLS 303
+ K F V+ + I+ + + DIALL+L + V+Y+ RP+CL + +
Sbjct: 453 EIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYT 512
Query: 304 AVEGRDGTVIGWGYDE-NDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
D V GWGY + D++ L+ A +P+V++++C ++ + + CAG+R
Sbjct: 513 -----DCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEEC---QKRYRGHKITHKMICAGYR 564
Query: 363 N 363
Sbjct: 565 E 565
>pdb|2F9O|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9P|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
Length = 245
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/229 (27%), Positives = 96/229 (41%), Gaps = 38/229 (16%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
GQ+ R +WPW V+L R + CGGSL+ +V+TAAHCV P D +
Sbjct: 4 GQEAPRSKWPWQVSL-RVRDRYWMHFCGGSLIHPQWVLTAAHCV------GPDVKDLATL 56
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLW 142
+ QH + + Q V R+ ++P F DIALL+L V+ S V V L
Sbjct: 57 RVQLREQHLYYQD---QLLPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVMLP 113
Query: 143 DDST--APLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHY- 199
S P V G + D F + V + + + +CD K++
Sbjct: 114 PASETFPPGMPCWVTGWGDVDNDEPLPPPFPLKQ-------VKVPIMEN--HICDAKYHL 164
Query: 200 ---------VVFTDV-------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
++ D+ + C GDSGG +V K++ W G+VS
Sbjct: 165 GAYTGDDVRIIRDDMLCAGNSQRDSCKGDSGGPLVCKVNGTWLQAGVVS 213
Score = 36.2 bits (82), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 32/108 (29%), Positives = 46/108 (42%), Gaps = 12/108 (11%)
Query: 240 LRVCDTKHYVVFTD----VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDD 295
LRV + ++ + D V R+ ++P F DIALL+L V+ S V V L
Sbjct: 56 LRVQLREQHLYYQDQLLPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVML--- 112
Query: 296 STAPLQLSAVEGRDGTVIGWGYDENDRVSE---ELKMAIMPIVSHQQC 340
P + G V GWG +ND LK +PI+ + C
Sbjct: 113 --PPASETFPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHIC 158
>pdb|2F9N|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
Length = 245
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/229 (27%), Positives = 96/229 (41%), Gaps = 38/229 (16%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
GQ+ R +WPW V+L R + CGGSL+ +V+TAAHCV P D +
Sbjct: 4 GQEAPRSKWPWQVSL-RVRDRYWMHFCGGSLIHPQWVLTAAHCV------GPDVKDLATL 56
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLW 142
+ QH + + Q V R+ ++P F DIALL+L V+ S V V L
Sbjct: 57 RVQLREQHLYYQD---QLLPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVMLP 113
Query: 143 DDST--APLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHY- 199
S P V G + D F + V + + + +CD K++
Sbjct: 114 PASETFPPGMPCWVTGWGDVDNDEPLPPPFPLKQ-------VKVPIMEN--HICDAKYHL 164
Query: 200 ---------VVFTDV-------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
++ D+ + C GDSGG +V K++ W G+VS
Sbjct: 165 GAYTGDDVRIIRDDMLCAGNSQRDSCQGDSGGPLVCKVNGTWLQAGVVS 213
Score = 36.2 bits (82), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 32/108 (29%), Positives = 46/108 (42%), Gaps = 12/108 (11%)
Query: 240 LRVCDTKHYVVFTD----VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDD 295
LRV + ++ + D V R+ ++P F DIALL+L V+ S V V L
Sbjct: 56 LRVQLREQHLYYQDQLLPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVML--- 112
Query: 296 STAPLQLSAVEGRDGTVIGWGYDENDRVSE---ELKMAIMPIVSHQQC 340
P + G V GWG +ND LK +PI+ + C
Sbjct: 113 --PPASETFPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHIC 158
>pdb|2JET|B Chain B, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 128
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 49/136 (36%), Positives = 68/136 (50%), Gaps = 16/136 (11%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G+ G WPW V+L G + CGGSL+S ++V+TAAHC K SD V+
Sbjct: 1 GEDAIPGSWPWQVSLQDKTGF---HFCGGSLISEDWVVTAAHCGVKT-------SD--VV 48
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL- 141
G++ Q SDE +Q ++ +V P FN DI LL+L++ +S V VCL
Sbjct: 49 VAGEFDQG--SDEENIQVLKIAQVFKNPKFNMFTVRNDITLLKLATPAQFSETVSAVCLP 106
Query: 142 -WDDSTAPLQLSAVEG 156
DD P + A G
Sbjct: 107 NVDDDFPPGTVCATTG 122
Score = 30.8 bits (68), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 19/56 (33%), Positives = 26/56 (46%), Gaps = 2/56 (3%)
Query: 254 VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL--WDDSTAPLQLSAVEG 307
+ +V P FN DI LL+L++ +S V VCL DD P + A G
Sbjct: 67 IAQVFKNPKFNMFTVRNDITLLKLATPAQFSETVSAVCLPNVDDDFPPGTVCATTG 122
>pdb|3ELA|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia Mutant In Complex With Soluble Tissue Factor
Length = 254
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 69/248 (27%), Positives = 118/248 (47%), Gaps = 35/248 (14%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G+ +G+ PW V L +N + +CGG+L++ +V++AAHC +DK + L+
Sbjct: 4 GKDCPKGECPWQVLLL----VNGAQLCGGTLINTIWVVSAAHC-----FDKIKNWRNLIA 54
Query: 83 YLGKYHQHQFSD-EGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
LG +H S+ +G Q+++V +V I T+ DIALL+L V + +V P+CL
Sbjct: 55 VLG---EHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCL 111
Query: 142 WDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSIT--VARDGL----RVCD 195
+ + + L+ V + V SG G + + + ++++ + +D L +V D
Sbjct: 112 PERTFSERTLAFVRFSLV----SGWGQLLDRGATALVLQVLNVPRLMTQDCLQQSRKVGD 167
Query: 196 TKHYVVFTDVA-------NVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHY 248
+ + + A + C GDSGG WYL GIVS G H+
Sbjct: 168 SPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSW-----GQGCATVGHF 222
Query: 249 VVFTDVKR 256
V+T V +
Sbjct: 223 GVYTRVSQ 230
Score = 35.4 bits (80), Expect = 0.052, Method: Compositional matrix adjust.
Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 254 VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVI 313
V +V I T+ DIALL+L V + +V P+CL + + + L+ V R V
Sbjct: 73 VAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFV--RFSLVS 130
Query: 314 GWGYDENDRVSEELKMAIM--PIVSHQQCLWSNPQFF-SQFTSDETFCAGFRN 363
GWG DR + L + ++ P + Q CL + + S ++ FCAG+ +
Sbjct: 131 GWG-QLLDRGATALVLQVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSD 182
>pdb|4H4F|A Chain A, Crystal Structure Of Human Chymotrypsin C (ctrc) Bound To
Inhibitor Eglin C From Hirudo Medicinalis
Length = 249
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 67/241 (27%), Positives = 115/241 (47%), Gaps = 21/241 (8%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
V G+ WPW ++L + + CGG+L++ N+V+TAAHC++ ++ T
Sbjct: 1 VVGGEDARPHSWPWQISLQYLKNDTWRHTCGGTLIASNFVLTAAHCIS--------NTRT 52
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
+ +GK + + DE G V +H++ +N+ DIAL++L+ V+ S ++
Sbjct: 53 YRVAVGK-NNLEVEDEEGSLFVGVDTIHVHKRWNALLLRNDIALIKLAEHVELSDTIQVA 111
Query: 140 CLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVS-ITVARD---GLRVCD 195
CL + + + T + G + K+ L+ +V T +R G RV
Sbjct: 112 CLPEKDSLLPKDYPCYVTGWGRLWTNGPIADKLQQG--LQPVVDHATCSRIDWWGFRVKK 169
Query: 196 TKHYVVFTDVANVCNGDSGGGMVFKIDS-AWYLRGIVSITVARDGLRVCDT-KHYVVFTD 253
T V + CNGDSGG + ++++ +W + GIVS R C+T K VV+T
Sbjct: 170 TMVCAGGDGVISACNGDSGGPLNCQLENGSWEVFGIVSFGSRRG----CNTRKKPVVYTR 225
Query: 254 V 254
V
Sbjct: 226 V 226
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 34/130 (26%), Positives = 60/130 (46%), Gaps = 11/130 (8%)
Query: 233 ITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 292
+ V ++ L V D + + F V +H++ +N+ DIAL++L+ V+ S ++ CL
Sbjct: 55 VAVGKNNLEVEDEEGSL-FVGVDTIHVHKRWNALLLRNDIALIKLAEHVELSDTIQVACL 113
Query: 293 WD-DSTAPLQLSAVEGRDGTVIGWGYD-ENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQ 350
+ DS P V GWG N ++++L+ + P+V H C S ++
Sbjct: 114 PEKDSLLPKDYPCY------VTGWGRLWTNGPIADKLQQGLQPVVDHATC--SRIDWWGF 165
Query: 351 FTSDETFCAG 360
CAG
Sbjct: 166 RVKKTMVCAG 175
>pdb|1LTO|A Chain A, Human Alpha1-Tryptase
pdb|1LTO|B Chain B, Human Alpha1-Tryptase
pdb|1LTO|C Chain C, Human Alpha1-Tryptase
pdb|1LTO|D Chain D, Human Alpha1-Tryptase
Length = 245
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 63/229 (27%), Positives = 96/229 (41%), Gaps = 38/229 (16%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
GQ+ R +WPW V+L R + CGGSL+ +V+TAAHC+ P D +
Sbjct: 4 GQEAPRSKWPWQVSL-RVRDRYWMHFCGGSLIHPQWVLTAAHCL------GPDVKDLATL 56
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLW 142
+ QH + + Q V R+ ++P F DIALL+L V+ S V V L
Sbjct: 57 RVQLREQHLYYQD---QLLPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVMLP 113
Query: 143 DDST--APLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHY- 199
S P V G + D F + V + + + +CD K++
Sbjct: 114 PASETFPPGMPCWVTGWGDVDNDEPLPPPFPLKQ-------VKVPIMEN--HICDAKYHL 164
Query: 200 ---------VVFTDV-------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
++ D+ + C GDSGG +V K++ W G+VS
Sbjct: 165 GAYTGDDVRIIRDDMLCAGNSQRDSCKGDSGGPLVCKVNGTWLQAGVVS 213
Score = 36.2 bits (82), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 32/108 (29%), Positives = 46/108 (42%), Gaps = 12/108 (11%)
Query: 240 LRVCDTKHYVVFTD----VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDD 295
LRV + ++ + D V R+ ++P F DIALL+L V+ S V V L
Sbjct: 56 LRVQLREQHLYYQDQLLPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVML--- 112
Query: 296 STAPLQLSAVEGRDGTVIGWGYDENDRVSE---ELKMAIMPIVSHQQC 340
P + G V GWG +ND LK +PI+ + C
Sbjct: 113 --PPASETFPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHIC 158
>pdb|1ELT|A Chain A, Structure Of Native Pancreatic Elastase From North
Atlantic Salmon At 1.61 Angstroms Resolution
Length = 236
Score = 71.6 bits (174), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 66/240 (27%), Positives = 109/240 (45%), Gaps = 18/240 (7%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
V G+ WPW ++L G + + CGGSL+ +V+TAAHCV + T
Sbjct: 1 VVGGRVAQPNSWPWQISLQYKSGSSYYHTCGGSLIRQGWVMTAAHCVD--------SART 52
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLG--DIALLQLSSDVDYSMYVR 137
+ LG+++ + ++EG Q V V I+ +NS + G DIALL+L++ + V+
Sbjct: 53 WRVVLGEHNLN--TNEGKEQIMTVNSVFIHSGWNSDDVAGGYDIALLRLNTQASLNSAVQ 110
Query: 138 PVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTK 197
L + + T +GG + + AW L + T + G K
Sbjct: 111 LAALPPSNQILPNNNPCYITGWGKTSTGGPLSDSLKQAW-LPSVDHATCSSSGWWGSTVK 169
Query: 198 HYVVFT--DVANVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVK 255
+V + CNGDSGG + +++ ++Y+ G+ S V+ G +K VFT V
Sbjct: 170 TTMVCAGGGANSGCNGDSGGPLNCQVNGSYYVHGVTSF-VSSSGCNA--SKKPTVFTRVS 226
>pdb|1DAN|H Chain H, Complex Of Active Site Inhibited Human Blood Coagulation
Factor Viia With Human Recombinant Soluble Tissue Factor
pdb|1QFK|H Chain H, Structure Of Human Factor Viia And Its Implications For
The Triggering Of Blood Coagulation
pdb|1CVW|H Chain H, Crystal Structure Of Active Site-inhibited Human
Coagulation Factor Viia (des-gla)
pdb|1FAK|H Chain H, Human Tissue Factor Complexed With Coagulation Factor Viia
Inhibited With A Bpti-Mutant
pdb|1DVA|H Chain H, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1DVA|I Chain I, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1JBU|H Chain H, Coagulation Factor Vii Zymogen (Egf2PROTEASE) IN COMPLEX
WITH Inhibitory Exosite Peptide A-183
pdb|1KLI|H Chain H, Cofactor-And Substrate-Assisted Activation Of Factor Viia
pdb|1KLJ|H Chain H, Crystal Structure Of Uninhibited Factor Viia
pdb|1J9C|H Chain H, Crystal Structure Of Tissue Factor-Factor Viia Complex
pdb|1W0Y|H Chain H, Tf7a_3771 Complex
pdb|1YGC|H Chain H, Short Factor Viia With A Small Molecule Inhibitor
pdb|1Z6J|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
Viia/tissue Factor/pyrazinone Inhibitor
pdb|1W2K|H Chain H, Tf7a_4380 Complex
pdb|1WQV|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Propylsulfonamide-D- Thr-Met-P-Aminobenzamidine
pdb|1W7X|H Chain H, Factor7- 413 Complex
pdb|1W8B|H Chain H, Factor7 - 413 Complex
pdb|1WSS|H Chain H, Human Factor Viia-Tissue Factor In Complex With Peprid
Mimetic Inhibitor That Has Two Charge Groups In P2 And
P4
pdb|1WTG|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Biphenylalanine-Gln-P-
Aminobenzamidine
pdb|1WUN|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Trp-Gln-P-Aminobenzamidine
pdb|1WV7|H Chain H, Human Factor Viia-tissue Factor Complexed With
Ethylsulfonamide-d-5-propoxy-trp-gln-p-aminobenzamidine
pdb|2B7D|H Chain H, Factor Viia Inhibitors: Chemical Optimization, Preclinical
Pharmacokinetics, Pharmacodynamics, And Efficacy In A
Baboon Thrombosis Model
pdb|2F9B|H Chain H, Discovery Of Novel Heterocyclic Factor Viia Inhibitors
pdb|2FLB|H Chain H, Discovery Of A Novel Hydroxy Pyrazole Based Factor Ixa
Inhibitor
pdb|2A2Q|H Chain H, Complex Of Active-Site Inhibited Human Coagulation Factor
Viia With Human Soluble Tissue Factor In The Presence Of
Ca2+, Mg2+, Na+, And Zn2+
pdb|2AER|H Chain H, Crystal Structure Of Benzamidine-Factor ViiaSOLUBLE TISSUE
Factor Complex.
pdb|2AEI|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
ViiaTISSUE FACTOR And
2-[[6-[3-(Aminoiminomethyl)phenoxy]-3,
5-Difluro-4-[(1-Methyl-3-
Phenylpropyl)amino]-2-Pyridinyl]oxy]-Benzoic Acid
pdb|2FIR|H Chain H, Crystal Structure Of Dfpr-ViiaSTF
pdb|2C4F|H Chain H, Crystal Structure Of Factor Vii.Stf Complexed With
Pd0297121
pdb|2FLR|H Chain H, Novel 5-azaindole Factor Viia Inhibitors
pdb|2B8O|H Chain H, Crystal Structure Of Glu-gly-arg-chloromethyl
Ketone-factor Viia/soluble Tissue Factor Complex
pdb|2PUQ|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia In Complex With Soluble Tissue Factor
pdb|2EC9|H Chain H, Crystal Structure Analysis Of Human Factor Viia , Souluble
Tissue Factor Complexed With Bcx-3607
pdb|2ZP0|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Benzylsulfonamide-D- Ile-Gln-P-Aminobenzamidine
pdb|2ZWL|H Chain H, Human Factor Viia-Tissue Factor Complexed With Highly
Selective Peptide Inhibitor
pdb|2ZZU|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-5-
(3-Carboxybenzyloxy)-Trp-Gln-P-Aminobenzamidine
pdb|3TH2|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH3|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH4|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|1O5D|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|2BZ6|H Chain H, Orally Available Factor7a Inhibitor
pdb|4ISI|H Chain H, Structure Of Factor Viia In Complex With The Inhibitor
(6s)-n-(4-
Carbamimidoylbenzyl)-1-chloro-3-(cyclobutylamino)-8,
8-diethyl-4-oxo-
4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide
Length = 254
Score = 71.6 bits (174), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 70/250 (28%), Positives = 115/250 (46%), Gaps = 39/250 (15%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G+ +G+ PW V L +N + +CGG+L++ +V++AAHC +DK + L+
Sbjct: 4 GKVCPKGECPWQVLLL----VNGAQLCGGTLINTIWVVSAAHC-----FDKIKNWRNLIA 54
Query: 83 YLGKYHQHQFSD-EGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
LG +H S+ +G Q+++V +V I T+ DIALL+L V + +V P+CL
Sbjct: 55 VLG---EHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCL 111
Query: 142 WDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVAR--------DGLRV 193
+ + + L+ V + V SG G + +D ++ + V R +V
Sbjct: 112 PERTFSERTLAFVRFSLV----SGWGQL--LDRGATALELMVLNVPRLMTQDCLQQSRKV 165
Query: 194 CDTKHYVVFTDVA-------NVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTK 246
D+ + + A + C GDSGG WYL GIVS G
Sbjct: 166 GDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSW-----GQGCATVG 220
Query: 247 HYVVFTDVKR 256
H+ V+T V +
Sbjct: 221 HFGVYTRVSQ 230
Score = 36.6 bits (83), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 34/113 (30%), Positives = 56/113 (49%), Gaps = 6/113 (5%)
Query: 254 VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVI 313
V +V I T+ DIALL+L V + +V P+CL + + + L+ V R V
Sbjct: 73 VAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFV--RFSLVS 130
Query: 314 GWGYDENDRVSEELKMAIM--PIVSHQQCLWSNPQFF-SQFTSDETFCAGFRN 363
GWG DR + L++ ++ P + Q CL + + S ++ FCAG+ +
Sbjct: 131 GWG-QLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSD 182
>pdb|2BOK|A Chain A, Factor Xa- Cation
pdb|2JKH|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2VVC|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVC|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVU|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVV|A Chain A, Aminopyrrolidine-Related Triazole Factor Xa Inhibitor
pdb|2VWL|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWN|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWO|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2XBV|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 37/224 (16%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
GQ+ G+ PW L E CGG+++S Y++TAAHC+ + + +
Sbjct: 4 GQECKDGECPWQALLINEENEGF---CGGTILSEFYILTAAHCLYQ--------AKRFKV 52
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL- 141
+G + Q +EGG +V+ V + F Y DIA+L+L + + + M V P CL
Sbjct: 53 RVGDRNTEQ--EEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLP 110
Query: 142 ---WDDSTAPLQLSAVEGTSVCNGDSGGGMVF-KIDSAWYLRGIVSITVARDGLRVCDTK 197
W +ST Q + + SG G K + + L+ + V R+ ++ +
Sbjct: 111 ERDWAESTLMTQKTGIV--------SGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSS- 161
Query: 198 HYVVF---------TDVANVCNGDSGGGMVFKIDSAWYLRGIVS 232
+++ T + C GDSGG V + +++ GIVS
Sbjct: 162 -FIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVS 204
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 36/114 (31%), Positives = 51/114 (44%), Gaps = 15/114 (13%)
Query: 253 DVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL----WDDSTAPLQLSAVEGR 308
+V+ V + F Y DIA+L+L + + + M V P CL W +ST Q +
Sbjct: 70 EVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQ------K 123
Query: 309 DGTVIGWGY-DENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
G V G+G E S LKM +P V C S+ +Q FCAG+
Sbjct: 124 TGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQ----NMFCAGY 173
>pdb|2Y5F|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5G|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5H|A Chain A, Factor Xa - Cation Inhibitor Complex
Length = 234
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 37/224 (16%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
GQ+ G+ PW L E CGG+++S Y++TAAHC+ + + +
Sbjct: 4 GQECKDGECPWQALLINEENEGF---CGGTILSEFYILTAAHCLYQ--------AKRFKV 52
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL- 141
+G + Q +EGG +V+ V + F Y DIA+L+L + + + M V P CL
Sbjct: 53 RVGDRNTEQ--EEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLP 110
Query: 142 ---WDDSTAPLQLSAVEGTSVCNGDSGGGMVF-KIDSAWYLRGIVSITVARDGLRVCDTK 197
W +ST Q + + SG G K + + L+ + V R+ ++ +
Sbjct: 111 ERDWAESTLMTQKTGIV--------SGFGRTHEKGEQSTRLKMLEVPYVDRNSCKL--SS 160
Query: 198 HYVVF---------TDVANVCNGDSGGGMVFKIDSAWYLRGIVS 232
+++ T + C GDSGG V + +++ GIVS
Sbjct: 161 SFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVS 204
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 36/114 (31%), Positives = 51/114 (44%), Gaps = 15/114 (13%)
Query: 253 DVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL----WDDSTAPLQLSAVEGR 308
+V+ V + F Y DIA+L+L + + + M V P CL W +ST Q +
Sbjct: 70 EVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQ------K 123
Query: 309 DGTVIGWGY-DENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
G V G+G E S LKM +P V C S+ +Q FCAG+
Sbjct: 124 TGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQ----NMFCAGY 173
>pdb|2BQ6|B Chain B, Crystal Structure Of Factor Xa In Complex With 21
pdb|2BQ7|B Chain B, Crystal Structure Of Factor Xa In Complex With 43
pdb|2BQW|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound 45
Length = 249
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 62/242 (25%), Positives = 105/242 (43%), Gaps = 45/242 (18%)
Query: 13 YNKAQP--------LVTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAH 64
+N+ QP + GQ+ G+ PW L E CGG+++S Y++TAAH
Sbjct: 1 FNQTQPERGDNNLTRIVGGQECKDGECPWQALLINEENEGF---CGGTILSEFYILTAAH 57
Query: 65 CVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALL 124
C+ + + + +G + Q +EGG +V+ V + F Y DIA+L
Sbjct: 58 CLYQ--------AKRFKVRVGDRNTEQ--EEGGEAVHEVEVVIKHNRFTKETYDFDIAVL 107
Query: 125 QLSSDVDYSMYVRPVCL----WDDSTAPLQLSAVEGTSVCNGDSGGGMVF-KIDSAWYLR 179
+L + + + M V P CL W +ST Q + + SG G K + L+
Sbjct: 108 RLKTPITFRMNVAPACLPERDWAESTLMTQKTGIV--------SGFGRTHEKGRQSTRLK 159
Query: 180 GIVSITVARDGLRVCDTKHYVVF---------TDVANVCNGDSGGGMVFKIDSAWYLRGI 230
+ V R+ ++ + +++ T + C GDSGG V + +++ GI
Sbjct: 160 MLEVPYVDRNSCKL--SSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGI 217
Query: 231 VS 232
VS
Sbjct: 218 VS 219
Score = 48.9 bits (115), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 52/114 (45%), Gaps = 15/114 (13%)
Query: 253 DVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL----WDDSTAPLQLSAVEGR 308
+V+ V + F Y DIA+L+L + + + M V P CL W +ST Q +
Sbjct: 85 EVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQ------K 138
Query: 309 DGTVIGWGY-DENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
G V G+G E R S LKM +P V C S+ +Q FCAG+
Sbjct: 139 TGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQ----NMFCAGY 188
>pdb|1PFX|C Chain C, Porcine Factor Ixa
pdb|1X7A|C Chain C, Porcine Factor Ixa Complexed To 1-{3-[amino(Imino)
Methyl]phenyl}-N-[4-(1h-Benzimidazol-1-Yl)-2-
Fluorophenyl]-
3-(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide
Length = 235
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 63/245 (25%), Positives = 110/245 (44%), Gaps = 36/245 (14%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G+ GQ+PW V L + CGGS+++ +V+TAAHC+ +P K + +
Sbjct: 4 GENAKPGQFPWQVLLNG----KIDAFCGGSIINEKWVVTAAHCI--EPGVK------ITV 51
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSS--NYLGDIALLQLSSDVDYSMYVRPVC 140
G+Y+ + E Q + V R + ++N++ Y DIALL+L + + YV P+C
Sbjct: 52 VAGEYNTEE--TEPTEQRRNVIRAIPHHSYNATVNKYSHDIALLELDEPLTLNSYVTPIC 109
Query: 141 LWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYV 200
+ D + L G SG G VF + + + + + + TK +
Sbjct: 110 IADKEYTNIFLKFGSGYV-----SGWGRVFNRGRSATILQYLKVPLVDRATCLRSTK-FT 163
Query: 201 VFTDV---------ANVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVF 251
+++++ + C GDSGG V +++ +L GI+S G Y ++
Sbjct: 164 IYSNMFCAGFHEGGKDSCQGDSGGPHVTEVEGTSFLTGIISW-----GEECAVKGKYGIY 218
Query: 252 TDVKR 256
T V R
Sbjct: 219 TKVSR 223
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 41/135 (30%), Positives = 61/135 (45%), Gaps = 12/135 (8%)
Query: 231 VSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSS--NYLGDIALLQLSSDVDYSMYVR 288
V ITV +T+ +V R + ++N++ Y DIALL+L + + YV
Sbjct: 47 VKITVVAGEYNTEETEPTEQRRNVIRAIPHHSYNATVNKYSHDIALLELDEPLTLNSYVT 106
Query: 289 PVCLWDDSTAPLQLSAVEGRDGTVIGWGYDEN-DRVSEELKMAIMPIVSHQQCLWSNPQF 347
P+C+ D + L G V GWG N R + L+ +P+V CL S
Sbjct: 107 PICIADKEYTNIFLKF---GSGYVSGWGRVFNRGRSATILQYLKVPLVDRATCLRS---- 159
Query: 348 FSQFT-SDETFCAGF 361
++FT FCAGF
Sbjct: 160 -TKFTIYSNMFCAGF 173
>pdb|1KDQ|A Chain A, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 131
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 48/139 (34%), Positives = 68/139 (48%), Gaps = 16/139 (11%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G+ G WPW V+L G + CGGSL+S ++V+TAAHC K SD
Sbjct: 1 IVNGEDAIPGSWPWQVSLQDKTGF---HFCGGSLISEDWVVTAAHCGVKT-------SD- 49
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
V+ G++ Q SDE +Q ++ +V P FN DI LL+L++ +S V V
Sbjct: 50 -VVVAGEFDQG--SDEENIQVLKIAQVFKNPKFNMFTVRNDITLLKLATPAQFSETVSAV 106
Query: 140 CL--WDDSTAPLQLSAVEG 156
L DD P + A G
Sbjct: 107 SLPNVDDDFPPGTVCATTG 125
>pdb|4DGJ|A Chain A, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|B Chain B, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|C Chain C, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|D Chain D, Structure Of A Human Enteropeptidase Light Chain Variant
Length = 235
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 51/219 (23%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G G WPW V LY + + +CG SLVS +++++AAHCV Y + ++
Sbjct: 4 GSDAKEGAWPWVVGLYYDDRL----LCGASLVSSDWLVSAAHCV----YGRNLEPSKWTA 55
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLW 142
LG + + + V + + + I P +N DIA++ L V+Y+ Y++P+ L
Sbjct: 56 ILGLHMKSNLTSPQTVP-RLIDEIVINPHYNRRRKDNDIAMMHLEFKVNYTDYIQPISL- 113
Query: 143 DDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVF 202
P + C+ G +V++ +A L+ ++ + + ++ +
Sbjct: 114 -----PEENQVFPPGRNCSIAGWGTVVYQGTTADILQEADVPLLSNERCQQQMPEYNITE 168
Query: 203 TDVA--------NVCNGDSGGGMVFKIDSAWYLRGIVSI 233
+ + C GDSGG ++ + ++ W+L G+ S
Sbjct: 169 NMICAGYEEGGIDSCQGDSGGPLMCQENNRWFLAGVTSF 207
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 26/110 (23%), Positives = 56/110 (50%), Gaps = 9/110 (8%)
Query: 254 VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVI 313
+ + I P +N DIA++ L V+Y+ Y++P+ L +++ GR+ ++
Sbjct: 75 IDEIVINPHYNRRRKDNDIAMMHLEFKVNYTDYIQPISLPEENQV-----FPPGRNCSIA 129
Query: 314 GWG-YDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
GWG ++ L+ A +P++S+++C P++ ++ CAG+
Sbjct: 130 GWGTVVYQGTTADILQEADVPLLSNERCQQQMPEY---NITENMICAGYE 176
>pdb|1SGF|G Chain G, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|Z Chain Z, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 237
Score = 69.3 bits (168), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 94/218 (43%), Gaps = 49/218 (22%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G K + PWHVA+YR Y+CGG L+ N+V+TAAHC YD D +
Sbjct: 4 GFKCEKNSQPWHVAVYRYT----QYLCGGVLLDPNWVLTAAHC-----YD-----DNYKV 49
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSS-----------NYLGDIALLQLSSDVD 131
+LGK + F DE Q++ V + +P FN S +Y D+ LL+LS D
Sbjct: 50 WLGK--NNLFKDEPSAQHRFVSKAIPHPGFNMSLMRKHIRFLEYDYSNDLMLLRLSKPAD 107
Query: 132 YSMYVRPVCLWDDSTAPLQLSAVEGTSVCNG-DSGGGMVFKIDSAWYLRGIVSITVARDG 190
+ V+P+ T P + + T + +G S F+ Y V++ + +
Sbjct: 108 ITDTVKPI------TLPTEEPKLGSTCLASGWGSITPTKFQFTDDLY---CVNLKLLPN- 157
Query: 191 LRVCDTKHYVVFTDV----------ANVCNGDSGGGMV 218
C H TD + C GDSGG ++
Sbjct: 158 -EDCAKAHIEKVTDAMLCAGEMDGGKDTCKGDSGGPLI 194
>pdb|1MTN|B Chain B, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|F Chain F, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|B Chain B, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|G Chain G, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|B Chain B, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|G Chain G, Bovine Chymotrypsin Complexed To Bpti
pdb|1AFQ|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|1VGC|B Chain B, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|B Chain B, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|B Chain B, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|B Chain B, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|B Chain B, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|B Chain B, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|C Chain C, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|D Chain D, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|B Chain B, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|F Chain F, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|B Chain B, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|F Chain F, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|F Chain F, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|F Chain F, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|F Chain F, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|F Chain F, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|F Chain F, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|F Chain F, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|F Chain F, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|B Chain B, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|F Chain F, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|B Chain B, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|F Chain F, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|B Chain B, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|F Chain F, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|F Chain F, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|B Chain B, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|B Chain B, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|B Chain B, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|B Chain B, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|B Chain B, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
pdb|3RU4|D Chain D, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 131
Score = 68.9 bits (167), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 41/122 (33%), Positives = 63/122 (51%), Gaps = 14/122 (11%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G++ G WPW V+L G + CGGSL++ N+V+TAAHC SD
Sbjct: 1 IVNGEEAVPGSWPWQVSLQDKTGF---HFCGGSLINENWVVTAAHC-------GVTTSD- 49
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
V+ G++ Q S++ +Q ++ +V +NS DI LL+LS+ +S V V
Sbjct: 50 -VVVAGEFDQGSSSEK--IQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAV 106
Query: 140 CL 141
CL
Sbjct: 107 CL 108
>pdb|1C5M|D Chain D, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
Length = 255
Score = 68.9 bits (167), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 37/224 (16%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
GQ+ G+ PW L E CGG+++S Y++TAAHC+ + + +
Sbjct: 4 GQECKDGECPWQALLINEENEGF---CGGTILSEFYILTAAHCLYQ--------AKRFKV 52
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL- 141
+G + Q +EGG +V+ V + F Y DIA+L+L + + + M V P CL
Sbjct: 53 RVGDRNTEQ--EEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLP 110
Query: 142 ---WDDSTAPLQLSAVEGTSVCNGDSGGGMVF-KIDSAWYLRGIVSITVARDGLRVCDTK 197
W +ST Q + + SG G K + L+ + V R+ ++ +
Sbjct: 111 ERDWAESTLMTQKTGIV--------SGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSS- 161
Query: 198 HYVVF---------TDVANVCNGDSGGGMVFKIDSAWYLRGIVS 232
+++ T + C GDSGG V + +++ GIVS
Sbjct: 162 -FIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVS 204
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 52/114 (45%), Gaps = 15/114 (13%)
Query: 253 DVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL----WDDSTAPLQLSAVEGR 308
+V+ V + F Y DIA+L+L + + + M V P CL W +ST Q +
Sbjct: 70 EVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQ------K 123
Query: 309 DGTVIGWGY-DENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
G V G+G E R S LKM +P V C S+ +Q FCAG+
Sbjct: 124 TGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQ----NMFCAGY 173
>pdb|1EZQ|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr128515
pdb|1F0R|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208815
pdb|1F0S|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208707
pdb|1KSN|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Fxv673
pdb|1NFU|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr132747
pdb|1NFW|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr209685
pdb|1NFX|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208944
pdb|1NFY|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr200095
pdb|1LPG|B Chain B, Crystal Structure Of Fxa In Complex With 79.
pdb|1LPK|B Chain B, Crystal Structure Of Fxa In Complex With 125.
pdb|1LPZ|B Chain B, Crystal Structure Of Fxa In Complex With 41.
pdb|1LQD|B Chain B, Crystal Structure Of Fxa In Complex With 45.
pdb|1P0S|H Chain H, Crystal Structure Of Blood Coagulation Factor Xa In
Complex With Ecotin M84r
pdb|2BOH|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound
"1"
pdb|2CJI|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J2U|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J34|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J38|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J4I|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J94|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J95|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2UWL|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWO|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWP|A Chain A, Factor Xa Inhibitor Complex
pdb|2VH0|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Biaryl Pyrrolidin-2-Ones Incorporating Basic
Heterocyclic Motifs
pdb|2VH6|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Biaryl P4 Motifs
pdb|2WYG|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2WYJ|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2Y7X|A Chain A, The Discovery Of Potent And Long-Acting Oral Factor Xa
Inhibitors With Tetrahydroisoquinoline And Benzazepine
P4 Motifs
pdb|2Y7Z|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y80|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y81|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y82|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|4A7I|B Chain B, Factor Xa In Complex With A Potent 2-Amino-Ethane
Sulfonamide Inhibitor
Length = 254
Score = 68.9 bits (167), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 37/224 (16%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
GQ+ G+ PW L E CGG+++S Y++TAAHC+ + + +
Sbjct: 4 GQECKDGECPWQALLINEENEGF---CGGTILSEFYILTAAHCLYQ--------AKRFKV 52
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL- 141
+G + Q +EGG +V+ V + F Y DIA+L+L + + + M V P CL
Sbjct: 53 RVGDRNTEQ--EEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLP 110
Query: 142 ---WDDSTAPLQLSAVEGTSVCNGDSGGGMVF-KIDSAWYLRGIVSITVARDGLRVCDTK 197
W +ST Q + + SG G K + L+ + V R+ ++ +
Sbjct: 111 ERDWAESTLMTQKTGIV--------SGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSS- 161
Query: 198 HYVVF---------TDVANVCNGDSGGGMVFKIDSAWYLRGIVS 232
+++ T + C GDSGG V + +++ GIVS
Sbjct: 162 -FIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVS 204
Score = 49.3 bits (116), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 52/114 (45%), Gaps = 15/114 (13%)
Query: 253 DVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL----WDDSTAPLQLSAVEGR 308
+V+ V + F Y DIA+L+L + + + M V P CL W +ST Q +
Sbjct: 70 EVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQ------K 123
Query: 309 DGTVIGWGY-DENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
G V G+G E R S LKM +P V C S+ +Q FCAG+
Sbjct: 124 TGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQ----NMFCAGY 173
>pdb|1HCG|A Chain A, Structure Of Human Des(1-45) Factor Xa At 2.2 Angstroms
Resolution
pdb|3KL6|A Chain A, Discovery Of Tetrahydropyrimidin-2(1h)-One Derivative
Tak-44 Potent, Selective And Orally Active Factor Xa
Inhibitor
pdb|2XBW|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBX|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBY|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC0|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC4|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC5|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 68.6 bits (166), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 37/224 (16%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
GQ+ G+ PW L E CGG+++S Y++TAAHC+ + + +
Sbjct: 4 GQECKDGECPWQALLINEENEGF---CGGTILSEFYILTAAHCLYQ--------AKRFKV 52
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL- 141
+G + Q +EGG +V+ V + F Y DIA+L+L + + + M V P CL
Sbjct: 53 RVGDRNTEQ--EEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLP 110
Query: 142 ---WDDSTAPLQLSAVEGTSVCNGDSGGGMVF-KIDSAWYLRGIVSITVARDGLRVCDTK 197
W +ST Q + + SG G K + L+ + V R+ ++ +
Sbjct: 111 ERDWAESTLMTQKTGIV--------SGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSS- 161
Query: 198 HYVVF---------TDVANVCNGDSGGGMVFKIDSAWYLRGIVS 232
+++ T + C GDSGG V + +++ GIVS
Sbjct: 162 -FIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVS 204
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 52/114 (45%), Gaps = 15/114 (13%)
Query: 253 DVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL----WDDSTAPLQLSAVEGR 308
+V+ V + F Y DIA+L+L + + + M V P CL W +ST Q +
Sbjct: 70 EVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQ------K 123
Query: 309 DGTVIGWGY-DENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
G V G+G E R S LKM +P V C S+ +Q FCAG+
Sbjct: 124 TGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQ----NMFCAGY 173
>pdb|1FJS|A Chain A, Crystal Structure Of The Inhibitor Zk-807834 (Ci-1031)
Complexed With Factor Xa
pdb|1Z6E|A Chain A, Factor Xa In Complex With The Inhibitor
1-(3'-Amino-1,2-Benzisoxazol-
5'-Yl)-N-(4-(2'-((Dimethylamino)methyl)-1h-Imidazol-1-
Yl)-2-
Fluorophenyl)-3-(Trifluoromethyl)-1h-Pyrazole-5-
Carboxamide (Razaxaban; Dpc906; Bms-561389)
pdb|2BMG|B Chain B, Crystal Structure Of Factor Xa In Complex With 50
pdb|2FZZ|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-Amino-1,2-
Benzisoxazol-5-Yl)-6-(2'-(((3r)-3-Hydroxy-1-
Pyrrolidinyl)
Methyl)-4-Biphenylyl)-3-(Trifluoromethyl)-1,4,5,6-
Tetrahydro-7h-Pyrazolo[3,4-C]pyridin-7-One
pdb|2G00|A Chain A, Factor Xa In Complex With The Inhibitor 3-(6-(2'-
((Dimethylamino)methyl)-4-Biphenylyl)-7-Oxo-3-
(Trifluoromethyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3,4-
C]pyridin-1-Yl)benzamide
pdb|2P93|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-(2-(4-(2-
Oxopyridin-1(2h)-Yl)benzamido)ethyl)thiophene-2-
Carboxamide
pdb|2P94|A Chain A, Factor Xa In Complex With The Inhibitor
3-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido)cyclohexyl)-1h-
Indole-6-Carboxamide
pdb|2P95|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido) Cyclopentyl)
Thiophene-2-Carboxamide
pdb|2PR3|A Chain A, Factor Xa Inhibitor
pdb|2Q1J|A Chain A, The Discovery Of Glycine And Related Amino Acid-Based
Factor Xa Inhibitors
pdb|2P16|A Chain A, Factor Xa In Complex With The Inhibitor Apixaban (Bms-
562247) Aka 1-(4-Methoxyphenyl)-7-Oxo-6-(4-(2-Oxo-1-
Piperidinyl)phenyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3, 4-
C]pyridine-3-Carboxamide
pdb|2RA0|A Chain A, X-Ray Structure Of Fxa In Complex With 7-Fluoroindazole
pdb|2PHB|A Chain A, An Orally Efficacious Factor Xa Inhibitor
pdb|3CEN|A Chain A, Factor Xa In Complex With The Inhibitor
N-(2-(((5-Chloro-2- Pyridinyl)
Amino)sulfonyl)phenyl)-4-(2-Oxo-1(2h)-
Pyridinyl)benzamide
pdb|3CS7|A Chain A, Factor Xa In Complex With The Inhibitor
1-(4-Methoxyphenyl)-
6-(4-(1-(Pyrrolidin-1-Ylmethyl)cyclopropyl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|2W26|A Chain A, Factor Xa In Complex With Bay59-7939
pdb|2W3I|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-disubstituted
Pyrrolidine-1,2-dicarboxamide Inhibitor 2
pdb|2W3K|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-Disubstituted
Pyrrolidine-1,2-Dicarboxamide Inhibitor 1
pdb|3FFG|A Chain A, Factor Xa In Complex With The Inhibitor (R)-6-(2'-((3-
Hydroxypyrrolidin-1-Yl)methyl)biphenyl-4-Yl)-1-(3-(5-
Oxo-4, 5-Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|3KQB|A Chain A, Factor Xa In Complex With The Inhibitor N-(3-Fluoro-2'-
(Methylsulfonyl)biphenyl-4-Yl)-1-(3-(5-Oxo-4,
5-Dihydro-1h-
Triazol-3-Yl)phenyl)-3-(Trifluoromethyl)-1h-
Pyrazole-5-Car
pdb|3KQC|A Chain A, Factor Xa In Complex With The Inhibitor 6-(2'-
(Methylsulfon Biphenyl-4-Yl)-1-(3-(5-Oxo-4,5-Dihydro-1h-
1,2,4-Triazol-3- Phenyl)-3-(Trifluoromethyl)-5,6-
Dihydro-1h-Pyrazolo[3,4-C] 7(4h)-One
pdb|3KQD|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-(5-Oxo-4,5-
Dih 2,4-Triazol-3-Yl)phenyl)-6-(2'-(Pyrrolidin-1-
Ylmethyl)biph Yl)-3-(Trifluoromethyl)-5,6-Dihydro-
1h-Pyrazolo[3,4-C]pyri One
pdb|3KQE|A Chain A, Factor Xa In Complex With The Inhibitor 3-Methyl-1-(3-(5-
Ox Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-6-(2'-
(Pyrrolidin-1- Biphenyl-4-Yl)-5,6-Dihydro-1h-
Pyrazolo[3,4-C]pyridin-7(4h)
pdb|3LIW|A Chain A, Factor Xa In Complex With
(R)-2-(1-Adamantylcarbamoylamino)-
3-(3-Carbamidoyl-Phenyl)-N-Phenethyl-Propionic Acid
Amide
pdb|3M36|A Chain A, Factor Xa In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3M37|A Chain A, Factor Xa In Complex With The Inhibitor 1-[2-(Aminomethyl)
Phenyl]-N-(3-Fluoro-2'-Sulfamoylbiphenyl-4-Yl)-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc602)
Length = 234
Score = 68.6 bits (166), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 37/224 (16%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
GQ+ G+ PW L E CGG+++S Y++TAAHC+ + + +
Sbjct: 4 GQECKDGECPWQALLINEENEGF---CGGTILSEFYILTAAHCLYQ--------AKRFKV 52
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL- 141
+G + Q +EGG +V+ V + F Y DIA+L+L + + + M V P CL
Sbjct: 53 RVGDRNTEQ--EEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLP 110
Query: 142 ---WDDSTAPLQLSAVEGTSVCNGDSGGGMVF-KIDSAWYLRGIVSITVARDGLRVCDTK 197
W +ST Q + + SG G K + L+ + V R+ ++ +
Sbjct: 111 ERDWAESTLMTQKTGIV--------SGFGRTHEKGRQSTRLKMLEVPYVDRNSCKL--SS 160
Query: 198 HYVVF---------TDVANVCNGDSGGGMVFKIDSAWYLRGIVS 232
+++ T + C GDSGG V + +++ GIVS
Sbjct: 161 SFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVS 204
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 52/114 (45%), Gaps = 15/114 (13%)
Query: 253 DVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL----WDDSTAPLQLSAVEGR 308
+V+ V + F Y DIA+L+L + + + M V P CL W +ST Q +
Sbjct: 70 EVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQ------K 123
Query: 309 DGTVIGWGY-DENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
G V G+G E R S LKM +P V C S+ +Q FCAG+
Sbjct: 124 TGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQ----NMFCAGY 173
>pdb|1MQ5|A Chain A, Crystal Structure Of
3-chloro-n-[4-chloro-2-[[(4-chlorophenyl)
Amino]carbonyl]phenyl]-4-[(4-methyl-1-
piperazinyl)methyl]-2- Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1MQ6|A Chain A, Crystal Structure Of
3-Chloro-N-[4-Chloro-2-[[(5-Chloro-2-Pyridinyl)
Amino]carbonyl]-6-Methoxyphenyl]-4-[[(4,
5-Dihydro-2-Oxazolyl)
Methylamino]methyl]-2-Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1V3X|A Chain A, Factor Xa In Complex With The Inhibitor
1-[6-Methyl-4,5,6,7-
Tetrahydrothiazolo(5,4-C)pyridin-2-Yl] Carbonyl-2-
Carbamoyl-4-(6-Chloronaphth-2-Ylsulphonyl)piperazine
pdb|1WU1|A Chain A, Factor Xa In Complex With The Inhibitor
4-[(5-Chloroindol-2-Yl)
Sulfonyl]-2-(2-Methylpropyl)-1-[[5-(Pyridin-4-Yl)
Pyrimidin-2- Yl]carbonyl]piperazine
pdb|2D1J|A Chain A, Factor Xa In Complex With The Inhibitor 2-[[4-[(5-
Chloroindol-2-Yl)sulfonyl]piperazin-1-Yl]
Carbonyl]thieno[3,2-B]pyridine N-Oxide
pdb|2H9E|H Chain H, Crystal Structure Of FxaSELECTIDENAPC2 TERNARY COMPLEX
pdb|2P3U|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-N-(4-Chloro-2-{[(5-Chloropyridin-2-Yl)
Amino]carbonyl}-6-Methoxyphenyl)-4-[(1-Methyl-1h-
Imidazol- 2-Yl)methyl]thiophene-2-Carboxamide {pfizer
320663}
pdb|2P3T|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-4-(2-Methylamino-Imidazol-1-Ylmethyl)-Thiophene-
2- Carboxylic Acid [4-Chloro-2-(5-Chloro-Pyridin-2-
Ylcarbamoyl)-6-Methoxy-Phenyl]-Amide
pdb|2EI6|A Chain A, Factor Xa In Complex With The Inhibitor (-)-Cis-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI7|A Chain A, Factor Xa In Complex With The Inhibitor Trans-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI8|A Chain A, Factor Xa In Complex With The Inhibitor (1s,2r,4s)-N1-[(5-
Chloroindol-2-Yl)carbonyl]-4-(N,N-Dimethylcarbamoyl)-N2-
[(5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,
4-C]pyridin-2-Yl) Carbonyl]-1,2-Cyclohexanediamine
pdb|3IIT|A Chain A, Factor Xa In Complex With A Cis-1,2-Diaminocyclohexane
Derivative
pdb|3Q3K|A Chain A, Factor Xa In Complex With A Phenylenediamine Derivative
pdb|3TK5|A Chain A, Factor Xa In Complex With D102-4380
pdb|3TK6|A Chain A, Factor Xa In Complex With D46-5241
Length = 233
Score = 68.6 bits (166), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 37/224 (16%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
GQ+ G+ PW L E CGG+++S Y++TAAHC+ + + +
Sbjct: 4 GQECKDGECPWQALLINEENEGF---CGGTILSEFYILTAAHCLYQ--------AKRFKV 52
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL- 141
+G + Q +EGG +V+ V + F Y DIA+L+L + + + M V P CL
Sbjct: 53 RVGDRNTEQ--EEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLP 110
Query: 142 ---WDDSTAPLQLSAVEGTSVCNGDSGGGMVF-KIDSAWYLRGIVSITVARDGLRVCDTK 197
W +ST Q + + SG G K + L+ + V R+ ++ +
Sbjct: 111 ERDWAESTLMTQKTGIV--------SGFGRTHEKGRQSTRLKMLEVPYVDRNSCKL--SS 160
Query: 198 HYVVF---------TDVANVCNGDSGGGMVFKIDSAWYLRGIVS 232
+++ T + C GDSGG V + +++ GIVS
Sbjct: 161 SFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVS 204
Score = 49.3 bits (116), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 52/114 (45%), Gaps = 15/114 (13%)
Query: 253 DVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL----WDDSTAPLQLSAVEGR 308
+V+ V + F Y DIA+L+L + + + M V P CL W +ST Q +
Sbjct: 70 EVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQ------K 123
Query: 309 DGTVIGWGY-DENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
G V G+G E R S LKM +P V C S+ +Q FCAG+
Sbjct: 124 TGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQ----NMFCAGY 173
>pdb|1XKA|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|D Chain D, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1G2L|A Chain A, Factor Xa Inhibitor Complex
pdb|1G2M|A Chain A, Factor Xa Inhibitor Complex
pdb|1IOE|A Chain A, Human Coagulation Factor Xa In Complex With M55532
pdb|1IQE|A Chain A, Human Coagulation Factor Xa In Complex With M55590
pdb|1IQF|A Chain A, Human Coagulation Factor Xa In Complex With M55165
pdb|1IQG|A Chain A, Human Coagulation Factor Xa In Complex With M55159
pdb|1IQH|A Chain A, Human Coagulation Factor Xa In Complex With M55143
pdb|1IQI|A Chain A, Human Coagulation Factor Xa In Complex With M55125
pdb|1IQJ|A Chain A, Human Coagulation Factor Xa In Complex With M55124
pdb|1IQK|A Chain A, Human Coagulation Factor Xa In Complex With M55113
pdb|1IQL|A Chain A, Human Coagulation Factor Xa In Complex With M54476
pdb|1IQM|A Chain A, Human Coagulation Factor Xa In Complex With M54471
pdb|1IQN|A Chain A, Human Coagulation Factor Xa In Complex With M55192
pdb|2P3F|H Chain H, Crystal Structure Of The Factor XaNAP5 COMPLEX
Length = 235
Score = 68.6 bits (166), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 37/224 (16%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
GQ+ G+ PW L E CGG+++S Y++TAAHC+ + + +
Sbjct: 4 GQECKDGECPWQALLINEENEGF---CGGTILSEFYILTAAHCLYQ--------AKRFKV 52
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL- 141
+G + Q +EGG +V+ V + F Y DIA+L+L + + + M V P CL
Sbjct: 53 RVGDRNTEQ--EEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLP 110
Query: 142 ---WDDSTAPLQLSAVEGTSVCNGDSGGGMVF-KIDSAWYLRGIVSITVARDGLRVCDTK 197
W +ST Q + + SG G K + L+ + V R+ ++ +
Sbjct: 111 ERDWAESTLMTQKTGIV--------SGFGRTHEKGRQSTRLKMLEVPYVDRNSCKL--SS 160
Query: 198 HYVVF---------TDVANVCNGDSGGGMVFKIDSAWYLRGIVS 232
+++ T + C GDSGG V + +++ GIVS
Sbjct: 161 SFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVS 204
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 52/114 (45%), Gaps = 15/114 (13%)
Query: 253 DVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL----WDDSTAPLQLSAVEGR 308
+V+ V + F Y DIA+L+L + + + M V P CL W +ST Q +
Sbjct: 70 EVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQ------K 123
Query: 309 DGTVIGWGY-DENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
G V G+G E R S LKM +P V C S+ +Q FCAG+
Sbjct: 124 TGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQ----NMFCAGY 173
>pdb|3ENS|B Chain B, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3ENS|D Chain D, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3HPT|B Chain B, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3HPT|D Chain D, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3K9X|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3K9X|D Chain D, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3SW2|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
6-Chloro-N-((3s)-
2-Oxo-1-(2-Oxo-2-((5s)-8-Oxo-5,6-Dihydro-1h-1,
5-Methanopyrido[1,2-
A][1,5]diazocin-3(2h,4h,
8h)-Yl)ethyl)piperidin-3-Yl)naphthalene-2- Sulfonamide
Length = 238
Score = 68.6 bits (166), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 37/224 (16%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
GQ+ G+ PW L E CGG+++S Y++TAAHC+ + + +
Sbjct: 4 GQECKDGECPWQALLINEENEGF---CGGTILSEFYILTAAHCLYQ--------AKRFKV 52
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL- 141
+G + Q +EGG +V+ V + F Y DIA+L+L + + + M V P CL
Sbjct: 53 RVGDRNTEQ--EEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLP 110
Query: 142 ---WDDSTAPLQLSAVEGTSVCNGDSGGGMVF-KIDSAWYLRGIVSITVARDGLRVCDTK 197
W +ST Q + + SG G K + L+ + V R+ ++ +
Sbjct: 111 ERDWAESTLMTQKTGIV--------SGFGRTHEKGRQSTRLKMLEVPYVDRNSCKL--SS 160
Query: 198 HYVVF---------TDVANVCNGDSGGGMVFKIDSAWYLRGIVS 232
+++ T + C GDSGG V + +++ GIVS
Sbjct: 161 SFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVS 204
Score = 49.3 bits (116), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 52/114 (45%), Gaps = 15/114 (13%)
Query: 253 DVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL----WDDSTAPLQLSAVEGR 308
+V+ V + F Y DIA+L+L + + + M V P CL W +ST Q +
Sbjct: 70 EVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQ------K 123
Query: 309 DGTVIGWGY-DENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
G V G+G E R S LKM +P V C S+ +Q FCAG+
Sbjct: 124 TGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQ----NMFCAGY 173
>pdb|2GD4|H Chain H, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
pdb|2GD4|B Chain B, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
Length = 241
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 58/224 (25%), Positives = 99/224 (44%), Gaps = 37/224 (16%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
GQ+ G+ PW L E CGG+++S Y++TAAHC+ + + +
Sbjct: 4 GQECKDGECPWQALLINEENEGF---CGGTILSEFYILTAAHCLYQ--------AKRFKV 52
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL- 141
+G + Q +EGG +V+ V + F Y DIA+L+L + + + M V P CL
Sbjct: 53 RVGDRNTEQ--EEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLP 110
Query: 142 ---WDDSTAPLQLSAVEGTSVCNGDSGGGMVF-KIDSAWYLRGIVSITVARDGLRVCDTK 197
W +ST Q + + SG G K + L+ + V R+ ++ +
Sbjct: 111 ERDWAESTLMTQKTGIV--------SGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSS- 161
Query: 198 HYVVF---------TDVANVCNGDSGGGMVFKIDSAWYLRGIVS 232
+++ T + C GD+GG V + +++ GIVS
Sbjct: 162 -FIITQNMFCAGYDTKQEDACQGDAGGPHVTRFKDTYFVTGIVS 204
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 52/114 (45%), Gaps = 15/114 (13%)
Query: 253 DVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL----WDDSTAPLQLSAVEGR 308
+V+ V + F Y DIA+L+L + + + M V P CL W +ST Q +
Sbjct: 70 EVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQ------K 123
Query: 309 DGTVIGWGY-DENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
G V G+G E R S LKM +P V C S+ +Q FCAG+
Sbjct: 124 TGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQ----NMFCAGY 173
>pdb|1SGF|A Chain A, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|X Chain X, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 240
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 58/197 (29%), Positives = 87/197 (44%), Gaps = 40/197 (20%)
Query: 32 PWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQ 91
PWHVA+YR Y CGG L+ N+V+TAAHC +D ++LGK +
Sbjct: 16 PWHVAVYRFN----KYQCGGVLLDRNWVLTAAHCY----------NDKYQVWLGK--NNF 59
Query: 92 FSDEGGVQNKQVKRVHIYPTFNSS-----------NYLGDIALLQLSSDVDYSMYVRPVC 140
DE Q++ V + +P FN S +Y D+ LL+LS D + V+P+
Sbjct: 60 LEDEPSDQHRLVSKAIPHPDFNMSLLNEHTPQPEDDYSNDLMLLRLSKPADITDVVKPI- 118
Query: 141 LWDDSTAPLQLSAVEGTSVCNG-DSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHY 199
T P + + T + +G S + FK Y + + + CD H
Sbjct: 119 -----TLPTEEPKLGSTCLASGWGSTTPIKFK-----YPDDLQCVNLKLLPNEDCDKAHE 168
Query: 200 VVFTDVANVCNGDSGGG 216
+ TD A +C G+ GG
Sbjct: 169 MKVTD-AMLCAGEMDGG 184
>pdb|2WPM|S Chain S, Factor Ixa Superactive Mutant, Egr-Cmk Inhibited
Length = 235
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 62/227 (27%), Positives = 97/227 (42%), Gaps = 37/227 (16%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
V G+ GQ+PW V L + CGGS+V+ +++TAAHC V++
Sbjct: 1 VVGGEDAKPGQFPWQVVLNG----KVDAFCGGSIVNEKWIVTAAHC---------VETGV 47
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSS--NYLGDIALLQLSSDVDYSMYVR 137
+ + H + E Q + V R+ + FN++ Y DIALL+L + + YV
Sbjct: 48 KITVVAGEHNIE-ETEHTEQKRNVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVT 106
Query: 138 PVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTK 197
P+C+ D + L G SG G VF A + + + + + TK
Sbjct: 107 PICIADKEYTNIFLKFGSGYV-----SGWGRVFHKGRAALVLQYLRVPLVDRATCLRSTK 161
Query: 198 HYVVFTDVANV------------CNGDSGGGMVFKIDSAWYLRGIVS 232
FT N+ C GDSGG V +++ +L GI+S
Sbjct: 162 ----FTITNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIIS 204
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 42/136 (30%), Positives = 64/136 (47%), Gaps = 12/136 (8%)
Query: 231 VSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSS--NYLGDIALLQLSSDVDYSMYVR 288
V ITV + +T+H +V R+ + FN++ Y DIALL+L + + YV
Sbjct: 47 VKITVVAGEHNIEETEHTEQKRNVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVT 106
Query: 289 PVCLWDDSTAPLQLSAVEGRDGTVIGWG-YDENDRVSEELKMAIMPIVSHQQCLWSNPQF 347
P+C+ D + L G V GWG R + L+ +P+V CL S
Sbjct: 107 PICIADKEYTNIFLKF---GSGYVSGWGRVFHKGRAALVLQYLRVPLVDRATCLRS---- 159
Query: 348 FSQFT-SDETFCAGFR 362
++FT ++ FCAGF
Sbjct: 160 -TKFTITNNMFCAGFH 174
>pdb|1FAX|A Chain A, Coagulation Factor Xa Inhibitor Complex
Length = 254
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 37/224 (16%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
GQ+ G+ PW L E CGG+++S Y++TAAHC+ + K D
Sbjct: 4 GQECKDGECPWQALLINEENEGF---CGGTILSEFYILTAAHCLYQAKRFKVRVGD---- 56
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL- 141
++ ++EGG +V+ V + F Y DIA+L+L + + + M V P CL
Sbjct: 57 ------RNTAAEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLP 110
Query: 142 ---WDDSTAPLQLSAVEGTSVCNGDSGGGMVF-KIDSAWYLRGIVSITVARDGLRVCDTK 197
W +ST Q + + SG G K + L+ + V R+ ++ +
Sbjct: 111 ERDWAESTLMTQKTGIV--------SGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSS- 161
Query: 198 HYVVF---------TDVANVCNGDSGGGMVFKIDSAWYLRGIVS 232
+++ T + C GDSGG V + +++ GIVS
Sbjct: 162 -FIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVS 204
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 52/114 (45%), Gaps = 15/114 (13%)
Query: 253 DVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL----WDDSTAPLQLSAVEGR 308
+V+ V + F Y DIA+L+L + + + M V P CL W +ST Q +
Sbjct: 70 EVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQ------K 123
Query: 309 DGTVIGWGY-DENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
G V G+G E R S LKM +P V C S+ +Q FCAG+
Sbjct: 124 TGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQ----NMFCAGY 173
>pdb|1ZHM|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Coagulation Factor Xia In Complex With Benzamidine
(s434a- T475a-k437 Mutant)
Length = 238
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 83/212 (39%), Gaps = 59/212 (27%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G + RG+WPW V L+ T ++CGGS++ +++TAAHC K L +
Sbjct: 4 GTASVRGEWPWQVTLHTTSPTQ-RHLCGGSIIGNQWILTAAHCFYGVESPK-----ILRV 57
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL- 141
Y G +Q + +++ Q +H S Y DIALL+L + V+Y+ RP+CL
Sbjct: 58 YSGILNQAEIAEDTSFFGVQEIIIHDQYKMAESGY--DIALLKLETTVNYADSQRPICLP 115
Query: 142 ------------W----------DDSTAPLQLSAVE------------------------ 155
W D LQ + +
Sbjct: 116 SKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAG 175
Query: 156 ----GTSVCNGDSGGGMVFKIDSAWYLRGIVS 183
G C GDSGG + K + W+L GI S
Sbjct: 176 YREGGKDACKGDSGGPLSCKHNEVWHLVGITS 207
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 31/114 (27%), Positives = 58/114 (50%), Gaps = 9/114 (7%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F V+ + I+ + + DIALL+L + V+Y+ RP+CL + + D
Sbjct: 73 FFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPICLPSKGDRNVIYT-----DC 127
Query: 311 TVIGWGYDE-NDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFRN 363
V GWGY + D++ L+ A +P+V++++C ++ + + CAG+R
Sbjct: 128 WVTGWGYRKLRDKIQNTLQKAKIPLVTNEEC---QKRYRGHKITHKMICAGYRE 178
>pdb|1RJX|B Chain B, Human Plasminogen Catalytic Domain, K698m Mutant
Length = 247
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 26/208 (12%)
Query: 31 WPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQH 90
WPW V+L G++ CGG+L+S +V+TAAHC+ K P + + LG + +
Sbjct: 29 WPWQVSLRTRFGMHF---CGGTLISPEWVLTAAHCLEKSP-----RPSSYKVILGAHQEV 80
Query: 91 QFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDS--TAP 148
E VQ +V R+ + PT DIALL+LSS + V P CL + A
Sbjct: 81 NL--EPHVQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVIPACLPSPNYVVAD 132
Query: 149 LQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTK----HYVVFTD 204
+ G G G G++ + + + +G RV T+ H TD
Sbjct: 133 RTECFITGWGETQGTFGAGLLMEAQLPVIENKVCNRYEFLNG-RVQSTELCAGHLAGGTD 191
Query: 205 VANVCNGDSGGGMVFKIDSAWYLRGIVS 232
C GDSGG +V + L+G+ S
Sbjct: 192 ---SCQGDSGGPLVCFEKDKYILQGVTS 216
Score = 33.9 bits (76), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 32/118 (27%), Positives = 50/118 (42%), Gaps = 15/118 (12%)
Query: 244 DTKHYVVFTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLS 303
+ + +V +V R+ + PT DIALL+LSS + V P CL P
Sbjct: 81 NLEPHVQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVIPACL------PSPNY 128
Query: 304 AVEGRDGTVI-GWGYDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
V R I GWG + + L A +P++ ++ C + +F + CAG
Sbjct: 129 VVADRTECFITGWGETQGTFGAGLLMEAQLPVIENKVC--NRYEFLNGRVQSTELCAG 184
>pdb|1ZHP|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine (S434a-T475a-K505
Mutant)
Length = 238
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/216 (27%), Positives = 92/216 (42%), Gaps = 18/216 (8%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G + RG+WPW V L+ T ++CGGS++ +++TAAHC K L +
Sbjct: 4 GTASVRGEWPWQVTLHTTSPTQ-RHLCGGSIIGNQWILTAAHCFYGVESPK-----ILRV 57
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLW 142
Y G +Q + ++ Q +H S Y DIALL+L + V+Y+ RP+CL
Sbjct: 58 YSGILNQAEIKEDTSFFGVQEIIIHDQYKMAESGY--DIALLKLETTVNYADSQRPICL- 114
Query: 143 DDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTK--HYV 200
+ + + G + KI + I +T R K H +
Sbjct: 115 ---PSKGDRNVIYTDCWVTGWGYRALRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKM 171
Query: 201 VFTDV----ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
+ + C GDSGG + K + W+L GI S
Sbjct: 172 ICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITS 207
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 33/125 (26%), Positives = 60/125 (48%), Gaps = 9/125 (7%)
Query: 240 LRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAP 299
L + K F V+ + I+ + + DIALL+L + V+Y+ RP+CL
Sbjct: 62 LNQAEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPICLPSKGDRN 121
Query: 300 LQLSAVEGRDGTVIGWGYDE-NDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFC 358
+ + D V GWGY D++ L+ A +P+V++++C ++ + + C
Sbjct: 122 VIYT-----DCWVTGWGYRALRDKIQNTLQKAKIPLVTNEEC---QKRYRGHKITHKMIC 173
Query: 359 AGFRN 363
AG+R
Sbjct: 174 AGYRE 178
>pdb|1XX9|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
pdb|1XX9|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
Length = 238
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 82/212 (38%), Gaps = 59/212 (27%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G + RG+WPW V L+ T ++CGGS++ +++TAAHC K L +
Sbjct: 4 GTASVRGEWPWQVTLHTTSPTQ-RHLCGGSIIGNQWILTAAHCFYGVESPK-----ILRV 57
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL- 141
Y G +Q + ++ Q +H S Y DIALL+L + V+Y+ RP+CL
Sbjct: 58 YSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGY--DIALLKLETTVNYTDSQRPICLP 115
Query: 142 ------------W----------DDSTAPLQLSAVE------------------------ 155
W D LQ + +
Sbjct: 116 SKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAG 175
Query: 156 ----GTSVCNGDSGGGMVFKIDSAWYLRGIVS 183
G C GDSGG + K + W+L GI S
Sbjct: 176 YREGGKDACKGDSGGPLSCKHNEVWHLVGITS 207
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 33/125 (26%), Positives = 61/125 (48%), Gaps = 9/125 (7%)
Query: 240 LRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAP 299
L + K F V+ + I+ + + DIALL+L + V+Y+ RP+CL
Sbjct: 62 LNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRN 121
Query: 300 LQLSAVEGRDGTVIGWGYDE-NDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFC 358
+ + D V GWGY + D++ L+ A +P+V++++C ++ + + C
Sbjct: 122 VIYT-----DCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEEC---QKRYRGHKITHKMIC 173
Query: 359 AGFRN 363
AG+R
Sbjct: 174 AGYRE 178
>pdb|1XXD|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXD|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXF|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
pdb|1XXF|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
Length = 238
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 82/212 (38%), Gaps = 59/212 (27%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G + RG+WPW V L+ T ++CGGS++ +++TAAHC K L +
Sbjct: 4 GTASVRGEWPWQVTLHTTSPTQ-RHLCGGSIIGNQWILTAAHCFYGVESPK-----ILRV 57
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL- 141
Y G +Q + ++ Q +H S Y DIALL+L + V+Y+ RP+CL
Sbjct: 58 YSGILNQAEIKEDTSFFGVQEIIIHDQYKMAESGY--DIALLKLETTVNYADSQRPICLP 115
Query: 142 ------------W----------DDSTAPLQLSAVE------------------------ 155
W D LQ + +
Sbjct: 116 SKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAG 175
Query: 156 ----GTSVCNGDSGGGMVFKIDSAWYLRGIVS 183
G C GDSGG + K + W+L GI S
Sbjct: 176 YREGGKDACKGDSGGPLSCKHNEVWHLVGITS 207
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 33/125 (26%), Positives = 61/125 (48%), Gaps = 9/125 (7%)
Query: 240 LRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAP 299
L + K F V+ + I+ + + DIALL+L + V+Y+ RP+CL
Sbjct: 62 LNQAEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPICLPSKGDRN 121
Query: 300 LQLSAVEGRDGTVIGWGYDE-NDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFC 358
+ + D V GWGY + D++ L+ A +P+V++++C ++ + + C
Sbjct: 122 VIYT-----DCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEEC---QKRYRGHKITHKMIC 173
Query: 359 AGFRN 363
AG+R
Sbjct: 174 AGYRE 178
>pdb|2WPH|S Chain S, Factor Ixa Superactive Triple Mutant
pdb|2WPJ|S Chain S, Factor Ixa Superactive Triple Mutant, Nacl-Soaked
pdb|2WPK|S Chain S, Factor Ixa Superactive Triple Mutant, Ethylene
Glycol-Soaked
pdb|2WPL|S Chain S, Factor Ixa Superactive Triple Mutant, Edta-Soaked
Length = 235
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 37/227 (16%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
V G+ GQ+PW V L + CGGS+V+ +++TAAHC V++
Sbjct: 1 VVGGEDAKPGQFPWQVVLNG----KVDAFCGGSIVNEKWIVTAAHC---------VETGV 47
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSS--NYLGDIALLQLSSDVDYSMYVR 137
+ + H + E Q + V R+ + FN++ Y DIALL+L + + YV
Sbjct: 48 KITVVAGEHNIE-ETEHTEQKRNVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVT 106
Query: 138 PVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTK 197
P+C+ D + L G SG G VF + + + + + + TK
Sbjct: 107 PICIADKEYTNIFLKFGSGYV-----SGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTK 161
Query: 198 HYVVFTDVANV------------CNGDSGGGMVFKIDSAWYLRGIVS 232
FT N+ C GDSGG V +++ +L GI+S
Sbjct: 162 ----FTITNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIIS 204
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 42/136 (30%), Positives = 64/136 (47%), Gaps = 12/136 (8%)
Query: 231 VSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSS--NYLGDIALLQLSSDVDYSMYVR 288
V ITV + +T+H +V R+ + FN++ Y DIALL+L + + YV
Sbjct: 47 VKITVVAGEHNIEETEHTEQKRNVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVT 106
Query: 289 PVCLWDDSTAPLQLSAVEGRDGTVIGWG-YDENDRVSEELKMAIMPIVSHQQCLWSNPQF 347
P+C+ D + L G V GWG R + L+ +P+V CL S
Sbjct: 107 PICIADKEYTNIFLKF---GSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRS---- 159
Query: 348 FSQFT-SDETFCAGFR 362
++FT ++ FCAGF
Sbjct: 160 -TKFTITNNMFCAGFH 174
>pdb|4DUR|A Chain A, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUR|B Chain B, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUU|A Chain A, The X-Ray Crystal Structure Of Full-Length Type I Human
Plasminogen
pdb|4A5T|S Chain S, Structural Basis For The Conformational Modulation
Length = 791
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 63/214 (29%), Positives = 91/214 (42%), Gaps = 38/214 (17%)
Query: 31 WPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQH 90
WPW V+L G+ + CGG+L+S +V+TAAHC+ K P + + LG + +
Sbjct: 573 WPWQVSLRTRFGM---HFCGGTLISPEWVLTAAHCLEKSPR-----PSSYKVILGAHQEV 624
Query: 91 QFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDS--TAP 148
E VQ +V R+ + PT DIALL+LSS + V P CL + A
Sbjct: 625 NL--EPHVQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVIPACLPSPNYVVAD 676
Query: 149 LQLSAVEGTSVCNGDSGGGMVFK----------IDSAWYLRGIVSITVARDGLRVCDTKH 198
+ G G G G++ + + +L G V T G H
Sbjct: 677 RTECFITGWGETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAG-------H 729
Query: 199 YVVFTDVANVCNGDSGGGMVFKIDSAWYLRGIVS 232
TD C GDSGG +V + L+G+ S
Sbjct: 730 LAGGTD---SCQGDSGGPLVCFEKDKYILQGVTS 760
Score = 34.3 bits (77), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 33/114 (28%), Positives = 49/114 (42%), Gaps = 15/114 (13%)
Query: 248 YVVFTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEG 307
+V +V R+ + PT DIALL+LSS + V P CL P V
Sbjct: 629 HVQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVIPACL------PSPNYVVAD 676
Query: 308 RDGTVI-GWGYDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
R I GWG + + LK A +P++ ++ C + +F + CAG
Sbjct: 677 RTECFITGWGETQGTFGAGLLKEAQLPVIENKVC--NRYEFLNGRVQSTELCAG 728
>pdb|1BUI|A Chain A, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
pdb|1BUI|B Chain B, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
Length = 250
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 26/208 (12%)
Query: 31 WPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQH 90
WPW V+L G++ CGG+L+S +V+TAAHC+ K P + + LG + +
Sbjct: 32 WPWQVSLRTRFGMHF---CGGTLISPEWVLTAAHCLEKSP-----RPSSYKVILGAHQEV 83
Query: 91 QFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDS--TAP 148
E VQ +V R+ + PT DIALL+LSS + V P CL + A
Sbjct: 84 NL--EPHVQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVIPACLPSPNYVVAD 135
Query: 149 LQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTK----HYVVFTD 204
+ G G G G++ + + + +G RV T+ H TD
Sbjct: 136 RTECFITGWGETQGTFGAGLLKEAQLPVIENKVCNRYEFLNG-RVQSTELCAGHLAGGTD 194
Query: 205 VANVCNGDSGGGMVFKIDSAWYLRGIVS 232
C GDSGG +V + L+G+ S
Sbjct: 195 ---SCQGDSGGPLVCFEKDKYILQGVTS 219
Score = 36.2 bits (82), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 33/118 (27%), Positives = 51/118 (43%), Gaps = 15/118 (12%)
Query: 244 DTKHYVVFTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLS 303
+ + +V +V R+ + PT DIALL+LSS + V P CL P
Sbjct: 84 NLEPHVQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVIPACL------PSPNY 131
Query: 304 AVEGRDGTVI-GWGYDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
V R I GWG + + LK A +P++ ++ C + +F + CAG
Sbjct: 132 VVADRTECFITGWGETQGTFGAGLLKEAQLPVIENKVC--NRYEFLNGRVQSTELCAG 187
>pdb|3UIR|A Chain A, Crystal Structure Of The Plasmin-Textilinin-1 Complex
pdb|3UIR|B Chain B, Crystal Structure Of The Plasmin-Textilinin-1 Complex
Length = 247
Score = 65.1 bits (157), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 26/208 (12%)
Query: 31 WPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQH 90
WPW V+L G++ CGG+L+S +V+TAAHC+ K P + + LG + +
Sbjct: 29 WPWQVSLRTRFGMHF---CGGTLISPEWVLTAAHCLEKSP-----RPSSYKVILGAHQEV 80
Query: 91 QFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDS--TAP 148
E VQ +V R+ + PT DIALL+LSS + V P CL + A
Sbjct: 81 NL--EPHVQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVIPACLPSPNYVVAD 132
Query: 149 LQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTK----HYVVFTD 204
+ G G G G++ + + + +G RV T+ H TD
Sbjct: 133 RTECFITGWGETQGTFGAGLLKEAQLPVIENKVCNRYEFLNG-RVQSTELCAGHLAGGTD 191
Query: 205 VANVCNGDSGGGMVFKIDSAWYLRGIVS 232
C GDSGG +V + L+G+ S
Sbjct: 192 ---SCQGDSGGPLVCFEKDKYILQGVTS 216
Score = 36.2 bits (82), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 33/118 (27%), Positives = 51/118 (43%), Gaps = 15/118 (12%)
Query: 244 DTKHYVVFTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLS 303
+ + +V +V R+ + PT DIALL+LSS + V P CL P
Sbjct: 81 NLEPHVQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVIPACL------PSPNY 128
Query: 304 AVEGRDGTVI-GWGYDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
V R I GWG + + LK A +P++ ++ C + +F + CAG
Sbjct: 129 VVADRTECFITGWGETQGTFGAGLLKEAQLPVIENKVC--NRYEFLNGRVQSTELCAG 184
>pdb|1RFN|A Chain A, Human Coagulation Factor Ixa In Complex With P-Amino
Benzamidine
pdb|3LC3|A Chain A, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC3|C Chain C, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC5|A Chain A, Selective Benzothiophine Inhibitors Of Factor Ixa
Length = 235
Score = 64.7 bits (156), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 57/224 (25%), Positives = 99/224 (44%), Gaps = 31/224 (13%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
V G+ GQ+PW V L + CGGS+V+ +++TAAHC V++
Sbjct: 1 VVGGEDAKPGQFPWQVVLNG----KVDAFCGGSIVNEKWIVTAAHC---------VETGV 47
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSS--NYLGDIALLQLSSDVDYSMYVR 137
+ + H + E Q + V R+ + +N++ Y DIALL+L + + YV
Sbjct: 48 KITVVAGEHNIE-ETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVT 106
Query: 138 PVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTK 197
P+C+ D + L G SG G VF + + + + + + TK
Sbjct: 107 PICIADKEYTNIFLKFGSGYV-----SGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTK 161
Query: 198 HYVVFTDV---------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
+ ++ ++ + C GDSGG V +++ +L GI+S
Sbjct: 162 -FTIYNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIIS 204
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/136 (30%), Positives = 63/136 (46%), Gaps = 12/136 (8%)
Query: 231 VSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSS--NYLGDIALLQLSSDVDYSMYVR 288
V ITV + +T+H +V R+ + +N++ Y DIALL+L + + YV
Sbjct: 47 VKITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVT 106
Query: 289 PVCLWDDSTAPLQLSAVEGRDGTVIGWG-YDENDRVSEELKMAIMPIVSHQQCLWSNPQF 347
P+C+ D + L G V GWG R + L+ +P+V CL S
Sbjct: 107 PICIADKEYTNIFLKF---GSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRS---- 159
Query: 348 FSQFT-SDETFCAGFR 362
++FT + FCAGF
Sbjct: 160 -TKFTIYNNMFCAGFH 174
>pdb|1BML|A Chain A, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
pdb|1BML|B Chain B, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
Length = 250
Score = 64.7 bits (156), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 26/208 (12%)
Query: 31 WPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQH 90
WPW V+L G++ CGG+L+S +V+TAAHC+ K P + + LG + +
Sbjct: 32 WPWQVSLRTRFGMHF---CGGTLISPEWVLTAAHCLEKSP-----RPSSYKVILGAHQEV 83
Query: 91 QFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDS--TAP 148
E VQ +V R+ + PT DIALL+LSS + V P CL + A
Sbjct: 84 NL--EPHVQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVIPACLPSPNYVVAD 135
Query: 149 LQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTK----HYVVFTD 204
+ G G G G++ + + + +G RV T+ H TD
Sbjct: 136 RTECFITGWGETQGTFGAGLLKEAQLPVIENKVCNRYEFLNG-RVQSTELCAGHLAGGTD 194
Query: 205 VANVCNGDSGGGMVFKIDSAWYLRGIVS 232
C GD+GG +V + L+G+ S
Sbjct: 195 ---SCQGDAGGPLVCFEKDKYILQGVTS 219
Score = 36.2 bits (82), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 33/118 (27%), Positives = 51/118 (43%), Gaps = 15/118 (12%)
Query: 244 DTKHYVVFTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLS 303
+ + +V +V R+ + PT DIALL+LSS + V P CL P
Sbjct: 84 NLEPHVQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVIPACL------PSPNY 131
Query: 304 AVEGRDGTVI-GWGYDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
V R I GWG + + LK A +P++ ++ C + +F + CAG
Sbjct: 132 VVADRTECFITGWGETQGTFGAGLLKEAQLPVIENKVC--NRYEFLNGRVQSTELCAG 187
>pdb|1QRZ|A Chain A, Catalytic Domain Of Plasminogen
pdb|1QRZ|B Chain B, Catalytic Domain Of Plasminogen
pdb|1QRZ|C Chain C, Catalytic Domain Of Plasminogen
pdb|1QRZ|D Chain D, Catalytic Domain Of Plasminogen
Length = 246
Score = 64.7 bits (156), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 62/208 (29%), Positives = 91/208 (43%), Gaps = 26/208 (12%)
Query: 31 WPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQH 90
WPW V+L G + CGG+L+S +V+TAAHC+ K P + + LG + +
Sbjct: 28 WPWQVSLRTRFG---QHFCGGTLISPEWVLTAAHCLEKSP-----RPSSYKVILGAHQEV 79
Query: 91 QFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDS--TAP 148
E VQ +V R+ + PT DIALL+LSS + V P CL + A
Sbjct: 80 NL--EPHVQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVIPACLPSPNYMVAD 131
Query: 149 LQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTK----HYVVFTD 204
+ G G G G++ + + + +G RV T+ H TD
Sbjct: 132 RTECFITGWGETQGTFGAGLLKEAQLPVIENKVCNRYEFLNG-RVQSTELCAGHLAGGTD 190
Query: 205 VANVCNGDSGGGMVFKIDSAWYLRGIVS 232
C GDSGG +V + L+G+ S
Sbjct: 191 ---SCQGDSGGPLVCFEKDKYILQGVTS 215
Score = 36.6 bits (83), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 31/117 (26%), Positives = 54/117 (46%), Gaps = 13/117 (11%)
Query: 244 DTKHYVVFTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLS 303
+ + +V +V R+ + PT DIALL+LSS + V P CL +P +
Sbjct: 80 NLEPHVQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVIPACL----PSPNYMV 129
Query: 304 AVEGRDGTVIGWGYDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
A + + + GWG + + LK A +P++ ++ C + +F + CAG
Sbjct: 130 A-DRTECFITGWGETQGTFGAGLLKEAQLPVIENKVC--NRYEFLNGRVQSTELCAG 183
>pdb|1L4D|A Chain A, Crystal Structure Of Microplasminogen-streptokinase Alpha
Domain Complex
Length = 249
Score = 64.7 bits (156), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 26/208 (12%)
Query: 31 WPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQH 90
WPW V+L G++ CGG+L+S +V+TAAHC+ K P + + LG + +
Sbjct: 31 WPWQVSLRTRFGMHF---CGGTLISPEWVLTAAHCLEKSP-----RPSSYKVILGAHQEV 82
Query: 91 QFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDS--TAP 148
E VQ +V R+ + PT DIALL+LSS + V P CL + A
Sbjct: 83 NL--EPHVQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVIPACLPSPNYVVAD 134
Query: 149 LQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTK----HYVVFTD 204
+ G G G G++ + + + +G RV T+ H TD
Sbjct: 135 RTECFITGWGETQGTFGAGLLKEAQLPVIENKVCNRYEFLNG-RVQSTELCAGHLAGGTD 193
Query: 205 VANVCNGDSGGGMVFKIDSAWYLRGIVS 232
C GD+GG +V + L+G+ S
Sbjct: 194 ---SCQGDAGGPLVCFEKDKYILQGVTS 218
Score = 36.2 bits (82), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 33/118 (27%), Positives = 51/118 (43%), Gaps = 15/118 (12%)
Query: 244 DTKHYVVFTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLS 303
+ + +V +V R+ + PT DIALL+LSS + V P CL P
Sbjct: 83 NLEPHVQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVIPACL------PSPNY 130
Query: 304 AVEGRDGTVI-GWGYDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
V R I GWG + + LK A +P++ ++ C + +F + CAG
Sbjct: 131 VVADRTECFITGWGETQGTFGAGLLKEAQLPVIENKVC--NRYEFLNGRVQSTELCAG 186
>pdb|2WPI|S Chain S, Factor Ixa Superactive Double Mutant
Length = 235
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 37/227 (16%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
V G+ GQ+PW V L + CGGS+V+ +++TAAHC V++
Sbjct: 1 VVGGEDAKPGQFPWQVVLNG----KVDAFCGGSIVNEKWIVTAAHC---------VETGV 47
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSS--NYLGDIALLQLSSDVDYSMYVR 137
+ + H + E Q + V R+ + +N++ Y DIALL+L + + YV
Sbjct: 48 KITVVAGEHNIE-ETEHTEQKRNVIRIIPHHNYNAAINTYNHDIALLELDEPLVLNSYVT 106
Query: 138 PVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTK 197
P+C+ D + L G SG G VF + + + + + + TK
Sbjct: 107 PICIADKEYTNIFLKFGSGYV-----SGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTK 161
Query: 198 HYVVFTDVANV------------CNGDSGGGMVFKIDSAWYLRGIVS 232
FT N+ C GDSGG V +++ +L GI+S
Sbjct: 162 ----FTITNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIIS 204
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 41/136 (30%), Positives = 64/136 (47%), Gaps = 12/136 (8%)
Query: 231 VSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSS--NYLGDIALLQLSSDVDYSMYVR 288
V ITV + +T+H +V R+ + +N++ Y DIALL+L + + YV
Sbjct: 47 VKITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAINTYNHDIALLELDEPLVLNSYVT 106
Query: 289 PVCLWDDSTAPLQLSAVEGRDGTVIGWG-YDENDRVSEELKMAIMPIVSHQQCLWSNPQF 347
P+C+ D + L G V GWG R + L+ +P+V CL S
Sbjct: 107 PICIADKEYTNIFLKF---GSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRS---- 159
Query: 348 FSQFT-SDETFCAGFR 362
++FT ++ FCAGF
Sbjct: 160 -TKFTITNNMFCAGFH 174
>pdb|1L4Z|A Chain A, X-Ray Crystal Structure Of The Complex Of Microplasminogen
With Alpha Domain Of Streptokinase In The Presence
Cadmium Ions
Length = 248
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 26/208 (12%)
Query: 31 WPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQH 90
WPW V+L G++ CGG+L+S +V+TAAHC+ K P + + LG + +
Sbjct: 30 WPWQVSLRTRFGMHF---CGGTLISPEWVLTAAHCLEKSP-----RPSSYKVILGAHQEV 81
Query: 91 QFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDS--TAP 148
E VQ +V R+ + PT DIALL+LSS + V P CL + A
Sbjct: 82 NL--EPHVQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVIPACLPSPNYVVAD 133
Query: 149 LQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTK----HYVVFTD 204
+ G G G G++ + + + +G RV T+ H TD
Sbjct: 134 RTECFITGWGETQGTFGAGLLKEAQLPVIENKVCNRYEFLNG-RVQSTELCAGHLAGGTD 192
Query: 205 VANVCNGDSGGGMVFKIDSAWYLRGIVS 232
C GD+GG +V + L+G+ S
Sbjct: 193 ---SCQGDAGGPLVCFEKDKYILQGVTS 217
Score = 36.2 bits (82), Expect = 0.032, Method: Compositional matrix adjust.
Identities = 33/118 (27%), Positives = 51/118 (43%), Gaps = 15/118 (12%)
Query: 244 DTKHYVVFTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLS 303
+ + +V +V R+ + PT DIALL+LSS + V P CL P
Sbjct: 82 NLEPHVQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVIPACL------PSPNY 129
Query: 304 AVEGRDGTVI-GWGYDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
V R I GWG + + LK A +P++ ++ C + +F + CAG
Sbjct: 130 VVADRTECFITGWGETQGTFGAGLLKEAQLPVIENKVC--NRYEFLNGRVQSTELCAG 185
>pdb|1DDJ|A Chain A, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|B Chain B, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|C Chain C, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|D Chain D, Crystal Structure Of Human Plasminogen Catalytic Domain
Length = 247
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 26/208 (12%)
Query: 31 WPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQH 90
WPW V+L G++ CGG+L+S +V+TAAHC+ K P + + LG + +
Sbjct: 29 WPWQVSLRTRFGMHF---CGGTLISPEWVLTAAHCLEKSP-----RPSSYKVILGAHQEV 80
Query: 91 QFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDS--TAP 148
E VQ +V R+ + PT DIALL+LSS + V P CL + A
Sbjct: 81 NL--EPHVQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVIPACLPSPNYVVAD 132
Query: 149 LQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTK----HYVVFTD 204
+ G G G G++ + + + +G RV T+ H TD
Sbjct: 133 RTECFITGWGETQGTFGAGLLKEAQLPVIENKVCNRYEFLNG-RVQSTELCAGHLAGGTD 191
Query: 205 VANVCNGDSGGGMVFKIDSAWYLRGIVS 232
C GD+GG +V + L+G+ S
Sbjct: 192 ---SCQGDAGGPLVCFEKDKYILQGVTS 216
Score = 36.2 bits (82), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 33/118 (27%), Positives = 51/118 (43%), Gaps = 15/118 (12%)
Query: 244 DTKHYVVFTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLS 303
+ + +V +V R+ + PT DIALL+LSS + V P CL P
Sbjct: 81 NLEPHVQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVIPACL------PSPNY 128
Query: 304 AVEGRDGTVI-GWGYDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
V R I GWG + + LK A +P++ ++ C + +F + CAG
Sbjct: 129 VVADRTECFITGWGETQGTFGAGLLKEAQLPVIENKVC--NRYEFLNGRVQSTELCAG 184
>pdb|3GOV|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-1
pdb|4DJZ|B Chain B, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
pdb|4DJZ|D Chain D, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 251
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 68/233 (29%), Positives = 100/233 (42%), Gaps = 40/233 (17%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKK--PYDKPV-DSDT 79
G+ +G PW L +N CGGSL+ ++++TAAHC+ + P D + DSD
Sbjct: 4 GRPAQKGTTPWIAMLSH---LNGQPFCGGSLLGSSWIVTAAHCLHQSLDPKDPTLRDSDL 60
Query: 80 LV-----IYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSM 134
L I LGK H SDE Q+ VK ++P ++ + + D+AL++L +
Sbjct: 61 LSPSDFKIILGK-HWRLRSDE-NEQHLGVKHTTLHPQYDPNTFENDVALVELLESPVLNA 118
Query: 135 YVRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVC 194
+V P+CL P Q EG V SG G F + ++ I + C
Sbjct: 119 FVMPICL---PEGPQQ----EGAMVIV--SGWGKQF---LQRFPETLMEIEIPIVDHSTC 166
Query: 195 DTKHYVVFTDVA-------------NVCNGDSGGGMVF--KIDSAWYLRGIVS 232
+ + V + C GDSGG MV + WYL G VS
Sbjct: 167 QKAYAPLKKKVTRDMICAGEKEGGKDACAGDSGGPMVTLNRERGQWYLVGTVS 219
Score = 47.8 bits (112), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 35/125 (28%), Positives = 54/125 (43%), Gaps = 15/125 (12%)
Query: 246 KHYVVFTD-------VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTA 298
KH+ + +D VK ++P ++ + + D+AL++L + +V P+CL
Sbjct: 72 KHWRLRSDENEQHLGVKHTTLHPQYDPNTFENDVALVELLESPVLNAFVMPICL---PEG 128
Query: 299 PLQLSAVEGRDGTVIGWGYDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFC 358
P Q EG V GWG R E L +PIV H C + + T D C
Sbjct: 129 PQQ----EGAMVIVSGWGKQFLQRFPETLMEIEIPIVDHSTCQKAYAPLKKKVTRD-MIC 183
Query: 359 AGFRN 363
AG +
Sbjct: 184 AGEKE 188
>pdb|1ZPZ|A Chain A, Factor Xi Catalytic Domain Complexed With N-((R)-1-(4-
Bromophenyl)ethyl)urea-Asn-Val-Arg-Alpha-Ketothiazole
pdb|1ZRK|A Chain A, Factor Xi Complexed With 3-Hydroxypropyl 3-(7-
Amidinonaphthalene-1-Carboxamido)benzenesulfonate
pdb|1ZSL|A Chain A, Factor Xi Complexed With A Pyrimidinone Inhibitor
Length = 238
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 30/222 (13%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G + RG+WPW V L+ T ++CGGS++ +++TAAHC K L +
Sbjct: 4 GTASVRGEWPWQVTLHTTSPTQ-RHLCGGSIIGNQWILTAAHCFYGVESPK-----ILRV 57
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLW 142
Y G +Q + +++ Q +H S Y DIALL+L + V+Y+
Sbjct: 58 YSGILNQSEIAEDTSFFGVQEIIIHDQYKMAESGY--DIALLKLETTVNYT--------- 106
Query: 143 DDSTAPLQLSAVEGTSVCNGD---SGGG---MVFKIDSAWYLRGIVSITVARDGLRVCDT 196
DS P+ L + +V D +G G + KI + I +T R
Sbjct: 107 -DSQRPISLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGH 165
Query: 197 K--HYVVFTDV----ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
K H ++ + C GDSGG + K + W+L GI S
Sbjct: 166 KITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITS 207
Score = 48.9 bits (115), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 30/114 (26%), Positives = 57/114 (50%), Gaps = 9/114 (7%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F V+ + I+ + + DIALL+L + V+Y+ RP+ L + + D
Sbjct: 73 FFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGDRNVIYT-----DC 127
Query: 311 TVIGWGYDE-NDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFRN 363
V GWGY + D++ L+ A +P+V++++C ++ + + CAG+R
Sbjct: 128 WVTGWGYRKLRDKIQNTLQKAKIPLVTNEEC---QKRYRGHKITHKMICAGYRE 178
>pdb|4IGD|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-1
Length = 406
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 71/249 (28%), Positives = 106/249 (42%), Gaps = 41/249 (16%)
Query: 8 CGTVVYN-KAQPLVTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCV 66
CG ++ K + G+ +G PW L +N CGGSL+ ++++TAAHC+
Sbjct: 143 CGLPKFSRKLMAQIFNGRPAQKGTTPWIAMLSH---LNGQPFCGGSLLGSSWIVTAAHCL 199
Query: 67 TKK--PYDKPV-DSDTLV-----IYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYL 118
+ P D + DSD L I LGK H SDE Q+ VK ++P ++ + +
Sbjct: 200 HQSLDPEDPTLRDSDLLSPSDFKIILGK-HWRLRSDE-NEQHLGVKHTTLHPQYDPNTFE 257
Query: 119 GDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYL 178
D+AL++L + +V P+CL P Q EG V SG G F +
Sbjct: 258 NDVALVELLESPVLNAFVMPICL---PEGPQQ----EGAMVIV--SGWGKQF---LQRFP 305
Query: 179 RGIVSITVARDGLRVCDTKHYVVFTDVA-------------NVCNGDSGGGMVF--KIDS 223
++ I + C + + V + C GDSGG MV +
Sbjct: 306 ETLMEIEIPIVDHSTCQKAYAPLKKKVTRDMICAGEKEGGKDACAGDSGGPMVTLNRERG 365
Query: 224 AWYLRGIVS 232
WYL G VS
Sbjct: 366 QWYLVGTVS 374
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 35/125 (28%), Positives = 54/125 (43%), Gaps = 15/125 (12%)
Query: 246 KHYVVFTD-------VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTA 298
KH+ + +D VK ++P ++ + + D+AL++L + +V P+CL
Sbjct: 227 KHWRLRSDENEQHLGVKHTTLHPQYDPNTFENDVALVELLESPVLNAFVMPICL---PEG 283
Query: 299 PLQLSAVEGRDGTVIGWGYDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFC 358
P Q EG V GWG R E L +PIV H C + + T D C
Sbjct: 284 PQQ----EGAMVIVSGWGKQFLQRFPETLMEIEIPIVDHSTCQKAYAPLKKKVTRD-MIC 338
Query: 359 AGFRN 363
AG +
Sbjct: 339 AGEKE 343
>pdb|1ZLR|A Chain A, Factor Xi Catalytic Domain Complexed With
2-Guanidino-1-(4-(4,4,5,5-
Tetramethyl-1,3,2-Dioxaborolan-2-Yl)phenyl)ethyl
Nicotinate
Length = 237
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 30/222 (13%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G + RG+WPW V L+ T ++CGGS++ +++TAAHC K L +
Sbjct: 4 GTASVRGEWPWQVTLHTTSPTQ-RHLCGGSIIGNQWILTAAHCFYGVESPK-----ILRV 57
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLW 142
Y G +Q + +++ Q +H S Y DIALL+L + V+Y+
Sbjct: 58 YSGILNQAEIAEDTSFFGVQEIIIHDQYKMAESGY--DIALLKLETTVNYA--------- 106
Query: 143 DDSTAPLQLSAVEGTSVCNGD---SGGG---MVFKIDSAWYLRGIVSITVARDGLRVCDT 196
DS P+ L + +V D +G G + KI + I +T R
Sbjct: 107 -DSQRPISLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGH 165
Query: 197 K--HYVVFTDV----ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
K H ++ + C GDSGG + K + W+L GI S
Sbjct: 166 KITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITS 207
Score = 48.9 bits (115), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 30/114 (26%), Positives = 57/114 (50%), Gaps = 9/114 (7%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F V+ + I+ + + DIALL+L + V+Y+ RP+ L + + D
Sbjct: 73 FFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDRNVIYT-----DC 127
Query: 311 TVIGWGYDE-NDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFRN 363
V GWGY + D++ L+ A +P+V++++C ++ + + CAG+R
Sbjct: 128 WVTGWGYRKLRDKIQNTLQKAKIPLVTNEEC---QKRYRGHKITHKMICAGYRE 178
>pdb|3KCG|H Chain H, Crystal Structure Of The Antithrombin-Factor Ixa-
Pentasaccharide Complex
Length = 235
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 31/224 (13%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
V G+ GQ+PW V L + CGGS+V+ +++TAAHC V++
Sbjct: 1 VVGGEDAKPGQFPWQVVLNG----KVDAFCGGSIVNEKWIVTAAHC---------VETGV 47
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSS--NYLGDIALLQLSSDVDYSMYVR 137
+ + H + E Q + V R+ + +N++ Y DIALL+L + + YV
Sbjct: 48 KITVVAGEHNIE-ETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVT 106
Query: 138 PVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTK 197
P+C+ D + L G SG G VF + + + + + + TK
Sbjct: 107 PICIADKEYTNIFLKFGSGYV-----SGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTK 161
Query: 198 HYVVFTDV---------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
+ ++ ++ + C GD+GG V +++ +L GI+S
Sbjct: 162 -FTIYNNMFCAGFHEGGRDSCQGDAGGPHVTEVEGTSFLTGIIS 204
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/136 (30%), Positives = 63/136 (46%), Gaps = 12/136 (8%)
Query: 231 VSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSS--NYLGDIALLQLSSDVDYSMYVR 288
V ITV + +T+H +V R+ + +N++ Y DIALL+L + + YV
Sbjct: 47 VKITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVT 106
Query: 289 PVCLWDDSTAPLQLSAVEGRDGTVIGWG-YDENDRVSEELKMAIMPIVSHQQCLWSNPQF 347
P+C+ D + L G V GWG R + L+ +P+V CL S
Sbjct: 107 PICIADKEYTNIFLKF---GSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRS---- 159
Query: 348 FSQFT-SDETFCAGFR 362
++FT + FCAGF
Sbjct: 160 -TKFTIYNNMFCAGFH 174
>pdb|1ZHR|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine
(S434a-T475a-C482s-K437a Mutant)
pdb|1ZPB|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 4-Methyl-Pentanoic Acid {1-[4-
Guanidino-1-(Thiazole-2-Carbonyl)-Butylcarbamoyl]-2-
Methyl- Propyl}-Amide
pdb|1ZPC|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
2-[2-(3-Chloro-Phenyl)-2-Hydroxy-
Acetylamino]-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]- 3-Methyl-Butyramide
pdb|2FDA|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Coagulation Factor Xia In Complex With
Alpha-Ketothiazole Arginine Derived Ligand
pdb|1ZMJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With 4-(Guanidinomethyl)-Phenylboronic Acid
pdb|1ZML|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With (R)-1-(4-(4-(Hydroxymethyl)-1,3,2-
Dioxaborolan-2-Yl)phenethyl)guanidine
pdb|1ZMN|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
(R)-1-(4-(4-(Hydroxymethyl)-1,3,
2-Dioxaborolan-2-Yl)phenyl)guanidine
pdb|1ZOM|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With A Peptidomimetic Inhibitor
pdb|1ZSJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
N-(7-Carbamimidoyl-Naphthalen-1-
Yl)-3-Hydroxy-2-Methyl-Benzamide
pdb|1ZSK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
6-Carbamimidoyl-4-(3-Hydroxy-2-
Methyl-Benzoylamino)-Naphthalene-2-Carboxylic Acid
Methyl Ester
pdb|1ZTJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Benzylamino-2-
Methylsulfanyl-6-Oxo-6h-Pyrimidin-1-Yl)-N-[4-Guanidino-
1- (Thiazole-2-Carbonyl)-Butyl]-Acetamide
pdb|1ZTK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Amino-6-Oxo-2-M-Tolyl-6h-
Pyrimidin-1-Yl)-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]-Acetamide
pdb|1ZTL|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With N-[4-Guanidino-1-(Thiazole-2-
Carbonyl)-Butyl]-2-{6-Oxo-5-[(Quinolin-8-Ylmethyl)-
Amino]- 2-M-Tolyl-6h-Pyrimidin-1-Yl}-Acetamide
Length = 238
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 30/222 (13%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G + RG+WPW V L+ T ++CGGS++ +++TAAHC K L +
Sbjct: 4 GTASVRGEWPWQVTLHTTSPTQ-RHLCGGSIIGNQWILTAAHCFYGVESPK-----ILRV 57
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLW 142
Y G +Q + +++ Q +H S Y DIALL+L + V+Y+
Sbjct: 58 YSGILNQAEIAEDTSFFGVQEIIIHDQYKMAESGY--DIALLKLETTVNYA--------- 106
Query: 143 DDSTAPLQLSAVEGTSVCNGD---SGGG---MVFKIDSAWYLRGIVSITVARDGLRVCDT 196
DS P+ L + +V D +G G + KI + I +T R
Sbjct: 107 -DSQRPISLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGH 165
Query: 197 K--HYVVFTDV----ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
K H ++ + C GDSGG + K + W+L GI S
Sbjct: 166 KITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITS 207
Score = 48.9 bits (115), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 30/114 (26%), Positives = 57/114 (50%), Gaps = 9/114 (7%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F V+ + I+ + + DIALL+L + V+Y+ RP+ L + + D
Sbjct: 73 FFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDRNVIYT-----DC 127
Query: 311 TVIGWGYDE-NDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFRN 363
V GWGY + D++ L+ A +P+V++++C ++ + + CAG+R
Sbjct: 128 WVTGWGYRKLRDKIQNTLQKAKIPLVTNEEC---QKRYRGHKITHKMICAGYRE 178
>pdb|2QY0|B Chain B, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
pdb|2QY0|D Chain D, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
Length = 242
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 39/127 (30%), Positives = 67/127 (52%), Gaps = 13/127 (10%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
GQK G +PW V N+ GG+L+ +++TAAH + K ++ ++ +L +
Sbjct: 4 GQKAKMGNFPWQVF------TNIHGRGGGALLGDRWILTAAHTLYPKEHEAQSNA-SLDV 56
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTF---NSSNYLGDIALLQLSSDVDYSMYVRPV 139
+LG + + G N ++RV ++P + S N+ GDIALL+L + V + P+
Sbjct: 57 FLGHTNVEELMKLG---NHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPI 113
Query: 140 CLWDDST 146
CL D+ T
Sbjct: 114 CLPDNDT 120
Score = 48.9 bits (115), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 34/111 (30%), Positives = 56/111 (50%), Gaps = 10/111 (9%)
Query: 254 VKRVHIYPTF---NSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
++RV ++P + S N+ GDIALL+L + V + P+CL D+ T G G
Sbjct: 74 IRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPICLPDNDTF-----YDLGLMG 128
Query: 311 TVIGWGYDENDRVSEELKMAIMPIVSHQQCL-WSNPQFFSQFTSDETFCAG 360
V G+G E ++++ +L+ +P+ + Q C W + S FCAG
Sbjct: 129 YVSGFGVME-EKIAHDLRFVRLPVANPQACENWLRGKNRMDVFSQNMFCAG 178
>pdb|3BG8|A Chain A, Crystal Structure Of Factor Xia In Complex With
Clavatadine A
Length = 238
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 30/222 (13%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G + RG+WPW V L+ T ++CGGS++ +++TAAHC K L +
Sbjct: 4 GTASVRGEWPWQVTLHTTSPTQ-RHLCGGSIIGNQWILTAAHCFYGVESPK-----ILRV 57
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLW 142
Y G +Q + ++ Q +H S Y DIALL+L + V+Y+
Sbjct: 58 YSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGY--DIALLKLETTVNYT--------- 106
Query: 143 DDSTAPLQLSAVEGTSVCNGD---SGGG---MVFKIDSAWYLRGIVSITVARDGLRVCDT 196
DS P+ L + +V D +G G + KI + I +T R
Sbjct: 107 -DSQRPISLPSKGERNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGH 165
Query: 197 K--HYVVFTDV----ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
K H ++ + C GDSGG + K + W+L GI S
Sbjct: 166 KITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITS 207
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 32/125 (25%), Positives = 60/125 (48%), Gaps = 9/125 (7%)
Query: 240 LRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAP 299
L + K F V+ + I+ + + DIALL+L + V+Y+ RP+ L
Sbjct: 62 LNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGERN 121
Query: 300 LQLSAVEGRDGTVIGWGYDE-NDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFC 358
+ + D V GWGY + D++ L+ A +P+V++++C ++ + + C
Sbjct: 122 VIYT-----DCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEEC---QKRYRGHKITHKMIC 173
Query: 359 AGFRN 363
AG+R
Sbjct: 174 AGYRE 178
>pdb|3SOR|A Chain A, Factor Xia In Complex With A Clorophenyl-tetrazole
Inhibitor
pdb|3SOS|A Chain A, Benzothiazinone Inhibitor In Complex With Fxia
Length = 238
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 30/222 (13%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G + RG+WPW V L+ T ++CGGS++ +++TAAHC K L +
Sbjct: 4 GTASVRGEWPWQVTLHTTSPTQ-RHLCGGSIIGNQWILTAAHCFYGVESPK-----ILRV 57
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLW 142
Y G +Q + ++ Q +H S Y DIALL+L + V+Y+
Sbjct: 58 YSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGY--DIALLKLETTVNYT--------- 106
Query: 143 DDSTAPLQLSAVEGTSVCNGD---SGGG---MVFKIDSAWYLRGIVSITVARDGLRVCDT 196
DS P+ L + +V D +G G + KI + I +T R
Sbjct: 107 -DSQRPISLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGH 165
Query: 197 K--HYVVFTDV----ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
K H ++ + C GDSGG + K + W+L GI S
Sbjct: 166 KITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITS 207
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 32/125 (25%), Positives = 60/125 (48%), Gaps = 9/125 (7%)
Query: 240 LRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAP 299
L + K F V+ + I+ + + DIALL+L + V+Y+ RP+ L
Sbjct: 62 LNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGDRN 121
Query: 300 LQLSAVEGRDGTVIGWGYDE-NDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFC 358
+ + D V GWGY + D++ L+ A +P+V++++C ++ + + C
Sbjct: 122 VIYT-----DCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEEC---QKRYRGHKITHKMIC 173
Query: 359 AGFRN 363
AG+R
Sbjct: 174 AGYRE 178
>pdb|1BDA|A Chain A, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
pdb|1BDA|B Chain B, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 65/247 (26%), Positives = 109/247 (44%), Gaps = 33/247 (13%)
Query: 7 SCGTVVYNKAQPLVTYGQKTARGQWPWHVALY----RTEGINLSYVCGGSLVSVNYVITA 62
+CG Y++ Q + G PW A++ R+ G ++CGG L+S ++++A
Sbjct: 1 TCGLRQYSQPQFRIKGGLFADIASHPWQAAIFAKHRRSPGER--FLCGGILISSCWILSA 58
Query: 63 AHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIA 122
AHC ++ L + LG+ ++ +E Q +V++ ++ F+ Y DIA
Sbjct: 59 AHCFQER-----FPPHHLTVILGRTYRVVPGEE--EQKFEVEKYIVHKEFDDDTYDNDIA 111
Query: 123 LLQLSSD----VDYSMYVRPVCLWDDSTAPLQL---SAVEGTSVCNGDSGGGMVFKIDSA 175
LLQL SD S VR VCL A LQL + E + ++ +
Sbjct: 112 LLQLKSDSSRCAQESSVVRTVCL---PPADLQLPDWTECELSGYGKHEALSPFYSERLKE 168
Query: 176 WYLR----------GIVSITVARDGLRVCDTKHYVVFTDVANVCNGDSGGGMVFKIDSAW 225
++R +++ TV + L DT+ ++ + C GDSGG +V D
Sbjct: 169 AHVRLYPSSRCTSQHLLNRTVTDNMLCAGDTRSGGPQANLHDACQGDSGGPLVCLNDGRM 228
Query: 226 YLRGIVS 232
L GI+S
Sbjct: 229 TLVGIIS 235
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 33/114 (28%), Positives = 52/114 (45%), Gaps = 13/114 (11%)
Query: 253 DVKRVHIYPTFNSSNYLGDIALLQLSSD----VDYSMYVRPVCLWDDSTAPLQLSAVEGR 308
+V++ ++ F+ Y DIALLQL SD S VR VCL P L +
Sbjct: 91 EVEKYIVHKEFDDDTYDNDIALLQLKSDSSRCAQESSVVRTVCL-----PPADLQLPDWT 145
Query: 309 DGTVIGWGYDE--NDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
+ + G+G E + SE LK A + + +C ++ ++ +D CAG
Sbjct: 146 ECELSGYGKHEALSPFYSERLKEAHVRLYPSSRC--TSQHLLNRTVTDNMLCAG 197
>pdb|1EAI|A Chain A, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1EAI|B Chain B, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1C1M|A Chain A, Porcine Elastase Under Xenon Pressure (8 Bar)
pdb|1HV7|A Chain A, Porcine Pancreatic Elastase Complexed With Gw311616a
pdb|1FZZ|A Chain A, The Crystal Structure Of The Complex Of Non-Peptidic
Inhibitor Ono-6818 And Porcine Pancreatic Elastase.
pdb|1GWA|A Chain A, Triiodide Derivative Of Porcine Pancreas Elastase
pdb|1L0Z|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Dry Paraffin
Oil
pdb|1L1G|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Glycerol
pdb|1LKA|A Chain A, Porcine Pancreatic ElastaseCA-Complex
pdb|1LKB|A Chain A, Porcine Pancreatic Elastase/na-complex
pdb|1MMJ|N Chain N, Porcine Pancreatic Elastase Complexed With A Potent
Peptidyl Inhibitor, Fr136706
pdb|1MCV|A Chain A, Crystal Structure Analysis Of A Hybrid Squash Inhibitor In
Complex With Porcine Pancreatic Elastase
pdb|1UO6|A Chain A, Porcine Pancreatic ElastaseXE-Complex
pdb|1UVO|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(crystal A)
pdb|1UVP|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(Crystal B)
pdb|2A7C|A Chain A, On The Routine Use Of Soft X-rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2A7J|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2BLO|A Chain A, Elastase Before A High Dose X-Ray "burn"
pdb|2BLQ|A Chain A, Elastase After A High Dose X-Ray "burn"
pdb|2D26|C Chain C, Active Site Distortion Is Sufficient For Proteinase
Inhibit Second Crystal Structure Of Covalent
Serpin-Proteinase Complex
pdb|2CV3|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With A Macroclyclic Peptide Inhibitor
pdb|2DE8|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With A
Unique Conformation Induced By Tris
pdb|2DE9|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With Tris After Soaking A Tris-Free Solution
pdb|2G4T|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastase (na)
pdb|2G4U|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastaase
(ca)
pdb|2OQU|A Chain A, High Pressure Cryocooling Of Capillary Sample
Cryoprotection And Diffraction Phasing At Long
Wavelengths
pdb|1QNJ|A Chain A, The Structure Of Native Porcine Pancreatic Elastase At
Atomic Resolution (1.1 A)
pdb|2IOT|A Chain A, Clavulanic Acid Bound To Elastase
pdb|2V0B|A Chain A, Sad Structure Solution Porcine Pancreatic Elastase From A
Selenate Derivative
pdb|2V35|A Chain A, Porcine Pancreatic Elastase In Complex With Inhibitor Jm54
pdb|3HGP|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By High
Resolution Crystallography
pdb|3HGN|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By Neutron
Crystallography
pdb|3UOU|A Chain A, Crystal Structure Of The Kunitz-Type Protease Inhibitor
Shpi-1 Lys13leu Mutant In Complex With Pancreatic
Elastase
Length = 240
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 64/241 (26%), Positives = 112/241 (46%), Gaps = 19/241 (7%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
V G + R WP ++L G + ++ CGG+L+ N+V+TAAHCV ++ T
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDREL--------T 52
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLG--DIALLQLSSDVDYSMYVR 137
+ +G+++ +Q ++G Q V+++ ++P +N+ + DIALL+L+ V + YV+
Sbjct: 53 FRVVVGEHNLNQ--NDGTEQYVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQ 110
Query: 138 PVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTK 197
L T S T + G + + A YL + + K
Sbjct: 111 LGVLPRAGTILANNSPCYITGWGLTRTNGQLAQTLQQA-YLPTVDYAICSSSSYWGSTVK 169
Query: 198 HYVVFT---DVANVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDV 254
+ +V V + C GDSGG + ++ + + G+ S V+R G V T+ VFT V
Sbjct: 170 NSMVCAGGDGVRSGCQGDSGGPLHCLVNGQYAVHGVTSF-VSRLGCNV--TRKPTVFTRV 226
Query: 255 K 255
Sbjct: 227 S 227
Score = 37.4 bits (85), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 28/113 (24%), Positives = 53/113 (46%), Gaps = 10/113 (8%)
Query: 251 FTDVKRVHIYPTFNSSNYLG--DIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGR 308
+ V+++ ++P +N+ + DIALL+L+ V + YV+ L T S
Sbjct: 71 YVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVLPRAGTILANNSPCY-- 128
Query: 309 DGTVIGWGYDE-NDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
+ GWG N ++++ L+ A +P V + C S+ ++ + CAG
Sbjct: 129 ---ITGWGLTRTNGQLAQTLQQAYLPTVDYAIC--SSSSYWGSTVKNSMVCAG 176
>pdb|1ZJD|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Kunitz Protease Inhibitor
Domain Of Protease Nexin Ii
Length = 237
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 30/222 (13%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G + RG+WPW V L+ T ++CGGS++ +++TAAHC K L +
Sbjct: 4 GTASVRGEWPWQVTLHTTSPTQ-RHLCGGSIIGNQWILTAAHCFYGVESPK-----ILRV 57
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLW 142
Y G +Q + ++ Q +H S Y DIALL+L + V+Y+
Sbjct: 58 YSGILNQAEIKEDTSFFGVQEIIIHDQYKMAESGY--DIALLKLETTVNYA--------- 106
Query: 143 DDSTAPLQLSAVEGTSVCNGD---SGGG---MVFKIDSAWYLRGIVSITVARDGLRVCDT 196
DS P+ L + +V D +G G + KI + I +T R
Sbjct: 107 -DSQRPISLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGH 165
Query: 197 K--HYVVFTDV----ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
K H ++ + C GDSGG + K + W+L GI S
Sbjct: 166 KITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITS 207
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 32/125 (25%), Positives = 60/125 (48%), Gaps = 9/125 (7%)
Query: 240 LRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAP 299
L + K F V+ + I+ + + DIALL+L + V+Y+ RP+ L
Sbjct: 62 LNQAEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDRN 121
Query: 300 LQLSAVEGRDGTVIGWGYDE-NDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFC 358
+ + D V GWGY + D++ L+ A +P+V++++C ++ + + C
Sbjct: 122 VIYT-----DCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEEC---QKRYRGHKITHKMIC 173
Query: 359 AGFRN 363
AG+R
Sbjct: 174 AGYRE 178
>pdb|1MD7|A Chain A, Monomeric Structure Of The Zymogen Of Complement Protease
C1r
Length = 328
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 39/127 (30%), Positives = 67/127 (52%), Gaps = 13/127 (10%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
GQK G +PW V N+ GG+L+ +++TAAH + K ++ ++ +L +
Sbjct: 93 GQKAKMGNFPWQVF------TNIHGRGGGALLGDRWILTAAHTLYPKEHEAQSNA-SLDV 145
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTF---NSSNYLGDIALLQLSSDVDYSMYVRPV 139
+LG + + G N ++RV ++P + S N+ GDIALL+L + V + P+
Sbjct: 146 FLGHTNVEELMKLG---NHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPI 202
Query: 140 CLWDDST 146
CL D+ T
Sbjct: 203 CLPDNDT 209
Score = 48.9 bits (115), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 34/111 (30%), Positives = 56/111 (50%), Gaps = 10/111 (9%)
Query: 254 VKRVHIYPTF---NSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
++RV ++P + S N+ GDIALL+L + V + P+CL D+ T G G
Sbjct: 163 IRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPICLPDNDTF-----YDLGLMG 217
Query: 311 TVIGWGYDENDRVSEELKMAIMPIVSHQQCL-WSNPQFFSQFTSDETFCAG 360
V G+G E ++++ +L+ +P+ + Q C W + S FCAG
Sbjct: 218 YVSGFGVME-EKIAHDLRFVRLPVANPQACENWLRGKNRMDVFSQNMFCAG 267
>pdb|1MD8|A Chain A, Monomeric Structure Of The Active Catalytic Domain Of
Complement Protease C1r
Length = 329
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 39/127 (30%), Positives = 67/127 (52%), Gaps = 13/127 (10%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
GQK G +PW V N+ GG+L+ +++TAAH + K ++ ++ +L +
Sbjct: 93 GQKAKMGNFPWQVF------TNIHGRGGGALLGDRWILTAAHTLYPKEHEAQSNA-SLDV 145
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTF---NSSNYLGDIALLQLSSDVDYSMYVRPV 139
+LG + + G N ++RV ++P + S N+ GDIALL+L + V + P+
Sbjct: 146 FLGHTNVEELMKLG---NHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPI 202
Query: 140 CLWDDST 146
CL D+ T
Sbjct: 203 CLPDNDT 209
Score = 48.9 bits (115), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 34/111 (30%), Positives = 56/111 (50%), Gaps = 10/111 (9%)
Query: 254 VKRVHIYPTF---NSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
++RV ++P + S N+ GDIALL+L + V + P+CL D+ T G G
Sbjct: 163 IRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPICLPDNDTF-----YDLGLMG 217
Query: 311 TVIGWGYDENDRVSEELKMAIMPIVSHQQCL-WSNPQFFSQFTSDETFCAG 360
V G+G E ++++ +L+ +P+ + Q C W + S FCAG
Sbjct: 218 YVSGFGVME-EKIAHDLRFVRLPVANPQACENWLRGKNRMDVFSQNMFCAG 267
>pdb|2ANY|A Chain A, Expression, Crystallization And The Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 28/221 (12%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G +++ G+WPW V+L + + ++CGGSL+ +V+TAAHC P D I
Sbjct: 4 GTESSWGEWPWQVSL-QVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPL-----QDVWRI 57
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLW 142
Y G + + Q+K + I+ + S DIAL++L + ++Y+ + +P+ L
Sbjct: 58 YSGILELSDITKD--TPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLEYTEFQKPISL- 114
Query: 143 DDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKH--YV 200
S + +++ G F + + + + C ++ Y
Sbjct: 115 --------PSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYK 166
Query: 201 VFTDV---------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
+ + + C GDSGG +V K + W L GI S
Sbjct: 167 ITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITS 207
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/125 (20%), Positives = 57/125 (45%), Gaps = 9/125 (7%)
Query: 240 LRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAP 299
L + D F+ +K + I+ + S DIAL++L + ++Y+ + +P+ L
Sbjct: 62 LELSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLEYTEFQKPISLPSKGDTS 121
Query: 300 LQLSAVEGRDGTVIGWGY-DENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFC 358
+ + V GWG+ E + L+ +P+V++++C ++ + C
Sbjct: 122 TIYT-----NCWVTGWGFSKEKGEIQNILQKVNIPLVTNEEC---QKRYQDYKITQRMVC 173
Query: 359 AGFRN 363
AG++
Sbjct: 174 AGYKE 178
>pdb|2EST|E Chain E, Crystallographic Study Of The Binding Of A Trifluoroacetyl
Dipeptide Anilide Inhibitor With Elastase
pdb|4EST|E Chain E, Crystal Structure Of The Covalent Complex Formed By A
Peptidyl Alpha, Alpha-Difluoro-Beta-Keto Amide With
Porcine Pancreatic Elastase At 1.78-Angstroms Resolution
pdb|5EST|E Chain E, Crystallographic Analysis Of The Inhibition Of Porcine
Pancreatic Elastase By A Peptidyl Boronic Acid:
Structure Of A Reaction Intermediate
pdb|7EST|E Chain E, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|8EST|E Chain E, Reaction Of Porcine Pancreatic Elastase With 7-substituted
3-alkoxy-4-chloroisocoumarins: Design Of Potent
Inhibitors Using The Crystal Structure Of The Complex
Formed With 4- Chloro-3-ethoxy-7-guanidino-isocoumarin
pdb|1ELA|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELC|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELB|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELD|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1ELE|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1NES|E Chain E, Structure Of The Product Complex Of Acetyl-ala-pro-ala
With Porcine Pancreatic Elastase At 1.65 Angstroms
Resolution
pdb|1BMA|A Chain A, Benzyl Methyl Aminimide Inhibitor Complexed To Porcine
Pancreatic Elastase
pdb|1FLE|E Chain E, Crystal Structure Of Elafin Complexed With Porcine
Pancreatic Elastase
pdb|1B0E|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With Mdl
101,146
pdb|1QGF|A Chain A, Porcine Pancreatic Elastase Complexed With (3r, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One
pdb|1QIX|B Chain B, Porcine Pancreatic Elastase Complexed With Human
Beta-casomorphin-7
pdb|1QR3|E Chain E, Structure Of Porcine Pancreatic Elastase In Complex With
Fr901277, A Novel Macrocyclic Inhibitor Of Elastases At
1.6 Angstrom Resolution
pdb|1E34|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2- One Soaked In Ph 9 Buffer For One Minute
pdb|1E35|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One Soaked In Ph 9 Buffer For Two
Minutes
pdb|1E36|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One
pdb|1E37|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 1 Minute
pdb|1E38|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 2 Minutes
pdb|1HAZ|B Chain B, Snapshots Of Serine Protease Catalysis: (c) Acyl-enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-casomorphin-7 Jumped To Ph 9 For 1 Minute
pdb|1H9L|B Chain B, Porcine Pancreatic Elastase Complexed With
Acetyl-Val-Glu-Pro-Ile-Cooh
pdb|1OKX|A Chain A, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|1OKX|B Chain B, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|2FO9|A Chain A, Structure Of Porcine Pancreatic Elastase In 95% Acetone
pdb|2FOA|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010 %
BENZENE
pdb|2FOB|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010
CYCLOHEXANE
pdb|2FOC|A Chain A, Structure Of Porcine Pancreatic Elastase In 55%
Dimethylformamide
pdb|2FOD|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Ethanol
pdb|2FOE|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Hexane
pdb|2FOF|A Chain A, Structure Of Porcine Pancreatic Elastase In 80%
Isopropanol
pdb|2FOG|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2FOH|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2BD4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin- 7 And Lys-Ser At Ph 5.0
pdb|2BD5|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Lys- Ser At Ph 5 And Immersed In
Ph 9 Buffer For 30 Seconds
pdb|2BD9|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 28 Seconds (2nd Ph Jump)
pdb|2BDC|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile At
Ph 5.0
pdb|2H1U|A Chain A, Porcine Pancreatic Elastase Complexed With Metpheleuglu At
Ph 5.0
pdb|1BTU|A Chain A, Porcine Pancreatic Elastase Complexed With (3s, 4r)-1-
Toluenesulphonyl-3-Ethyl-Azetidin-2-One-4-Carboxylic
Acid
pdb|1EAS|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 3.
Design, Synthesis, X-Ray Crystallographic Analysis, And
Structure-Activity Relationships For A Series Of Orally
Active 3-Amino-6-Phenylpyridin- 2-One Trifluoromethyl
Ketones
pdb|1EAT|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 5.
Design, Synthesis, And X-Ray Crystallography Of A Series
Of Orally Active 5- Amino-Pyrimidin-6-One-Containing
Trifluoromethylketones
pdb|1EAU|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 6.
Design Of A Potent, Intratracheally Active,
Pyridone-Based Trifluoromethyl Ketone
pdb|1ELF|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ELG|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ESA|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|1EST|A Chain A, The Atomic Structure Of Crystalline Porcine Pancreatic
Elastase At 2.5 Angstroms Resolution. Comparisons With
The Structure Of Alpha- Chymotrypsin
pdb|1INC|A Chain A, Crystal Structures Of The Complex Of Porcine Pancreatic
Elastase With Two Valine-Derived Benzoxazinone
Inhibitors
pdb|1JIM|A Chain A, Stereospecific Reaction Of 3-Methoxy-4-Chloro-7-
Aminoisocoumarin With Crystalline Porcine Pancreatic
Elastase
pdb|1LVY|A Chain A, Porcine Elastase
pdb|3EST|A Chain A, Structure Of Native Porcine Pancreatic Elastase At 1.65
Angstroms Resolution
pdb|6EST|A Chain A, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|9EST|A Chain A, Structural Study Of Porcine Pancreatic Elastase Complexed
With 7- Amino-3-(2-Bromoethoxy)-4-Chloroisocoumarin As A
Nonreactivatable Doubly Covalent Enzyme-Inhibitor
Complex
pdb|1GVK|B Chain B, Porcine Pancreatic Elastase Acyl Enzyme At 0.95 A
Resolution
pdb|3E3T|A Chain A, Structure Of Porcine Pancreatic Elastase With The Magic
Triangle I3c
pdb|3MNB|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. First Stage Of
Radiation Damage
pdb|3MNC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Second Stage Of
Radiation Damage
pdb|3MNS|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Third Stage Of
Radiation Damage
pdb|3MNX|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fourth Stage Of
Radiation Damage
pdb|3MO3|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fifth Stage Of
Radiation Damage
pdb|3MO6|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Sixth Stage Of
Radiation Damage
pdb|3MO9|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Seventh Stage Of
Radiation Damage
pdb|3MOC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Eighth Stage Of
Radiation Damage
pdb|3MTY|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. First Step Of Radiation
Damage
pdb|3MU0|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU1|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3MU4|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. First Step Of Radiation
Damage
pdb|3MU5|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU8|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3ODD|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Second Step Of Radiation
Damage
pdb|3ODF|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Second Step Of Radiation
Damage
pdb|2BB4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Asp- Phe At Ph 5.0
pdb|2BD2|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0
pdb|2BD3|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Lys- Ala-nh2 At Ph 5.0
pdb|2BD7|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
pdb|2BD8|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 30 Seconds
pdb|2BDA|A Chain A, Porcine Pancreatic Elastase Complexed With N-Acetyl-Npi
And Ala-Ala At Ph 5.0
pdb|2BDB|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile And
Ala-ala At Ph 5.0
pdb|1ESB|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|4GVU|A Chain A, Lyngbyastatin 7-porcine Pancreatic Elastase Co-crystal
Structure
Length = 240
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 64/241 (26%), Positives = 111/241 (46%), Gaps = 19/241 (7%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
V G + R WP ++L G + ++ CGG+L+ N+V+TAAHCV ++ T
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDREL--------T 52
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLG--DIALLQLSSDVDYSMYVR 137
+ +G+++ +Q + G Q V+++ ++P +N+ + DIALL+L+ V + YV+
Sbjct: 53 FRVVVGEHNLNQ--NNGTEQYVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQ 110
Query: 138 PVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTK 197
L T S T + G + + A YL + + K
Sbjct: 111 LGVLPRAGTILANNSPCYITGWGLTRTNGQLAQTLQQA-YLPTVDYAICSSSSYWGSTVK 169
Query: 198 HYVVFT---DVANVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDV 254
+ +V V + C GDSGG + ++ + + G+ S V+R G V T+ VFT V
Sbjct: 170 NSMVCAGGDGVRSGCQGDSGGPLHCLVNGQYAVHGVTSF-VSRLGCNV--TRKPTVFTRV 226
Query: 255 K 255
Sbjct: 227 S 227
Score = 37.4 bits (85), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 28/113 (24%), Positives = 53/113 (46%), Gaps = 10/113 (8%)
Query: 251 FTDVKRVHIYPTFNSSNYLG--DIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGR 308
+ V+++ ++P +N+ + DIALL+L+ V + YV+ L T S
Sbjct: 71 YVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVLPRAGTILANNSPCY-- 128
Query: 309 DGTVIGWGYDE-NDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
+ GWG N ++++ L+ A +P V + C S+ ++ + CAG
Sbjct: 129 ---ITGWGLTRTNGQLAQTLQQAYLPTVDYAIC--SSSSYWGSTVKNSMVCAG 176
>pdb|1GPZ|A Chain A, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
pdb|1GPZ|B Chain B, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
Length = 399
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 39/127 (30%), Positives = 67/127 (52%), Gaps = 13/127 (10%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
GQK G +PW V N+ GG+L+ +++TAAH + K ++ ++ +L +
Sbjct: 161 GQKAKMGNFPWQVF------TNIHGRGGGALLGDRWILTAAHTLYPKEHEAQSNA-SLDV 213
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTF---NSSNYLGDIALLQLSSDVDYSMYVRPV 139
+LG + + G N ++RV ++P + S N+ GDIALL+L + V + P+
Sbjct: 214 FLGHTNVEELMKLG---NHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPI 270
Query: 140 CLWDDST 146
CL D+ T
Sbjct: 271 CLPDNDT 277
Score = 48.5 bits (114), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 34/111 (30%), Positives = 56/111 (50%), Gaps = 10/111 (9%)
Query: 254 VKRVHIYPTF---NSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
++RV ++P + S N+ GDIALL+L + V + P+CL D+ T G G
Sbjct: 231 IRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPICLPDNDTF-----YDLGLMG 285
Query: 311 TVIGWGYDENDRVSEELKMAIMPIVSHQQCL-WSNPQFFSQFTSDETFCAG 360
V G+G E ++++ +L+ +P+ + Q C W + S FCAG
Sbjct: 286 YVSGFGVME-EKIAHDLRFVRLPVANPQACENWLRGKNRMDVFSQNMFCAG 335
>pdb|1HAX|B Chain B, Snapshots Of Serine Protease Catalysis: (A) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 At Ph 5
pdb|1HAY|B Chain B, Snapshots Of Serine Protease Catalysis: (B) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 10 Seconds
pdb|1HB0|B Chain B, Snapshots Of Serine Protease Catalysis: (D) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 2 Minutes
Length = 240
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 64/241 (26%), Positives = 111/241 (46%), Gaps = 19/241 (7%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
V G + R WP ++L G + ++ CGG+L+ N+V+TAAHCV ++ T
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDREL--------T 52
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLG--DIALLQLSSDVDYSMYVR 137
+ +G+++ +Q + G Q V+++ ++P +N+ + DIALL+L+ V + YV+
Sbjct: 53 FRVVVGEHNLNQ--NNGTEQYVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQ 110
Query: 138 PVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTK 197
L T S T + G + + A YL + + K
Sbjct: 111 LGVLPRAGTILRNNSPCYITGWGLTRTNGQLAQTLQQA-YLPTVDYAICSSSSYWGSTVK 169
Query: 198 HYVVFT---DVANVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDV 254
+ +V V + C GDSGG + ++ + + G+ S V+R G V T+ VFT V
Sbjct: 170 NSMVCAGGDGVRSGCQGDSGGPLHCLVNGQYAVHGVTSF-VSRLGCNV--TRKPTVFTRV 226
Query: 255 K 255
Sbjct: 227 S 227
Score = 37.0 bits (84), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 28/113 (24%), Positives = 53/113 (46%), Gaps = 10/113 (8%)
Query: 251 FTDVKRVHIYPTFNSSNYLG--DIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGR 308
+ V+++ ++P +N+ + DIALL+L+ V + YV+ L T S
Sbjct: 71 YVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVLPRAGTILRNNSPCY-- 128
Query: 309 DGTVIGWGYDE-NDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
+ GWG N ++++ L+ A +P V + C S+ ++ + CAG
Sbjct: 129 ---ITGWGLTRTNGQLAQTLQQAYLPTVDYAIC--SSSSYWGSTVKNSMVCAG 176
>pdb|1KIG|H Chain H, Bovine Factor Xa
Length = 241
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 19/215 (8%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G+ A G+ PW L E CGG++++ YV+TAAHC+ + + +
Sbjct: 4 GRDCAEGECPWQALLVNEENEGF---CGGTILNEFYVLTAAHCLHQ--------AKRFTV 52
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLW 142
+G + Q +EG +V+ + F Y DIA+L+L + + + V P CL
Sbjct: 53 RVGDRNTEQ--EEGNEMAHEVEMTVKHSRFVKETYDFDIAVLRLKTPIRFRRNVAPACLP 110
Query: 143 DDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVF 202
+ A L + T + +G ++ S + + + + L T +F
Sbjct: 111 EKDWAEATL-MTQKTGIVSGFGRTHEKGRLSSTLKMLEVPYVDRSTCKLSSSFTITPNMF 169
Query: 203 -----TDVANVCNGDSGGGMVFKIDSAWYLRGIVS 232
T + C GDSGG V + +++ GIVS
Sbjct: 170 CAGYDTQPEDACQGDSGGPHVTRFKDTYFVTGIVS 204
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 36/115 (31%), Positives = 52/115 (45%), Gaps = 17/115 (14%)
Query: 253 DVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL----WDDSTAPLQLSAVEGR 308
+V+ + F Y DIA+L+L + + + V P CL W ++T Q +
Sbjct: 70 EVEMTVKHSRFVKETYDFDIAVLRLKTPIRFRRNVAPACLPEKDWAEATLMTQ------K 123
Query: 309 DGTVIGWGY-DENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFT-SDETFCAGF 361
G V G+G E R+S LKM +P V C S S FT + FCAG+
Sbjct: 124 TGIVSGFGRTHEKGRLSSTLKMLEVPYVDRSTCKLS-----SSFTITPNMFCAGY 173
>pdb|2ANW|A Chain A, Expression, Crystallization And Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 28/221 (12%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G ++ G+WPW V+L + + ++CGGSL+ +V+TAAHC P D I
Sbjct: 4 GTNSSWGEWPWQVSL-QVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQ-----DVWRI 57
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLW 142
Y G + + + Q+K + I+ + S DIAL++L + ++Y+ + +P+ L
Sbjct: 58 YSGILNLSDITKD--TPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPISL- 114
Query: 143 DDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKH--YV 200
S + +++ G F + + + + C ++ Y
Sbjct: 115 --------PSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYK 166
Query: 201 VFTDV---------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
+ + + C GDSGG +V K + W L GI S
Sbjct: 167 ITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITS 207
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 26/125 (20%), Positives = 57/125 (45%), Gaps = 9/125 (7%)
Query: 240 LRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAP 299
L + D F+ +K + I+ + S DIAL++L + ++Y+ + +P+ L
Sbjct: 62 LNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPISLPSKGDTS 121
Query: 300 LQLSAVEGRDGTVIGWGY-DENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFC 358
+ + V GWG+ E + L+ +P+V++++C ++ + C
Sbjct: 122 TIYT-----NCWVTGWGFSKEKGEIQNILQKVNIPLVTNEEC---QKRYQDYKITQRMVC 173
Query: 359 AGFRN 363
AG++
Sbjct: 174 AGYKE 178
>pdb|1Z8G|A Chain A, Crystal Structure Of The Extracellular Region Of The
Transmembrane Serine Protease Hepsin With Covalently
Bound Preferred Substrate
Length = 372
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 67/230 (29%), Positives = 96/230 (41%), Gaps = 33/230 (14%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G+ T+ G+WPW V+L R +G +L CGGSL+S ++V+TAAHC P V S
Sbjct: 118 IVGGRDTSLGRWPWQVSL-RYDGAHL---CGGSLLSGDWVLTAAHCF---PERNRVLSRW 170
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHI-YPTFNSSNYLGDIALLQLSSDVDYSMYVRP 138
V + GVQ ++ + NS DIAL+ LSS + + Y++P
Sbjct: 171 RVFAGAVAQASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQP 230
Query: 139 VCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCD--- 195
VCL P A+ +C G + A L+ ++ D VC+
Sbjct: 231 VCL------PAAGQALVDGKICTVTGWGNTQYYGQQAGVLQEARVPIISND---VCNGAD 281
Query: 196 -------TKHYVVFTDVANV--CNGDSGGGMV----FKIDSAWYLRGIVS 232
K + + C GDSGG V W L GIVS
Sbjct: 282 FYGNQIKPKMFCAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGIVS 331
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 35/102 (34%), Positives = 51/102 (50%), Gaps = 14/102 (13%)
Query: 264 NSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWG----YDE 319
NS DIAL+ LSS + + Y++PVCL A V+G+ TV GWG Y +
Sbjct: 205 NSEENSNDIALVHLSSPLPLTEYIQPVCLPAAGQA-----LVDGKICTVTGWGNTQYYGQ 259
Query: 320 NDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
V +E A +PI+S+ C + F+ + FCAG+
Sbjct: 260 QAGVLQE---ARVPIISNDVC--NGADFYGNQIKPKMFCAGY 296
>pdb|3T2N|A Chain A, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
pdb|3T2N|B Chain B, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
Length = 372
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 67/230 (29%), Positives = 97/230 (42%), Gaps = 33/230 (14%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G+ T+ G+WPW V+L R +G +L CGGSL+S ++V+TAAHC P V S
Sbjct: 118 IVGGRDTSLGRWPWQVSL-RYDGAHL---CGGSLLSGDWVLTAAHCF---PERNRVLSRW 170
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHI-YPTFNSSNYLGDIALLQLSSDVDYSMYVRP 138
V + GVQ ++ + NS DIAL+ LSS + + Y++P
Sbjct: 171 RVFAGAVAQASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQP 230
Query: 139 VCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKH 198
VCL P A+ +C G + A L+ ++ D VC+
Sbjct: 231 VCL------PAAGQALVDGKICTVTGWGNTQYYGQQAGVLQEARVPIISND---VCNGAD 281
Query: 199 YV-------VF-----TDVANVCNGDSGGGMV----FKIDSAWYLRGIVS 232
+ +F + C GDSGG V W L GIVS
Sbjct: 282 FYGNQIKPKMFCAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGIVS 331
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 35/102 (34%), Positives = 51/102 (50%), Gaps = 14/102 (13%)
Query: 264 NSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWG----YDE 319
NS DIAL+ LSS + + Y++PVCL A V+G+ TV GWG Y +
Sbjct: 205 NSEENSNDIALVHLSSPLPLTEYIQPVCLPAAGQA-----LVDGKICTVTGWGNTQYYGQ 259
Query: 320 NDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
V +E A +PI+S+ C + F+ + FCAG+
Sbjct: 260 QAGVLQE---ARVPIISNDVC--NGADFYGNQIKPKMFCAGY 296
>pdb|2XXL|A Chain A, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
pdb|2XXL|B Chain B, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
Length = 408
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 56/233 (24%), Positives = 101/233 (43%), Gaps = 36/233 (15%)
Query: 4 RDVSCGTVVYNKAQPLVTYGQKTARGQWPWHVALYRTEGINLS-YVCGGSLVSVNYVITA 62
+ CG + + V+ G + PW +AL R + S ++CGG+++S Y++TA
Sbjct: 107 ENFDCGNFLSQR----VSNGYEVKLSSRPW-MALLRYQQFGESRFLCGGAMISERYILTA 161
Query: 63 AHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDE-------------GGVQNKQVKRVHIY 109
AHCV + +D I LG +H+ S E V N +++ I+
Sbjct: 162 AHCVHG------LQNDLYEIRLG---EHRISTEEDCRQQGRKKKCAPPVVNVGIEKHLIH 212
Query: 110 PTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL-----WDDSTAPLQLSAVEGTSVCNGDS 164
+++ + + DIALL+L+ V + +++P+CL + + V G S
Sbjct: 213 EKYDARHIMHDIALLKLNRSVPFQKHIKPICLPITDELKEKAEQISTYFVTGWGTTENGS 272
Query: 165 GGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVANVCNGDSGGGM 217
++ + + R S R V ++ V D+ + C GDSGG +
Sbjct: 273 SSDVLLQANVPLQPRSACSQAYRR---AVPLSQLCVGGGDLQDSCKGDSGGPL 322
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 27/92 (29%), Positives = 48/92 (52%), Gaps = 2/92 (2%)
Query: 249 VVFTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGR 308
VV +++ I+ +++ + + DIALL+L+ V + +++P+CL T L+ A +
Sbjct: 201 VVNVGIEKHLIHEKYDARHIMHDIALLKLNRSVPFQKHIKPICL--PITDELKEKAEQIS 258
Query: 309 DGTVIGWGYDENDRVSEELKMAIMPIVSHQQC 340
V GWG EN S+ L A +P+ C
Sbjct: 259 TYFVTGWGTTENGSSSDVLLQANVPLQPRSAC 290
>pdb|1O5E|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5F|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1P57|B Chain B, Extracellular Domain Of Human Hepsin
Length = 255
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 66/227 (29%), Positives = 94/227 (41%), Gaps = 27/227 (11%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G+ T+ G+WPW V+L R +G +L CGGSL+S ++V+TAAHC P V S
Sbjct: 1 IVGGRDTSLGRWPWQVSL-RYDGAHL---CGGSLLSGDWVLTAAHCF---PERNRVLSRW 53
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHI-YPTFNSSNYLGDIALLQLSSDVDYSMYVRP 138
V + GVQ ++ + NS DIAL+ LSS + + Y++P
Sbjct: 54 RVFAGAVAQASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQP 113
Query: 139 VCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCD--- 195
VCL P A+ +C G + A L+ ++ D D
Sbjct: 114 VCL------PAAGQALVDGKICTVTGWGNTQYYGQQAGVLQEARVPIISNDVCNGADFYG 167
Query: 196 ----TKHYVVFTDVANV--CNGDSGGGMV----FKIDSAWYLRGIVS 232
K + + C GDSGG V W L GIVS
Sbjct: 168 NQIKPKMFCAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGIVS 214
Score = 48.5 bits (114), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 8/99 (8%)
Query: 264 NSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDE-NDR 322
NS DIAL+ LSS + + Y++PVCL A V+G+ TV GWG + +
Sbjct: 88 NSEENSNDIALVHLSSPLPLTEYIQPVCLPAAGQA-----LVDGKICTVTGWGNTQYYGQ 142
Query: 323 VSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+ L+ A +PI+S+ C + F+ + FCAG+
Sbjct: 143 QAGVLQEARVPIISNDVC--NGADFYGNQIKPKMFCAGY 179
>pdb|3IG6|B Chain B, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
pdb|3IG6|D Chain D, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
Length = 253
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 61/229 (26%), Positives = 98/229 (42%), Gaps = 34/229 (14%)
Query: 23 GQKTARGQWPWHVALYRT-EGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLV 81
G+ T PW A+YR G +++YVCGGSL+S +VI+A HC P + +
Sbjct: 4 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYP-----KKEDYI 58
Query: 82 IYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSN--YLGDIALLQLSSD----VDYSMY 135
+YLG+ + S+ G +V+ + ++ +++ + DIALL++ S S
Sbjct: 59 VYLGRSRLN--SNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 136 VRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCD 195
++ +CL P ++ E T +S + Y + V R C
Sbjct: 117 IQTICLPSMYNDPQFGTSCEITGFGKENSTDYL--------YPEQLKMTVVKLISHRECQ 168
Query: 196 TKHYV---VFTDV---------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
HY V T + + C GDSGG +V + L GIVS
Sbjct: 169 QPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVS 217
Score = 32.7 bits (73), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 23/96 (23%), Positives = 45/96 (46%), Gaps = 13/96 (13%)
Query: 271 DIALLQLSSD----VDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRV--S 324
DIALL++ S S ++ +CL P ++ E + G+G + +
Sbjct: 97 DIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCE-----ITGFGKENSTDYLYP 151
Query: 325 EELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
E+LKM ++ ++SH++C P ++ + + CA
Sbjct: 152 EQLKMTVVKLISHREC--QQPHYYGSEVTTKMLCAA 185
>pdb|2VNT|A Chain A, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|B Chain B, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|C Chain C, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|D Chain D, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|E Chain E, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|F Chain F, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
Length = 276
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 63/229 (27%), Positives = 99/229 (43%), Gaps = 34/229 (14%)
Query: 23 GQKTARGQWPWHVALYRT-EGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLV 81
G+ T PW A+YR G +++YVCGGSL+S +VI+A HC D P D +
Sbjct: 27 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFI----DYPKKED-YI 81
Query: 82 IYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSN--YLGDIALLQLSSD----VDYSMY 135
+YLG+ + S+ G +V+ + ++ +++ + DIALL++ S S
Sbjct: 82 VYLGRSRLN--SNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 139
Query: 136 VRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCD 195
++ +CL P ++ E T +S + Y + V R C
Sbjct: 140 IQTICLPSMYNDPQFGTSCEITGFGKENSTDYL--------YPEQLKMTVVKLISHRECQ 191
Query: 196 TKHYV---VFTDV---------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
HY V T + + C GDSGG +V + L GIVS
Sbjct: 192 QPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVS 240
Score = 32.7 bits (73), Expect = 0.37, Method: Compositional matrix adjust.
Identities = 23/96 (23%), Positives = 45/96 (46%), Gaps = 13/96 (13%)
Query: 271 DIALLQLSSD----VDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRV--S 324
DIALL++ S S ++ +CL P ++ E + G+G + +
Sbjct: 120 DIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCE-----ITGFGKENSTDYLYP 174
Query: 325 EELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
E+LKM ++ ++SH++C P ++ + + CA
Sbjct: 175 EQLKMTVVKLISHREC--QQPHYYGSEVTTKMLCAA 208
>pdb|1RTF|B Chain B, Complex Of Benzamidine With The Catalytic Domain Of Human
Two Chain Tissue Plasminogen Activator [(Tc)-T-Pa]
pdb|1A5H|A Chain A, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
pdb|1A5H|B Chain B, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
Length = 252
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 33/222 (14%)
Query: 32 PWHVALY----RTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKY 87
PW A++ R+ G ++CGG L+S ++++AAHC ++ L + LG+
Sbjct: 13 PWQAAIFAKHRRSPGER--FLCGGILISSCWILSAAHCFQER-----FPPHHLTVILGRT 65
Query: 88 HQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSD----VDYSMYVRPVCLWD 143
++ +E Q +V++ ++ F+ Y DIALLQL SD S VR VCL
Sbjct: 66 YRVVPGEE--EQKFEVEKYIVHKEFDDDTYDNDIALLQLKSDSSRCAQESSVVRTVCL-- 121
Query: 144 DSTAPLQL---SAVEGTSVCNGDSGGGMVFKIDSAWYLR----------GIVSITVARDG 190
A LQL + E + ++ + ++R +++ TV +
Sbjct: 122 -PPADLQLPDWTECELSGYGKHEALSPFYSERLKEAHVRLYPSSRCTSQHLLNRTVTDNM 180
Query: 191 LRVCDTKHYVVFTDVANVCNGDSGGGMVFKIDSAWYLRGIVS 232
L DT+ ++ + C GDSGG +V D L GI+S
Sbjct: 181 LCAGDTRSGGPQANLHDACQGDSGGPLVCLNDGRMTLVGIIS 222
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 33/114 (28%), Positives = 52/114 (45%), Gaps = 13/114 (11%)
Query: 253 DVKRVHIYPTFNSSNYLGDIALLQLSSD----VDYSMYVRPVCLWDDSTAPLQLSAVEGR 308
+V++ ++ F+ Y DIALLQL SD S VR VCL P L +
Sbjct: 78 EVEKYIVHKEFDDDTYDNDIALLQLKSDSSRCAQESSVVRTVCL-----PPADLQLPDWT 132
Query: 309 DGTVIGWGYDE--NDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
+ + G+G E + SE LK A + + +C ++ ++ +D CAG
Sbjct: 133 ECELSGYGKHEALSPFYSERLKEAHVRLYPSSRC--TSQHLLNRTVTDNMLCAG 184
>pdb|1O5A|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1O5B|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5C|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
Length = 253
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 63/229 (27%), Positives = 98/229 (42%), Gaps = 34/229 (14%)
Query: 23 GQKTARGQWPWHVALYRT-EGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLV 81
G+ T PW A+YR G +++YVCGGSL+S +VI+A HC P + +
Sbjct: 4 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYP-----KKEDYI 58
Query: 82 IYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSN--YLGDIALLQLSSD----VDYSMY 135
+YLG+ + S+ G +V+ + ++ +++ + DIALL++ S S
Sbjct: 59 VYLGRSRLN--SNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 136 VRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCD 195
++ +CL P ++ E T G G D Y + V R C
Sbjct: 117 IQTICLPSMYNDPQFGTSCEIT-------GFGKEASTDYL-YPEQLKMTVVKLISHRECQ 168
Query: 196 TKHYV---VFTDV---------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
HY V T + + C GDSGG +V + L GIVS
Sbjct: 169 QPHYYGSEVTTKMLCAADPQWKTDACQGDSGGPLVCSLQGRMTLTGIVS 217
Score = 32.7 bits (73), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 23/96 (23%), Positives = 45/96 (46%), Gaps = 13/96 (13%)
Query: 271 DIALLQLSSD----VDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRV--S 324
DIALL++ S S ++ +CL P ++ E + G+G + +
Sbjct: 97 DIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCE-----ITGFGKEASTDYLYP 151
Query: 325 EELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
E+LKM ++ ++SH++C P ++ + + CA
Sbjct: 152 EQLKMTVVKLISHREC--QQPHYYGSEVTTKMLCAA 185
>pdb|1FIW|A Chain A, Three-Dimensional Structure Of Beta-Acrosin From Ram
Spermatozoa
Length = 290
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 38/123 (30%), Positives = 68/123 (55%), Gaps = 8/123 (6%)
Query: 23 GQKTARGQWPWHVAL--YRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTL 80
GQ A G WPW V+L + +VCGGSL++ +++TAAHC K K V +D
Sbjct: 4 GQDAAHGAWPWMVSLQIFTYHNNRRYHVCGGSLLNSQWLLTAAHCFRIK---KKV-TDWR 59
Query: 81 VIYLGKYHQHQFSD--EGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRP 138
+I+ K + + + +Q + V+++ I+ +++S+ DIAL++++ V ++ P
Sbjct: 60 LIFGAKEVEWGTNKPVKPPLQERYVEKIIIHEKYSASSEANDIALMKITPPVTCGHFIGP 119
Query: 139 VCL 141
CL
Sbjct: 120 GCL 122
Score = 35.4 bits (80), Expect = 0.049, Method: Compositional matrix adjust.
Identities = 24/110 (21%), Positives = 55/110 (50%), Gaps = 8/110 (7%)
Query: 254 VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVI 313
V+++ I+ +++S+ DIAL++++ V ++ P CL P ++ + V
Sbjct: 84 VEKIIIHEKYSASSEANDIALMKITPPVTCGHFIGPGCLPQFRAGPPRVP----QTCWVA 139
Query: 314 GWGYDEND--RVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
GWG+ + + R S L+ A + ++ C ++ ++++ CAG+
Sbjct: 140 GWGFLQENARRTSPMLQEARVDLIDLGLC--NSTRWYNGRIRSTNVCAGY 187
>pdb|1OWD|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWI|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWJ|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWK|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQT|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1U6Q|A Chain A, Substituted 2-naphthamadine Inhibitors Of Urokinase
Length = 245
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 61/229 (26%), Positives = 98/229 (42%), Gaps = 34/229 (14%)
Query: 23 GQKTARGQWPWHVALYRT-EGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLV 81
G+ T PW A+YR G +++YVCGGSL+S +VI+A HC P + +
Sbjct: 4 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYP-----KKEDYI 58
Query: 82 IYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSN--YLGDIALLQLSSD----VDYSMY 135
+YLG+ + S+ G +V+ + ++ +++ + DIALL++ S S
Sbjct: 59 VYLGRSRLN--SNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 136 VRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCD 195
++ +CL P ++ E T +S + Y + V R C
Sbjct: 117 IQTICLPSMYNDPQFGTSCEITGFGKENSTDYL--------YPEQLKMTVVKLISHRECQ 168
Query: 196 TKHYV---VFTDV---------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
HY V T + + C GDSGG +V + L GIVS
Sbjct: 169 QPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVS 217
Score = 32.7 bits (73), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 23/96 (23%), Positives = 45/96 (46%), Gaps = 13/96 (13%)
Query: 271 DIALLQLSSD----VDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRV--S 324
DIALL++ S S ++ +CL P ++ E + G+G + +
Sbjct: 97 DIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCE-----ITGFGKENSTDYLYP 151
Query: 325 EELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
E+LKM ++ ++SH++C P ++ + + CA
Sbjct: 152 EQLKMTVVKLISHREC--QQPHYYGSEVTTKMLCAA 185
>pdb|1LMW|B Chain B, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
pdb|1LMW|D Chain D, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
Length = 253
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 61/229 (26%), Positives = 98/229 (42%), Gaps = 34/229 (14%)
Query: 23 GQKTARGQWPWHVALYRT-EGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLV 81
G+ T PW A+YR G +++YVCGGSL+S +VI+A HC P + +
Sbjct: 4 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYP-----KKEDYI 58
Query: 82 IYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSN--YLGDIALLQLSSD----VDYSMY 135
+YLG+ + S+ G +V+ + ++ +++ + DIALL++ S S
Sbjct: 59 VYLGRSRLN--SNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 136 VRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCD 195
++ +CL P ++ E T +S + Y + V R C
Sbjct: 117 IQTICLPSMYNDPQFGTSCEITGFGKENSTDYL--------YPEQLKMTVVKLISHRECQ 168
Query: 196 TKHYV---VFTDV---------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
HY V T + + C GDSGG +V + L GIVS
Sbjct: 169 QPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVS 217
Score = 32.7 bits (73), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 23/96 (23%), Positives = 45/96 (46%), Gaps = 13/96 (13%)
Query: 271 DIALLQLSSD----VDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRV--S 324
DIALL++ S S ++ +CL P ++ E + G+G + +
Sbjct: 97 DIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCE-----ITGFGKENSTDYLYP 151
Query: 325 EELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
E+LKM ++ ++SH++C P ++ + + CA
Sbjct: 152 EQLKMTVVKLISHREC--QQPHYYGSEVTTKMLCAA 185
>pdb|1GI8|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI7|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI9|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
Length = 245
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 63/229 (27%), Positives = 98/229 (42%), Gaps = 34/229 (14%)
Query: 23 GQKTARGQWPWHVALYRT-EGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLV 81
G+ T PW A+YR G +++YVCGGSL+S +VI+A HC P + +
Sbjct: 4 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYP-----KKEDYI 58
Query: 82 IYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSN--YLGDIALLQLSSD----VDYSMY 135
+YLG+ + S+ G +V+ + ++ +++ + DIALL++ S S
Sbjct: 59 VYLGRSRLN--SNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 136 VRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCD 195
++ +CL P ++ E T G G D Y + V R C
Sbjct: 117 IQTICLPSMYNDPQFGTSCEIT-------GFGKEASTDYL-YPEQLKMTVVKLISHRECQ 168
Query: 196 TKHYV---VFTDV---------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
HY V T + + C GDSGG +V + L GIVS
Sbjct: 169 QPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVS 217
Score = 32.7 bits (73), Expect = 0.34, Method: Compositional matrix adjust.
Identities = 23/96 (23%), Positives = 45/96 (46%), Gaps = 13/96 (13%)
Query: 271 DIALLQLSSD----VDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRV--S 324
DIALL++ S S ++ +CL P ++ E + G+G + +
Sbjct: 97 DIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCE-----ITGFGKEASTDYLYP 151
Query: 325 EELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
E+LKM ++ ++SH++C P ++ + + CA
Sbjct: 152 EQLKMTVVKLISHREC--QQPHYYGSEVTTKMLCAA 185
>pdb|1GJ7|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJ8|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJA|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJB|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1O3P|B Chain B, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1C5W|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5X|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Y|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Z|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GJ9|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJD|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJC|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
Length = 253
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 63/229 (27%), Positives = 98/229 (42%), Gaps = 34/229 (14%)
Query: 23 GQKTARGQWPWHVALYRT-EGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLV 81
G+ T PW A+YR G +++YVCGGSL+S +VI+A HC P + +
Sbjct: 4 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYP-----KKEDYI 58
Query: 82 IYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSN--YLGDIALLQLSSD----VDYSMY 135
+YLG+ + S+ G +V+ + ++ +++ + DIALL++ S S
Sbjct: 59 VYLGRSRLN--SNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 136 VRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCD 195
++ +CL P ++ E T G G D Y + V R C
Sbjct: 117 IQTICLPSMYNDPQFGTSCEIT-------GFGKEASTDYL-YPEQLKMTVVKLISHRECQ 168
Query: 196 TKHYV---VFTDV---------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
HY V T + + C GDSGG +V + L GIVS
Sbjct: 169 QPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVS 217
Score = 32.7 bits (73), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 23/96 (23%), Positives = 45/96 (46%), Gaps = 13/96 (13%)
Query: 271 DIALLQLSSD----VDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRV--S 324
DIALL++ S S ++ +CL P ++ E + G+G + +
Sbjct: 97 DIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCE-----ITGFGKEASTDYLYP 151
Query: 325 EELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
E+LKM ++ ++SH++C P ++ + + CA
Sbjct: 152 EQLKMTVVKLISHREC--QQPHYYGSEVTTKMLCAA 185
>pdb|1EUF|A Chain A, Bovine Duodenase(New Serine Protease), Crystal Structure
Length = 227
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 52/190 (27%), Positives = 88/190 (46%), Gaps = 29/190 (15%)
Query: 37 LYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEG 96
L++T G S++CGG LV ++V+TAAHC+ ++ + LG ++ + E
Sbjct: 19 LFKTSG--KSHICGGFLVREDFVLTAAHCL----------GSSINVTLGAHNIME--RER 64
Query: 97 GVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEG 156
Q V+R +P +N DI LL+L+ D + V P+ L P L+ V+
Sbjct: 65 TQQVIPVRRPIPHPDYNDETLANDIMLLKLTRKADITDKVSPINL------PRSLAEVKP 118
Query: 157 TSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDV--------ANV 208
+C+ G + + S L+ V + V + + K+Y+ FT + N
Sbjct: 119 GMMCSVAGWGRLGVNMPSTDKLQE-VDLEVQSEEKCIARFKNYIPFTQICAGDPSKRKNS 177
Query: 209 CNGDSGGGMV 218
+GDSGG +V
Sbjct: 178 FSGDSGGPLV 187
>pdb|1OWE|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWH|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQA|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQO|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
Length = 245
Score = 58.5 bits (140), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 34/229 (14%)
Query: 23 GQKTARGQWPWHVALYRT-EGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLV 81
G+ T PW A+YR G +++YVCGGSL+S +VI+A HC P + +
Sbjct: 4 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYP-----KKEDYI 58
Query: 82 IYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSN--YLGDIALLQLSSD----VDYSMY 135
+YLG+ + S+ G +V+ + ++ +++ + DIALL++ S S
Sbjct: 59 VYLGRSRLN--SNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 136 VRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCD 195
++ +CL P ++ E T S + Y + V R C
Sbjct: 117 IQTICLPSMYNDPQFGTSCEITGFGKEQSTDYL--------YPEQLKMTVVKLISHRECQ 168
Query: 196 TKHYV---VFTDV---------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
HY V T + + C GDSGG +V + L GIVS
Sbjct: 169 QPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVS 217
Score = 33.5 bits (75), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 23/96 (23%), Positives = 46/96 (47%), Gaps = 13/96 (13%)
Query: 271 DIALLQLSSD----VDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRV--S 324
DIALL++ S S ++ +CL P ++ E + G+G +++
Sbjct: 97 DIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCE-----ITGFGKEQSTDYLYP 151
Query: 325 EELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
E+LKM ++ ++SH++C P ++ + + CA
Sbjct: 152 EQLKMTVVKLISHREC--QQPHYYGSEVTTKMLCAA 185
>pdb|1AO5|A Chain A, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
pdb|1AO5|B Chain B, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
Length = 237
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 40/140 (28%), Positives = 62/140 (44%), Gaps = 27/140 (19%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
V G + PW VA+Y + ++CGG L+ N+V+TAAHC D
Sbjct: 1 VVGGFNCEKNSQPWQVAVYYQK----EHICGGVLLDRNWVLTAAHCYV----------DQ 46
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSS-----------NYLGDIALLQLSS 128
++LGK F +E Q++ V + +P FN S ++ D+ LL+LS
Sbjct: 47 YEVWLGK--NKLFQEEPSAQHRLVSKSFPHPGFNMSLLMLQTIPPGADFSDDLMLLRLSK 104
Query: 129 DVDYSMYVRPVCLWDDSTAP 148
D + V+P+ L P
Sbjct: 105 PADITDVVKPIALPTKEPKP 124
>pdb|1L2E|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor
pdb|1LO6|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor At 1.56 A Resolution
Length = 223
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 36/220 (16%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ +G + P+ ALY + + +CGG L+ +V+TAAHC KKP
Sbjct: 1 LVHGGPCDKTSHPYQAALYTSGHL----LCGGVLIHPLWVLTAAHC--KKP--------N 46
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
L ++LGK++ Q E + V R I+P ++++++ DI LL+L+ S ++P+
Sbjct: 47 LQVFLGKHNLRQ--RESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPL 104
Query: 140 CLWDDSTAPLQLSAVEGTSVCN----GDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCD 195
PL+ T+ C+ G + G Y+ +VS
Sbjct: 105 --------PLERDCSANTTSCHILGWGKTADGDFPDTIQCAYIH-LVSREECEHAYPGQI 155
Query: 196 TKHYVVFTDV---ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
T++ + D + C GDSGG +V +LRG+VS
Sbjct: 156 TQNMLCAGDEKYGKDSCQGDSGGPLV----CGDHLRGLVS 191
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 26/109 (23%), Positives = 52/109 (47%), Gaps = 11/109 (10%)
Query: 252 TDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGT 311
+ V R I+P ++++++ DI LL+L+ S ++P+ L D +A
Sbjct: 66 SSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPLPLERDCSA-------NTTSCH 118
Query: 312 VIGWGYDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
++GWG + + ++ A + +VS ++C + P +Q CAG
Sbjct: 119 ILGWGKTADGDFPDTIQCAYIHLVSREECEHAYPGQITQ----NMLCAG 163
>pdb|2OLG|A Chain A, Crystal Structure Of The Serine Protease Domain Of
Prophenoloxidase Activating Factor-I In A Zymogen Form
Length = 278
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 59/232 (25%), Positives = 104/232 (44%), Gaps = 23/232 (9%)
Query: 20 VTYGQKTARGQWPWHVAL-YRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSD 78
+ G T ++PW + Y+ + CGGSL++ Y++TAAHCV + V
Sbjct: 23 ILNGDDTVPEEFPWTAMIGYKNSSNFEQFACGGSLINNRYIVTAAHCVAGRVLR--VVGA 80
Query: 79 TLVIYLGKYHQHQFSDEGG-----VQNKQVKRVHIYPTFNSSNYLG-------DIALLQL 126
+ LG+++ D G V +K + + I T +Y+ DIAL++L
Sbjct: 81 LNKVRLGEWNTATDPDCYGAVRVCVPDKPID-LGIEETIQHPDYVDGSKDRYHDIALIRL 139
Query: 127 SSDVDYSMYVRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITV 186
+ V+++ Y+RPVCL +Q+ T V G + G I + + +
Sbjct: 140 NRQVEFTNYIRPVCL-PQPNEEVQVGQ-RLTVVGWGRTETGQYSTIKQKLAVPVVHAEQC 197
Query: 187 ARD----GLRVCDTKHYVVFTDVANVCNGDSGGGMVF-KIDSAWYLRGIVSI 233
A+ G+RV ++ + C GDSGG ++ + + ++L G+VS
Sbjct: 198 AKTFGAAGVRVRSSQLCAGGEKAKDSCGGDSGGPLLAERANQQFFLEGLVSF 249
Score = 47.8 bits (112), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 26/71 (36%), Positives = 41/71 (57%), Gaps = 7/71 (9%)
Query: 271 DIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVE-GRDGTVIGWGYDENDRVSEELKM 329
DIAL++L+ V+++ Y+RPVCL P V+ G+ TV+GWG E + S +
Sbjct: 133 DIALIRLNRQVEFTNYIRPVCL------PQPNEEVQVGQRLTVVGWGRTETGQYSTIKQK 186
Query: 330 AIMPIVSHQQC 340
+P+V +QC
Sbjct: 187 LAVPVVHAEQC 197
>pdb|1BRU|P Chain P, Structure Of Porcine Pancreatic Elastase Complexed With
The Elastase Inhibitor Gr143783
Length = 241
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 63/235 (26%), Positives = 101/235 (42%), Gaps = 47/235 (20%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
V G+ WPW V+L + CGG+LV ++V+TAAHC++ S T
Sbjct: 1 VVGGEDARPNSWPWQVSLQYDSSGQWRHTCGGTLVDQSWVLTAAHCISS--------SRT 52
Query: 80 LVIYLGKYHQHQFS-DEGGVQNKQVKRVHIYPTFNSSNYL--GDIALLQLSSDVDYSMYV 136
+ LG+ H S +E G +V ++ ++ +NS+ DIALL+L+S V + +
Sbjct: 53 YRVVLGR---HSLSTNEPGSLAVKVSKLVVHQDWNSNQLSNGNDIALLKLASPVSLTDKI 109
Query: 137 RPVCLWDDSTAPLQLSAVEGTSVC----------NGDSGG----GMVFKIDSAWYLRGIV 182
+ CL P + + VC NG S G + +D A
Sbjct: 110 QLGCL------PAAGTILPNNYVCYVTGWGRLQTNGASPDILQQGQLLVVDYA------- 156
Query: 183 SITVARDGLRVCDTKHYVVFT---DVANVCNGDSGGGMVFK-IDSAWYLRGIVSI 233
T ++ G K ++ + + CNGDSGG + + + W + GIVS
Sbjct: 157 --TCSKPGWWGSTVKTNMICAGGDGIISSCNGDSGGPLNCQGANGQWQVHGIVSF 209
>pdb|2B9L|A Chain A, Crystal Structure Of Prophenoloxidase Activating Factor-Ii
From The Beetle Holotrichia Diomphalia
Length = 394
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 36/121 (29%), Positives = 62/121 (51%), Gaps = 8/121 (6%)
Query: 29 GQWPWHVALYRTEGINLS----YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYL 84
G++PW VA+ + I S VCGGSL++ + V+T AHCV Y +D+ + I
Sbjct: 140 GEFPWMVAVLKANVIPGSGEEQLVCGGSLIAPSVVLTGAHCVNS--YQSNLDA--IKIRA 195
Query: 85 GKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDD 144
G++ + Q +++++V I+ FN + D+ALL L + + + +CL
Sbjct: 196 GEWDTLTEKERLPYQERKIRQVIIHSNFNPKTVVNDVALLLLDRPLVQADNIGTICLPQQ 255
Query: 145 S 145
S
Sbjct: 256 S 256
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 32/113 (28%), Positives = 49/113 (43%), Gaps = 12/113 (10%)
Query: 254 VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVI 313
+++V I+ FN + D+ALL L + + + +CL P Q + +
Sbjct: 214 IRQVIIHSNFNPKTVVNDVALLLLDRPLVQADNIGTICL------PQQSQIFDSTECFAS 267
Query: 314 GWGYDE---NDRVSEELKMAIMPIVSHQQCL--WSNPQFFSQFTSDETF-CAG 360
GWG E R S LK +P V +C N + +F D+TF CAG
Sbjct: 268 GWGKKEFGSRHRYSNILKKIQLPTVDRDKCQADLRNTRLGLKFVLDQTFVCAG 320
>pdb|1SC8|U Chain U, Urokinase Plasminogen Activator B-Chain-J435 Complex
pdb|1VJ9|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt464 Complex
pdb|1VJA|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt463 Complex
Length = 262
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 62/229 (27%), Positives = 98/229 (42%), Gaps = 34/229 (14%)
Query: 23 GQKTARGQWPWHVALYRT-EGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLV 81
G+ T PW A+YR G +++YVCGGSL+S +VI+A HC D P D +
Sbjct: 19 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFI----DYPKKED-YI 73
Query: 82 IYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSN--YLGDIALLQLSSD----VDYSMY 135
+YLG+ + S+ G +V+ + ++ +++ + DIALL++ S S
Sbjct: 74 VYLGRSRLN--SNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 131
Query: 136 VRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCD 195
++ + L P ++ E T +S + Y + V R C
Sbjct: 132 IQTISLPSMYNDPQFGTSCEITGFGKENSTDYL--------YPEQLKMTVVKLISHRECQ 183
Query: 196 TKHYV---VFTDV---------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
HY V T + + C GDSGG +V + L GIVS
Sbjct: 184 QPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVS 232
Score = 29.3 bits (64), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 10/36 (27%), Positives = 21/36 (58%), Gaps = 2/36 (5%)
Query: 325 EELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
E+LKM ++ ++SH++C P ++ + + CA
Sbjct: 167 EQLKMTVVKLISHREC--QQPHYYGSEVTTKMLCAA 200
>pdb|3MWI|U Chain U, The Complex Crystal Structure Of Urokianse And
5-Nitro-1h-Indole-2- Amidine
Length = 246
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 34/229 (14%)
Query: 23 GQKTARGQWPWHVALYRT-EGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLV 81
G+ T PW A+YR G +++YVCGGSL+S +VI+A HC P + +
Sbjct: 4 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYP-----KKEDYI 58
Query: 82 IYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSN--YLGDIALLQLSSD----VDYSMY 135
+YLG+ + S+ G +V+ + ++ +++ + DIALL++ S S
Sbjct: 59 VYLGRSRLN--SNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 136 VRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCD 195
++ + L P ++ E T +S + Y + V R C
Sbjct: 117 IQTIALPSMYNDPQFGTSCEITGFGKENSTDYL--------YPEQLKMTVVKLISHRECQ 168
Query: 196 TKHYV---VFTDV---------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
HY V T + + C GDSGG +V + L GIVS
Sbjct: 169 QPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVS 217
Score = 29.6 bits (65), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 10/36 (27%), Positives = 21/36 (58%), Gaps = 2/36 (5%)
Query: 325 EELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
E+LKM ++ ++SH++C P ++ + + CA
Sbjct: 152 EQLKMTVVKLISHREC--QQPHYYGSEVTTKMLCAA 185
>pdb|1W0Z|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W10|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W11|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W12|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W13|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W14|U Chain U, Urokinase Type Plasminogen Activator
pdb|3MHW|U Chain U, The Complex Crystal Structure Of Urokianse And 2-
Aminobenzothiazole
Length = 247
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 34/229 (14%)
Query: 23 GQKTARGQWPWHVALYRT-EGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLV 81
G+ T PW A+YR G +++YVCGGSL+S +VI+A HC P + +
Sbjct: 4 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYP-----KKEDYI 58
Query: 82 IYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSN--YLGDIALLQLSSD----VDYSMY 135
+YLG+ + S+ G +V+ + ++ +++ + DIALL++ S S
Sbjct: 59 VYLGRSRLN--SNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 136 VRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCD 195
++ + L P ++ E T +S + Y + V R C
Sbjct: 117 IQTISLPSMYNDPQFGTSCEITGFGKENSTDYL--------YPEQLKMTVVKLISHRECQ 168
Query: 196 TKHYV---VFTDV---------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
HY V T + + C GDSGG +V + L GIVS
Sbjct: 169 QPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVS 217
Score = 29.3 bits (64), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 10/36 (27%), Positives = 21/36 (58%), Gaps = 2/36 (5%)
Query: 325 EELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
E+LKM ++ ++SH++C P ++ + + CA
Sbjct: 152 EQLKMTVVKLISHREC--QQPHYYGSEVTTKMLCAA 185
>pdb|1EJN|A Chain A, Urokinase Plasminogen Activator B-Chain Inhibitor Complex
pdb|1F5K|U Chain U, Urokinase Plasminogen Activator B-Chain-Benzamidine
Complex
pdb|1F5L|A Chain A, Urokinase Plasminogen Activator B-Chain-Amiloride Complex
pdb|1F92|A Chain A, Urokinase Plasminogen Activator B Chain-Uki-1d Complex
pdb|2R2W|U Chain U, Urokinase Plasminogen Activator B-Chain-Gppe Complex
pdb|2VIN|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIO|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIP|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIQ|A Chain A, Fragment-based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-type
Plasminogen Activator
pdb|2VIV|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIW|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
Length = 253
Score = 55.8 bits (133), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 34/229 (14%)
Query: 23 GQKTARGQWPWHVALYRT-EGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLV 81
G+ T PW A+YR G +++YVCGGSL+S +VI+A HC P + +
Sbjct: 4 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYP-----KKEDYI 58
Query: 82 IYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSN--YLGDIALLQLSSD----VDYSMY 135
+YLG+ + S+ G +V+ + ++ +++ + DIALL++ S S
Sbjct: 59 VYLGRSRLN--SNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 136 VRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCD 195
++ + L P ++ E T +S + Y + V R C
Sbjct: 117 IQTISLPSMYNDPQFGTSCEITGFGKENSTDYL--------YPEQLKMTVVKLISHRECQ 168
Query: 196 TKHYV---VFTDV---------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
HY V T + + C GDSGG +V + L GIVS
Sbjct: 169 QPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVS 217
Score = 29.3 bits (64), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 10/36 (27%), Positives = 21/36 (58%), Gaps = 2/36 (5%)
Query: 325 EELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
E+LKM ++ ++SH++C P ++ + + CA
Sbjct: 152 EQLKMTVVKLISHREC--QQPHYYGSEVTTKMLCAA 185
>pdb|4FU7|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU8|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU9|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUB|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUC|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUD|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUE|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUF|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUG|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUH|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUI|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUJ|A Chain A, Crystal Structure Of The Urokinase
pdb|4DVA|U Chain U, The Crystal Structure Of Human Urokinase-type Plasminogen
Activator Catalytic Domain
pdb|4DW2|U Chain U, The Crystal Structure Of Upa In Complex With The Fab
Fragment Of Mab- 112
Length = 246
Score = 55.8 bits (133), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 60/229 (26%), Positives = 96/229 (41%), Gaps = 34/229 (14%)
Query: 23 GQKTARGQWPWHVALYRT-EGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLV 81
G+ T PW A+YR G +++YVCGGSL+S +VI+A HC P + +
Sbjct: 4 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYP-----KKEDYI 58
Query: 82 IYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSN--YLGDIALLQLSSD----VDYSMY 135
+YLG+ + S+ G +V+ + ++ +++ + DIALL++ S S
Sbjct: 59 VYLGRSRLN--SNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 136 VRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCD 195
++ + L P ++ E T S + Y + V R C
Sbjct: 117 IQTIALPSMYNDPQFGTSCEITGFGKEQSTDYL--------YPEQLKMTVVKLISHRECQ 168
Query: 196 TKHYV---VFTDV---------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
HY V T + + C GDSGG +V + L GIVS
Sbjct: 169 QPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVS 217
Score = 30.4 bits (67), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 22/96 (22%), Positives = 45/96 (46%), Gaps = 13/96 (13%)
Query: 271 DIALLQLSSD----VDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRV--S 324
DIALL++ S S ++ + L P ++ E + G+G +++
Sbjct: 97 DIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCE-----ITGFGKEQSTDYLYP 151
Query: 325 EELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
E+LKM ++ ++SH++C P ++ + + CA
Sbjct: 152 EQLKMTVVKLISHREC--QQPHYYGSEVTTKMLCAA 185
>pdb|1FV9|A Chain A, Crystal Structure Of Human Microurokinase In Complex With
2- Amino-5-Hydroxy-Benzimidazole
Length = 245
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 34/229 (14%)
Query: 23 GQKTARGQWPWHVALYRT-EGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLV 81
G+ T PW A+YR G +++YVCGGSL+S +VI+A HC P + +
Sbjct: 4 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYP-----KKEDYI 58
Query: 82 IYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSN--YLGDIALLQLSSD----VDYSMY 135
+YLG+ + S+ G +V+ + ++ +++ + DIALL++ S S
Sbjct: 59 VYLGRSRLN--SNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 136 VRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCD 195
++ + L P ++ E T +S + Y + V R C
Sbjct: 117 IQTIALPSMYNDPQFGTSCEITGFGKENSTDYL--------YPEQLKMTVVKLISHRECQ 168
Query: 196 TKHYV---VFTDV---------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
HY V T + + C GDSGG +V + L GIVS
Sbjct: 169 QPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVS 217
Score = 29.3 bits (64), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 10/36 (27%), Positives = 21/36 (58%), Gaps = 2/36 (5%)
Query: 325 EELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
E+LKM ++ ++SH++C P ++ + + CA
Sbjct: 152 EQLKMTVVKLISHREC--QQPHYYGSEVTTKMLCAA 185
>pdb|2NWN|A Chain A, New Pharmacophore For Serine Protease Inhibition Revealed
By Crystal Structure Of Human Urokinase-Type Plasminogen
Activator Complexed With A Cyclic Peptidyl Inhibitor,
Upain-1
pdb|2O8T|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145Q) IN COMPLEX WITH
Inhibitors
pdb|3KGP|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KHV|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KID|U Chain U, The Crystal Structures Of 2-Aminobenzothiazole-Based
Inhibitors In Complexes With Urokinase-Type Plasminogen
Activator
pdb|3M61|U Chain U, Crystal Structure Of Complex Of Urokinase And A Upain-1
Variant(W3a) In Ph4.6 Condition
pdb|3OX7|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph4.6
pdb|3OY5|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph7.4
pdb|3OY6|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh036 At Ph4.6
pdb|3QN7|A Chain A, Potent And Selective Bicyclic Peptide Inhibitor (Uk18) Of
Human Urokinase-Type Plasminogen Activator(Upa)
Length = 253
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 60/229 (26%), Positives = 96/229 (41%), Gaps = 34/229 (14%)
Query: 23 GQKTARGQWPWHVALYRT-EGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLV 81
G+ T PW A+YR G +++YVCGGSL+S +VI+A HC P + +
Sbjct: 4 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYP-----KKEDYI 58
Query: 82 IYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSN--YLGDIALLQLSSD----VDYSMY 135
+YLG+ + S+ G +V+ + ++ +++ + DIALL++ S S
Sbjct: 59 VYLGRSRLN--SNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 136 VRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCD 195
++ + L P ++ E T S + Y + V R C
Sbjct: 117 IQTIALPSMYNDPQFGTSCEITGFGKEQSTDYL--------YPEQLKMTVVKLISHRECQ 168
Query: 196 TKHYV---VFTDV---------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
HY V T + + C GDSGG +V + L GIVS
Sbjct: 169 QPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVS 217
Score = 30.0 bits (66), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 22/96 (22%), Positives = 45/96 (46%), Gaps = 13/96 (13%)
Query: 271 DIALLQLSSD----VDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRV--S 324
DIALL++ S S ++ + L P ++ E + G+G +++
Sbjct: 97 DIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCE-----ITGFGKEQSTDYLYP 151
Query: 325 EELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
E+LKM ++ ++SH++C P ++ + + CA
Sbjct: 152 EQLKMTVVKLISHREC--QQPHYYGSEVTTKMLCAA 185
>pdb|2F91|A Chain A, 1.2a Resolution Structure Of A Crayfish Trypsin Complexed
With A Peptide Inhibitor, Sgti
Length = 237
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 29/222 (13%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSY-VCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLV 81
G G++P+ ++ T I S+ CG S+ + NY ITA HCV Y+ P L
Sbjct: 4 GTDATLGEFPYQLSFQETF-IGFSFHFCGASIYNENYAITAGHCVYGDDYENP---SGLQ 59
Query: 82 IYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
I G+ +EG Q V ++ ++ F+ + DI+LL+LS + ++ V P+ L
Sbjct: 60 IVAGELDMS--VNEGSEQIITVSKIILHENFDYNLLDNDISLLKLSGSLTFNDNVAPIAL 117
Query: 142 WDDSTAPLQLSAVEGTSVCNG---DSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKH 198
P Q G + G S GG + L+ + V+ + R
Sbjct: 118 ------PEQGHTATGDVIVTGWGTTSEGGNTPDV-----LQKVTVPLVSDEDCRADYGAD 166
Query: 199 YVVFTDV--------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
++ + + + C GDSGG + + YL GIVS
Sbjct: 167 EILDSMICAGVPEGGKDSCQGDSGGPLAASDTGSTYLAGIVS 208
>pdb|4GAW|A Chain A, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|B Chain B, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|C Chain C, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|D Chain D, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|E Chain E, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|F Chain F, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|G Chain G, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|H Chain H, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|I Chain I, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|J Chain J, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|K Chain K, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|L Chain L, Crystal Structure Of Active Human Granzyme H
Length = 226
Score = 54.7 bits (130), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 51/183 (27%), Positives = 82/183 (44%), Gaps = 33/183 (18%)
Query: 49 CGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRVHI 108
CGG LV ++V+TAAHC ++ + LG ++ + E Q VKR
Sbjct: 29 CGGILVRKDFVLTAAHC----------QGSSINVTLGAHNIKE--QERTQQFIPVKRPIP 76
Query: 109 YPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGM 168
+P +N N+ DI LLQL ++ VRP+ L P + V+ +C+ +G G
Sbjct: 77 HPAYNPKNFSNDIMLLQLERKAKWTTAVRPLRL------PSSKAQVKPGQLCS-VAGWGY 129
Query: 169 VFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVANVC-----------NGDSGGGM 217
V A L+ ++ +TV +D C+ + ++ +C GDSGG +
Sbjct: 130 VSMSTLATTLQEVL-LTVQKDCQ--CERLFHGNYSRATEICVGDPKKTQTGFKGDSGGPL 186
Query: 218 VFK 220
V K
Sbjct: 187 VCK 189
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 41/168 (24%), Positives = 72/168 (42%), Gaps = 12/168 (7%)
Query: 196 TKHYVVFTDVANVCNGDSGGGMVFKID---SAWYLRGIVSITVARDGLRVCDTKHYVVFT 252
++ Y+ F + GG++ + D +A + +G SI V + + + F
Sbjct: 11 SRPYMAFVQFLQEKSRKRCGGILVRKDFVLTAAHCQG-SSINVTLGAHNIKEQERTQQFI 69
Query: 253 DVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
VKR +P +N N+ DI LLQL ++ VRP+ L S A ++ G+ +V
Sbjct: 70 PVKRPIPHPAYNPKNFSNDIMLLQLERKAKWTTAVRPLRL-PSSKAQVK----PGQLCSV 124
Query: 313 IGWGYDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
GWGY ++ L+ ++ + QC F ++ C G
Sbjct: 125 AGWGYVSMSTLATTLQEVLLTVQKDCQC---ERLFHGNYSRATEICVG 169
>pdb|2O8U|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|2O8W|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|3PB1|E Chain E, Crystal Structure Of A Michaelis Complex Between
Plasminogen Activator Inhibitor-1 And Urokinase-Type
Plasminogen Activator
Length = 253
Score = 54.7 bits (130), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 34/229 (14%)
Query: 23 GQKTARGQWPWHVALYRT-EGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLV 81
G+ T PW A+YR G +++YVCGGSL+S +VI+A HC P + +
Sbjct: 4 GEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYP-----KKEDYI 58
Query: 82 IYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSN--YLGDIALLQLSSD----VDYSMY 135
+YLG+ + S+ G +V+ + ++ +++ + DIALL++ S S
Sbjct: 59 VYLGRSRLN--SNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 136 VRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCD 195
++ + L P ++ E T S + Y + V R C
Sbjct: 117 IQTIALPSMYNDPQFGTSCEITGFGKEQSTDYL--------YPEQLKMTVVKLISHRECQ 168
Query: 196 TKHYV---VFTDV---------ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
HY V T + + C GD+GG +V + L GIVS
Sbjct: 169 QPHYYGSEVTTKMLCAADPQWKTDSCQGDAGGPLVCSLQGRMTLTGIVS 217
Score = 30.4 bits (67), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 22/96 (22%), Positives = 45/96 (46%), Gaps = 13/96 (13%)
Query: 271 DIALLQLSSD----VDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRV--S 324
DIALL++ S S ++ + L P ++ E + G+G +++
Sbjct: 97 DIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCE-----ITGFGKEQSTDYLYP 151
Query: 325 EELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
E+LKM ++ ++SH++C P ++ + + CA
Sbjct: 152 EQLKMTVVKLISHREC--QQPHYYGSEVTTKMLCAA 185
>pdb|2OQ5|A Chain A, Crystal Structure Of Desc1, A New Member Of The Type Ii
Transmembrane Serine Proteinases Family
Length = 232
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 54/217 (24%), Positives = 84/217 (38%), Gaps = 74/217 (34%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVD---SDT 79
G + G+WPW +L + S+ CG +L++ ++++AAHC T Y P S
Sbjct: 4 GTEVEEGEWPWQASLQ----WDGSHRCGATLINATWLVSAAHCFTT--YKNPARWTASFG 57
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
+ I K + ++R+ ++ + ++ DI+L +LSS V Y+ V V
Sbjct: 58 VTIKPSK------------MKRGLRRIIVHEKYKHPSHDYDISLAELSSPVPYTNAVHRV 105
Query: 140 CL-------------------------------------------------WDDSTAPLQ 150
CL ++D+ P
Sbjct: 106 CLPDASYEFQPGDVMFVTGFGALKNDGYSQNHLRQAQVTLIDATTCNEPQAYNDAITPRM 165
Query: 151 LSA--VEG-TSVCNGDSGGGMVFK-IDSAWYLRGIVS 183
L A +EG T C GDSGG +V WYL GIVS
Sbjct: 166 LCAGSLEGKTDACQGDSGGPLVSSDARDIWYLAGIVS 202
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 30/108 (27%), Positives = 54/108 (50%), Gaps = 8/108 (7%)
Query: 254 VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVI 313
++R+ ++ + ++ DI+L +LSS V Y+ V VCL D++ Q V V
Sbjct: 69 LRRIIVHEKYKHPSHDYDISLAELSSPVPYTNAVHRVCL-PDASYEFQPGDVM----FVT 123
Query: 314 GWGYDENDRVSE-ELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
G+G +ND S+ L+ A + ++ C + PQ ++ + CAG
Sbjct: 124 GFGALKNDGYSQNHLRQAQVTLIDATTC--NEPQAYNDAITPRMLCAG 169
>pdb|3TJU|A Chain A, Crystal Structure Of Human Granzyme H With An Inhibitor
pdb|3TJV|A Chain A, Crystal Structure Of Human Granzyme H With A Peptidyl
Substrate
pdb|3TK9|A Chain A, Crystal Structure Of Human Granzyme H
Length = 226
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 50/183 (27%), Positives = 82/183 (44%), Gaps = 33/183 (18%)
Query: 49 CGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRVHI 108
CGG LV ++V+TAAHC ++ + LG ++ + E Q VKR
Sbjct: 29 CGGILVRKDFVLTAAHC----------QGSSINVTLGAHNIKE--QERTQQFIPVKRPIP 76
Query: 109 YPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGM 168
+P +N N+ +I LLQL ++ VRP+ L P + V+ +C+ +G G
Sbjct: 77 HPAYNPKNFSNNIMLLQLERKAKWTTAVRPLRL------PSSKAQVKPGQLCS-VAGWGY 129
Query: 169 VFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVANVC-----------NGDSGGGM 217
V A L+ ++ +TV +D C+ + ++ +C GDSGG +
Sbjct: 130 VSMSTLATTLQEVL-LTVQKDCQ--CERLFHGNYSRATEICVGDPKKTQTGFKGDSGGPL 186
Query: 218 VFK 220
V K
Sbjct: 187 VCK 189
Score = 48.9 bits (115), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 40/168 (23%), Positives = 72/168 (42%), Gaps = 12/168 (7%)
Query: 196 TKHYVVFTDVANVCNGDSGGGMVFKID---SAWYLRGIVSITVARDGLRVCDTKHYVVFT 252
++ Y+ F + GG++ + D +A + +G SI V + + + F
Sbjct: 11 SRPYMAFVQFLQEKSRKRCGGILVRKDFVLTAAHCQG-SSINVTLGAHNIKEQERTQQFI 69
Query: 253 DVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
VKR +P +N N+ +I LLQL ++ VRP+ L S A ++ G+ +V
Sbjct: 70 PVKRPIPHPAYNPKNFSNNIMLLQLERKAKWTTAVRPLRL-PSSKAQVK----PGQLCSV 124
Query: 313 IGWGYDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
GWGY ++ L+ ++ + QC F ++ C G
Sbjct: 125 AGWGYVSMSTLATTLQEVLLTVQKDCQC---ERLFHGNYSRATEICVG 169
>pdb|2HNT|C Chain C, Crystallographic Structure Of Human Gamma-Thrombin
Length = 70
Score = 53.1 bits (126), Expect = 3e-07, Method: Composition-based stats.
Identities = 25/70 (35%), Positives = 39/70 (55%), Gaps = 2/70 (2%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G G PW V L+R L +CG SL+S +V+TAAHC+ P+DK +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQEL--LCGASLISDRWVLTAAHCLLYPPWDKNFTEND 58
Query: 80 LVIYLGKYHQ 89
L++ +GK+ +
Sbjct: 59 LLVRIGKHSR 68
>pdb|3H7O|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
pdb|3H7O|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
Length = 228
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 59/197 (29%), Positives = 88/197 (44%), Gaps = 29/197 (14%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCV-TKKPYDKPVDSDTLV 81
G+KT Q PW VA+ RT S CGG+++S +V+TAAHCV +KP +T+V
Sbjct: 3 GEKTDIKQVPWTVAV-RTYPGEESLTCGGAILSQWFVLTAAHCVFDQKP-------ETIV 54
Query: 82 IYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYL-GDIALLQLSSDVDYSMYVRPVC 140
I +Y ++ G + V H+Y +F + DIA+L+LS RP+
Sbjct: 55 I---QYESTNLWEDPGKSDPYVS--HVYLSFYRQETMENDIAILELS---------RPLK 100
Query: 141 LWDDSTAPLQLSAVEGTSVCNGD---SGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTK 197
L + P +L +E D SG G +D + +TV L C TK
Sbjct: 101 LDGLKSKPAKLPDIEFRPKTGSDVLVSGYGDGQTMDPKDHDLKSAQLTVV--DLDECRTK 158
Query: 198 HYVVFTDVANVCNGDSG 214
+ +F + C G
Sbjct: 159 YGPIFLSLQVFCAQKVG 175
>pdb|3BSQ|A Chain A, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|B Chain B, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|C Chain C, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
Length = 227
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 59/224 (26%), Positives = 90/224 (40%), Gaps = 50/224 (22%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G ARG PW VAL ++ CGG LV+ +V+TAAHC
Sbjct: 4 GAPCARGSHPWQVALLSGNQLH----CGGVLVNERWVLTAAHC----------------- 42
Query: 83 YLGKYHQHQFSDEGG---VQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
+ +Y H SD G Q + + +P +++ ++ D+ L++L+S S V+ V
Sbjct: 43 KMNEYTVHLGSDTLGDRRAQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKV 102
Query: 140 CLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHY 199
L P V SG G D + ++ + V + C TK Y
Sbjct: 103 RLPSRCEPPGTTCTV---------SGWGTTTSPDVT-FPSDLMCVDVKLISPQDC-TKVY 151
Query: 200 VVFTDVA-----------NVCNGDSGGGMVFKIDSAWYLRGIVS 232
+ + N CNGDSGG +V + L+G+VS
Sbjct: 152 KDLLENSMLCAGIPDSKKNACNGDSGGPLVCR----GTLQGLVS 191
>pdb|1FXY|A Chain A, Coagulation Factor Xa-Trypsin Chimera Inhibited With
D-Phe-Pro-Arg- Chloromethylketone
Length = 228
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 36/120 (30%), Positives = 57/120 (47%), Gaps = 16/120 (13%)
Query: 29 GQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYH 88
G+ PW L E CGG+++S Y++TAAHC+ + + + +G +
Sbjct: 10 GEVPWQALLINEENEGF---CGGTILSEFYILTAAHCLYQ--------AKRFKVRVGDRN 58
Query: 89 QHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAP 148
Q +EGG +V+ V + F Y DIA+L+L + + + M V P L TAP
Sbjct: 59 TEQ--EEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPASL---PTAP 113
>pdb|1FQ3|A Chain A, Crystal Structure Of Human Granzyme B
pdb|1FQ3|B Chain B, Crystal Structure Of Human Granzyme B
Length = 227
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 48/181 (26%), Positives = 75/181 (41%), Gaps = 32/181 (17%)
Query: 49 CGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRVHI 108
CGG L+ ++V+TAAHC ++ + LG ++ + E Q VKR
Sbjct: 29 CGGFLIQDDFVLTAAHCW----------GSSINVTLGAHNIKE--QEPTQQFIPVKRPIP 76
Query: 109 YPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGM 168
+P +N N+ DI LLQL + V+P+ L P + V+ C+ +G G
Sbjct: 77 HPAYNPKNFSNDIMLLQLERKAKRTRAVQPLRL------PSNKAQVKPGQTCS-VAGWGQ 129
Query: 169 VFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVANVC-----------NGDSGGGM 217
+ + V +TV D D +HY + +C GDSGG +
Sbjct: 130 TAPLGKHSHTLQEVKMTVQEDRKCESDLRHY--YDSTIELCVGDPEIKKTSFKGDSGGPL 187
Query: 218 V 218
V
Sbjct: 188 V 188
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 27/104 (25%), Positives = 45/104 (43%), Gaps = 9/104 (8%)
Query: 232 SITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVC 291
SI V + + + F VKR +P +N N+ DI LLQL + V+P+
Sbjct: 49 SINVTLGAHNIKEQEPTQQFIPVKRPIPHPAYNPKNFSNDIMLLQLERKAKRTRAVQPLR 108
Query: 292 LWDDSTAPLQLSAVEGRDGTVIGWG----YDENDRVSEELKMAI 331
L + + G+ +V GWG ++ +E+KM +
Sbjct: 109 LPSN-----KAQVKPGQTCSVAGWGQTAPLGKHSHTLQEVKMTV 147
>pdb|1IAU|A Chain A, Human Granzyme B In Complex With Ac-Iepd-Cho
Length = 227
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 48/181 (26%), Positives = 75/181 (41%), Gaps = 32/181 (17%)
Query: 49 CGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRVHI 108
CGG L+ ++V+TAAHC ++ + LG ++ + E Q VKR
Sbjct: 29 CGGFLIRDDFVLTAAHCW----------GSSINVTLGAHNIKE--QEPTQQFIPVKRPIP 76
Query: 109 YPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGM 168
+P +N N+ DI LLQL + V+P+ L P + V+ C+ +G G
Sbjct: 77 HPAYNPKNFSNDIMLLQLERKAKRTRAVQPLRL------PSNKAQVKPGQTCS-VAGWGQ 129
Query: 169 VFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVANVC-----------NGDSGGGM 217
+ + V +TV D D +HY + +C GDSGG +
Sbjct: 130 TAPLGKHSHTLQEVKMTVQEDRKCESDLRHY--YDSTIELCVGDPEIKKTSFKGDSGGPL 187
Query: 218 V 218
V
Sbjct: 188 V 188
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 27/104 (25%), Positives = 45/104 (43%), Gaps = 9/104 (8%)
Query: 232 SITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVC 291
SI V + + + F VKR +P +N N+ DI LLQL + V+P+
Sbjct: 49 SINVTLGAHNIKEQEPTQQFIPVKRPIPHPAYNPKNFSNDIMLLQLERKAKRTRAVQPLR 108
Query: 292 LWDDSTAPLQLSAVEGRDGTVIGWG----YDENDRVSEELKMAI 331
L + + G+ +V GWG ++ +E+KM +
Sbjct: 109 LPSN-----KAQVKPGQTCSVAGWGQTAPLGKHSHTLQEVKMTV 147
>pdb|2QXG|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXG|B Chain B, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXH|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXI|A Chain A, High Resolution Structure Of Human Kallikrein 7 In Complex
With Suc-Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXJ|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-ala-pro-phe-chloromethylketone And Copper
Length = 224
Score = 52.0 bits (123), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 59/224 (26%), Positives = 90/224 (40%), Gaps = 50/224 (22%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G ARG PW VAL ++ CGG LV+ +V+TAAHC
Sbjct: 4 GAPCARGSHPWQVALLSGNQLH----CGGVLVNERWVLTAAHC----------------- 42
Query: 83 YLGKYHQHQFSDEGG---VQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
+ +Y H SD G Q + + +P +++ ++ D+ L++L+S S V+ V
Sbjct: 43 KMNEYTVHLGSDTLGDRRAQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKV 102
Query: 140 CLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVS----ITVARDGLR--- 192
L P V G + + F D ++S V +D L
Sbjct: 103 RLPSRCEPPGTTCTVSGWGT---TTSPDVTFPSDLMCVDVKLISPQDCTKVYKDLLENSM 159
Query: 193 ----VCDTKHYVVFTDVANVCNGDSGGGMVFKIDSAWYLRGIVS 232
+ D+K N CNGDSGG +V + L+G+VS
Sbjct: 160 LCAGIPDSK--------KNACNGDSGGPLVCR----GTLQGLVS 191
>pdb|1PYT|C Chain C, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 253
Score = 52.0 bits (123), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 63/262 (24%), Positives = 102/262 (38%), Gaps = 45/262 (17%)
Query: 13 YNKAQPLVTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYD 72
+++ V G+ W W V+L + + CGGSL++ ++V+TA HC++
Sbjct: 5 FSRPSSRVVNGEDAVPYSWSWQVSLQYEKDGAFHHTCGGSLIAPDWVVTAGHCIST---- 60
Query: 73 KPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYL--GDIALLQLSSDV 130
S T + LG+Y + V + ++P +NS+ DIAL++LS
Sbjct: 61 ----SRTYQVVLGEYDRSVLQGSEQVIPINAGDLFVHPLWNSNCVACGNDIALVKLSRSA 116
Query: 131 DYSMYVRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDG 190
V+ L P + + C SG G + Y G + +
Sbjct: 117 QLGDKVQLANL------PPAGDILPNEAPCY-ISGWGRL-------YTGGPLPDKLQEAL 162
Query: 191 LRVCDTKHYVVFT---------------DVANVCNGDSGGGM-VFKIDSAWYLRGIVSIT 234
L V D +H + D + C+GDSGG + D +W + G+ S
Sbjct: 163 LPVVDYEHCSQYDWWGITVKKTMVCAGGDTRSGCDGDSGGPLNCPAADGSWQVHGVTSFV 222
Query: 235 VARDGLRVCDT-KHYVVFTDVK 255
A C+T K VFT V
Sbjct: 223 SAFG----CNTIKKPTVFTRVS 240
>pdb|2EEK|A Chain A, Crystal Structure Of Atlantic Cod Trypsin Complexed With
Benzamidine
Length = 220
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 19/153 (12%)
Query: 214 GGGMVFK---IDSAWYLRGIVSITVARDGLRVCD-TKHYVVFTDVKRVHIYPTFNSSNYL 269
GG +V K + +A + ++ + + +RV + T+ Y+ + V R +P ++S N
Sbjct: 26 GGSLVSKDWVVSAAHCYKSVLRVRLGEHHIRVNEGTEQYISSSSVIR---HPNYSSYNIN 82
Query: 270 GDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRV-SEELK 328
DI L++L+ + YV V L + A + TV GWG + ++L+
Sbjct: 83 NDIMLIKLTKPATLNQYVHAVALPTECAADATMC-------TVSGWGNTMSSVADGDKLQ 135
Query: 329 MAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+PI+SH C S P +Q FCAG+
Sbjct: 136 CLSLPILSHADCANSYPGMITQ----SMFCAGY 164
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 54/195 (27%), Positives = 84/195 (43%), Gaps = 35/195 (17%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSLVS ++V++AAHC L + LG++H +EG Q V
Sbjct: 23 HFCGGSLVSKDWVVSAAHCY----------KSVLRVRLGEHHIR--VNEGTEQYISSSSV 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEG-----TSVCN 161
+P ++S N DI L++L+ + YV V L + A + V G +SV +
Sbjct: 71 IRHPNYSSYNINNDIMLIKLTKPATLNQYVHAVALPTECAADATMCTVSGWGNTMSSVAD 130
Query: 162 GDSGGGMVFKI----DSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVANVCNGDSGGGM 217
GD + I D A G+++ ++ G + C GDSGG +
Sbjct: 131 GDKLQCLSLPILSHADCANSYPGMITQSMFCAGY----------LEGGKDSCQGDSGGPV 180
Query: 218 VFKIDSAWYLRGIVS 232
V L+G+VS
Sbjct: 181 VCN----GVLQGVVS 191
>pdb|1HYL|A Chain A, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|1HYL|B Chain B, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|2HLC|A Chain A, Hl Collagenase Structure At 1.7a Resolution
pdb|2HLC|B Chain B, Hl Collagenase Structure At 1.7a Resolution
Length = 230
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 35/119 (29%), Positives = 60/119 (50%), Gaps = 14/119 (11%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G + G +P+ L T CGGSL+ +++TAAHCV D+ ++V+
Sbjct: 4 GYEAYTGLFPYQAGLDITLQDQRRVWCGGSLIDNKWILTAAHCVH--------DAVSVVV 55
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
YLG Q++ G +R+ + FN YL D+AL+++ V+Y+ ++P+ L
Sbjct: 56 YLGSAVQYE-----GEAVVNSERIISHSMFNPDTYLNDVALIKIPH-VEYTDNIQPIRL 108
Score = 30.8 bits (68), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 22/69 (31%), Positives = 35/69 (50%), Gaps = 4/69 (5%)
Query: 255 KRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIG 314
+R+ + FN YL D+AL+++ V+Y+ ++P+ L S L + E TV G
Sbjct: 72 ERIISHSMFNPDTYLNDVALIKIPH-VEYTDNIQPIRL--PSGEELN-NKFENIWATVSG 127
Query: 315 WGYDENDRV 323
WG D V
Sbjct: 128 WGQSNTDTV 136
>pdb|1YBW|A Chain A, Protease Domain Of Hgfa With No Inhibitor
pdb|1YBW|B Chain B, Protease Domain Of Hgfa With No Inhibitor
pdb|1YC0|A Chain A, Short Form Hgfa With First Kunitz Domain From Hai-1
pdb|2R0K|A Chain A, Protease Domain Of Hgfa With Inhibitor Fab58
Length = 283
Score = 51.2 bits (121), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 37/233 (15%)
Query: 17 QPLVTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVD 76
+P + G + G PW A+Y I S+ C GSLV +V++AAHC + P
Sbjct: 33 RPRIIGGSSSLPGSHPWLAAIY----IGDSF-CAGSLVHTCWVVSAAHCFSHSP-----P 82
Query: 77 SDTLVIYLGKYHQHQFSDEGGVQNKQVKR---VHIYPTFNSSNYLGDIALLQLSSDVD-- 131
D++ + LG++ ++ +D Q +++ +Y FN S++ D+ L++L D
Sbjct: 83 RDSVSVVLGQHFFNRTTDV--TQTFGIEKYIPYTLYSVFNPSDH--DLVLIRLKKKGDRC 138
Query: 132 --YSMYVRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDS-AWYLRGIVSITVAR 188
S +V+P+CL P S C G + + + LR + VA
Sbjct: 139 ATRSQFVQPICL------PEPGSTFPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVAD 192
Query: 189 D--------GLRVCDTKHYVVFTDV-ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
G + + D ++ C GDSGG + + + YL GI+S
Sbjct: 193 HKCSSPEVYGADISPNMLCAGYFDCKSDACQGDSGGPLACEKNGVAYLYGIIS 245
>pdb|2ZPR|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
pdb|2ZPR|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
Length = 222
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/102 (34%), Positives = 53/102 (51%), Gaps = 13/102 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSLV+ N+V++AAHC + + + LG+++ EG Q RV
Sbjct: 23 HFCGGSLVNENWVVSAAHCYKSR----------VAVRLGEHNIKV--TEGSEQFISSSRV 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAP 148
+P ++S N DI L++LS + YV+PV L S AP
Sbjct: 71 IRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVAL-PSSCAP 111
Score = 48.9 bits (115), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 17/152 (11%)
Query: 214 GGGMVFK---IDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLG 270
GG +V + + +A + V++ + ++V T+ F RV +P ++S N
Sbjct: 26 GGSLVNENWVVSAAHCYKSRVAVRLGEHNIKV--TEGSEQFISSSRVIRHPNYSSYNIDN 83
Query: 271 DIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRV-SEELKM 329
DI L++LS + YV+PV L S AP G TV GWG + ++L+
Sbjct: 84 DIMLIKLSKPATLNTYVQPVAL-PSSCAP------AGTMCTVSGWGNTMSSTADGDKLQC 136
Query: 330 AIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+PI+S+ C S P ++ FCAG+
Sbjct: 137 LNIPILSYSDCNNSYPGMI----TNAMFCAGY 164
>pdb|1GVL|A Chain A, Human Prokallikrein 6 (Hk6) PROZYME PROPROTEASE M
Proneurosin
Length = 223
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 28/216 (12%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ +G + P+ ALY + + +CGG L+ +V+TAAHC KKP
Sbjct: 2 LVHGGPCDKTSHPYQAALYTSGHL----LCGGVLIHPLWVLTAAHC--KKP--------N 47
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
L ++LGK++ Q + V R I+P ++++++ DI LL+L+ S ++P+
Sbjct: 48 LQVFLGKHNLRQQESS--QEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPL 105
Query: 140 CLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHY 199
L D +A + G G + G Y+ +VS T++
Sbjct: 106 PLERDCSAQTTSCHILGW----GKTADGDFPDTIQCAYIH-LVSREECEHAYPGQITQNM 160
Query: 200 VVFTDV---ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
+ D + C GDSGG +V +LRG+VS
Sbjct: 161 LCAGDEKYGKDSCQGDSGGPLV----CGDHLRGLVS 192
Score = 42.0 bits (97), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 27/107 (25%), Positives = 54/107 (50%), Gaps = 11/107 (10%)
Query: 254 VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVI 313
V R I+P ++++++ DI LL+L+ S ++P+ L D +A Q ++ ++
Sbjct: 69 VVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPLPLERDCSA--QTTSCH-----IL 121
Query: 314 GWGYDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
GWG + + ++ A + +VS ++C + P +Q CAG
Sbjct: 122 GWGKTADGDFPDTIQCAYIHLVSREECEHAYPGQITQ----NMLCAG 164
>pdb|1FON|A Chain A, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
pdb|1FON|B Chain B, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
Length = 240
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 62/252 (24%), Positives = 97/252 (38%), Gaps = 45/252 (17%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G+ W W V+L + + CGGSL++ ++V+TA HC++ S T +
Sbjct: 2 GEDAVPYSWSWQVSLQYEKDGAFHHTCGGSLIAPDWVVTAGHCIST--------SRTYQV 53
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYL--GDIALLQLSSDVDYSMYVRPVC 140
LG+Y + V + ++P +NS+ DIAL++LS V+
Sbjct: 54 VLGEYDRSVLEGSEQVIPINAGDLFVHPLWNSNCVACGNDIALVKLSRSAQLGDKVQLAN 113
Query: 141 LWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKH-- 198
L P + + C SG G + Y G + + + L D +H
Sbjct: 114 L------PPAGDILPNEAPCY-ISGWGRL-------YTGGPLPDKLQQALLPTVDYEHCS 159
Query: 199 -------------YVVFTDVANVCNGDSGGGM-VFKIDSAWYLRGIVSITVARDGLRVCD 244
D + CNGDSGG + D +W + G+ S A C+
Sbjct: 160 QWDWWGITVKKTMVCAGGDTRSGCNGDSGGPLNCPAADGSWQVHGVTSFVSAFG----CN 215
Query: 245 T-KHYVVFTDVK 255
T K VFT V
Sbjct: 216 TIKKPTVFTRVS 227
>pdb|1FUJ|A Chain A, Pr3 (Myeloblastin)
pdb|1FUJ|B Chain B, Pr3 (Myeloblastin)
pdb|1FUJ|C Chain C, Pr3 (Myeloblastin)
pdb|1FUJ|D Chain D, Pr3 (Myeloblastin)
Length = 221
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 17/185 (9%)
Query: 34 HVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFS 93
++A + G S+ CGG+L+ ++V+TAAHC+ P + + LG ++ +
Sbjct: 14 YMASLQMRGNPGSHFCGGTLIHPSFVLTAAHCLRDIP------QRLVNVVLGAHNVR--T 65
Query: 94 DEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSA 153
E Q+ V +V + +++ N L DI L+QLSS + S V V L P Q
Sbjct: 66 QEPTQQHFSVAQVFLN-NYDAENKLNDILLIQLSSPANLSASVATVQL------PQQDQP 118
Query: 154 VEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVANVCNGDS 213
V + C G G V D + +++TV R + +V A +C GDS
Sbjct: 119 VPHGTQCLA-MGWGRVGAHDPPAQVLQELNVTVVTFFCRPHNICTFVPRRK-AGICFGDS 176
Query: 214 GGGMV 218
GG ++
Sbjct: 177 GGPLI 181
Score = 31.6 bits (70), Expect = 0.69, Method: Compositional matrix adjust.
Identities = 23/75 (30%), Positives = 35/75 (46%), Gaps = 11/75 (14%)
Query: 263 FNSSNYLGDIALLQLSSDVDYSMYVRPVCL-WDDSTAPLQLSAVEGRDGTVIGWG----Y 317
+++ N L DI L+QLSS + S V V L D P G +GWG +
Sbjct: 83 YDAENKLNDILLIQLSSPANLSASVATVQLPQQDQPVP------HGTQCLAMGWGRVGAH 136
Query: 318 DENDRVSEELKMAIM 332
D +V +EL + ++
Sbjct: 137 DPPAQVLQELNVTVV 151
>pdb|1MBQ|A Chain A, Anionic Trypsin From Pacific Chum Salmon
Length = 220
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 35/102 (34%), Positives = 53/102 (51%), Gaps = 13/102 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSLV+ N+V++AAHC + + + LG+++ EG Q RV
Sbjct: 23 HFCGGSLVNENWVVSAAHCYKSR----------VEVRLGEHNIKV--TEGSEQFISSSRV 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAP 148
+P ++S N DI L++LS + YV+PV L S AP
Sbjct: 71 IRHPNYSSYNIDNDIMLIKLSKSATLNTYVQPVAL-PSSCAP 111
Score = 48.5 bits (114), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 17/152 (11%)
Query: 214 GGGMVFK---IDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLG 270
GG +V + + +A + V + + ++V T+ F RV +P ++S N
Sbjct: 26 GGSLVNENWVVSAAHCYKSRVEVRLGEHNIKV--TEGSEQFISSSRVIRHPNYSSYNIDN 83
Query: 271 DIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVSE-ELKM 329
DI L++LS + YV+PV L S AP G TV GWG + + +L+
Sbjct: 84 DIMLIKLSKSATLNTYVQPVAL-PSSCAP------AGTMCTVSGWGNTMSSTADKNKLQC 136
Query: 330 AIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+PI+S+ C S P ++ FCAG+
Sbjct: 137 LNIPILSYSDCNNSYPGMI----TNAMFCAGY 164
>pdb|2ZPQ|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
pdb|2ZPQ|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
Length = 222
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 35/102 (34%), Positives = 53/102 (51%), Gaps = 13/102 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSLV+ N+V++AAHC + + + LG+++ EG Q RV
Sbjct: 23 HFCGGSLVNENWVVSAAHCYKSR----------VEVRLGEHNIK--VTEGSEQFISSSRV 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAP 148
+P ++S N DI L++LS + YV+PV L S AP
Sbjct: 71 IRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVAL-PSSCAP 111
Score = 48.1 bits (113), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 17/152 (11%)
Query: 214 GGGMVFK---IDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLG 270
GG +V + + +A + V + + ++V T+ F RV +P ++S N
Sbjct: 26 GGSLVNENWVVSAAHCYKSRVEVRLGEHNIKV--TEGSEQFISSSRVIRHPNYSSYNIDN 83
Query: 271 DIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVSE-ELKM 329
DI L++LS + YV+PV L S AP G TV GWG + + +L+
Sbjct: 84 DIMLIKLSKPATLNTYVQPVAL-PSSCAP------AGTMCTVSGWGNTMSSTADKNKLQC 136
Query: 330 AIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+PI+S+ C S P ++ FCAG+
Sbjct: 137 LNIPILSYSDCNNSYPGMI----TNAMFCAGY 164
>pdb|2ZPS|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 3 From Chum
Salmon
Length = 222
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 35/102 (34%), Positives = 53/102 (51%), Gaps = 13/102 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSLV+ N+V++AAHC + + + LG+++ EG Q RV
Sbjct: 23 HFCGGSLVNENWVVSAAHCYKTR----------VEVRLGEHNIK--VTEGSEQFISSSRV 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAP 148
+P ++S N DI L++LS + YV+PV L S AP
Sbjct: 71 IRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVAL-PSSCAP 111
Score = 48.1 bits (113), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 17/152 (11%)
Query: 214 GGGMVFK---IDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLG 270
GG +V + + +A + V + + ++V T+ F RV +P ++S N
Sbjct: 26 GGSLVNENWVVSAAHCYKTRVEVRLGEHNIKV--TEGSEQFISSSRVIRHPNYSSYNIDN 83
Query: 271 DIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVSE-ELKM 329
DI L++LS + YV+PV L S AP G TV GWG + + +L+
Sbjct: 84 DIMLIKLSKPATLNTYVQPVAL-PSSCAP------AGTMCTVSGWGNTMSSTADKNKLQC 136
Query: 330 AIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+PI+S+ C S P ++ FCAG+
Sbjct: 137 LNIPILSYSDCNNSYPGMI----TNAMFCAGY 164
>pdb|1BIT|A Chain A, The Crystal Structure Of Anionic Salmon Trypsin In A
Second Crystal Form
Length = 237
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 35/102 (34%), Positives = 53/102 (51%), Gaps = 13/102 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSLV+ N+V++AAHC + + + LG+++ EG Q RV
Sbjct: 38 HFCGGSLVNENWVVSAAHCYKSR----------VEVRLGEHNIKV--TEGSEQFISSSRV 85
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAP 148
+P ++S N DI L++LS + YV+PV L S AP
Sbjct: 86 IRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVAL-PTSCAP 126
Score = 48.9 bits (115), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 17/152 (11%)
Query: 214 GGGMVFK---IDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLG 270
GG +V + + +A + V + + ++V T+ F RV +P ++S N
Sbjct: 41 GGSLVNENWVVSAAHCYKSRVEVRLGEHNIKV--TEGSEQFISSSRVIRHPNYSSYNIDN 98
Query: 271 DIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRV-SEELKM 329
DI L++LS + YV+PV L S AP G TV GWG + S +L+
Sbjct: 99 DIMLIKLSKPATLNTYVQPVAL-PTSCAP------AGTMCTVSGWGNTMSSTADSNKLQC 151
Query: 330 AIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+PI+S+ C S P ++ FCAG+
Sbjct: 152 LNIPILSYSDCNNSYPGMI----TNAMFCAGY 179
>pdb|1UTJ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTK|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTL|M Chain M, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTM|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
Length = 242
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 35/102 (34%), Positives = 53/102 (51%), Gaps = 13/102 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSLV+ N+V++AAHC + + + LG+++ EG Q RV
Sbjct: 43 HFCGGSLVNENWVVSAAHCYKSR----------VEVRLGEHNIKV--TEGSEQFISSSRV 90
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAP 148
+P ++S N DI L++LS + YV+PV L S AP
Sbjct: 91 IRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVAL-PTSCAP 131
Score = 48.9 bits (115), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 17/152 (11%)
Query: 214 GGGMVFK---IDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLG 270
GG +V + + +A + V + + ++V T+ F RV +P ++S N
Sbjct: 46 GGSLVNENWVVSAAHCYKSRVEVRLGEHNIKV--TEGSEQFISSSRVIRHPNYSSYNIDN 103
Query: 271 DIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRV-SEELKM 329
DI L++LS + YV+PV L S AP G TV GWG + S +L+
Sbjct: 104 DIMLIKLSKPATLNTYVQPVAL-PTSCAP------AGTMCTVSGWGNTMSSTADSNKLQC 156
Query: 330 AIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+PI+S+ C S P ++ FCAG+
Sbjct: 157 LNIPILSYSDCNNSYPGMI----TNAMFCAGY 184
>pdb|4D8N|A Chain A, Human Kallikrein 6 Inhibitors With A
Para-Amidobenzylanmine P1 Group Carry A High Binding
Efficiency
pdb|3VFE|A Chain A, Virtual Screening And X-Ray Crystallography For Human
Kallikrein 6 Inhibitors With An Amidinothiophene P1
Group
Length = 223
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 36/220 (16%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ +G + P+ ALY + + +CGG L+ +V+TAAHC KKP
Sbjct: 1 LVHGGPCDKTSHPYQAALYTSGHL----LCGGVLIHPLWVLTAAHC--KKP--------N 46
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
L ++LGK++ Q + V R I+P ++++++ DI LL+L+ S ++P+
Sbjct: 47 LQVFLGKHNLGQQESS--QEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPL 104
Query: 140 CLWDDSTAPLQLSAVEGTSVCN----GDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCD 195
PL+ T+ C+ G + G Y+ +VS
Sbjct: 105 --------PLERDCSAQTTSCHILGWGKTADGDFPDTIQCAYIH-LVSREECEHAYPGQI 155
Query: 196 TKHYVVFTDV---ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
T++ + D + C GDSGG +V +LRG+VS
Sbjct: 156 TQNMLCAGDEKYGKDSCQGDSGGPLV----CGDHLRGLVS 191
Score = 42.0 bits (97), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 27/107 (25%), Positives = 54/107 (50%), Gaps = 11/107 (10%)
Query: 254 VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVI 313
V R I+P ++++++ DI LL+L+ S ++P+ L D +A Q ++ ++
Sbjct: 68 VVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPLPLERDCSA--QTTSCH-----IL 120
Query: 314 GWGYDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
GWG + + ++ A + +VS ++C + P +Q CAG
Sbjct: 121 GWGKTADGDFPDTIQCAYIHLVSREECEHAYPGQITQ----NMLCAG 163
>pdb|1HJ8|A Chain A, 1.00 Aa Trypsin From Atlantic Salmon
Length = 222
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 35/102 (34%), Positives = 53/102 (51%), Gaps = 13/102 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSLV+ N+V++AAHC + + + LG+++ EG Q RV
Sbjct: 23 HFCGGSLVNENWVVSAAHCYKSR----------VEVRLGEHNIKV--TEGSEQFISSSRV 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAP 148
+P ++S N DI L++LS + YV+PV L S AP
Sbjct: 71 IRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVAL-PTSCAP 111
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 17/152 (11%)
Query: 214 GGGMVFK---IDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLG 270
GG +V + + +A + V + + ++V T+ F RV +P ++S N
Sbjct: 26 GGSLVNENWVVSAAHCYKSRVEVRLGEHNIKV--TEGSEQFISSSRVIRHPNYSSYNIDN 83
Query: 271 DIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRV-SEELKM 329
DI L++LS + YV+PV L S AP G TV GWG + S +L+
Sbjct: 84 DIMLIKLSKPATLNTYVQPVAL-PTSCAP------AGTMCTVSGWGNTMSSTADSNKLQC 136
Query: 330 AIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+PI+S+ C S P ++ FCAG+
Sbjct: 137 LNIPILSYSDCNNSYPGMI----TNAMFCAGY 164
>pdb|2HNT|E Chain E, Crystallographic Structure Of Human Gamma-Thrombin
Length = 81
Score = 49.7 bits (117), Expect = 2e-06, Method: Composition-based stats.
Identities = 27/64 (42%), Positives = 38/64 (59%), Gaps = 3/64 (4%)
Query: 254 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTV 312
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A G G V
Sbjct: 8 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA--GYKGRV 65
Query: 313 IGWG 316
GWG
Sbjct: 66 TGWG 69
Score = 41.2 bits (95), Expect = 0.001, Method: Composition-based stats.
Identities = 21/52 (40%), Positives = 32/52 (61%), Gaps = 1/52 (1%)
Query: 103 VKRVHIYPTFN-SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSA 153
+++++I+P +N N DIAL++L V +S Y+ PVCL D TA L A
Sbjct: 8 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQA 59
>pdb|2TBS|A Chain A, Cold-Adaption Of Enzymes: Structural Comparison Between
Salmon And Bovine Trypsins
Length = 222
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 35/102 (34%), Positives = 53/102 (51%), Gaps = 13/102 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSLV+ N+V++AAHC + + + LG+++ EG Q RV
Sbjct: 23 HFCGGSLVNENWVVSAAHCYKSR----------VEVRLGEHNIKV--TEGSEQFISSSRV 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAP 148
+P ++S N DI L++LS + YV+PV L S AP
Sbjct: 71 IRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVAL-PTSCAP 111
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 17/152 (11%)
Query: 214 GGGMVFK---IDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLG 270
GG +V + + +A + V + + ++V T+ F RV +P ++S N
Sbjct: 26 GGSLVNENWVVSAAHCYKSRVEVRLGEHNIKV--TEGSEQFISSSRVIRHPNYSSYNIDN 83
Query: 271 DIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRV-SEELKM 329
DI L++LS + YV+PV L S AP G TV GWG + S++L+
Sbjct: 84 DIMLIKLSKPATLNTYVQPVAL-PTSCAP------AGTMCTVSGWGNTMSSTADSDKLQC 136
Query: 330 AIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+PI+S+ C S P ++ FCAG+
Sbjct: 137 LNIPILSYSDCNDSYPGMI----TNAMFCAGY 164
>pdb|1BZX|E Chain E, The Crystal Structure Of Anionic Salmon Trypsin In Complex
With Bovine Pancreatic Trypsin Inhibitor
pdb|2STA|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (Cucurbita Maxima Trypsin Inhibitor I)
pdb|2STB|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (cucurbita Pepo Trypsin Inhibitor Ii)
Length = 222
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 35/102 (34%), Positives = 53/102 (51%), Gaps = 13/102 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSLV+ N+V++AAHC + + + LG+++ EG Q RV
Sbjct: 23 HFCGGSLVNENWVVSAAHCYKSR----------VEVRLGEHNIKV--TEGSEQFISSSRV 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAP 148
+P ++S N DI L++LS + YV+PV L S AP
Sbjct: 71 IRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVAL-PTSCAP 111
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 17/152 (11%)
Query: 214 GGGMVFK---IDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLG 270
GG +V + + +A + V + + ++V T+ F RV +P ++S N
Sbjct: 26 GGSLVNENWVVSAAHCYKSRVEVRLGEHNIKV--TEGSEQFISSSRVIRHPNYSSYNIDN 83
Query: 271 DIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRV-SEELKM 329
DI L++LS + YV+PV L S AP G TV GWG + S +L+
Sbjct: 84 DIMLIKLSKPATLNTYVQPVAL-PTSCAP------AGTMCTVSGWGNTMSSTADSNKLQC 136
Query: 330 AIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+PI+S+ C S P ++ FCAG+
Sbjct: 137 LNIPILSYSDCNNSYPGMI----TNAMFCAGY 164
>pdb|1SPJ|A Chain A, Structure Of Mature Human Tissue Kallikrein (Human
Kallikrein 1 Or Klk1) At 1.70 Angstrom Resolution With
Vacant Active Site
Length = 238
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 36/120 (30%), Positives = 53/120 (44%), Gaps = 27/120 (22%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G + + PW ALY ++ CGG LV +V+TAAHC+ SD +
Sbjct: 4 GWECEQHSQPWQAALYHFS----TFQCGGILVHRQWVLTAAHCI----------SDNYQL 49
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSS-----------NYLGDIALLQLSSDVD 131
+LG++ + F DE Q V +P FN S +Y D+ LL+L+ D
Sbjct: 50 WLGRH--NLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPAD 107
>pdb|1EQ9|A Chain A, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
pdb|1EQ9|B Chain B, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
Length = 222
Score = 48.9 bits (115), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 24/203 (11%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G+ G++P+ V+L R G S+ CG S++ N V+TAAHCV D + +
Sbjct: 1 IVGGKDAPVGKYPYQVSL-RLSG---SHRCGASILDNNNVLTAAHCV-----DGLSNLNR 51
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
L +++G + + D V++ V + Y F N D+AL+ L++ + ++ V+P+
Sbjct: 52 LKVHVGTNYLSESGDVYDVEDAVVNKN--YDDFLLRN---DVALVHLTNPIKFNDLVQPI 106
Query: 140 CL----WDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCD 195
L D + P L+ T + GG L RD RV D
Sbjct: 107 KLSTNDEDLESNPCTLTGWGSTRL------GGNTPNALQEIELIVHPQKQCERDQWRVID 160
Query: 196 TKHYVVFTDVANVCNGDSGGGMV 218
+ + C+GDSGG +V
Sbjct: 161 SHICTLTKRGEGACHGDSGGPLV 183
>pdb|2WUB|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUB|C Chain C, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUC|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non- Inhibitory Antibody Fab40.Deltatrp And
Ac-Kqlr-Chloromethylketone
pdb|3K2U|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Inhibitory Antibody Fab40
Length = 257
Score = 48.9 bits (115), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 37/227 (16%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G + G PW A+Y + C GSLV +V++AAHC + P D++ +
Sbjct: 4 GSSSLPGSHPWLAAIYIGDSF-----CAGSLVHTCWVVSAAHCFSHSP-----PRDSVSV 53
Query: 83 YLGKYHQHQFSDEGGVQNKQVKR---VHIYPTFNSSNYLGDIALLQLSSDVD----YSMY 135
LG++ ++ +D Q +++ +Y FN S++ D+ L++L D S +
Sbjct: 54 VLGQHFFNRTTDV--TQTFGIEKYIPYTLYSVFNPSDH--DLVLIRLKKKGDRCATRSQF 109
Query: 136 VRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDS-AWYLRGIVSITVARD----- 189
V+P+CL P S C G + + + LR + VA
Sbjct: 110 VQPICL------PEPGSTFPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSSP 163
Query: 190 ---GLRVCDTKHYVVFTDV-ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
G + + D ++ C GDSGG + + + YL GI+S
Sbjct: 164 EVYGADISPNMLCAGYFDCKSDACQGDSGGPLACEKNGVAYLYGIIS 210
>pdb|2R0L|A Chain A, Short Form Hgfa With Inhibitory Fab75
Length = 248
Score = 48.9 bits (115), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 37/227 (16%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G + G PW A+Y + C GSLV +V++AAHC + P D++ +
Sbjct: 4 GSSSLPGSHPWLAAIYIGDSF-----CAGSLVHTCWVVSAAHCFSHSP-----PRDSVSV 53
Query: 83 YLGKYHQHQFSDEGGVQNKQVKR---VHIYPTFNSSNYLGDIALLQLSSDVD----YSMY 135
LG++ ++ +D Q +++ +Y FN S++ D+ L++L D S +
Sbjct: 54 VLGQHFFNRTTDV--TQTFGIEKYIPYTLYSVFNPSDH--DLVLIRLKKKGDRCATRSQF 109
Query: 136 VRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDS-AWYLRGIVSITVARD----- 189
V+P+CL P S C G + + + LR + VA
Sbjct: 110 VQPICL------PEPGSTFPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSSP 163
Query: 190 ---GLRVCDTKHYVVFTDV-ANVCNGDSGGGMVFKIDSAWYLRGIVS 232
G + + D ++ C GDSGG + + + YL GI+S
Sbjct: 164 EVYGADISPNMLCAGYFDCKSDACQGDSGGPLACEKNGVAYLYGIIS 210
>pdb|1NPM|A Chain A, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
pdb|1NPM|B Chain B, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
Length = 225
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 37/113 (32%), Positives = 56/113 (49%), Gaps = 19/113 (16%)
Query: 32 PWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQ 91
PW AL++ E + +CGG LV +V+TAAHC +K + LG H Q
Sbjct: 13 PWQAALFQGERL----ICGGVLVGDRWVLTAAHCKKQK----------YSVRLGD-HSLQ 57
Query: 92 FSDEGGVQNKQVKRVHIYPTFNSSN---YLGDIALLQLSSDVDYSMYVRPVCL 141
D+ Q QV + +P +N+SN + DI L++L + + V+PV L
Sbjct: 58 SRDQ-PEQEIQVAQSIQHPCYNNSNPEDHSHDIMLIRLQNSANLGDKVKPVQL 109
>pdb|1J15|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J16|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J17|T Chain T, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99175190RT
Length = 223
Score = 47.8 bits (112), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 50/190 (26%), Positives = 86/190 (45%), Gaps = 24/190 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + LG+++ + EG Q ++
Sbjct: 23 HFCGGSLINDQWVVSAAHCYKSR----------IQVRLGEHNINVL--EGNEQFVNAAKI 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVE---GTSVCNGD 163
+P F+ Y DI L++LSS V + V V L S AP + G ++ +G
Sbjct: 71 IKHPNFDRETYNNDIMLIKLSSPVKLNARVATVAL-PSSCAPAGTQCLISGWGNTLSSGV 129
Query: 164 SGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVA-NVCNGDSGGGMVFKID 222
+ ++ +D+ + A + D V F + + C GDSGG +V +
Sbjct: 130 NEPDLLQCLDAPLLPQADCE---ASSSFIITDNMVCVGFLEGGKDACQGDSGGPVVCNGE 186
Query: 223 SAWYLRGIVS 232
L+GIVS
Sbjct: 187 ----LQGIVS 192
Score = 38.5 bits (88), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 32/113 (28%), Positives = 48/113 (42%), Gaps = 13/113 (11%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P F+ Y DI L++LSS V + V V L S AP G
Sbjct: 64 FVNAAKIIKHPNFDRETYNNDIMLIKLSSPVKLNARVATVAL-PSSCAP------AGTQC 116
Query: 311 TVIGWGYDENDRVSEE--LKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+ GWG + V+E L+ P++ C S+ S +D C GF
Sbjct: 117 LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASS----SFIITDNMVCVGF 165
>pdb|1A0J|A Chain A, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|B Chain B, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|C Chain C, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|D Chain D, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species
Length = 223
Score = 47.8 bits (112), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 36/113 (31%), Positives = 51/113 (45%), Gaps = 13/113 (11%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F D +V ++P++NS N DI L++LS + YV V L A G
Sbjct: 64 FIDSVKVIMHPSYNSRNLDNDIMLIKLSKPASLNSYVSTVALPSS-------CASSGTRC 116
Query: 311 TVIGWG--YDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
V GWG + + L+ +PI+S C N + Q TS+ FCAGF
Sbjct: 117 LVSGWGNLSGSSSNYPDTLRCLDLPILSSSSC---NSAYPGQITSN-MFCAGF 165
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 14/96 (14%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFS-DEGGVQNKQVKR 105
+ CGGSL+S +V++AAHC + + + LG +H + +EG Q +
Sbjct: 23 HFCGGSLISSTWVVSAAHCYKSR----------IQVRLG---EHNIAVNEGTEQFIDSVK 69
Query: 106 VHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
V ++P++NS N DI L++LS + YV V L
Sbjct: 70 VIMHPSYNSRNLDNDIMLIKLSKPASLNSYVSTVAL 105
>pdb|1FIZ|A Chain A, Three Dimensional Structure Of Beta-Acrosin From Boar
Spermatozoa
Length = 263
Score = 47.8 bits (112), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 35/132 (26%), Positives = 59/132 (44%), Gaps = 6/132 (4%)
Query: 20 VTYGQKTARGQWPWHVAL--YRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDS 77
V G G WPW V+L + + CGG L++ ++V+TAAHC K K V
Sbjct: 1 VVGGMSAEPGAWPWMVSLQIFMYHNNRRYHTCGGILLNSHWVLTAAHCFKNK---KKVTD 57
Query: 78 DTLVIYLGKYHQHQFSD-EGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYV 136
L+ + + +Q + V+ + I+ + S + DIAL++++ V ++
Sbjct: 58 WRLIFGANEVVWGSNKPVKPPLQERFVEEIIIHEKYVSGLEINDIALIKITPPVPCGPFI 117
Query: 137 RPVCLWDDSTAP 148
P CL P
Sbjct: 118 GPGCLPQFKAGP 129
Score = 37.0 bits (84), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 25/110 (22%), Positives = 52/110 (47%), Gaps = 8/110 (7%)
Query: 254 VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVI 313
V+ + I+ + S + DIAL++++ V ++ P CL P + + V
Sbjct: 84 VEEIIIHEKYVSGLEINDIALIKITPPVPCGPFIGPGCLPQFKAGPPRAP----QTCWVT 139
Query: 314 GWGY--DENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
GWGY ++ R S L+ A + ++ + C ++ ++++ CAG+
Sbjct: 140 GWGYLKEKGPRTSPTLQEARVALIDLELC--NSTRWYNGRIRSTNVCAGY 187
>pdb|1Q3X|A Chain A, Crystal Structure Of The Catalytic Region Of Human Masp-2
pdb|1Q3X|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-2
Length = 328
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 60/237 (25%), Positives = 96/237 (40%), Gaps = 57/237 (24%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
GQK G +PW V + G+L+ N+V+TAAH V Y++ D+ L I
Sbjct: 90 GQKAKPGDFPWQVLILG------GTTAAGALLYDNWVLTAAHAV----YEQKHDASALDI 139
Query: 83 YLGKY-----HQHQFSDEGGVQNKQVKRVHIYPTF-NSSNYLGDIALLQLSSDVDYSMYV 136
+G H Q E V I+ + + + + DIAL++L++ V + +
Sbjct: 140 RMGTLKRLSPHYTQAWSEA---------VFIHEGYTHDAGFDNDIALIKLNNKVVINSNI 190
Query: 137 RPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFK------------------IDSAWYL 178
P+CL + GT+ G + G + + + Y
Sbjct: 191 TPICLPRKEAESFMRTDDIGTASGWGLTQRGFLARNLMYVDIPIVDHQKCTAAYEKPPYP 250
Query: 179 RGIVSITVARDGLRVCDTKHYVVFTDVANVCNGDSGGGMVFKIDSA---WYLRGIVS 232
RG V+ + GL + + C GDSGG +VF +DS W++ GIVS
Sbjct: 251 RGSVTANMLCAGLE----------SGGKDSCRGDSGGALVF-LDSETERWFVGGIVS 296
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 27/98 (27%), Positives = 45/98 (45%), Gaps = 11/98 (11%)
Query: 271 DIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRD---GTVIGWGYDENDRVSEEL 327
DIAL++L++ V + + P+CL P + + R GT GWG + ++ L
Sbjct: 174 DIALIKLNNKVVINSNITPICL------PRKEAESFMRTDDIGTASGWGLTQRGFLARNL 227
Query: 328 KMAIMPIVSHQQC--LWSNPQFFSQFTSDETFCAGFRN 363
+PIV HQ+C + P + + CAG +
Sbjct: 228 MYVDIPIVDHQKCTAAYEKPPYPRGSVTANMLCAGLES 265
>pdb|1ZJK|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-2
Length = 403
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 60/237 (25%), Positives = 96/237 (40%), Gaps = 57/237 (24%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
GQK G +PW V + G+L+ N+V+TAAH V Y++ D+ L I
Sbjct: 165 GQKAKPGDFPWQVLILG------GTTAAGALLYDNWVLTAAHAV----YEQKHDASALDI 214
Query: 83 YLGKY-----HQHQFSDEGGVQNKQVKRVHIYPTF-NSSNYLGDIALLQLSSDVDYSMYV 136
+G H Q E V I+ + + + + DIAL++L++ V + +
Sbjct: 215 RMGTLKRLSPHYTQAWSEA---------VFIHEGYTHDAGFDNDIALIKLNNKVVINSNI 265
Query: 137 RPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFK------------------IDSAWYL 178
P+CL + GT+ G + G + + + Y
Sbjct: 266 TPICLPRKEAESFMRTDDIGTASGWGLTQRGFLARNLMYVDIPIVDHQKCTAAYEKPPYP 325
Query: 179 RGIVSITVARDGLRVCDTKHYVVFTDVANVCNGDSGGGMVFKIDSA---WYLRGIVS 232
RG V+ + GL + + C GDSGG +VF +DS W++ GIVS
Sbjct: 326 RGSVTANMLCAGLE----------SGGKDSCRGDSGGALVF-LDSETERWFVGGIVS 371
Score = 42.0 bits (97), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 27/98 (27%), Positives = 45/98 (45%), Gaps = 11/98 (11%)
Query: 271 DIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRD---GTVIGWGYDENDRVSEEL 327
DIAL++L++ V + + P+CL P + + R GT GWG + ++ L
Sbjct: 249 DIALIKLNNKVVINSNITPICL------PRKEAESFMRTDDIGTASGWGLTQRGFLARNL 302
Query: 328 KMAIMPIVSHQQC--LWSNPQFFSQFTSDETFCAGFRN 363
+PIV HQ+C + P + + CAG +
Sbjct: 303 MYVDIPIVDHQKCTAAYEKPPYPRGSVTANMLCAGLES 340
>pdb|3TVJ|B Chain B, Catalytic Fragment Of Masp-2 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 242
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 60/237 (25%), Positives = 96/237 (40%), Gaps = 57/237 (24%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
GQK G +PW V + G+L+ N+V+TAAH V Y++ D+ L I
Sbjct: 4 GQKAKPGDFPWQVLILG------GTTAAGALLYDNWVLTAAHAV----YEQKHDASALDI 53
Query: 83 YLGKY-----HQHQFSDEGGVQNKQVKRVHIYPTF-NSSNYLGDIALLQLSSDVDYSMYV 136
+G H Q E V I+ + + + + DIAL++L++ V + +
Sbjct: 54 RMGTLKRLSPHYTQAWSEA---------VFIHEGYTHDAGFDNDIALIKLNNKVVINSNI 104
Query: 137 RPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFK------------------IDSAWYL 178
P+CL + GT+ G + G + + + Y
Sbjct: 105 TPICLPRKEAESFMRTDDIGTASGWGLTQRGFLARNLMYVDIPIVDHQKCTAAYEKPPYP 164
Query: 179 RGIVSITVARDGLRVCDTKHYVVFTDVANVCNGDSGGGMVFKIDSA---WYLRGIVS 232
RG V+ + GL + + C GDSGG +VF +DS W++ GIVS
Sbjct: 165 RGSVTANMLCAGLE----------SGGKDSCRGDSGGALVF-LDSETERWFVGGIVS 210
Score = 42.0 bits (97), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 27/98 (27%), Positives = 45/98 (45%), Gaps = 11/98 (11%)
Query: 271 DIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRD---GTVIGWGYDENDRVSEEL 327
DIAL++L++ V + + P+CL P + + R GT GWG + ++ L
Sbjct: 88 DIALIKLNNKVVINSNITPICL------PRKEAESFMRTDDIGTASGWGLTQRGFLARNL 141
Query: 328 KMAIMPIVSHQQC--LWSNPQFFSQFTSDETFCAGFRN 363
+PIV HQ+C + P + + CAG +
Sbjct: 142 MYVDIPIVDHQKCTAAYEKPPYPRGSVTANMLCAGLES 179
>pdb|4F4O|C Chain C, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|F Chain F, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|I Chain I, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|L Chain L, Structure Of The Haptoglobin-Haemoglobin Complex
Length = 347
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/112 (26%), Positives = 47/112 (41%), Gaps = 19/112 (16%)
Query: 263 FNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDR 322
F+ N DI L++L V + V P+CL P + G G V GWG + N
Sbjct: 179 FHPDNSTVDIGLIKLKQKVPVNERVMPICL------PSKDYVNVGLVGYVSGWGRNANLN 232
Query: 323 VSEELKMAIMPIVSHQQCLW-------------SNPQFFSQFTSDETFCAGF 361
+E LK ++P+ ++C+ +P ++ TFCAG
Sbjct: 233 FTEHLKYVMLPVADQEKCVQYYEGSTVPEKKTPKSPVGVQPILNEHTFCAGL 284
>pdb|3I77|A Chain A, 3599170-Loops Of Fxa In Sgt
Length = 230
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 22/217 (10%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
V G + A+G++P+ V L E CGG+L + + V+TAAHCV+ + + +
Sbjct: 1 VVGGTRAAQGEFPFMVRLINEENEGF---CGGALYAQDIVLTAAHCVSGSGNNTSITATG 57
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
V+ L Q S V++ +V + P F Y D AL++L+ ++ +P
Sbjct: 58 GVVDL------QSSSAVKVRSTKVLQA---PGFTKETYGKDWALIKLAQPIN-----QPT 103
Query: 140 CLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHY 199
+TA Q + N + G + + + + + + V +
Sbjct: 104 LKIATTTAYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSSSSFILVANEMIC 163
Query: 200 VVFTDVANV--CNGDSGGGMVFKIDSA--WYLRGIVS 232
+ D V C GDSGG M F+ D+A W GIVS
Sbjct: 164 AGYPDTGGVDTCQGDSGGPM-FRKDNADEWIQVGIVS 199
>pdb|1QL9|A Chain A, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99rt
pdb|1J14|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99rt
Length = 223
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/190 (25%), Positives = 87/190 (45%), Gaps = 24/190 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + LG+++ + EG Q ++
Sbjct: 23 HFCGGSLINDQWVVSAAHCYKSR----------IQVRLGEHNINVL--EGNEQFVNAAKI 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVE---GTSVCNGD 163
+P F+ Y DI L++LSS V + V V L S AP + G ++ +G
Sbjct: 71 IKHPNFDRETYNNDIMLIKLSSPVKLNARVATVAL-PSSCAPAGTQCLISGWGNTLSSGV 129
Query: 164 SGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVA-NVCNGDSGGGMVFKID 222
+ ++ +D+ + + ++ D V F + + C GDSGG +V +
Sbjct: 130 NEPDLLQCLDAPLLPQADCEASYPG---KITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE 186
Query: 223 SAWYLRGIVS 232
L+GIVS
Sbjct: 187 ----LQGIVS 192
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 32/113 (28%), Positives = 47/113 (41%), Gaps = 13/113 (11%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P F+ Y DI L++LSS V + V V L S AP G
Sbjct: 64 FVNAAKIIKHPNFDRETYNNDIMLIKLSSPVKLNARVATVAL-PSSCAP------AGTQC 116
Query: 311 TVIGWGYDENDRVSEE--LKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+ GWG + V+E L+ P++ C S P +D C GF
Sbjct: 117 LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKI----TDNMVCVGF 165
>pdb|3FZZ|A Chain A, Structure Of Grc
pdb|3FZZ|B Chain B, Structure Of Grc
Length = 227
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 48/180 (26%), Positives = 78/180 (43%), Gaps = 22/180 (12%)
Query: 49 CGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRVHI 108
CGG LV +V+TAAHC + ++ + LG ++ + E Q V +
Sbjct: 30 CGGFLVRDKFVLTAAHCKGR----------SMTVTLGAHNIK--AKEETQQIIPVAKAIP 77
Query: 109 YPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGM 168
+P +N + DI LL+L + + VRP+ L P + + V+ C +G G
Sbjct: 78 HPDYNPDDRSNDIMLLKLVRNAKRTRAVRPLNL------PRRNAHVKPGDECY-VAGWGK 130
Query: 169 VFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVANVCNGDSG-GGMVFKIDSAWYL 227
V V +TV +D +VC+++ + +C GDS G F+ DS L
Sbjct: 131 VTPDGEFPKTLHEVKLTVQKD--QVCESQFQSSYNRANEICVGDSKIKGASFEEDSGGPL 188
>pdb|3G01|A Chain A, Structure Of Grc Mutant E192rE193G
pdb|3G01|B Chain B, Structure Of Grc Mutant E192rE193G
Length = 227
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 48/180 (26%), Positives = 78/180 (43%), Gaps = 22/180 (12%)
Query: 49 CGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRVHI 108
CGG LV +V+TAAHC + ++ + LG ++ + E Q V +
Sbjct: 30 CGGFLVRDKFVLTAAHCKGR----------SMTVTLGAHNIK--AKEETQQIIPVAKAIP 77
Query: 109 YPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGM 168
+P +N + DI LL+L + + VRP+ L P + + V+ C +G G
Sbjct: 78 HPDYNPDDRSNDIMLLKLVRNAKRTRAVRPLNL------PRRNAHVKPGDECY-VAGWGK 130
Query: 169 VFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVANVCNGDSG-GGMVFKIDSAWYL 227
V V +TV +D +VC+++ + +C GDS G F+ DS L
Sbjct: 131 VTPDGEFPKTLHEVKLTVQKD--QVCESQFQSSYNRANEICVGDSKIKGASFRGDSGGPL 188
>pdb|4FXG|H Chain H, Complement C4 In Complex With Masp-2
pdb|4FXG|J Chain J, Complement C4 In Complex With Masp-2
Length = 242
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 59/237 (24%), Positives = 96/237 (40%), Gaps = 57/237 (24%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
GQK G +PW V + G+L+ N+V+TAAH V Y++ D+ L I
Sbjct: 4 GQKAKPGDFPWQVLILG------GTTAAGALLYDNWVLTAAHAV----YEQKHDASALDI 53
Query: 83 YLGKY-----HQHQFSDEGGVQNKQVKRVHIYPTF-NSSNYLGDIALLQLSSDVDYSMYV 136
+G H Q E V I+ + + + + DIAL++L++ V + +
Sbjct: 54 RMGTLKRLSPHYTQAWSEA---------VFIHEGYTHDAGFDNDIALIKLNNKVVINSNI 104
Query: 137 RPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFK------------------IDSAWYL 178
P+CL + GT+ G + G + + + Y
Sbjct: 105 TPICLPRKEAESFMRTDDIGTASGWGLTQRGFLARNLMYVDIPIVDHQKCTAAYEKPPYP 164
Query: 179 RGIVSITVARDGLRVCDTKHYVVFTDVANVCNGDSGGGMVFKIDSA---WYLRGIVS 232
RG V+ + GL + + C GD+GG +VF +DS W++ GIVS
Sbjct: 165 RGSVTANMLCAGLE----------SGGKDSCRGDAGGALVF-LDSETERWFVGGIVS 210
Score = 42.0 bits (97), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 27/98 (27%), Positives = 45/98 (45%), Gaps = 11/98 (11%)
Query: 271 DIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRD---GTVIGWGYDENDRVSEEL 327
DIAL++L++ V + + P+CL P + + R GT GWG + ++ L
Sbjct: 88 DIALIKLNNKVVINSNITPICL------PRKEAESFMRTDDIGTASGWGLTQRGFLARNL 141
Query: 328 KMAIMPIVSHQQC--LWSNPQFFSQFTSDETFCAGFRN 363
+PIV HQ+C + P + + CAG +
Sbjct: 142 MYVDIPIVDHQKCTAAYEKPPYPRGSVTANMLCAGLES 179
>pdb|1FI8|A Chain A, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
pdb|1FI8|B Chain B, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
Length = 228
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 55/199 (27%), Positives = 83/199 (41%), Gaps = 38/199 (19%)
Query: 46 SYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQN-KQVK 104
S CGG L+ ++V+TAAHC K + + LG H ++ +Q V
Sbjct: 27 SKKCGGFLIREDFVLTAAHCSGSK----------IQVTLG---AHNIKEQEKMQQIIPVV 73
Query: 105 RVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGTSVCNGDS 164
++ +P +NS DI LL+L S S V+P+ L P + V+ VC +
Sbjct: 74 KIIPHPAYNSKTISNDIMLLKLKSKAKRSSAVKPLNL------PRRNVKVKPGDVCY-VA 126
Query: 165 GGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVANVC-----------NGDS 213
G G + + V +TV D + C++ F +C GDS
Sbjct: 127 GWGKLGPMGKYSDTLQEVELTVQED--QKCESYLKNYFDKANEICAGDPKIKRASFRGDS 184
Query: 214 GGGMVFKIDSAWYLRGIVS 232
GG +V K +A GIVS
Sbjct: 185 GGPLVCKKVAA----GIVS 199
Score = 30.8 bits (68), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 37/172 (21%), Positives = 73/172 (42%), Gaps = 18/172 (10%)
Query: 196 TKHYVVFTDVANVCNGDSG-GGMVFKID---SAWYLRG-IVSITVARDGLRVCDTKHYVV 250
++ Y+ + + + +G GG + + D +A + G + +T+ ++ + ++
Sbjct: 11 SRPYMAYLQIMDEYSGSKKCGGFLIREDFVLTAAHCSGSKIQVTLGAHNIKEQEKMQQII 70
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
V ++ +P +NS DI LL+L S S V+P+ L P + V+ D
Sbjct: 71 --PVVKIIPHPAYNSKTISNDIMLLKLKSKAKRSSAVKPLNL------PRRNVKVKPGDV 122
Query: 311 T-VIGWG-YDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
V GWG + S+ L+ + + Q+C +F + CAG
Sbjct: 123 CYVAGWGKLGPMGKYSDTLQEVELTVQEDQKCESYLKNYFDKANE---ICAG 171
>pdb|3I78|A Chain A, 3599170186220-Loops Of Fxa In Sgt
Length = 229
Score = 45.4 bits (106), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 69/250 (27%), Positives = 107/250 (42%), Gaps = 50/250 (20%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
V G + A+G++P+ V L E CGG+L + + V+TAAHCV+ + + +
Sbjct: 1 VVGGTRAAQGEFPFMVRLINEENEGF---CGGALYAQDIVLTAAHCVSGSGNNTSITATG 57
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
V+ L Q S V++ +V + P F Y D AL++L+ ++ +P
Sbjct: 58 GVVDL------QSSSAVKVRSTKVLQA---PGFTKETYGKDWALIKLAQPIN-----QPT 103
Query: 140 CLWDDSTAPLQLSAVEGTSVCNGDSG--------GGMVFKIDSAWYLRGIVSITVARDGL 191
+TA Q + N + G + F D+A R S + + +
Sbjct: 104 LKIATTTAYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAA--CRSSSSFILVANEM 161
Query: 192 RVC---DTKHYVVFTDVANVCNGDSGGGMVFKIDSA--WYLRGIVS--ITVARDGLRVCD 244
+C DTK + C GDSGG M F+ D+A W GIVS AR G
Sbjct: 162 -ICAGYDTKQ-------EDTCQGDSGGPM-FRKDNADEWVQVGIVSWGEGCARKG----- 207
Query: 245 TKHYVVFTDV 254
Y V+T+V
Sbjct: 208 --KYGVYTEV 215
>pdb|1DST|A Chain A, Mutant Of Factor D With Enhanced Catalytic Activity
Length = 228
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 59/222 (26%), Positives = 90/222 (40%), Gaps = 35/222 (15%)
Query: 43 INLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQ 102
+N +++CGG LV+ +V++AAHC+ K + + LG + Q E +
Sbjct: 20 LNGAHLCGGVLVAEQWVLSAAHCLEDAADGK------VQVLLGAHSLSQ--PEPSKRLYD 71
Query: 103 VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLW---DDSTAPLQLSAVEGTSV 159
V R +P + D+ LLQLS VRP+ W D AP L V G +
Sbjct: 72 VLRAVPHPDYQPDTIDHDLLLLQLSEKATLGPAVRPL-PWQRVDRDVAPGTLCDVAGWGI 130
Query: 160 CNGDSGGGMVFKIDSAWYL------RGIVSITVARDGLRVCDTKHYVVFTDVANVCNGDS 213
N + DS ++ R + DG + ++ + C GDS
Sbjct: 131 VNHAG-----RRPDSLQHVLLPVLDRATCNRRTHHDG--AITERLMCAESNRRDSCKGDS 183
Query: 214 GGGMVFKIDSAWYLRGIVSITVARDGLRVC-DTKHYVVFTDV 254
GG +V L G+VS G RVC + K ++T V
Sbjct: 184 GGPLV----CGGVLEGVVSW-----GSRVCGNRKKPGIYTRV 216
Score = 32.0 bits (71), Expect = 0.55, Method: Compositional matrix adjust.
Identities = 26/92 (28%), Positives = 37/92 (40%), Gaps = 12/92 (13%)
Query: 253 DVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLW---DDSTAPLQLSAVEGRD 309
DV R +P + D+ LLQLS VRP+ W D AP L
Sbjct: 71 DVLRAVPHPDYQPDTIDHDLLLLQLSEKATLGPAVRPL-PWQRVDRDVAPGTLC------ 123
Query: 310 GTVIGWGY-DENDRVSEELKMAIMPIVSHQQC 340
V GWG + R + L+ ++P++ C
Sbjct: 124 -DVAGWGIVNHAGRRPDSLQHVLLPVLDRATC 154
>pdb|1AZZ|A Chain A, Fiddler Crab Collagenase Complexed To Ecotin
pdb|1AZZ|B Chain B, Fiddler Crab Collagenase Complexed To Ecotin
Length = 226
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 34/119 (28%), Positives = 55/119 (46%), Gaps = 14/119 (11%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G + WP AL+ I+ Y CGGSL+S +++TAAHC+ + VD +
Sbjct: 4 GVEAVPNSWPHQAALF----IDDMYFCGGSLISPEWILTAAHCMDGAGF---VD-----V 51
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
LG ++ + DE Q ++ +NS DIA+++L V + + V L
Sbjct: 52 VLGAHNIRE--DEATQVTIQSTDFTVHENYNSFVISNDIAVIRLPVPVTLTAAIATVGL 108
>pdb|1CO7|E Chain E, R117h Mutant Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
Length = 245
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 48/190 (25%), Positives = 87/190 (45%), Gaps = 24/190 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + LG+++ + EG Q ++
Sbjct: 45 HFCGGSLINDQWVVSAAHCYKSR----------IQVRLGEHNINVL--EGNEQFVNAAKI 92
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVE---GTSVCNGD 163
+P F+ DI L++LSS V + +V V L S AP + G ++ +G
Sbjct: 93 IKHPNFDRKTLNNDIMLIKLSSPVKLNAHVATVAL-PSSCAPAGTQCLISGWGNTLSSGV 151
Query: 164 SGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVA-NVCNGDSGGGMVFKID 222
+ ++ +D+ + + ++ D V F + + C GDSGG +V +
Sbjct: 152 NEPDLLQCLDAPLLPQADCEASYPG---KITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE 208
Query: 223 SAWYLRGIVS 232
L+GIVS
Sbjct: 209 ----LQGIVS 214
Score = 37.4 bits (85), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 31/113 (27%), Positives = 47/113 (41%), Gaps = 13/113 (11%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P F+ DI L++LSS V + +V V L S AP G
Sbjct: 86 FVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNAHVATVAL-PSSCAP------AGTQC 138
Query: 311 TVIGWGYDENDRVSEE--LKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+ GWG + V+E L+ P++ C S P +D C GF
Sbjct: 139 LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKI----TDNMVCVGF 187
>pdb|1DLE|A Chain A, Factor B Serine Protease Domain
pdb|1DLE|B Chain B, Factor B Serine Protease Domain
Length = 298
Score = 45.1 bits (105), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 80/195 (41%), Gaps = 37/195 (18%)
Query: 30 QWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQ 89
+ PW + C G++VS +V+TAAHC T VD K H
Sbjct: 26 KQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFT-------VDD--------KEHS 70
Query: 90 HQFSDEGGVQNKQVKRVHIYPTFNSSN---------YLGDIALLQLSSDVDYSMYVRPVC 140
+ S G ++ +++ V +P +N + Y D+AL++L + + Y +RP+C
Sbjct: 71 IKVSVGGEKRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPIC 130
Query: 141 L--WDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKH 198
L + +T L+L T+ C + + I ++ V+ + ++ +
Sbjct: 131 LPCTEGTTRALRLPP---TTTCQQQK--------EELLPAQDIKALFVSEEEKKLTRKEV 179
Query: 199 YVVFTDVANVCNGDS 213
Y+ D C D+
Sbjct: 180 YIKNGDKKGSCERDA 194
Score = 28.9 bits (63), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 9/22 (40%), Positives = 16/22 (72%)
Query: 271 DIALLQLSSDVDYSMYVRPVCL 292
D+AL++L + + Y +RP+CL
Sbjct: 110 DVALIKLKNKLKYGQTIRPICL 131
>pdb|1RRK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
pdb|1RS0|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With Di-Isopropyl-Phosphate (Dip)
pdb|1RTK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With 4-Guanidinobenzoic Acid
Length = 497
Score = 45.1 bits (105), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 32/121 (26%), Positives = 54/121 (44%), Gaps = 24/121 (19%)
Query: 30 QWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQ 89
+ PW + C G++VS +V+TAAHC T VD K H
Sbjct: 225 KQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFT-------VDD--------KEHS 269
Query: 90 HQFSDEGGVQNKQVKRVHIYPTFNSSN---------YLGDIALLQLSSDVDYSMYVRPVC 140
+ S G ++ +++ V +P +N + Y D+AL++L + + Y +RP+C
Sbjct: 270 IKVSVGGEKRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPIC 329
Query: 141 L 141
L
Sbjct: 330 L 330
Score = 28.9 bits (63), Expect = 5.1, Method: Compositional matrix adjust.
Identities = 9/22 (40%), Positives = 16/22 (72%)
Query: 271 DIALLQLSSDVDYSMYVRPVCL 292
D+AL++L + + Y +RP+CL
Sbjct: 309 DVALIKLKNKLKYGQTIRPICL 330
>pdb|2WIN|I Chain I, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|J Chain J, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|K Chain K, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|L Chain L, C3 Convertase (C3bbb) Stabilized By Scin
Length = 507
Score = 45.1 bits (105), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 32/121 (26%), Positives = 54/121 (44%), Gaps = 24/121 (19%)
Query: 30 QWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQ 89
+ PW + C G++VS +V+TAAHC T VD K H
Sbjct: 233 KQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFT-------VDD--------KEHS 277
Query: 90 HQFSDEGGVQNKQVKRVHIYPTFNSSN---------YLGDIALLQLSSDVDYSMYVRPVC 140
+ S G ++ +++ V +P +N + Y D+AL++L + + Y +RP+C
Sbjct: 278 IKVSVGGEKRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPIC 337
Query: 141 L 141
L
Sbjct: 338 L 338
Score = 28.9 bits (63), Expect = 5.1, Method: Compositional matrix adjust.
Identities = 9/22 (40%), Positives = 16/22 (72%)
Query: 271 DIALLQLSSDVDYSMYVRPVCL 292
D+AL++L + + Y +RP+CL
Sbjct: 317 DVALIKLKNKLKYGQTIRPICL 338
>pdb|2XWB|F Chain F, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|H Chain H, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 732
Score = 44.7 bits (104), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 32/119 (26%), Positives = 53/119 (44%), Gaps = 24/119 (20%)
Query: 32 PWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQ 91
PW + C G++VS +V+TAAHC T VD K H +
Sbjct: 460 PWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFT-------VDD--------KEHSIK 504
Query: 92 FSDEGGVQNKQVKRVHIYPTFNSSN---------YLGDIALLQLSSDVDYSMYVRPVCL 141
S G ++ +++ V +P +N + Y D+AL++L + + Y +RP+CL
Sbjct: 505 VSVGGEKRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICL 563
Score = 28.9 bits (63), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 9/22 (40%), Positives = 16/22 (72%)
Query: 271 DIALLQLSSDVDYSMYVRPVCL 292
D+AL++L + + Y +RP+CL
Sbjct: 542 DVALIKLKNKLKYGQTIRPICL 563
>pdb|2OK5|A Chain A, Human Complement Factor B
Length = 752
Score = 44.7 bits (104), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 32/119 (26%), Positives = 53/119 (44%), Gaps = 24/119 (20%)
Query: 32 PWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQ 91
PW + C G++VS +V+TAAHC T VD K H +
Sbjct: 479 PWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFT-------VDD--------KEHSIK 523
Query: 92 FSDEGGVQNKQVKRVHIYPTFNSSN---------YLGDIALLQLSSDVDYSMYVRPVCL 141
S G ++ +++ V +P +N + Y D+AL++L + + Y +RP+CL
Sbjct: 524 VSVGGEKRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICL 582
Score = 28.9 bits (63), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 9/22 (40%), Positives = 16/22 (72%)
Query: 271 DIALLQLSSDVDYSMYVRPVCL 292
D+AL++L + + Y +RP+CL
Sbjct: 561 DVALIKLKNKLKYGQTIRPICL 582
>pdb|3HRZ|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|I Chain I, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|2XWJ|I Chain I, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|J Chain J, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|K Chain K, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|L Chain L, Crystal Structure Of Complement C3b In Complex With Factor
B
Length = 741
Score = 44.7 bits (104), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 32/119 (26%), Positives = 53/119 (44%), Gaps = 24/119 (20%)
Query: 32 PWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQ 91
PW + C G++VS +V+TAAHC T VD K H +
Sbjct: 469 PWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFT-------VDD--------KEHSIK 513
Query: 92 FSDEGGVQNKQVKRVHIYPTFNSSN---------YLGDIALLQLSSDVDYSMYVRPVCL 141
S G ++ +++ V +P +N + Y D+AL++L + + Y +RP+CL
Sbjct: 514 VSVGGEKRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICL 572
Score = 28.9 bits (63), Expect = 4.7, Method: Compositional matrix adjust.
Identities = 9/22 (40%), Positives = 16/22 (72%)
Query: 271 DIALLQLSSDVDYSMYVRPVCL 292
D+AL++L + + Y +RP+CL
Sbjct: 551 DVALIKLKNKLKYGQTIRPICL 572
>pdb|3RP2|A Chain A, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
pdb|3RP2|B Chain B, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
Length = 224
Score = 44.7 bits (104), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 12/101 (11%)
Query: 45 LSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVK 104
L +CGG L+S +V+TAAHC ++ + + LG + + E Q +V+
Sbjct: 26 LRVICGGFLISRQFVLTAAHCKGRE----------ITVILGAHDVRK--RESTQQKIKVE 73
Query: 105 RVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDS 145
+ I+ ++NS L DI LL+L V+ + V V L S
Sbjct: 74 KQIIHESYNSVPNLHDIMLLKLEKKVELTPAVNVVPLPSPS 114
>pdb|3N7O|A Chain A, X-Ray Structure Of Human Chymase In Complex With Small
Molecule Inhibitor
Length = 226
Score = 44.7 bits (104), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 59/237 (24%), Positives = 92/237 (38%), Gaps = 61/237 (25%)
Query: 46 SYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGV-QNKQVK 104
S CGG L+ N+V+TAAHC + ++ + LG H ++E Q +V
Sbjct: 27 SKFCGGFLIRRNFVLTAAHCAGR----------SITVTLGA---HNITEEEDTWQKLEVI 73
Query: 105 RVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGTSVCNGDS 164
+ +P +N+S DI LL+L ++ V + P Q + V +C
Sbjct: 74 KQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPF------PSQFNFVPPGRMCR--- 124
Query: 165 GGGMVFKIDSAWYLRGIV---SITVARDGLRVCDTK---HYVVFTDVANVC--------- 209
+ W G++ S T+ LR+ D + H+ F +C
Sbjct: 125 --------VAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNLQLCVGNPRKTKS 176
Query: 210 --NGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFN 264
GDSGG ++ A +GIVS + D K VFT + H P N
Sbjct: 177 AFKGDSGGPLL----CAGAAQGIVSYGRS-------DAKPPAVFTRIS--HYQPWIN 220
>pdb|1KLT|A Chain A, Crystal Structure Of Pmsf-Treated Human Chymase At 1.9
Angstroms Resolution
Length = 226
Score = 44.7 bits (104), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 59/237 (24%), Positives = 92/237 (38%), Gaps = 61/237 (25%)
Query: 46 SYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGV-QNKQVK 104
S CGG L+ N+V+TAAHC + ++ + LG H ++E Q +V
Sbjct: 27 SKFCGGFLIRRNFVLTAAHCAGR----------SITVTLG---AHNITEEEDTWQKLEVI 73
Query: 105 RVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGTSVCNGDS 164
+ +P +N+S DI LL+L ++ V + P Q + V +C
Sbjct: 74 KQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPF------PSQFNFVPPGRMCR--- 124
Query: 165 GGGMVFKIDSAWYLRGIV---SITVARDGLRVCDTK---HYVVFTDVANVC--------- 209
+ W G++ S T+ LR+ D + H+ F +C
Sbjct: 125 --------VAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNLQLCVGNPRKTKS 176
Query: 210 --NGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFN 264
GDSGG ++ A +GIVS + D K VFT + H P N
Sbjct: 177 AFKGDSGGPLL----CAGVAQGIVSYGRS-------DAKPPAVFTRIS--HYRPWIN 220
>pdb|1AKS|A Chain A, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
pdb|1UHB|A Chain A, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 125
Score = 44.7 bits (104), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 33/119 (27%), Positives = 54/119 (45%), Gaps = 17/119 (14%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G A P+ V+L S+ CGGSL++ +V++AAHC + + +
Sbjct: 4 GYTCAANSIPYQVSLNSG-----SHFCGGSLINSQWVVSAAHCYKSR----------IQV 48
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
LG+++ EG Q ++ +P FN + DI L++LSS + V V L
Sbjct: 49 RLGEHNIDVL--EGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSL 105
Score = 29.6 bits (65), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 19/66 (28%), Positives = 30/66 (45%), Gaps = 7/66 (10%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P FN + DI L++LSS + V V L P +A G +
Sbjct: 64 FINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSL------PRSCAAA-GTEC 116
Query: 311 TVIGWG 316
+ GWG
Sbjct: 117 LISGWG 122
>pdb|1NN6|A Chain A, Human Pro-Chymase
Length = 228
Score = 44.7 bits (104), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 59/237 (24%), Positives = 92/237 (38%), Gaps = 61/237 (25%)
Query: 46 SYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGV-QNKQVK 104
S CGG L+ N+V+TAAHC + ++ + LG H ++E Q +V
Sbjct: 29 SKFCGGFLIRRNFVLTAAHCAGR----------SITVTLG---AHNITEEEDTWQKLEVI 75
Query: 105 RVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGTSVCNGDS 164
+ +P +N+S DI LL+L ++ V + P Q + V +C
Sbjct: 76 KQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPF------PSQFNFVPPGRMCR--- 126
Query: 165 GGGMVFKIDSAWYLRGIV---SITVARDGLRVCDTK---HYVVFTDVANVC--------- 209
+ W G++ S T+ LR+ D + H+ F +C
Sbjct: 127 --------VAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNLQLCVGNPRKTKS 178
Query: 210 --NGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFN 264
GDSGG ++ A +GIVS + D K VFT + H P N
Sbjct: 179 AFKGDSGGPLL----CAGVAQGIVSYGRS-------DAKPPAVFTRIS--HYRPWIN 222
>pdb|4AN7|A Chain A, Kunitz Type Trypsin Inhibitor Complex With Porcine Trypsin
Length = 231
Score = 44.7 bits (104), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 33/119 (27%), Positives = 54/119 (45%), Gaps = 17/119 (14%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G A P+ V+L S+ CGGSL++ +V++AAHC + + +
Sbjct: 12 GYTCAANSIPYQVSLNSG-----SHFCGGSLINSQWVVSAAHCYKSR----------IQV 56
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
LG+++ EG Q ++ +P FN + DI L++LSS + V V L
Sbjct: 57 RLGEHNIDVL--EGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSL 113
Score = 35.4 bits (80), Expect = 0.050, Method: Compositional matrix adjust.
Identities = 30/113 (26%), Positives = 47/113 (41%), Gaps = 13/113 (11%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P FN + DI L++LSS + V V L + A G +
Sbjct: 72 FINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSL-------PRSCAAAGTEC 124
Query: 311 TVIGWGYDENDRVS--EELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+ GWG ++ S L+ P++S C S P Q T + C GF
Sbjct: 125 LISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYP---GQITGN-MICVGF 173
>pdb|4AFQ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFQ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFS|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFZ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFZ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AG1|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|B Chain B, Human Chymase - Fynomer Complex
Length = 226
Score = 44.7 bits (104), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 59/237 (24%), Positives = 92/237 (38%), Gaps = 61/237 (25%)
Query: 46 SYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGV-QNKQVK 104
S CGG L+ N+V+TAAHC + ++ + LG H ++E Q +V
Sbjct: 27 SKFCGGFLIRRNFVLTAAHCAGR----------SITVTLG---AHNITEEEDTWQKLEVI 73
Query: 105 RVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGTSVCNGDS 164
+ +P +N+S DI LL+L ++ V + P Q + V +C
Sbjct: 74 KQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPF------PSQFNFVPPGRMCR--- 124
Query: 165 GGGMVFKIDSAWYLRGIV---SITVARDGLRVCDTK---HYVVFTDVANVC--------- 209
+ W G++ S T+ LR+ D + H+ F +C
Sbjct: 125 --------VAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNLQLCVGNPRKTKS 176
Query: 210 --NGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFN 264
GDSGG ++ A +GIVS + D K VFT + H P N
Sbjct: 177 AFKGDSGGPLL----CAGVAQGIVSYGRS-------DAKPPAVFTRIS--HYRPWIN 220
>pdb|1FY1|A Chain A, [r23s,F25e]hbp, A Mutant Of Human Heparin Binding Protein
(Cap37)
Length = 225
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 48/204 (23%), Positives = 86/204 (42%), Gaps = 29/204 (14%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G+K Q+P+ +A + +G S+ CGG+L+ +V+TAA C + +
Sbjct: 1 IVGGRKARPRQFPF-LASIQNQG---SHECGGALIHARFVMTAASCFQSQ------NPGV 50
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNY-----LGDIALLQLSSDVDYSM 134
+ LG Y + + +Q ++ + + + Y L D+ LLQL + + +
Sbjct: 51 STVVLGAYDLRR-------RERQSRQTFSISSMSENGYDPQQNLNDLMLLQLDREANLTS 103
Query: 135 YVRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVC 194
V + L PLQ + VE + C G + + R V++TV +
Sbjct: 104 SVTILPL------PLQNATVEAGTRCQVAGWGSQRSGGRLSRFPR-FVNVTVTPEDQCRP 156
Query: 195 DTKHYVVFTDVANVCNGDSGGGMV 218
+ V T +CNGD G +V
Sbjct: 157 NNVCTGVLTRRGGICNGDGGTPLV 180
>pdb|1F7Z|A Chain A, Rat Trypsinogen K15a Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 233
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 48/190 (25%), Positives = 86/190 (45%), Gaps = 24/190 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + LG+++ + EG Q ++
Sbjct: 33 HFCGGSLINDQWVVSAAHCYKSR----------IQVRLGEHNINVL--EGNEQFVNAAKI 80
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVE---GTSVCNGD 163
+P F+ DI L++LSS V + V V L S AP + G ++ +G
Sbjct: 81 IKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVAL-PSSCAPAGTQCLISGWGNTLSSGV 139
Query: 164 SGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVA-NVCNGDSGGGMVFKID 222
+ ++ +D+ + + ++ D V F + + C GDSGG +V +
Sbjct: 140 NEPDLLQCLDAPLLPQADCEASYPG---KITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE 196
Query: 223 SAWYLRGIVS 232
L+GIVS
Sbjct: 197 ----LQGIVS 202
Score = 35.8 bits (81), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 31/113 (27%), Positives = 46/113 (40%), Gaps = 13/113 (11%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P F+ DI L++LSS V + V V L S AP G
Sbjct: 74 FVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVAL-PSSCAP------AGTQC 126
Query: 311 TVIGWGYDENDRVSEE--LKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+ GWG + V+E L+ P++ C S P +D C GF
Sbjct: 127 LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKI----TDNMVCVGF 175
>pdb|1FY8|E Chain E, Crystal Structure Of The Deltaile16val17 Rat Anionic
Trypsinogen-Bpti Complex
Length = 231
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 48/190 (25%), Positives = 86/190 (45%), Gaps = 24/190 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + LG+++ + EG Q ++
Sbjct: 31 HFCGGSLINDQWVVSAAHCYKSR----------IQVRLGEHNINVL--EGNEQFVNAAKI 78
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVE---GTSVCNGD 163
+P F+ DI L++LSS V + V V L S AP + G ++ +G
Sbjct: 79 IKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVAL-PSSCAPAGTQCLISGWGNTLSSGV 137
Query: 164 SGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVA-NVCNGDSGGGMVFKID 222
+ ++ +D+ + + ++ D V F + + C GDSGG +V +
Sbjct: 138 NEPDLLQCLDAPLLPQADCEASYPG---KITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE 194
Query: 223 SAWYLRGIVS 232
L+GIVS
Sbjct: 195 ----LQGIVS 200
Score = 35.8 bits (81), Expect = 0.044, Method: Compositional matrix adjust.
Identities = 31/113 (27%), Positives = 46/113 (40%), Gaps = 13/113 (11%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P F+ DI L++LSS V + V V L S AP G
Sbjct: 72 FVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVAL-PSSCAP------AGTQC 124
Query: 311 TVIGWGYDENDRVSEE--LKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+ GWG + V+E L+ P++ C S P +D C GF
Sbjct: 125 LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKI----TDNMVCVGF 173
>pdb|1F5R|A Chain A, Rat Trypsinogen Mutant Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 231
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 48/190 (25%), Positives = 86/190 (45%), Gaps = 24/190 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + LG+++ + EG Q ++
Sbjct: 31 HFCGGSLINDQWVVSAAHCYKSR----------IQVRLGEHNINVL--EGNEQFVNAAKI 78
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVE---GTSVCNGD 163
+P F+ DI L++LSS V + V V L S AP + G ++ +G
Sbjct: 79 IKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVAL-PSSCAPAGTQCLISGWGNTLSSGV 137
Query: 164 SGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVA-NVCNGDSGGGMVFKID 222
+ ++ +D+ + + ++ D V F + + C GDSGG +V +
Sbjct: 138 NEPDLLKCLDAPLLPQADCEASYPG---KITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE 194
Query: 223 SAWYLRGIVS 232
L+GIVS
Sbjct: 195 ----LQGIVS 200
Score = 37.0 bits (84), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 32/113 (28%), Positives = 46/113 (40%), Gaps = 13/113 (11%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P F+ DI L++LSS V + V V L S AP G
Sbjct: 72 FVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVAL-PSSCAP------AGTQC 124
Query: 311 TVIGWGYDENDRVSEE--LKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+ GWG + V+E LK P++ C S P +D C GF
Sbjct: 125 LISGWGNTLSSGVNEPDLLKCLDAPLLPQADCEASYPGKI----TDNMVCVGF 173
>pdb|2XRC|A Chain A, Human Complement Factor I
pdb|2XRC|B Chain B, Human Complement Factor I
pdb|2XRC|C Chain C, Human Complement Factor I
pdb|2XRC|D Chain D, Human Complement Factor I
Length = 565
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/107 (26%), Positives = 49/107 (45%), Gaps = 11/107 (10%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G++ G PW VA+ GI CGG + +++TAAHC+ + T+V
Sbjct: 325 GKRAQLGDLPWQVAIKDASGI----TCGGIYIGGCWILTAAHCLRASKTHRYQIWTTVVD 380
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSD 129
++ D + + V R+ + +N+ Y DIAL+++ D
Sbjct: 381 WI-------HPDLKRIVIEYVDRIIFHENYNAGTYQNDIALIEMKKD 420
>pdb|2ZGC|A Chain A, Crystal Structure Of Active Human Granzyme M
pdb|2ZGH|A Chain A, Crystal Structure Of Active Granzyme M Bound To Its
Product
pdb|2ZKS|A Chain A, Structural Insights Into The Proteolytic Machinery Of
Apoptosis- Inducing Granzyme M
Length = 240
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 35/111 (31%), Positives = 51/111 (45%), Gaps = 17/111 (15%)
Query: 32 PWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQ 91
P+ +L R N S++CGG LV +V+TAAHC+ ++ L + LG H
Sbjct: 13 PYMASLQR----NGSHLCGGVLVHPKWVLTAAHCLAQR-------MAQLRLVLG---LHT 58
Query: 92 FSDEGGVQNKQVKRVHIYPTFNSSNYL-GDIALLQLSSDVDYSMYVRPVCL 141
G +K +P + L D+ALLQL V S +RP+ L
Sbjct: 59 LDSPG--LTFHIKAAIQHPRYKPVPALENDLALLQLDGKVKPSRTIRPLAL 107
Score = 32.0 bits (71), Expect = 0.51, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 39/89 (43%), Gaps = 8/89 (8%)
Query: 271 DIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGY-DENDRVSEELKM 329
D+ALLQL V S +RP+ L G ++ GWG + R+S L+
Sbjct: 86 DLALLQLDGKVKPSRTIRPLALPSKRQV-----VAAGTRCSMAGWGLTHQGGRLSRVLRE 140
Query: 330 AIMPIVSHQQCLWSNPQFFSQFTSDETFC 358
+ ++ + C +N +F++ S C
Sbjct: 141 LDLQVLDTRMC--NNSRFWNGSLSPSMVC 167
>pdb|3BEU|A Chain A, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
pdb|3BEU|B Chain B, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
Length = 224
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 69/250 (27%), Positives = 107/250 (42%), Gaps = 55/250 (22%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
V G + A+G++P+ V LS CGG+L + + V+TAAHCV+ + + +
Sbjct: 1 VVGGTRAAQGEFPFMV--------RLSMGCGGALYAQDIVLTAAHCVSGSGNNTSITATG 52
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
V+ L Q S V++ +V + P F Y D AL++L+ ++ +P
Sbjct: 53 GVVDL------QSSSAVKVRSTKVLQA---PGFTKETYGKDWALIKLAQPIN-----QPT 98
Query: 140 CLWDDSTAPLQLSAVEGTSVCNGDSG--------GGMVFKIDSAWYLRGIVSITVARDGL 191
+TA Q + N + G + F D+A R S + + +
Sbjct: 99 LKIATTTAYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAA--CRSSSSFILVANEM 156
Query: 192 RVC---DTKHYVVFTDVANVCNGDSGGGMVFKIDSA--WYLRGIVS--ITVARDGLRVCD 244
+C DTK + C GDSGG M F+ D+A W GIVS AR G
Sbjct: 157 -ICAGYDTKQ-------EDTCQGDSGGPM-FRKDNADEWVQVGIVSWGEGCARKG----- 202
Query: 245 TKHYVVFTDV 254
Y V+T+V
Sbjct: 203 --KYGVYTEV 210
>pdb|1XVM|A Chain A, Trypsin From Fusarium Oxysporum- Room Temperature To
Atomic Resolution
pdb|1XVO|A Chain A, Trypsin From Fusarium Oxysporum At Ph 6
pdb|1FY5|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDN|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FY4|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FN8|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDQ|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
Length = 224
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 32/108 (29%), Positives = 56/108 (51%), Gaps = 17/108 (15%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G + G +P+ V++ R G CGGSL++ N V+TAAHCV+ Y + I
Sbjct: 4 GTSASAGDFPFIVSISRNGG----PWCGGSLLNANTVLTAAHCVSG--YAQ----SGFQI 53
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDV 130
G + GG+ + V ++P+++ +N D+A+L+LS+ +
Sbjct: 54 RAGSLSR----TSGGIT-SSLSSVRVHPSYSGNNN--DLAILKLSTSI 94
>pdb|2KAI|A Chain A, Refined 2.5 Angstroms X-Ray Crystal Structure Of The
Complex Formed By Porcine Kallikrein A And The Bovine
Pancreatic Trypsin Inhibitor. Crystallization, Patterson
Search, Structure Determination, Refinement, Structure
And Comparison With Its Components And With The Bovine
Trypsin- Pancreatic Trypsin Inhibitor Complex
pdb|2PKA|A Chain A, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|2PKA|X Chain X, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|1HIA|A Chain A, Kallikrein Complexed With Hirustasin
pdb|1HIA|X Chain X, Kallikrein Complexed With Hirustasin
Length = 80
Score = 43.9 bits (102), Expect = 1e-04, Method: Composition-based stats.
Identities = 29/93 (31%), Positives = 45/93 (48%), Gaps = 16/93 (17%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G++ + PW VA+Y S+ CGG LV+ +V+TAAHC +D +
Sbjct: 4 GRECEKNSHPWQVAIYHYS----SFQCGGVLVNPKWVLTAAHC----------KNDNYEV 49
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSS 115
+LG++ + F +E Q V +P FN S
Sbjct: 50 WLGRH--NLFENENTAQFFGVTADFPHPGFNLS 80
>pdb|1TFX|A Chain A, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1TFX|B Chain B, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1LDT|T Chain T, Complex Of Leech-Derived Tryptase Inhibitor With Porcine
Trypsin
pdb|1AVW|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Orthorhombic Crystal Form
pdb|1AVX|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Tetragonal Crystal Form
pdb|1EJA|A Chain A, Structure Of Porcine Trypsin Complexed With Bdellastasin,
An Antistasin-Type Inhibitor
pdb|1S5S|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S6F|A Chain A, Porcine Trypsin Covalent Complex With Borate And
Guanidine- 3 Inhibitor
pdb|1S6H|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S81|A Chain A, Porcine Trypsin With No Inhibitor Bound
pdb|1S82|A Chain A, Porcine Trypsin Complexed With Borate And Ethylene Glycol
pdb|1S83|A Chain A, Porcine Trypsin Complexed With 4-amino Propanol
pdb|1S84|A Chain A, Porcine Trypsin Covalent Complex With 4-Amino Butanol,
Borate And Ethylene Glycol
pdb|1S85|A Chain A, Porcine Trypsin Complexed With P-Hydroxymethyl Benzamidine
And Borate
pdb|1H9I|E Chain E, Complex Of Eeti-Ii Mutant With Porcine Trypsin
pdb|1V6D|A Chain A, The Crystal Structure Of The Trypsin Complex With
Synthetic Heterochiral Peptide
pdb|1TX6|A Chain A, Trypsin:bbi Complex
pdb|1TX6|B Chain B, Trypsin:bbi Complex
pdb|1TX6|C Chain C, Trypsin:bbi Complex
pdb|1TX6|D Chain D, Trypsin:bbi Complex
pdb|1Z7K|A Chain A, Crystal Structure Of Trypsin- Ovomucoid Turkey Egg White
Inhibitor Complex
pdb|1YF4|A Chain A, Crystal Structure Of Trypsin-Vasopressin Complex
Length = 223
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 33/122 (27%), Positives = 55/122 (45%), Gaps = 17/122 (13%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G A P+ V+L S+ CGGSL++ +V++AAHC +
Sbjct: 1 IVGGYTCAANSIPYQVSLNSG-----SHFCGGSLINSQWVVSAAHCYKSR---------- 45
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
+ + LG+++ EG Q ++ +P FN + DI L++LSS + V V
Sbjct: 46 IQVRLGEHNIDVL--EGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATV 103
Query: 140 CL 141
L
Sbjct: 104 SL 105
Score = 35.4 bits (80), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 30/113 (26%), Positives = 47/113 (41%), Gaps = 13/113 (11%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P FN + DI L++LSS + V V L + A G +
Sbjct: 64 FINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSL-------PRSCAAAGTEC 116
Query: 311 TVIGWGYDENDRVS--EELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+ GWG ++ S L+ P++S C S P Q T + C GF
Sbjct: 117 LISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYP---GQITGN-MICVGF 165
>pdb|2A31|A Chain A, Trypsin In Complex With Borate
pdb|2A32|A Chain A, Trypsin In Complex With Benzene Boronic Acid
Length = 223
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 33/119 (27%), Positives = 54/119 (45%), Gaps = 17/119 (14%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G A P+ V+L S+ CGGSL++ +V++AAHC + + +
Sbjct: 4 GYTCAANSIPYQVSLNSG-----SHFCGGSLINSQWVVSAAHCYKSR----------IQV 48
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
LG+++ EG Q ++ +P FN + DI L++LSS + V V L
Sbjct: 49 RLGEHNIDVL--EGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSL 105
Score = 35.4 bits (80), Expect = 0.044, Method: Compositional matrix adjust.
Identities = 30/113 (26%), Positives = 47/113 (41%), Gaps = 13/113 (11%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P FN + DI L++LSS + V V L + A G +
Sbjct: 64 FINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSL-------PRSCAAAGTEC 116
Query: 311 TVIGWGYDENDRVS--EELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+ GWG ++ S L+ P++S C S P Q T + C GF
Sbjct: 117 LISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYP---GQITGN-MICVGF 165
>pdb|1GDU|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1PQ5|A Chain A, Trypsin At Ph 5, 0.85 A
pdb|1PQ7|A Chain A, Trypsin At 0.8 A, Ph5 BORAX
pdb|1PQ8|A Chain A, Trypsin At Ph 4 At Atomic Resolution
pdb|2G51|A Chain A, Anomalous Substructure Of Trypsin (P1)
pdb|2G52|A Chain A, Anomalous Substructure Of Trypsin (P21)
pdb|1TRY|A Chain A, Structure Of Inhibited Trypsin From Fusarium Oxysporum At
1.55 Angstroms
pdb|2VU8|E Chain E, Crystal Structure Of An Insect Inhibitor With A Fungal
Trypsin
Length = 224
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 32/108 (29%), Positives = 56/108 (51%), Gaps = 17/108 (15%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G + G +P+ V++ R G CGGSL++ N V+TAAHCV+ Y + I
Sbjct: 4 GTSASAGDFPFIVSISRNGG----PWCGGSLLNANTVLTAAHCVSG--YAQ----SGFQI 53
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDV 130
G + GG+ + V ++P+++ +N D+A+L+LS+ +
Sbjct: 54 RAGSLSR----TSGGIT-SSLSSVRVHPSYSGNNN--DLAILKLSTSI 94
>pdb|1PPZ|A Chain A, Trypsin Complexes At Atomic And Ultra-High Resolution
pdb|1PQA|A Chain A, Trypsin With Pmsf At Atomic Resolution
Length = 224
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 31/108 (28%), Positives = 54/108 (50%), Gaps = 17/108 (15%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G + G +P+ V++ R G CGGSL++ N V+TAAHCV+ I
Sbjct: 4 GTSASAGDFPFIVSISRNGG----PWCGGSLLNANTVLTAAHCVSGYAQSG------FQI 53
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDV 130
G + GG+ + V ++P+++ +N D+A+L+LS+ +
Sbjct: 54 RAGSLSR----TSGGIT-SSLSSVRVHPSYSGNNN--DLAILKLSTSI 94
>pdb|3TGI|E Chain E, Wild-Type Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
pdb|1ANE|A Chain A, Anionic Trypsin Wild Type
pdb|3FP6|E Chain E, Anionic Trypsin In Complex With Bovine Pancreatic Trypsin
Inhibitor (Bpti) Determined To The 1.49 A Resolution
Limit
Length = 223
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 48/190 (25%), Positives = 86/190 (45%), Gaps = 24/190 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + LG+++ + EG Q ++
Sbjct: 23 HFCGGSLINDQWVVSAAHCYKSR----------IQVRLGEHNINVL--EGNEQFVNAAKI 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVE---GTSVCNGD 163
+P F+ DI L++LSS V + V V L S AP + G ++ +G
Sbjct: 71 IKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVAL-PSSCAPAGTQCLISGWGNTLSSGV 129
Query: 164 SGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVA-NVCNGDSGGGMVFKID 222
+ ++ +D+ + + ++ D V F + + C GDSGG +V +
Sbjct: 130 NEPDLLQCLDAPLLPQADCEASYPG---KITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE 186
Query: 223 SAWYLRGIVS 232
L+GIVS
Sbjct: 187 ----LQGIVS 192
Score = 36.2 bits (82), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 31/113 (27%), Positives = 46/113 (40%), Gaps = 13/113 (11%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P F+ DI L++LSS V + V V L S AP G
Sbjct: 64 FVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVAL-PSSCAP------AGTQC 116
Query: 311 TVIGWGYDENDRVSEE--LKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+ GWG + V+E L+ P++ C S P +D C GF
Sbjct: 117 LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKI----TDNMVCVGF 165
>pdb|1FDP|A Chain A, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|B Chain B, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|C Chain C, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|D Chain D, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
Length = 235
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 58/222 (26%), Positives = 89/222 (40%), Gaps = 35/222 (15%)
Query: 43 INLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQ 102
+N +++CGG LV+ +V++AAHC+ K + + LG + Q E +
Sbjct: 27 LNGAHLCGGVLVAEQWVLSAAHCLEDAADGK------VQVLLGAHSLSQ--PEPSKRLYD 78
Query: 103 VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLW---DDSTAPLQLSAVEGTSV 159
V R +P D+ LLQLS VRP+ W D AP L V G +
Sbjct: 79 VLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPL-PWQRVDRDVAPGTLCDVAGWGI 137
Query: 160 CNGDSGGGMVFKIDSAWYL------RGIVSITVARDGLRVCDTKHYVVFTDVANVCNGDS 213
N + DS ++ R + DG + ++ + C GDS
Sbjct: 138 VNHAG-----RRPDSLQHVLLPVLDRATCNRRTHHDG--AITERLMCAESNRRDSCKGDS 190
Query: 214 GGGMVFKIDSAWYLRGIVSITVARDGLRVC-DTKHYVVFTDV 254
GG +V L G+V+ G RVC + K ++T V
Sbjct: 191 GGPLVC----GGVLEGVVT-----SGSRVCGNRKKPGIYTRV 223
>pdb|1PJP|A Chain A, The 2.2 A Crystal Structure Of Human Chymase In Complex
With Succinyl- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|1T31|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|2HVX|A Chain A, Discovery Of Potent, Orally Active, Nonpeptide Inhibitors
Of Human Mast Cell Chymase By Using Structure-Based Drug
Design
pdb|3S0N|A Chain A, Crystal Structure Of Human Chymase With Benzimidazolone
Inhibitor
Length = 226
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 59/237 (24%), Positives = 92/237 (38%), Gaps = 61/237 (25%)
Query: 46 SYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGV-QNKQVK 104
S CGG L+ N+V+TAAHC + ++ + LG H ++E Q +V
Sbjct: 27 SKFCGGFLIRRNFVLTAAHCAGR----------SITVTLGA---HNITEEEDTWQKLEVI 73
Query: 105 RVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGTSVCNGDS 164
+ +P +N+S DI LL+L ++ V + P Q + V +C
Sbjct: 74 KQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPF------PSQKNFVPPGRMCR--- 124
Query: 165 GGGMVFKIDSAWYLRGIV---SITVARDGLRVCDTK---HYVVFTDVANVC--------- 209
+ W G++ S T+ LR+ D + H+ F +C
Sbjct: 125 --------VAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNLQLCVGNPRKTKS 176
Query: 210 --NGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFN 264
GDSGG ++ A +GIVS + D K VFT + H P N
Sbjct: 177 AFKGDSGGPLL----CAGAAQGIVSYGRS-------DAKPPAVFTRIS--HYQPWIN 220
>pdb|3MYW|A Chain A, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
pdb|3MYW|B Chain B, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
Length = 223
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 33/119 (27%), Positives = 54/119 (45%), Gaps = 17/119 (14%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G A P+ V+L S+ CGGSL++ +V++AAHC + + +
Sbjct: 4 GYTCAANSVPYQVSLNSG-----SHFCGGSLINSQWVVSAAHCYKSR----------IQV 48
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
LG+++ EG Q ++ +P FN + DI L++LSS + V V L
Sbjct: 49 RLGEHNIDVL--EGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSL 105
Score = 34.7 bits (78), Expect = 0.081, Method: Compositional matrix adjust.
Identities = 29/113 (25%), Positives = 47/113 (41%), Gaps = 13/113 (11%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P FN + DI L++LSS + V V L + A G +
Sbjct: 64 FINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSL-------PRSCAAAGTEC 116
Query: 311 TVIGWGYDENDRVS--EELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+ GWG ++ S L+ P++S C + P Q T + C GF
Sbjct: 117 LISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSAYP---GQITGN-MICVGF 165
>pdb|1TON|A Chain A, Rat Submaxillary Gland Serine Protease, Tonin. Structure
Solution And Refinement At 1.8 Angstroms Resolution
Length = 235
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 35/126 (27%), Positives = 56/126 (44%), Gaps = 29/126 (23%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G K + PW VA+ Y+CGG L+ ++VITAAHC S+ +
Sbjct: 4 GYKCEKNSQPWQVAVIN------EYLCGGVLIDPSWVITAAHCY----------SNNYQV 47
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTF------NSS-----NYLGDIALLQLSSDVD 131
LG+ + F DE Q + V++ +P + N + ++ D+ LL LS D
Sbjct: 48 LLGR--NNLFKDEPFAQRRLVRQSFRHPDYIPLIVTNDTEQPVHDHSNDLMLLHLSEPAD 105
Query: 132 YSMYVR 137
+ V+
Sbjct: 106 ITGGVK 111
>pdb|1MCT|A Chain A, The Refined 1.6 Angstroms Resolution Crystal Structure Of
The Complex Formed Between Porcine Beta-trypsin And
Mcti-a, A Trypsin Inhibitor Of Squash Family
pdb|1QQU|A Chain A, Crystal Structure Of Porcine Beta Trypsin With Bound
Acetate Ion
pdb|1FMG|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.04%
Polydocanol
pdb|1FN6|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.1%
Polydocanol
pdb|1FNI|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01%
Polydocanol
Length = 223
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 33/119 (27%), Positives = 54/119 (45%), Gaps = 17/119 (14%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G A P+ V+L S+ CGGSL++ +V++AAHC + + +
Sbjct: 4 GYTCAANSIPYQVSLNSG-----SHFCGGSLINSQWVVSAAHCYKSR----------IQV 48
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
LG+++ EG Q ++ +P FN + DI L++LSS + V V L
Sbjct: 49 RLGEHNIDVL--EGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSL 105
Score = 36.6 bits (83), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 30/113 (26%), Positives = 48/113 (42%), Gaps = 13/113 (11%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P FN + DI L++LSS + V V L + A G +
Sbjct: 64 FINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSL-------PRSCAAAGTEC 116
Query: 311 TVIGWGYDENDRVS--EELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+ GWG ++ S L+ P++S+ C S P Q T + C GF
Sbjct: 117 LISGWGNTKSSGSSYPSLLQCLKAPVLSNSSCKSSYP---GQITGN-MICVGF 165
>pdb|1OP8|A Chain A, Crystal Structure Of Human Granzyme A
pdb|1OP8|B Chain B, Crystal Structure Of Human Granzyme A
pdb|1OP8|C Chain C, Crystal Structure Of Human Granzyme A
pdb|1OP8|D Chain D, Crystal Structure Of Human Granzyme A
pdb|1OP8|E Chain E, Crystal Structure Of Human Granzyme A
pdb|1OP8|F Chain F, Crystal Structure Of Human Granzyme A
Length = 234
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 44/185 (23%), Positives = 81/185 (43%), Gaps = 34/185 (18%)
Query: 48 VCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRVH 107
+C G+L++ ++V+TAAHC K + LG + + +E Q VK+
Sbjct: 25 ICAGALIAKDWVLTAAHCNLNKRSQ---------VILGAHSITR--EEPTKQIMLVKKEF 73
Query: 108 IYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGG 167
YP ++ + GD+ LLQL+ + YV + L P + V+ ++C +G G
Sbjct: 74 PYPCYDPATREGDLKLLQLTEKAKINKYVTILHL------PKKGDDVKPGTMCQ-VAGWG 126
Query: 168 MVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVANV--------------CNGDS 213
+SA + + + + +VC+ +++ F V + CNGDS
Sbjct: 127 RTH--NSASWSDTLREVNITIIDRKVCNDRNHYNFNPVIGMNMVCAGSLRGGRDSCNGDS 184
Query: 214 GGGMV 218
G ++
Sbjct: 185 GSPLL 189
Score = 34.7 bits (78), Expect = 0.094, Method: Compositional matrix adjust.
Identities = 30/110 (27%), Positives = 44/110 (40%), Gaps = 10/110 (9%)
Query: 254 VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWD--DSTAPLQLSAVEGRDGT 311
VK+ YP ++ + GD+ LLQL+ + YV + L D P G
Sbjct: 69 VKKEFPYPCYDPATREGDLKLLQLTEKAKINKYVTILHLPKKGDDVKP-------GTMCQ 121
Query: 312 VIGWGYDENDRV-SEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
V GWG N S+ L+ + I+ + C N F+ CAG
Sbjct: 122 VAGWGRTHNSASWSDTLREVNITIIDRKVCNDRNHYNFNPVIGMNMVCAG 171
>pdb|1AND|A Chain A, Anionic Trypsin Mutant With Arg 96 Replaced By His
Length = 223
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 48/190 (25%), Positives = 86/190 (45%), Gaps = 24/190 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + LG+++ + EG Q ++
Sbjct: 23 HFCGGSLINDQWVVSAAHCYKSR----------IQVRLGEHNINVL--EGNEQFVNAAKI 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVE---GTSVCNGD 163
+P F+ DI L++LSS V + V V L S AP + G ++ +G
Sbjct: 71 IKHPNFDHKTLNNDIMLIKLSSPVKLNARVATVAL-PSSCAPAGTQCLISGWGNTLSSGV 129
Query: 164 SGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVA-NVCNGDSGGGMVFKID 222
+ ++ +D+ + + ++ D V F + + C GDSGG +V +
Sbjct: 130 NEPDLLQCLDAPLLPQADCEASYPG---KITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE 186
Query: 223 SAWYLRGIVS 232
L+GIVS
Sbjct: 187 ----LQGIVS 192
Score = 36.2 bits (82), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 31/113 (27%), Positives = 46/113 (40%), Gaps = 13/113 (11%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P F+ DI L++LSS V + V V L S AP G
Sbjct: 64 FVNAAKIIKHPNFDHKTLNNDIMLIKLSSPVKLNARVATVAL-PSSCAP------AGTQC 116
Query: 311 TVIGWGYDENDRVSEE--LKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+ GWG + V+E L+ P++ C S P +D C GF
Sbjct: 117 LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKI----TDNMVCVGF 165
>pdb|1AMH|A Chain A, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
pdb|1AMH|B Chain B, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
Length = 223
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 48/190 (25%), Positives = 86/190 (45%), Gaps = 24/190 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + LG+++ + EG Q ++
Sbjct: 23 HFCGGSLINDQWVVSAAHCYKSR----------IQVRLGEHNINVL--EGNEQFVNAAKI 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVE---GTSVCNGD 163
+P F+ DI L++LSS V + V V L S AP + G ++ +G
Sbjct: 71 IKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVAL-PSSCAPAGTQCLISGWGNTLSSGV 129
Query: 164 SGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVA-NVCNGDSGGGMVFKID 222
+ ++ +D+ + + ++ D V F + + C GDSGG +V +
Sbjct: 130 NEPDLLQCLDAPLLPQADCEASYPG---KITDNMVCVGFLEGGKSSCQGDSGGPVVCNGE 186
Query: 223 SAWYLRGIVS 232
L+GIVS
Sbjct: 187 ----LQGIVS 192
Score = 36.6 bits (83), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 31/113 (27%), Positives = 46/113 (40%), Gaps = 13/113 (11%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P F+ DI L++LSS V + V V L S AP G
Sbjct: 64 FVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVAL-PSSCAP------AGTQC 116
Query: 311 TVIGWGYDENDRVSEE--LKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+ GWG + V+E L+ P++ C S P +D C GF
Sbjct: 117 LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKI----TDNMVCVGF 165
>pdb|1ORF|A Chain A, The Oligomeric Structure Of Human Granzyme A Reveals The
Molecular Determinants Of Substrate Specificity
Length = 234
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 44/185 (23%), Positives = 81/185 (43%), Gaps = 34/185 (18%)
Query: 48 VCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRVH 107
+C G+L++ ++V+TAAHC K + LG + + +E Q VK+
Sbjct: 25 ICAGALIAKDWVLTAAHCNLNKRSQ---------VILGAHSITR--EEPTKQIMLVKKEF 73
Query: 108 IYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGG 167
YP ++ + GD+ LLQL+ + YV + L P + V+ ++C +G G
Sbjct: 74 PYPCYDPATREGDLKLLQLTEKAKINKYVTILHL------PKKGDDVKPGTMCQ-VAGWG 126
Query: 168 MVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVANV--------------CNGDS 213
+SA + + + + +VC+ +++ F V + CNGDS
Sbjct: 127 RTH--NSASWSDTLREVEITIIDRKVCNDRNHYNFNPVIGMNMVCAGSLRGGRDSCNGDS 184
Query: 214 GGGMV 218
G ++
Sbjct: 185 GSPLL 189
Score = 34.7 bits (78), Expect = 0.086, Method: Compositional matrix adjust.
Identities = 30/110 (27%), Positives = 44/110 (40%), Gaps = 10/110 (9%)
Query: 254 VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWD--DSTAPLQLSAVEGRDGT 311
VK+ YP ++ + GD+ LLQL+ + YV + L D P G
Sbjct: 69 VKKEFPYPCYDPATREGDLKLLQLTEKAKINKYVTILHLPKKGDDVKP-------GTMCQ 121
Query: 312 VIGWGYDENDRV-SEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
V GWG N S+ L+ + I+ + C N F+ CAG
Sbjct: 122 VAGWGRTHNSASWSDTLREVEITIIDRKVCNDRNHYNFNPVIGMNMVCAG 171
>pdb|1AN1|E Chain E, Leech-Derived Tryptase InhibitorTRYPSIN COMPLEX
pdb|1C9P|A Chain A, Complex Of Bdellastasin With Porcine Trypsin
Length = 223
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 33/119 (27%), Positives = 53/119 (44%), Gaps = 17/119 (14%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G A P+ V+L S+ CGGSL++ +V++AAHC + + +
Sbjct: 4 GYTCAANSIPYQVSLNSG-----SHFCGGSLINSQWVVSAAHCYKSR----------IQV 48
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
LG+++ EG Q ++ +P FN + DI L++LSS V V L
Sbjct: 49 RLGEHNIDVL--EGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLXSRVATVSL 105
Score = 35.4 bits (80), Expect = 0.056, Method: Compositional matrix adjust.
Identities = 30/113 (26%), Positives = 46/113 (40%), Gaps = 13/113 (11%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P FN + DI L++LSS V V L + A G +
Sbjct: 64 FINAAKIITHPNFNGNTLDNDIMLIKLSSPATLXSRVATVSL-------PRSCAAAGTEC 116
Query: 311 TVIGWGYDENDRVS--EELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+ GWG ++ S L+ P++S C S P Q T + C GF
Sbjct: 117 LISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYP---GQITGN-MICVGF 165
>pdb|1DSU|A Chain A, Human Factor D, Complement Activating Enzyme
pdb|1DSU|B Chain B, Human Factor D, Complement Activating Enzyme
pdb|1DFP|A Chain A, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DFP|B Chain B, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DIC|A Chain A, Structure Of 3,4-Dichloroisocoumarin-Inhibited Factor D
pdb|1BIO|A Chain A, Human Complement Factor D In Complex With Isatoic
Anhydride Inhibitor
pdb|1HFD|A Chain A, Human Complement Factor D In A P21 Crystal Form
pdb|4D9R|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9R|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 58/222 (26%), Positives = 89/222 (40%), Gaps = 35/222 (15%)
Query: 43 INLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQ 102
+N +++CGG LV+ +V++AAHC+ K + + LG + Q E +
Sbjct: 20 LNGAHLCGGVLVAEQWVLSAAHCLEDAADGK------VQVLLGAHSLSQ--PEPSKRLYD 71
Query: 103 VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLW---DDSTAPLQLSAVEGTSV 159
V R +P D+ LLQLS VRP+ W D AP L V G +
Sbjct: 72 VLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPL-PWQRVDRDVAPGTLCDVAGWGI 130
Query: 160 CNGDSGGGMVFKIDSAWYL------RGIVSITVARDGLRVCDTKHYVVFTDVANVCNGDS 213
N + DS ++ R + DG + ++ + C GDS
Sbjct: 131 VNHAG-----RRPDSLQHVLLPVLDRATCNRRTHHDG--AITERLMCAESNRRDSCKGDS 183
Query: 214 GGGMVFKIDSAWYLRGIVSITVARDGLRVC-DTKHYVVFTDV 254
GG +V L G+V+ G RVC + K ++T V
Sbjct: 184 GGPLVC----GGVLEGVVT-----SGSRVCGNRKKPGIYTRV 216
>pdb|1BRB|E Chain E, Crystal Structures Of Rat Anionic Trypsin Complexed With
The Protein Inhibitors Appi And Bpti
pdb|1BRC|E Chain E, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
pdb|1BRA|A Chain A, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
Length = 223
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 48/190 (25%), Positives = 85/190 (44%), Gaps = 24/190 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + LG+++ + EG Q ++
Sbjct: 23 HFCGGSLINDQWVVSAAHCYKSR----------IQVRLGEHNINVL--EGNEQFVNAAKI 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVE---GTSVCNGD 163
+P F+ DI L++LSS V + V V L S AP + G ++ +G
Sbjct: 71 IKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVAL-PSSCAPAGTQCLISGWGNTLSSGV 129
Query: 164 SGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVAN-VCNGDSGGGMVFKID 222
+ ++ +D+ + + ++ D V F + C GDSGG +V +
Sbjct: 130 NEPDLLQCLDAPLLPQADCEASYPG---KITDNMVCVGFLEGGKGSCQGDSGGPVVCNGE 186
Query: 223 SAWYLRGIVS 232
L+GIVS
Sbjct: 187 ----LQGIVS 192
Score = 36.2 bits (82), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 31/113 (27%), Positives = 46/113 (40%), Gaps = 13/113 (11%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P F+ DI L++LSS V + V V L S AP G
Sbjct: 64 FVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVAL-PSSCAP------AGTQC 116
Query: 311 TVIGWGYDENDRVSEE--LKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+ GWG + V+E L+ P++ C S P +D C GF
Sbjct: 117 LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKI----TDNMVCVGF 165
>pdb|3TGJ|E Chain E, S195a Trypsinogen Complexed With Bovine Pancreatic Trypsin
Inhibitor (Bpti)
Length = 233
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 47/190 (24%), Positives = 86/190 (45%), Gaps = 24/190 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + LG+++ + EG Q ++
Sbjct: 33 HFCGGSLINDQWVVSAAHCYKSR----------IQVRLGEHNINVL--EGNEQFVNAAKI 80
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVE---GTSVCNGD 163
+P F+ DI L++LSS V + V V L S AP + G ++ +G
Sbjct: 81 IKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVAL-PSSCAPAGTQCLISGWGNTLSSGV 139
Query: 164 SGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVA-NVCNGDSGGGMVFKID 222
+ ++ +D+ + + ++ D V F + + C GD+GG +V +
Sbjct: 140 NEPDLLQCLDAPLLPQADCEASYPG---KITDNMVCVGFLEGGKDSCQGDAGGPVVCNGE 196
Query: 223 SAWYLRGIVS 232
L+GIVS
Sbjct: 197 ----LQGIVS 202
Score = 35.8 bits (81), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 31/113 (27%), Positives = 46/113 (40%), Gaps = 13/113 (11%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P F+ DI L++LSS V + V V L S AP G
Sbjct: 74 FVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVAL-PSSCAP------AGTQC 126
Query: 311 TVIGWGYDENDRVSEE--LKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+ GWG + V+E L+ P++ C S P +D C GF
Sbjct: 127 LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKI----TDNMVCVGF 175
>pdb|2I6Q|A Chain A, Complement Component C2a
pdb|2I6S|A Chain A, Complement Component C2a
Length = 517
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 58/133 (43%), Gaps = 18/133 (13%)
Query: 32 PWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQ 91
PWHV + C G+L+S +V+TAAHC + D + +G + Q
Sbjct: 244 PWHVTIKPKS----QETCRGALISDQWVLTAAHC-----FRDGNDHSLWRVNVGD-PKSQ 293
Query: 92 FSDEGGVQNKQVKRVHIYPTFNSSN------YLGDIALLQLSSDVDYSMYVRPVCLWDDS 145
+ E ++ + + F N Y DIALL+L+ V S + RP+CL
Sbjct: 294 WGKEFLIEKAVISPG--FDVFAKKNQGILEFYGDDIALLKLAQKVKMSTHARPICLPCTM 351
Query: 146 TAPLQLSAVEGTS 158
A L L +G++
Sbjct: 352 EANLALRRPQGST 364
Score = 33.5 bits (75), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 30/118 (25%), Positives = 50/118 (42%), Gaps = 33/118 (27%)
Query: 268 YLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEG---RDGTVIGWGYDENDRVS 324
Y DIALL+L+ V S + RP+CL A L L +G RD EN+ ++
Sbjct: 323 YGDDIALLKLAQKVKMSTHARPICLPCTMEANLALRRPQGSTCRD--------HENELLN 374
Query: 325 EE-----------------LKMAI-----MPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
++ LKM + +VS ++ ++ N + +D+ C+G
Sbjct: 375 KQSVPAHFVALNGSKLNINLKMGVEWTSCAEVVSQEKTMFPNLTDVREVVTDQFLCSG 432
>pdb|2ODP|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
pdb|2ODQ|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
Length = 509
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 58/133 (43%), Gaps = 18/133 (13%)
Query: 32 PWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQ 91
PWHV + C G+L+S +V+TAAHC + D + +G + Q
Sbjct: 236 PWHVTIKPKS----QETCRGALISDQWVLTAAHC-----FRDGNDHSLWRVNVGD-PKSQ 285
Query: 92 FSDEGGVQNKQVKRVHIYPTFNSSN------YLGDIALLQLSSDVDYSMYVRPVCLWDDS 145
+ E ++ + + F N Y DIALL+L+ V S + RP+CL
Sbjct: 286 WGKEFLIEKAVISPG--FDVFAKKNQGILEFYGDDIALLKLAQKVKMSTHARPICLPCTM 343
Query: 146 TAPLQLSAVEGTS 158
A L L +G++
Sbjct: 344 EANLALRRPQGST 356
Score = 33.5 bits (75), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 30/118 (25%), Positives = 50/118 (42%), Gaps = 33/118 (27%)
Query: 268 YLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEG---RDGTVIGWGYDENDRVS 324
Y DIALL+L+ V S + RP+CL A L L +G RD EN+ ++
Sbjct: 315 YGDDIALLKLAQKVKMSTHARPICLPCTMEANLALRRPQGSTCRD--------HENELLN 366
Query: 325 EE-----------------LKMAI-----MPIVSHQQCLWSNPQFFSQFTSDETFCAG 360
++ LKM + +VS ++ ++ N + +D+ C+G
Sbjct: 367 KQSVPAHFVALNGSKLNINLKMGVEWTSCAEVVSQEKTMFPNLTDVREVVTDQFLCSG 424
>pdb|1GVZ|A Chain A, Prostate Specific Antigen (Psa) From Stallion Seminal
Plasma
Length = 237
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 38/120 (31%), Positives = 55/120 (45%), Gaps = 33/120 (27%)
Query: 32 PWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQ 91
PW VA+Y + CGG LV +V+TAAHC+ SD I+LG+++ +
Sbjct: 13 PWQVAVYHQG----HFQCGGVLVHPQWVLTAAHCM----------SDDYQIWLGRHNLSK 58
Query: 92 FSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQL 151
DE Q QV + P F D++LL+ Y+RP +DD + L L
Sbjct: 59 --DEDTAQFHQVSDSFLDPQF-------DLSLLK-------KKYLRP---YDDISHDLML 99
>pdb|1A7S|A Chain A, Atomic Resolution Structure Of Hbp
pdb|1AE5|A Chain A, Human Heparin Binding Protein
Length = 225
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 47/204 (23%), Positives = 85/204 (41%), Gaps = 29/204 (14%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G+K Q+P+ +A + +G + CGG+L+ +V+TAA C + +
Sbjct: 1 IVGGRKARPRQFPF-LASIQNQG---RHFCGGALIHARFVMTAASCFQSQ------NPGV 50
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNY-----LGDIALLQLSSDVDYSM 134
+ LG Y + + +Q ++ + + + Y L D+ LLQL + + +
Sbjct: 51 STVVLGAYDLRR-------RERQSRQTFSISSMSENGYDPQQNLNDLMLLQLDREANLTS 103
Query: 135 YVRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVC 194
V + L PLQ + VE + C G + + R V++TV +
Sbjct: 104 SVTILPL------PLQNATVEAGTRCQVAGWGSQRSGGRLSRFPR-FVNVTVTPEDQCRP 156
Query: 195 DTKHYVVFTDVANVCNGDSGGGMV 218
+ V T +CNGD G +V
Sbjct: 157 NNVCTGVLTRRGGICNGDGGTPLV 180
>pdb|1FY3|A Chain A, [g175q]hbp, A Mutant Of Human Heparin Binding Protein
(cap37)
Length = 225
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 47/204 (23%), Positives = 85/204 (41%), Gaps = 29/204 (14%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G+K Q+P+ +A + +G + CGG+L+ +V+TAA C + +
Sbjct: 1 IVGGRKARPRQFPF-LASIQNQG---RHFCGGALIHARFVMTAASCFQSQ------NPGV 50
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNY-----LGDIALLQLSSDVDYSM 134
+ LG Y + + +Q ++ + + + Y L D+ LLQL + + +
Sbjct: 51 STVVLGAYDLRR-------RERQSRQTFSISSMSENGYDPQQNLNDLMLLQLDREANLTS 103
Query: 135 YVRPVCLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVC 194
V + L PLQ + VE + C G + + R V++TV +
Sbjct: 104 SVTILPL------PLQNATVEAGTRCQVAGWGSQRSGGRLSRFPR-FVNVTVTPEDQCRP 156
Query: 195 DTKHYVVFTDVANVCNGDSGGGMV 218
+ V T +CNGD G +V
Sbjct: 157 NNVCTGVLTRRGGICNGDQGTPLV 180
>pdb|1OP2|A Chain A, Crystal Structure Of Aav-Sp-Ii, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/103 (28%), Positives = 50/103 (48%), Gaps = 17/103 (16%)
Query: 35 VALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSD 94
VA + T G + CGG+L++ +V+TAAHC DS + LG + + ++
Sbjct: 16 VAFFNTTG----FFCGGTLINPEWVVTAAHC----------DSTNFQMQLGVHSKKVLNE 61
Query: 95 EGGVQNKQVKRVHIYPTFNSSNYL-GDIALLQLSSDVDYSMYV 136
+ Q + K I P N++ L DI L++L + S ++
Sbjct: 62 D--EQTRNPKEKFICPNKNNNEVLDKDIMLIKLDKPISNSKHI 102
>pdb|1K9O|E Chain E, Crystal Structure Of Michaelis Serpin-Trypsin Complex
pdb|1YKT|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLC|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLD|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|3FP7|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Cleaved At The
Scissile Bond (Lys15-Ala16) Determined To The 1.46 A
Resolution Limit
pdb|3FP8|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Determined To The
1.46 A Resolution Limit
Length = 223
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 47/190 (24%), Positives = 86/190 (45%), Gaps = 24/190 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + LG+++ + EG Q ++
Sbjct: 23 HFCGGSLINDQWVVSAAHCYKSR----------IQVRLGEHNINVL--EGNEQFVNAAKI 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVE---GTSVCNGD 163
+P F+ DI L++LSS V + V V L S AP + G ++ +G
Sbjct: 71 IKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVAL-PSSCAPAGTQCLISGWGNTLSSGV 129
Query: 164 SGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVA-NVCNGDSGGGMVFKID 222
+ ++ +D+ + + ++ D V F + + C GD+GG +V +
Sbjct: 130 NEPDLLQCLDAPLLPQADCEASYPG---KITDNMVCVGFLEGGKDSCQGDAGGPVVCNGE 186
Query: 223 SAWYLRGIVS 232
L+GIVS
Sbjct: 187 ----LQGIVS 192
Score = 36.6 bits (83), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 31/113 (27%), Positives = 46/113 (40%), Gaps = 13/113 (11%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P F+ DI L++LSS V + V V L S AP G
Sbjct: 64 FVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVAL-PSSCAP------AGTQC 116
Query: 311 TVIGWGYDENDRVSEE--LKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+ GWG + V+E L+ P++ C S P +D C GF
Sbjct: 117 LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKI----TDNMVCVGF 165
>pdb|3TGK|E Chain E, Trypsinogen Mutant D194n And Deletion Of Ile 16-Val 17
Complexed With Bovine Pancreatic Trypsin Inhibitor
(Bpti)
Length = 231
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 13/102 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + LG+++ + EG Q ++
Sbjct: 31 HFCGGSLINDQWVVSAAHCYKSR----------IQVRLGEHNINVL--EGNEQFVNAAKI 78
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAP 148
+P F+ DI L++LSS V + V V L S AP
Sbjct: 79 IKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVAL-PSSCAP 119
Score = 35.8 bits (81), Expect = 0.039, Method: Compositional matrix adjust.
Identities = 31/113 (27%), Positives = 46/113 (40%), Gaps = 13/113 (11%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P F+ DI L++LSS V + V V L S AP G
Sbjct: 72 FVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVAL-PSSCAP------AGTQC 124
Query: 311 TVIGWGYDENDRVSEE--LKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+ GWG + V+E L+ P++ C S P +D C GF
Sbjct: 125 LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKI----TDNMVCVGF 173
>pdb|1SLX|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Zinc-Bound
pdb|1SLV|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Copper- Bound
pdb|1SLU|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin
Length = 223
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 48/190 (25%), Positives = 86/190 (45%), Gaps = 24/190 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + LG+++ + EG Q ++
Sbjct: 23 HFCGGSLINDQWVVSAAHCYKSR----------IQVRLGEHNINVL--EGNEQFVNAAKI 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVE---GTSVCNGD 163
+P F+ DI L++LSS V + V V L S AP + G ++ +G
Sbjct: 71 IKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVAL-PSSCAPAGTQCLISGWGHTLSSGV 129
Query: 164 SGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVA-NVCNGDSGGGMVFKID 222
+ ++ +D+ + + ++ D V F + + C GDSGG +V +
Sbjct: 130 NHPDLLQCLDAPLLPQADCEASYPG---KITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE 186
Query: 223 SAWYLRGIVS 232
L+GIVS
Sbjct: 187 ----LQGIVS 192
Score = 35.8 bits (81), Expect = 0.042, Method: Compositional matrix adjust.
Identities = 30/113 (26%), Positives = 46/113 (40%), Gaps = 13/113 (11%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P F+ DI L++LSS V + V V L S AP G
Sbjct: 64 FVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVAL-PSSCAP------AGTQC 116
Query: 311 TVIGWGYDENDRVSEE--LKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+ GWG+ + V+ L+ P++ C S P +D C GF
Sbjct: 117 LISGWGHTLSSGVNHPDLLQCLDAPLLPQADCEASYPGKI----TDNMVCVGF 165
>pdb|1ANB|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Glu
Length = 223
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 13/102 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + LG+++ + EG Q ++
Sbjct: 23 HFCGGSLINDQWVVSAAHCYKSR----------IQVRLGEHNINVL--EGNEQFVNAAKI 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAP 148
+P F+ DI L++LSS V + V V L S AP
Sbjct: 71 IKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVAL-PSSCAP 111
Score = 36.2 bits (82), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 31/113 (27%), Positives = 46/113 (40%), Gaps = 13/113 (11%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P F+ DI L++LSS V + V V L S AP G
Sbjct: 64 FVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVAL-PSSCAP------AGTQC 116
Query: 311 TVIGWGYDENDRVSEE--LKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+ GWG + V+E L+ P++ C S P +D C GF
Sbjct: 117 LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKI----TDNMVCVGF 165
>pdb|1ANC|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Lys
Length = 223
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 13/102 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + LG+++ + EG Q ++
Sbjct: 23 HFCGGSLINDQWVVSAAHCYKSR----------IQVRLGEHNINVL--EGNEQFVNAAKI 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAP 148
+P F+ DI L++LSS V + V V L S AP
Sbjct: 71 IKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVAL-PSSCAP 111
Score = 36.2 bits (82), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 31/113 (27%), Positives = 46/113 (40%), Gaps = 13/113 (11%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P F+ DI L++LSS V + V V L S AP G
Sbjct: 64 FVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVAL-PSSCAP------AGTQC 116
Query: 311 TVIGWGYDENDRVSEE--LKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+ GWG + V+E L+ P++ C S P +D C GF
Sbjct: 117 LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKI----TDNMVCVGF 165
>pdb|1DPO|A Chain A, Structure Of Rat Trypsin
Length = 223
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 13/102 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + LG+++ + EG Q ++
Sbjct: 23 HFCGGSLINDQWVVSAAHCYKSR----------IQVRLGEHNINVL--EGNEQFVNAAKI 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAP 148
+P F+ DI L++LSS V + V V L S AP
Sbjct: 71 IKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVAL-PSSCAP 111
Score = 36.6 bits (83), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 31/113 (27%), Positives = 46/113 (40%), Gaps = 13/113 (11%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P F+ DI L++LSS V + V V L S AP G
Sbjct: 64 FVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVAL-PSSCAP------AGTQC 116
Query: 311 TVIGWGYDENDRVSEE--LKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+ GWG + V+E L+ P++ C S P +D C GF
Sbjct: 117 LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKI----TDNMVCVGF 165
>pdb|1Y59|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5A|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5B|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5U|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
Length = 223
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 41/150 (27%), Positives = 63/150 (42%), Gaps = 23/150 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS Y DI
Sbjct: 30 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSETYNNDIM 86
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S + V + L P A G + GWG ++ S + LK
Sbjct: 87 LIKLKSAASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 139
Query: 332 MPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
PI+S C + P Q TS+ FCAG+
Sbjct: 140 APILSDSSCKSAYP---GQITSN-MFCAGY 165
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 27/95 (28%), Positives = 47/95 (49%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC Y + + LG+ + + EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHC-----YKSGIQ-----VRLGEDNINVV--EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS Y DI L++L S + V + L
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLNSRVASISL 105
>pdb|2ZGJ|A Chain A, Crystal Structure Of D86n-gzmm Complexed With Its Optimal
Synthesized Substrate
Length = 240
Score = 42.7 bits (99), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 34/111 (30%), Positives = 52/111 (46%), Gaps = 17/111 (15%)
Query: 32 PWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQ 91
P+ +L R N S++CGG LV +V+TAAHC+ ++ + LV+ L H
Sbjct: 13 PYMASLQR----NGSHLCGGVLVHPKWVLTAAHCLAQR-----MAQLRLVLGL-----HT 58
Query: 92 FSDEGGVQNKQVKRVHIYPTFNSSNYL-GDIALLQLSSDVDYSMYVRPVCL 141
G +K +P + L ++ALLQL V S +RP+ L
Sbjct: 59 LDSPG--LTFHIKAAIQHPRYKPVPALENNLALLQLDGKVKPSRTIRPLAL 107
Score = 30.4 bits (67), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 22/89 (24%), Positives = 39/89 (43%), Gaps = 8/89 (8%)
Query: 271 DIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGY-DENDRVSEELKM 329
++ALLQL V S +RP+ L G ++ GWG + R+S L+
Sbjct: 86 NLALLQLDGKVKPSRTIRPLALPSKRQV-----VAAGTRCSMAGWGLTHQGGRLSRVLRE 140
Query: 330 AIMPIVSHQQCLWSNPQFFSQFTSDETFC 358
+ ++ + C +N +F++ S C
Sbjct: 141 LDLQVLDTRMC--NNSRFWNGSLSPSMVC 167
>pdb|2XW9|A Chain A, Crystal Structure Of Complement Factor D Mutant S183a
pdb|2XWB|I Chain I, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|J Chain J, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 228
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 57/222 (25%), Positives = 89/222 (40%), Gaps = 35/222 (15%)
Query: 43 INLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQ 102
+N +++CGG LV+ +V++AAHC+ K + + LG + Q E +
Sbjct: 20 LNGAHLCGGVLVAEQWVLSAAHCLEDAADGK------VQVLLGAHSLSQ--PEPSKRLYD 71
Query: 103 VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLW---DDSTAPLQLSAVEGTSV 159
V R +P D+ LLQLS VRP+ W D AP L V G +
Sbjct: 72 VLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPL-PWQRVDRDVAPGTLCDVAGWGI 130
Query: 160 CNGDSGGGMVFKIDSAWYL------RGIVSITVARDGLRVCDTKHYVVFTDVANVCNGDS 213
N + DS ++ R + DG + ++ + C GD+
Sbjct: 131 VNHAG-----RRPDSLQHVLLPVLDRATCNRRTHHDG--AITERLMCAESNRRDSCKGDA 183
Query: 214 GGGMVFKIDSAWYLRGIVSITVARDGLRVC-DTKHYVVFTDV 254
GG +V L G+V+ G RVC + K ++T V
Sbjct: 184 GGPLVC----GGVLEGVVT-----SGSRVCGNRKKPGIYTRV 216
>pdb|1SLW|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Nickel- Bound
Length = 223
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 47/190 (24%), Positives = 86/190 (45%), Gaps = 24/190 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + LG+++ + EG Q ++
Sbjct: 23 HFCGGSLINDQWVVSAAHCYKSR----------IQVRLGEHNINVL--EGNEQFVNAAKI 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVE---GTSVCNGD 163
+P F+ DI L++LSS V + V + L S AP + G ++ +G
Sbjct: 71 IKHPNFDRKTLNNDIMLIKLSSPVKLNARVATIAL-PSSCAPAGTQCLISGWGHTLSSGV 129
Query: 164 SGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVA-NVCNGDSGGGMVFKID 222
+ ++ +D+ + + ++ D V F + + C GDSGG +V +
Sbjct: 130 NHPDLLQCLDAPLLPQADCEASYPG---KITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE 186
Query: 223 SAWYLRGIVS 232
L+GIVS
Sbjct: 187 ----LQGIVS 192
Score = 35.4 bits (80), Expect = 0.055, Method: Compositional matrix adjust.
Identities = 29/113 (25%), Positives = 46/113 (40%), Gaps = 13/113 (11%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P F+ DI L++LSS V + V + L S AP G
Sbjct: 64 FVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATIAL-PSSCAP------AGTQC 116
Query: 311 TVIGWGYDENDRVSEE--LKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+ GWG+ + V+ L+ P++ C S P +D C GF
Sbjct: 117 LISGWGHTLSSGVNHPDLLQCLDAPLLPQADCEASYPGKI----TDNMVCVGF 165
>pdb|1OP0|A Chain A, Crystal Structure Of Aav-sp-i, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 29/103 (28%), Positives = 50/103 (48%), Gaps = 17/103 (16%)
Query: 35 VALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSD 94
VA + T G + CGG+L++ +V+TAAHC DS + LG + + ++
Sbjct: 16 VAFFNTTG----FFCGGTLINPEWVVTAAHC----------DSTDFQMQLGVHSKKVLNE 61
Query: 95 EGGVQNKQVKRVHIYPTFNSSNYL-GDIALLQLSSDVDYSMYV 136
+ Q + K I P N++ L DI L++L + S ++
Sbjct: 62 D--EQTRNPKEKFICPNKNNNEVLDKDIMLIKLDKPISNSKHI 102
>pdb|2ASU|B Chain B, Crystal Structure Of The Beta-Chain Of HgflMSP
Length = 234
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 54/229 (23%), Positives = 87/229 (37%), Gaps = 24/229 (10%)
Query: 29 GQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYH 88
G PW V+L +G + CGGSLV +++TA C + P+ ++LG
Sbjct: 7 GNSPWTVSLRNRQG---QHFCGGSLVKEQWILTARQCFSS--CHMPLTGYE--VWLGTLF 59
Query: 89 QHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDD--ST 146
Q+ E +Q V ++ P+ + + LL+L V + V +CL +
Sbjct: 60 QNPQHGEPSLQRVPVAKMVCGPSGS------QLVLLKLERSVTLNQRVALICLPPEWYVV 113
Query: 147 APLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVA 206
P + G G +G V + + R +R + + V
Sbjct: 114 PPGTKCEIAGWGETKG-TGNDTVLNVALLNVISNQECNIKHRGRVRESEMCTEGLLAPVG 172
Query: 207 NVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHY-VVFTDV 254
C GD GG + ++W L GI+ RVC + VFT V
Sbjct: 173 -ACEGDYGGPLACFTHNSWVLEGIIIPN------RVCARSRWPAVFTRV 214
Score = 28.1 bits (61), Expect = 7.2, Method: Compositional matrix adjust.
Identities = 17/70 (24%), Positives = 30/70 (42%), Gaps = 5/70 (7%)
Query: 271 DIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVSEELKMA 330
+ LL+L V + V +CL P G + GWG + L +A
Sbjct: 85 QLVLLKLERSVTLNQRVALICL-----PPEWYVVPPGTKCEIAGWGETKGTGNDTVLNVA 139
Query: 331 IMPIVSHQQC 340
++ ++S+Q+C
Sbjct: 140 LLNVISNQEC 149
>pdb|1TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|1TRM|B Chain B, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|2TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
Length = 223
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 47/190 (24%), Positives = 86/190 (45%), Gaps = 24/190 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + LG+++ + EG Q ++
Sbjct: 23 HFCGGSLINDQWVVSAAHCYKSR----------IQVRLGEHNINVL--EGNEQFVNAAKI 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVE---GTSVCNGD 163
+P F+ +I L++LSS V + V V L S AP + G ++ +G
Sbjct: 71 IKHPNFDRKTLNNNIMLIKLSSPVKLNARVATVAL-PSSCAPAGTQCLISGWGNTLSSGV 129
Query: 164 SGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVA-NVCNGDSGGGMVFKID 222
+ ++ +D+ + + ++ D V F + + C GDSGG +V +
Sbjct: 130 NEPDLLQCLDAPLLPQADCEASYPG---KITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE 186
Query: 223 SAWYLRGIVS 232
L+GIVS
Sbjct: 187 ----LQGIVS 192
Score = 34.7 bits (78), Expect = 0.079, Method: Compositional matrix adjust.
Identities = 30/113 (26%), Positives = 46/113 (40%), Gaps = 13/113 (11%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P F+ +I L++LSS V + V V L S AP G
Sbjct: 64 FVNAAKIIKHPNFDRKTLNNNIMLIKLSSPVKLNARVATVAL-PSSCAP------AGTQC 116
Query: 311 TVIGWGYDENDRVSEE--LKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+ GWG + V+E L+ P++ C S P +D C GF
Sbjct: 117 LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKI----TDNMVCVGF 165
>pdb|1YM0|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component B: A Novel, Glycosylated Two-chained Trypsin
Length = 238
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 52/217 (23%), Positives = 97/217 (44%), Gaps = 33/217 (15%)
Query: 30 QWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQ 89
++PW V++ R + S+ CGGS+++ +V+ AAHC+ + + LV + +
Sbjct: 11 EFPWQVSVRRKS--SDSHFCGGSIINDRWVVCAAHCMQGE-------APALVSLV--VGE 59
Query: 90 HQFSDEGGV-QNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAP 148
H S V Q V + + ++ + D+++++ + + + + V P+C D +
Sbjct: 60 HDSSAASTVRQTHDVDSIFVNENYDPATLENDVSVIKTAVAITFDINVGPICAPDPAN-- 117
Query: 149 LQLSAVEGTSVCNG----DSGGG--------MVFKIDSAWYLRGIVSITVARDGLRVCDT 196
V S C+G +SGG + I + + + + D + +C T
Sbjct: 118 ---DYVYRKSQCSGWGTINSGGVCCPAVLRYVTLNITTNAFCDAVYTSDTIYDDM-ICAT 173
Query: 197 KHYVVFTDVANVCNGDSGGGMVFKIDSAWY-LRGIVS 232
+ TD + C GDSGG + K S + L GIVS
Sbjct: 174 DN-TGMTD-RDSCQGDSGGPLSVKDGSGIFSLVGIVS 208
>pdb|2R9P|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|B Chain B, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|C Chain C, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|D Chain D, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|3L33|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L3T|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3P92|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17G)
pdb|3P95|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17D)
Length = 224
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 30/103 (29%), Positives = 49/103 (47%), Gaps = 15/103 (14%)
Query: 46 SYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKR 105
S+ CGGSL+S +V++AAHC + + + LG+++ EG Q +
Sbjct: 22 SHFCGGSLISEQWVVSAAHCYKTR----------IQVRLGEHNIKVL--EGNEQFINAAK 69
Query: 106 VHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAP 148
+ +P +N DI L++LSS + V + L TAP
Sbjct: 70 IIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISL---PTAP 109
>pdb|1EZS|C Chain C, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZS|D Chain D, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZU|C Chain C, Ecotin Y69f, D70p Bound To D102n Trypsin
pdb|1EZU|D Chain D, Ecotin Y69f, D70p Bound To D102n Trypsin
Length = 223
Score = 41.6 bits (96), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 47/190 (24%), Positives = 86/190 (45%), Gaps = 24/190 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + LG+++ + EG Q ++
Sbjct: 23 HFCGGSLINDQWVVSAAHCYKSR----------IQVRLGEHNINVL--EGDEQFVNAAKI 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVE---GTSVCNGD 163
+P F+ +I L++LSS V + V V L S AP + G ++ +G
Sbjct: 71 IKHPNFDRKTLNNNIMLIKLSSPVKLNARVATVAL-PSSCAPAGTQCLISGWGNTLSSGV 129
Query: 164 SGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVA-NVCNGDSGGGMVFKID 222
+ ++ +D+ + + ++ D V F + + C GDSGG +V +
Sbjct: 130 NEPDLLQCLDAPLLPQADCEASYPG---KITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE 186
Query: 223 SAWYLRGIVS 232
L+GIVS
Sbjct: 187 ----LQGIVS 192
Score = 34.7 bits (78), Expect = 0.081, Method: Compositional matrix adjust.
Identities = 30/113 (26%), Positives = 46/113 (40%), Gaps = 13/113 (11%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P F+ +I L++LSS V + V V L S AP G
Sbjct: 64 FVNAAKIIKHPNFDRKTLNNNIMLIKLSSPVKLNARVATVAL-PSSCAP------AGTQC 116
Query: 311 TVIGWGYDENDRVSEE--LKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+ GWG + V+E L+ P++ C S P +D C GF
Sbjct: 117 LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKI----TDNMVCVGF 165
>pdb|2XWA|A Chain A, Crystal Structure Of Complement Factor D Mutant R202a
pdb|2XWA|B Chain B, Crystal Structure Of Complement Factor D Mutant R202a
Length = 228
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 48/185 (25%), Positives = 74/185 (40%), Gaps = 25/185 (13%)
Query: 43 INLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQ 102
+N +++CGG LV+ +V++AAHC+ K + + LG + Q E +
Sbjct: 20 LNGAHLCGGVLVAEQWVLSAAHCLEDAADGK------VQVLLGAHSLSQ--PEPSKRLYD 71
Query: 103 VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLW---DDSTAPLQLSAVEGTSV 159
V R +P D+ LLQLS VRP+ W D AP L V G +
Sbjct: 72 VLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPL-PWQRVDRDVAPGTLCDVAGWGI 130
Query: 160 CNGDSGGGMVFKIDSAWYL------RGIVSITVARDGLRVCDTKHYVVFTDVANVCNGDS 213
N + DS ++ R + DG + ++ + C GDS
Sbjct: 131 VNHAG-----RRPDSLQHVLLPVLDRATCNRRTHHDG--AITERLMCAESNRRDSCKGDS 183
Query: 214 GGGMV 218
GG +V
Sbjct: 184 GGPLV 188
>pdb|1SGT|A Chain A, Refined Crystal Structure Of Streptomyces Griseus Trypsin
At 1.7 Angstroms Resolution
Length = 223
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 54/217 (24%), Positives = 90/217 (41%), Gaps = 29/217 (13%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
V G + A+G++P+ V LS CGG+L + + V+TAAHCV+ + + +
Sbjct: 1 VVGGTRAAQGEFPFMV--------RLSMGCGGALYAQDIVLTAAHCVSGSGNNTSITATG 52
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
V+ L G + +V P +N + D AL++L+ ++ +P
Sbjct: 53 GVVDL---------QSGAAVKVRSTKVLQAPGYNGTGK--DWALIKLAQPIN-----QPT 96
Query: 140 CLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHY 199
+TA Q + N + G + + + + A V + +
Sbjct: 97 LKIATTTAYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGNELVANEEIC 156
Query: 200 VVFTDVANV--CNGDSGGGMVFKIDSA--WYLRGIVS 232
+ D V C GDSGG M F+ D+A W GIVS
Sbjct: 157 AGYPDTGGVDTCQGDSGGPM-FRKDNADEWIQVGIVS 192
>pdb|1H4W|A Chain A, Structure Of Human Trypsin Iv (Brain Trypsin)
Length = 224
Score = 41.2 bits (95), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 30/103 (29%), Positives = 49/103 (47%), Gaps = 15/103 (14%)
Query: 46 SYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKR 105
S+ CGGSL+S +V++AAHC + + + LG+++ EG Q +
Sbjct: 22 SHFCGGSLISEQWVVSAAHCYKTR----------IQVRLGEHNIKVL--EGNEQFINAVK 69
Query: 106 VHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAP 148
+ +P +N DI L++LSS + V + L TAP
Sbjct: 70 IIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISL---PTAP 109
>pdb|4GSO|A Chain A, Structure Of Jararacussin-I
Length = 232
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 13/96 (13%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
Y CG +L++ +V+TAAHC DS + LG + + +++ Q + K
Sbjct: 23 YFCGLTLINQEWVVTAAHC----------DSTNFQMQLGVHSKKVLNED--EQTRNPKEK 70
Query: 107 HIYPTFNSSNYL-GDIALLQLSSDVDYSMYVRPVCL 141
I P N S L DI L++L + S ++ P+ L
Sbjct: 71 FICPNKNMSEVLDKDIMLIKLDKPISNSKHIAPLSL 106
>pdb|1OSS|A Chain A, T190p Streptomyces Griseus Trypsin In Complex With
Benzamidine
Length = 223
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 29/217 (13%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
V G + A+G++P+ V LS CGG+L + + V+TAAHCV+ + + +
Sbjct: 1 VVGGTRAAQGEFPFMV--------RLSMGCGGALYAQDIVLTAAHCVSGSGNNTSITATG 52
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
V+ L Q S V++ +V + P +N + D AL++L+ ++ +P
Sbjct: 53 GVVDL------QSSSAVKVRSTKVLQA---PGYNGTGK--DWALIKLAQPIN-----QPT 96
Query: 140 CLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHY 199
+TA Q + N + G + + + + A V + +
Sbjct: 97 LKIATTTAYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGNELVANEEIC 156
Query: 200 VVFTDVANV--CNGDSGGGMVFKIDSA--WYLRGIVS 232
+ D V C GDSGG M F+ D+A W GIVS
Sbjct: 157 AGYPDTGGVDPCQGDSGGPM-FRKDNADEWIQVGIVS 192
>pdb|2RDL|A Chain A, Hamster Chymase 2
pdb|2RDL|B Chain B, Hamster Chymase 2
Length = 226
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 42/187 (22%), Positives = 74/187 (39%), Gaps = 44/187 (23%)
Query: 48 VCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRVH 107
C G L+ N+V+TAAHC + ++ + LG +++ D Q +V++
Sbjct: 29 ACSGFLIRRNFVMTAAHCAGR----------SITVLLGAHNKKVKEDTW--QKLEVEKQF 76
Query: 108 IYPTFNSSNYLGDIALLQLSSDVDYSMYV--RPVCLWDDSTAPLQLSAVEGTSVCNGDSG 165
+P ++ L DI LL+L + ++ V P+ +S P ++ G N +
Sbjct: 77 PHPKYDDRLVLNDIMLLKLKEKANLTLGVGTLPISAKSNSIPPGRVCRAVGWGRTNVNEP 136
Query: 166 GGMVFKIDSAWYLRGIVSITVARDGLRVCDT---KHYVVF-----------TDVANVCNG 211
S T+ +R+ D KH+ F + NV G
Sbjct: 137 P----------------SDTLQEVKMRILDPQACKHFEDFHQEPQLCVGNPKKIRNVYKG 180
Query: 212 DSGGGMV 218
DSGG ++
Sbjct: 181 DSGGPLL 187
>pdb|1OS8|A Chain A, Recombinant Streptomyces Griseus Trypsin
Length = 223
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 29/217 (13%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
V G + A+G++P+ V LS CGG+L + + V+TAAHCV+ + + +
Sbjct: 1 VVGGTRAAQGEFPFMV--------RLSMGCGGALYAQDIVLTAAHCVSGSGNNTSITATG 52
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
V+ L Q S V++ +V + P +N + D AL++L+ ++ +P
Sbjct: 53 GVVDL------QSSSAVKVRSTKVLQA---PGYNGTGK--DWALIKLAQPIN-----QPT 96
Query: 140 CLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHY 199
+TA Q + N + G + + + + A V + +
Sbjct: 97 LKIATTTAYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGNELVANEEIC 156
Query: 200 VVFTDVANV--CNGDSGGGMVFKIDSA--WYLRGIVS 232
+ D V C GDSGG M F+ D+A W GIVS
Sbjct: 157 AGYPDTGGVDTCQGDSGGPM-FRKDNADEWIQVGIVS 192
>pdb|1ELV|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Complement C1s Protease
Length = 333
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 23/75 (30%), Positives = 38/75 (50%), Gaps = 3/75 (4%)
Query: 266 SNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVSE 325
+N+ DIAL++L V V P+CL S+ + ++G G + GWG E +
Sbjct: 169 TNFDNDIALVRLKDPVKMGPTVSPICLPGTSS---DYNLMDGDLGLISGWGRTEKRDRAV 225
Query: 326 ELKMAIMPIVSHQQC 340
LK A +P+ ++C
Sbjct: 226 RLKAARLPVAPLRKC 240
Score = 35.0 bits (79), Expect = 0.059, Method: Compositional matrix adjust.
Identities = 55/215 (25%), Positives = 86/215 (40%), Gaps = 53/215 (24%)
Query: 50 GGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRVHIY 109
GG+L++ +V+TAAH V + +Y+G Q S + + V I+
Sbjct: 106 GGALINEYWVLTAAHVVE--------GNREPTMYVGSTSV-QTSRLAKSKMLTPEHVFIH 156
Query: 110 PTFN-------SSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGTSVCNG 162
P + +N+ DIAL++L V V P+CL S+ ++ +G
Sbjct: 157 PGWKLLAVPEGRTNFDNDIALVRLKDPVKMGPTVSPICLPGTSSD---------YNLMDG 207
Query: 163 D----SGGGMVFKIDSAWYLRGIVSITVARDGLRVC----------DTKHYVVFTDV--- 205
D SG G K D A L+ + VA LR C D + YV ++
Sbjct: 208 DLGLISGWGRTEKRDRAVRLKA-ARLPVAP--LRKCKEVKVEKPTADAEAYVFTPNMICA 264
Query: 206 -----ANVCNGDSGGGMVFK---IDSAWYLRGIVS 232
+ C GDSGG + + +Y G+VS
Sbjct: 265 GGEKGMDSCKGDSGGAFAVQDPNDKTKFYAAGLVS 299
>pdb|3F1S|B Chain B, Crystal Structure Of Protein Z Complexed With Protein
Z-Dependent Inhibitor
Length = 283
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 33/140 (23%), Positives = 55/140 (39%), Gaps = 36/140 (25%)
Query: 7 SCGTVVYNKAQPLVTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHC- 65
+CG + K P + PW V L +EG + CGG ++ N+V+T A C
Sbjct: 48 ACGVLTSEKRAPDLQ--------DLPWQVKLTNSEGKDF---CGGVIIRENFVLTTAKCS 96
Query: 66 -----VTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGD 120
+T K Y D L+I ++ VH++ +++ D
Sbjct: 97 LLHRNITVKTYFNRTSQDPLMI-------------------KITHVHVHMRYDADAGEND 137
Query: 121 IALLQLSSDVDYSMYVRPVC 140
++LL+L + PVC
Sbjct: 138 LSLLELEWPIQCPGAGLPVC 157
>pdb|3S9A|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Closed-Form)
pdb|3S9B|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V (Open-Form)
pdb|3S9C|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V In Complex
With The Fragment (Residues 1533-1546) Of Human Factor V
pdb|3SBK|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Ppack-Bound Form)
Length = 234
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/122 (26%), Positives = 58/122 (47%), Gaps = 13/122 (10%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
V G + + P+ VALY + + C G+L++ +V+TAAHC D
Sbjct: 1 VVGGDECNINEHPFLVALYTSASSTIH--CAGALINREWVLTAAHC----------DRRN 48
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
+ I LG + ++ +++ ++ + K + F + DI L++L V YS ++ PV
Sbjct: 49 IRIKLGMHSKNIRNEDEQIRVPRGKYFCLNTKF-PNGLDKDIMLIRLRRPVTYSTHIAPV 107
Query: 140 CL 141
L
Sbjct: 108 SL 109
>pdb|3VEQ|B Chain B, A Binary Complex Betwwen Bovine Pancreatic Trypsin And A
Engineered Mutant Trypsin Inhibitor
Length = 223
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 41/150 (27%), Positives = 63/150 (42%), Gaps = 23/150 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS+ DI
Sbjct: 30 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSNTLNNDIM 86
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S + V V L P A G + GWG ++ S + LK
Sbjct: 87 LIKLKSAASLNSRVASVSL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 139
Query: 332 MPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
PI+S C + P Q TS+ FCAG+
Sbjct: 140 APILSDSSCKSAYP---GQITSN-MFCAGY 165
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 27/95 (28%), Positives = 47/95 (49%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC Y + + LG+ + + EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHC-----YKSGIQ-----VRLGEDNINVV--EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS+ DI L++L S + V V L
Sbjct: 71 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASVSL 105
>pdb|3H5C|B Chain B, X-Ray Structure Of Protein Z-Protein Z Inhibitor Complex
Length = 317
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 29/115 (25%), Positives = 48/115 (41%), Gaps = 28/115 (24%)
Query: 32 PWHVALYRTEGINLSYVCGGSLVSVNYVITAAHC------VTKKPYDKPVDSDTLVIYLG 85
PW V L +EG + CGG ++ N+V+T A C +T K Y D L+I
Sbjct: 106 PWQVKLTNSEGKDF---CGGVIIRENFVLTTAKCSLLHRNITVKTYFNRTSQDPLMI--- 159
Query: 86 KYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVC 140
++ VH++ +++ D++LL+L + PVC
Sbjct: 160 ----------------KITHVHVHMRYDADAGENDLSLLELEWPIQCPGAGLPVC 198
>pdb|1TAW|A Chain A, Bovine Trypsin Complexed To Appi
pdb|1ZR0|A Chain A, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
pdb|1ZR0|C Chain C, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
Length = 223
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 40/150 (26%), Positives = 63/150 (42%), Gaps = 23/150 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS+ DI
Sbjct: 30 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSNTLNNDIM 86
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S + V + L P A G + GWG ++ S + LK
Sbjct: 87 LIKLKSAASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 139
Query: 332 MPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
PI+S C + P Q TS+ FCAG+
Sbjct: 140 APILSTSSCKSAYP---GQITSN-MFCAGY 165
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 47/95 (49%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC Y + + LG+ + + EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHC-----YKSGIQ-----VRLGEDNINVV--EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS+ DI L++L S + V + L
Sbjct: 71 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISL 105
>pdb|4DG4|A Chain A, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|B Chain B, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|D Chain D, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|G Chain G, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
Length = 224
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 29/102 (28%), Positives = 48/102 (47%), Gaps = 15/102 (14%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL+S +V++AAHC + + + LG+++ EG Q ++
Sbjct: 23 HFCGGSLISEQWVVSAAHCYKTR----------IQVRLGEHNIKVL--EGNEQFINAAKI 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAP 148
+P +N DI L++LSS + V + L TAP
Sbjct: 71 IRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISL---PTAP 109
>pdb|1TAB|E Chain E, Structure Of The Trypsin-Binding Domain Of Bowman-Birk
Type Protease Inhibitor And Its Interaction With Trypsin
pdb|1TPA|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2PTC|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1PPC|E Chain E, Geometry Of Binding Of The Benzamidine-and Arginine-based
Inhibitors
N-alpha-(2-naphthyl-sulphonyl-glycyl)-dl-p-
amidinophenylalanyl- Piperidine (napap) And
(2r,4r)-4-methyl-1-[n-alpha-(3-methyl-1,2,3,4-
Tetrahydro-8-quinolinesulphonyl)-l-arginyl]-2-piperidine
Carboxylic Acid (mqpa) To Human Alpha-thrombin: X-ray
Crystallographic Determination Of The Napap-trypsin
Complex And Modeling Of Napap- Thrombin And
Mqpa-thrombin
pdb|1PPE|E Chain E, The Refined 2.0 Angstroms X-Ray Crystal Structure Of The
Complex Formed Between Bovine Beta-Trypsin And Cmti-I, A
Trypsin Inhibitor From Squash Seeds (Cucurbita Maxima):
Topological Similarity Of The Squash Seed Inhibitors
With The Carboxypeptidase A Inhibitor From Potatoes
pdb|1PPH|E Chain E, Geometry Of Binding Of The Nalpha-Tosylated Piperidides Of
M-Amidino-, P-Amidino-And P-Guanidino Phenylalanine To
Thrombin And Trypsin: X- Ray Crystal Structures Of Their
Trypsin Complexes And Modeling Of Their Thrombin
Complexes
pdb|1SMF|E Chain E, Studies On An Artificial Trypsin Inhibitor Peptide Derived
From The Mung Bean Inhibitor
pdb|1JRT|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1JRS|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1CE5|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzamidine
pdb|2BZA|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzylamine
pdb|1QCP|A Chain A, Crystal Structure Of The Rwj-51084 Bovine Pancreatic Beta-
Trypsin At 1.8 A
pdb|1SBW|A Chain A, Crystal Structure Of Mung Bean Inhibitor Lysine Active
Fragment Complex With Bovine Beta-Trypsin At 1.8a
Resolution
pdb|1YYY|1 Chain 1, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1SFI|A Chain A, High Resolution Structure Of A Potent, Cyclic Protease
Inhibitor From Sunflower Seeds
pdb|1TIO|A Chain A, High Packing Density Form Of Bovine Beta-trypsin In
Cyclohexane
pdb|2TIO|A Chain A, Low Packing Density Form Of Bovine Beta-Trypsin In
Cyclohexane
pdb|2BTC|E Chain E, Bovine Trypsin In Complex With Squash Seed Inhibitor
(Cucurbita Pepo Trypsin Inhibitor Ii)
pdb|3BTE|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta-Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTD|E Chain E, The Crystal Structures Of The Complexes Between The Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTF|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTG|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTH|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTK|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTM|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTQ|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTT|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTW|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|1QBN|A Chain A, Bovine Trypsin 2-[amino(Imino)methyl]-2-Hydroxyphenoxy]-6-
[3-(4,5-Dihydro-1h-Imidazol-2-Yl)phenoxy]pyridine-4-
Carboxylic Acid (Zk-806688) Complex
pdb|1QBO|A Chain A, Bovine Trypsin
7-[[6-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
2-Methyl-Benzimidazol-1-Yl]methyl]naphthalene-2-
Carboximidamid Zk-806711 Inhibitor Complex
pdb|1QB9|A Chain A, Bovine Trypsin
7-[[2-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
9h-Carbozol-9-Yl] Methyl]naphthalene-2-Carboximidamide
(Zk- 806450) Complex
pdb|1QB1|A Chain A, Bovine Trypsin With 1-[2-[5-[amino(imino)methyl]-2-
Hydroxyphenoxy]-6-[3-(4,
5-dihydro-1-methyl-1h-imidazol-2-
Yl)phenoxy]pyridin-4-yl]piperidine-3-carboxylic Acid
(zk- 806974)
pdb|1QB6|A Chain A, Bovine Trypsin 3,3'-[3,5-Difluoro-4-Methyl-2, 6-
Pyridinediylbis(Oxy)]bis(Benzenecarboximidamide) (Zk-
805623) Complex
pdb|1QA0|A Chain A, Bovine Trypsin 2-Aminobenzimidazole Complex
pdb|1F2S|E Chain E, Crystal Structure Of The Complex Formed Between Bovine
Beta- Trypsin And Mcti-A, A Trypsin Inhibitor Of Squash
Family At 1.8 A Resolution
pdb|1D6R|A Chain A, Crystal Structure Of Cancer Chemopreventive Bowman-Birk
Inhibitor In Ternary Complex With Bovine Trypsin At 2.3
A Resolution. Structural Basis Of Janus-Faced Serine
Protease Inhibitor Specificity
pdb|1C9T|A Chain A, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|B Chain B, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|C Chain C, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|D Chain D, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|E Chain E, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|F Chain F, Complex Of Bdellastasin With Bovine Trypsin
pdb|1QL7|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1QL8|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1G9I|E Chain E, Crystal Structure Of Beta-Trysin Complex In Cyclohexane
pdb|1EJM|A Chain A, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|C Chain C, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|E Chain E, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1JIR|A Chain A, Crystal Structure Of Trypsin Complex With Amylamine In
Cyclohexane
pdb|1J8A|A Chain A, Crystal Structure Of Benzamidine Inhibited Bovine
Pancreatic Trypsin At 105k To 1.21a Resolution From
Laboratory Source With High Number Of Waters Modelled
pdb|1G36|A Chain A, Trypsin Inhibitor Complex
pdb|1K1P|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1O|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1N|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1M|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1L|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1J|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1I|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1EB2|A Chain A, Trypsin Inhibitor Complex (Bpo)
pdb|1GJ6|A Chain A, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1N6X|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1N6Y|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1OYQ|A Chain A, Trypsin Inhibitor Complex
pdb|1O2H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O2O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2P|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Q|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2R|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2S|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2T|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2U|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2V|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2W|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2X|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Y|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Z|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O30|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O31|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O32|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O33|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O34|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O35|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O36|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O37|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O38|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O39|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3A|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3B|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3C|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3D|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3E|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3F|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3G|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O3N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1NC6|A Chain A, Potent, Small Molecule Inhibitors Of Human Mast Cell
Tryptase. Anti-Asthmatic Action Of A Dipeptide-Based
Transition State Analogue Containing Benzothiazole
Ketone
pdb|1P2I|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2J|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2K|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OX1|A Chain A, Crystal Structure Of The Bovine Trypsin Complex With A
Synthetic 11 Peptide Inhibitor
pdb|1RXP|A Chain A, Structure Of Trypsin (Orthorhombic) With 1-(4-Tert-
Butylcarbamoyl- Piperazine-1-Carbonyl)-3-(3-Guanidino-
Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid
pdb|1S0Q|A Chain A, Native Bovine Pancreatic Trypsin
pdb|1S0R|A Chain A, Bovine Pancreatic Trypsin Inhibited With Benzamidine At
Atomic Resolution
pdb|2A7H|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|1TX7|A Chain A, Bovine Trypsin Complexed With P-
Amidinophenylmethylphosphinic Acid (Ampa)
pdb|2BLV|A Chain A, Trypsin Before A High Dose X-Ray "burn"
pdb|2BLW|A Chain A, Trypsin After A High Dose X-Ray "burn"
pdb|1TX8|A Chain A, Bovine Trypsin Complexed With Amso
pdb|1Y3U|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3V|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3W|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3X|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3Y|A Chain A, Trypsin Inhibitor Complex
pdb|1YP9|A Chain A, Trypsin Inhibitor Complex
pdb|2AYW|A Chain A, Crystal Structure Of The Complex Formed Between Trypsin
And A Designed Synthetic Highly Potent Inhibitor In The
Presence Of Benzamidine At 0.97 A Resolution
pdb|2FI3|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser,
Cys38->ser) In Complex With Trypsin
pdb|2FX4|A Chain A, Bovine Trypsin Bound By 4-piperidinebutyrate To Make
Acylenzyme Complex
pdb|2FX6|A Chain A, Bovine Trypsin Complexed With 2-Aminobenzamidazole
pdb|2AGE|X Chain X, Succinyl-Aapr-Trypsin Acyl-Enzyme At 1.15 A Resolution
pdb|2AGG|X Chain X, Succinyl-Aapk-Trypsin Acyl-Enzyme At 1.28 A Resolution
pdb|2AGI|X Chain X, The Leupeptin-Trypsin Covalent Complex At 1.14 A
Resolution
pdb|2AH4|X Chain X, Guanidinobenzoyl-Trypsin Acyl-Enzyme At 1.13 A Resolution
pdb|2G5N|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G5V|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G8T|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2F3C|E Chain E, Crystal Structure Of Infestin 1, A Kazal-Type
Serineprotease Inhibitor, In Complex With Trypsin
pdb|2G81|E Chain E, Crystal Structure Of The Bowman-Birk Inhibitor From Vigna
Unguiculata Seeds In Complex With Beta-Trypsin At 1.55
Angstrons Resolution
pdb|2G55|A Chain A, Anomalous Substructure Of Trypsin (P3121)
pdb|2OTV|A Chain A, Crystal Structure Of The Complex Formed Between Bovine
Trypsin And Nicotinamide At 1.56 A Resolution
pdb|2J9N|A Chain A, Robotically Harvested Trypsin Complexed With Benzamidine
Containing Polypeptide Mediated Crystal Contacts
pdb|2OXS|A Chain A, Crytal Structure Of The Trypsin Complex With Benzamidine
At High Temperature (35 C)
pdb|2UUY|A Chain A, Structure Of A Tick Tryptase Inhibitor In Complex With
Bovine Trypsin
pdb|2ILN|A Chain A, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2ILN|B Chain B, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2CMY|A Chain A, Crystal Complex Between Bovine Trypsin And Veronica
Hederifolia Trypsin Inhibitor
pdb|1AQ7|A Chain A, Trypsin With Inhibitor Aeruginosin 98-b
pdb|1AUJ|A Chain A, Bovine Trypsin Complexed To Meta-Cyano-Benzylic Inhibitor
pdb|1AZ8|A Chain A, Bovine Trypsin Complexed To Bis-Phenylamidine Inhibitor
pdb|1BJU|A Chain A, Beta-Trypsin Complexed With Acpu
pdb|1BJV|A Chain A, Beta-Trypsin Complexed With Appu
pdb|1GBT|A Chain A, Structure Of An Acyl-Enzyme Intermediate During Catalysis:
(Guanidinobenzoyl) Trypsin
pdb|1MAX|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MAY|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MTS|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTU|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTV|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTW|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1TLD|A Chain A, Crystal Structure Of Bovine Beta-Trypsin At 1.5 Angstroms
Resolution In A Crystal Form With Low Molecular Packing
Density. Active Site Geometry, Ion Pairs And Solvent
Structure
pdb|1TPO|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPP|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPS|A Chain A, Atomic Structure Of The Trypsin-A90720a Complex: A Unified
Approach To Structure And Function
pdb|1TYN|A Chain A, Atomic Structure Of The Trypsin-cyclotheonamide A Complex:
Lessons For The Design Of Serine Protease Inhibitors
pdb|1XUF|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUG|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUH|A Chain A, Trypsin-Keto-Babim-Co+2, Ph 8.2
pdb|1XUI|A Chain A, Trypsin-Keto-Babim, Zn+2-Free, Ph 8.2
pdb|1XUJ|A Chain A, Trypsin-Keto-Babim-Zn+2, Ph 8.2
pdb|1XUK|A Chain A, Trypsin-Babim-Sulfate, Ph 5.9
pdb|2PLX|A Chain A, Trypsin Complexed To A Synthetic Peptide From Veronica
Hederifolia
pdb|2PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3PTB|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|3PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1C1N|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1O|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1P|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1Q|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1R|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1T|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2D|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2E|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2F|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2G|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2H|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2I|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2J|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2K|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2L|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2M|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5P|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Q|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5R|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5S|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5T|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5U|A Chain A, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5V|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GHZ|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI0|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI1|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI2|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI3|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI4|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI5|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI6|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2O9Q|A Chain A, The Crystal Structure Of Bovine Trypsin Complexed With A
Small Inhibition Peptide Orb2k
pdb|2QN5|T Chain T, Crystal Structure And Functional Study Of The Bowman-Birk
Inhibitor From Rice Bran In Complex With Bovine Trypsin
pdb|2QYI|A Chain A, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2QYI|C Chain C, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2ZDK|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDL|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDM|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDN|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFS|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFT|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZHD|A Chain A, Exploring Trypsin S3 Pocket
pdb|3D65|E Chain E, Crystal Structure Of Textilinin-1, A Kunitz-Type Serine
Protease Inhibitor From The Australian Common Brown
Snake Venom, In Complex With Trypsin
pdb|3E8L|A Chain A, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|3E8L|B Chain B, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|2ZQ1|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZQ2|A Chain A, Exploring Trypsin S3 Pocket
pdb|3ITI|A Chain A, Structure Of Bovine Trypsin With The Mad Triangle B3c
pdb|3GY2|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY3|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY4|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY5|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY6|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Bis-Benzamidines Diminazene And Pentamidine
pdb|3GY7|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY8|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3AAS|A Chain A, Bovine Beta-Trypsin Bound To Meta-Guanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAU|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diguanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|B Chain B, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3M35|A Chain A, Trypsin In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3MFJ|A Chain A, Bovine Trypsin At 0.8 A Resolution, Restrained Refinement
pdb|3MI4|A Chain A, Bovine Trypsin At 0.8 A Resolution, Non-Restrained
Refinemen
pdb|3I29|A Chain A, Crystal Structure Of A Binary Complex Between An Mutant
Tryp Inhibitor With Bovine Trypsin
pdb|3A7T|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide
pdb|3A7V|A Chain A, Crystal Structure Of Trypsin Complexed With
3-Formylbenzimidamide
pdb|3A7W|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((Tetrahydro-2h-
Pyran-2-Yloxyimino)methyl)benzimidamide (Soaking 4hours)
pdb|3A7X|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
45seconds)
pdb|3A7Y|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
3-Yloxyimino)methyl)benzimidamide (Soaking 2hours)
pdb|3A7Z|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
4-Yloxyimino)methyl)benzimidamide (Soaking 3hours)
pdb|3A80|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic Acid
(Soaking 40seconds)
pdb|3A81|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 8
Hours)
pdb|3A82|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid
pdb|3A83|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide
pdb|3A84|A Chain A, Crystal Structure Of Trypsin Complexed With(E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 5
Seconds)
pdb|3A85|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 15
Seconds)
pdb|3A86|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 30
Seconds)
pdb|3A87|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 5
Minutes)
pdb|3A88|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 30
Minutes)
pdb|3A89|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 4
Hours)
pdb|3A8A|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide And Aniline
pdb|3A8B|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((4-
Bromophenylimino)methyl)benzimidamide
pdb|3A8C|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
With Mixture Of
[(E)-2-(4-Carbamimidoylbenzylideneaminooxy)acetic Acid]
And [(E)-2-
(4-Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic
Acid])
pdb|3A8D|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Under
Aniline-Free Condition)
pdb|3LJJ|A Chain A, Bovine Trypsin In Complex With Ub-Thr 10
pdb|3LJO|A Chain A, Bovine Trypsin In Complex With Ub-Thr 11
pdb|2XTT|B Chain B, Bovine Trypsin In Complex With Evolutionary Enhanced
Schistocerca Gregaria Protease Inhibitor 1 (Sgpi-1-P02)
pdb|3NK8|A Chain A, Trypsin In Complex With Fluorine-Containing Fragment
pdb|3NKK|A Chain A, Trypsin In Complex With Fluorine Containing Fragment
pdb|3M7Q|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Pancreatic Trypsin
pdb|3RDZ|A Chain A, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3RDZ|B Chain B, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3ATI|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3ATK|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3ATL|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamidine
pdb|3ATM|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXA|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3RXB|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobutanoic Acid
pdb|3RXC|A Chain A, Crystal Structure Of Trypsin Complexed With
2-Aminopyridine
pdb|3RXD|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3RXE|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide
pdb|3RXF|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminopyridine
pdb|3RXG|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminocyclohexanol
pdb|3RXH|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Imidazol-4-Yl) Ethanamine
pdb|3RXI|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXJ|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobenzoic Acid
pdb|3RXK|A Chain A, Crystal Structure Of Trypsin Complexed With Methyl
4-Amino-1-Methyl- Pyrrolidine-2-Carboxylate
pdb|3RXL|A Chain A, Crystal Structure Of Trypsin Complexed With
(2,5-Dimethyl-3-Furyl) Methanamine
pdb|3RXM|A Chain A, Crystal Structure Of Trypsin Complexed With
[2-(2-Thienyl)thiazol-4- Yl]methanamine
pdb|3RXO|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Pyrrol-1-Ylphenyl) Methanamine
pdb|3RXP|A Chain A, Crystal Structure Of Trypsin Complexed With
(1,5-Dimethylpyrazol-3- Yl)methanamine
pdb|3RXQ|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F01
And F05, Cocktail Experiment)
pdb|3RXR|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine (F01 And F03, Cocktail Experiment)
pdb|3RXS|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine (F04 And A06, Cocktail
Experiment)
pdb|3RXT|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamin (F04 And F03, Cocktail
Experiment)
pdb|3RXU|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And A06, Cocktail Experiment)
pdb|3RXV|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And F03, Cocktail Experiment)
pdb|3T25|A Chain A, Tmao-Grown Orthorhombic Trypsin (Bovine)
pdb|3T26|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Sarcosine
pdb|3T27|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Betaine
pdb|3T28|A Chain A, Tmao-Grown Trypsin (Bovine)-Previously Unreported
Tetragonal Crystal Form
pdb|3T29|A Chain A, Tmao-Grown Trigonal Trypsin (Bovine)
pdb|4AB8|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4AB9|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABA|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABB|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABD|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABE|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABF|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABG|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABH|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABI|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Pta)sfti-1(1,14), That Was 1,4-
Disubstituted With A 1,2,3-Trizol To Mimic A Trans Amide
Bond
pdb|4ABJ|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Ica)sfti-1(1,14), That Was 1,5-
Disubstituted With 1,2,3-Trizol To Mimic A Cis Amide
Bond
pdb|3VPK|A Chain A, Crystal Structure Of 6-guanidinohexanoyl Trypsin
pdb|3UNR|A Chain A, Bond Length Analysis Of Asp, Glu And His Residues In
Trypsin At 1.2a Resolution
pdb|3RU4|T Chain T, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
pdb|1C1S|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|4I8G|A Chain A, Bovine Trypsin At 0.8 Resolution
pdb|4I8H|A Chain A, Bovine Trypsin At 0.75 Resolution
pdb|4I8J|A Chain A, Bovine Trypsin At 0.87 A Resolution
pdb|4I8K|A Chain A, Bovine Trypsin At 0.85 Resolution
pdb|4I8L|A Chain A, Bovine Trypsin At 0.87 Resolution
pdb|4AOQ|A Chain A, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|B Chain B, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|C Chain C, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOR|A Chain A, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|B Chain B, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|C Chain C, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
Length = 223
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 40/150 (26%), Positives = 63/150 (42%), Gaps = 23/150 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS+ DI
Sbjct: 30 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSNTLNNDIM 86
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S + V + L P A G + GWG ++ S + LK
Sbjct: 87 LIKLKSAASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 139
Query: 332 MPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
PI+S C + P Q TS+ FCAG+
Sbjct: 140 APILSDSSCKSAYP---GQITSN-MFCAGY 165
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 47/95 (49%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC Y + + LG+ + + EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHC-----YKSGIQ-----VRLGEDNINVV--EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS+ DI L++L S + V + L
Sbjct: 71 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISL 105
>pdb|3UNQ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UPE|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|B Chain B, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 44/95 (46%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + V+ EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVV------------EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS Y DI L++L S + V + L
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLNSRVASISL 105
Score = 32.0 bits (71), Expect = 0.51, Method: Compositional matrix adjust.
Identities = 31/124 (25%), Positives = 50/124 (40%), Gaps = 19/124 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS Y DI
Sbjct: 30 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSETYNNDIM 86
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S + V + L P A G + GWG ++ S + LK
Sbjct: 87 LIKLKSAASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 139
Query: 332 MPIV 335
PI+
Sbjct: 140 APIL 143
>pdb|4B2C|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
pdb|4B2C|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
Length = 223
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 44/95 (46%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + V+ EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVV------------EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS Y DI L++L S + V + L
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLNSRVASISL 105
Score = 32.0 bits (71), Expect = 0.52, Method: Compositional matrix adjust.
Identities = 31/124 (25%), Positives = 50/124 (40%), Gaps = 19/124 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS Y DI
Sbjct: 30 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSETYNNDIM 86
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S + V + L P A G + GWG ++ S + LK
Sbjct: 87 LIKLKSAASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 139
Query: 332 MPIV 335
PI+
Sbjct: 140 APIL 143
>pdb|3OTJ|E Chain E, A Crystal Structure Of Trypsin Complexed With Bpti (Bovine
Pancreatic Trypsin Inhibitor) By X-RayNEUTRON JOINT
REFINEMENT
Length = 223
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 40/150 (26%), Positives = 63/150 (42%), Gaps = 23/150 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS+ DI
Sbjct: 30 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSNTLNNDIM 86
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S + V + L P A G + GWG ++ S + LK
Sbjct: 87 LIKLKSAASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 139
Query: 332 MPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
PI+S C + P Q TS+ FCAG+
Sbjct: 140 APILSDSSCKSAYP---GQITSN-MFCAGY 165
Score = 37.4 bits (85), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 47/95 (49%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC Y + + LG+ + + EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHC-----YKSGIQ-----VRLGEDNINVV--EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS+ DI L++L S + V + L
Sbjct: 71 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISL 105
>pdb|3UQV|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 44/95 (46%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + V+ EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVV------------EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS Y DI L++L S + V + L
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLNSRVASISL 105
Score = 32.0 bits (71), Expect = 0.50, Method: Compositional matrix adjust.
Identities = 31/124 (25%), Positives = 50/124 (40%), Gaps = 19/124 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS Y DI
Sbjct: 30 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSETYNNDIM 86
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S + V + L P A G + GWG ++ S + LK
Sbjct: 87 LIKLKSAASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 139
Query: 332 MPIV 335
PI+
Sbjct: 140 APIL 143
>pdb|3UNS|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UOP|A Chain A, Bovine Trypsin Variant X(triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UQO|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 44/95 (46%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + V+ EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVV------------EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS Y DI L++L S + V + L
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLNSRVASISL 105
Score = 32.0 bits (71), Expect = 0.51, Method: Compositional matrix adjust.
Identities = 31/124 (25%), Positives = 50/124 (40%), Gaps = 19/124 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS Y DI
Sbjct: 30 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSETYNNDIM 86
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S + V + L P A G + GWG ++ S + LK
Sbjct: 87 LIKLKSAASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 139
Query: 332 MPIV 335
PI+
Sbjct: 140 APIL 143
>pdb|1G3B|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Magnesium(Ii) Chelate
pdb|1G3C|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff Base
Iron(Iii) Chelate
pdb|1G3D|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Copper (Ii) Chelate
pdb|1G3E|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff-Base
Copper (Ii) Chelate
Length = 228
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 40/150 (26%), Positives = 63/150 (42%), Gaps = 23/150 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS+ DI
Sbjct: 35 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSNTLNNDIM 91
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S + V + L P A G + GWG ++ S + LK
Sbjct: 92 LIKLKSAASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 144
Query: 332 MPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
PI+S C + P Q TS+ FCAG+
Sbjct: 145 APILSDSSCKSAYP---GQITSN-MFCAGY 170
Score = 37.7 bits (86), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 46/95 (48%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + LG+ + + EG Q +
Sbjct: 28 HFCGGSLINSQWVVSAAHCYK----------SGIQVRLGEDNINVV--EGNEQFISASKS 75
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS+ DI L++L S + V + L
Sbjct: 76 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISL 110
>pdb|4B2B|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
pdb|4B2B|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
Length = 223
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 44/95 (46%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + V+ EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVV------------EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS Y DI L++L S + V + L
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLNSRVASISL 105
Score = 32.0 bits (71), Expect = 0.57, Method: Compositional matrix adjust.
Identities = 31/124 (25%), Positives = 50/124 (40%), Gaps = 19/124 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS Y DI
Sbjct: 30 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSETYNNDIM 86
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S + V + L P A G + GWG ++ S + LK
Sbjct: 87 LIKLKSAASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 139
Query: 332 MPIV 335
PI+
Sbjct: 140 APIL 143
>pdb|5PTP|A Chain A, Structure Of Hydrolase (Serine Proteinase)
Length = 223
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 40/150 (26%), Positives = 63/150 (42%), Gaps = 23/150 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS+ DI
Sbjct: 30 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSNTLNNDIM 86
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S + V + L P A G + GWG ++ S + LK
Sbjct: 87 LIKLKSAASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 139
Query: 332 MPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
PI+S C + P Q TS+ FCAG+
Sbjct: 140 APILSDSSCKSAYP---GQITSN-MFCAGY 165
Score = 37.4 bits (85), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 47/95 (49%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC Y + + LG+ + + EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHC-----YKSGIQ-----VRLGEDNINVV--EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS+ DI L++L S + V + L
Sbjct: 71 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISL 105
>pdb|1TGS|Z Chain Z, Three-Dimensional Structure Of The Complex Between
Pancreatic Secretory Inhibitor (Kazal Type) And
Trypsinogen At 1.8 Angstroms Resolution. Structure
Solution, Crystallographic Refinement And Preliminary
Structural Interpretation
pdb|2TGP|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2TPI|Z Chain Z, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3TPI|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|4TPI|Z Chain Z, The Refined 2.2-angstroms (0.22-nm) X-ray Crystal
Structure Of The Ternary Complex Formed By Bovine
Trypsinogen, Valine-valine And The Arg15 Analogue Of
Bovine Pancreatic Trypsin Inhibitor
pdb|1BTZ|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTX|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTW|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTP|A Chain A, Unique Binding Of A Novel Synthetic Inhibitor, N-[3-[4-[4-
(Amidinophenoxy)-Carbonyl]phenyl]-2-Methyl-2-Propenoyl]-
N- Allylglycine Methanesulfonate To Bovine Trypsin,
Revealed By The Crystal Structure Of The Complex
pdb|1BTY|A Chain A, Crystal Structure Of Beta-Trypsin In Complex With
Benzamidine
pdb|1TGB|A Chain A, Crystal Structure Of Bovine Trypsinogen At 1.8 Angstroms
Resolution. Ii. Crystallographic Refinement, Refined
Crystal Structure And Comparison With Bovine Trypsin
pdb|1TGC|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TGN|A Chain A, Structure Of Bovine Trypsinogen At 1.9 Angstroms
Resolution
pdb|1TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TNG|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNH|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNI|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNJ|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNK|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNL|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|2TGA|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|2TGD|A Chain A, Lack Of The Transition State Stabilization Site Is A
Factor In The Inactivity Of Trypsinogen, A Serine
Protease Zymogen. Structure Of Dfp Inhibited Bovine
Trypsinogen At 2.1 Angstroms Resolution
pdb|2TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
Length = 229
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 37/149 (24%), Positives = 63/149 (42%), Gaps = 21/149 (14%)
Query: 221 IDSAWYL------RGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIAL 274
I+S W + + + + + D + V + F + ++P++NS+ DI L
Sbjct: 36 INSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSNTLNNDIML 93
Query: 275 LQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAIM 332
++L S + V + L P A G + GWG ++ S + LK
Sbjct: 94 IKLKSAASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKA 146
Query: 333 PIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
PI+S C + P Q TS+ FCAG+
Sbjct: 147 PILSDSSCKSAYP---GQITSN-MFCAGY 171
Score = 37.7 bits (86), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 46/95 (48%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + LG+ + + EG Q +
Sbjct: 29 HFCGGSLINSQWVVSAAHCYKSG----------IQVRLGEDNINVV--EGNEQFISASKS 76
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS+ DI L++L S + V + L
Sbjct: 77 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISL 111
>pdb|3PWB|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PWC|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PYH|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3Q00|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Comlex
With Small Molecule Inhibitor
Length = 223
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 44/95 (46%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC K + D + + EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHCY-KSGIQVRLGEDNINVV-----------EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS Y DI L++L S + V + L
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLNSRVASISL 105
Score = 32.0 bits (71), Expect = 0.57, Method: Compositional matrix adjust.
Identities = 38/150 (25%), Positives = 59/150 (39%), Gaps = 23/150 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS Y DI
Sbjct: 30 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSETYNNDIM 86
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S + V + L P A G + GWG ++ S + LK
Sbjct: 87 LIKLKSAASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 139
Query: 332 MPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
PI+S S S + FCAG+
Sbjct: 140 APILSDS----SCKSASSFIITSNMFCAGY 165
>pdb|3UWI|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|B Chain B, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|C Chain C, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|D Chain D, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|E Chain E, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|F Chain F, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|G Chain G, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|H Chain H, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|I Chain I, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|J Chain J, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|K Chain K, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|L Chain L, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|M Chain M, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|N Chain N, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|O Chain O, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|P Chain P, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V12|A Chain A, Bovine Trypsin Variant X(tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V13|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 44/95 (46%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + V+ EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVV------------EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS Y DI L++L S + V + L
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLNSRVASISL 105
Score = 32.0 bits (71), Expect = 0.61, Method: Compositional matrix adjust.
Identities = 31/124 (25%), Positives = 50/124 (40%), Gaps = 19/124 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS Y DI
Sbjct: 30 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSETYNNDIM 86
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S + V + L P A G + GWG ++ S + LK
Sbjct: 87 LIKLKSAASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 139
Query: 332 MPIV 335
PI+
Sbjct: 140 APIL 143
>pdb|4B2A|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
pdb|4B2A|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
Length = 223
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 44/95 (46%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC K + D + + EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHCY-KSGIQVRLGEDNINVV-----------EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS Y DI L++L S + V + L
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLNSRVASISL 105
Score = 32.0 bits (71), Expect = 0.54, Method: Compositional matrix adjust.
Identities = 38/150 (25%), Positives = 59/150 (39%), Gaps = 23/150 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS Y DI
Sbjct: 30 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSETYNNDIM 86
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S + V + L P A G + GWG ++ S + LK
Sbjct: 87 LIKLKSAASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 139
Query: 332 MPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
PI+S S S + FCAG+
Sbjct: 140 APILSDS----SCKSASSFIITSNMFCAGY 165
>pdb|4B1T|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
pdb|4B1T|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
Length = 223
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 44/95 (46%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC K + D + + EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHCY-KSGIQVRLGEDNINVV-----------EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS Y DI L++L S + V + L
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLNSRVASISL 105
Score = 32.0 bits (71), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 38/150 (25%), Positives = 59/150 (39%), Gaps = 23/150 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS Y DI
Sbjct: 30 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSETYNNDIM 86
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S + V + L P A G + GWG ++ S + LK
Sbjct: 87 LIKLKSAASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 139
Query: 332 MPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
PI+S S S + FCAG+
Sbjct: 140 APILSDS----SCKSASSFIITSNMFCAGY 165
>pdb|1V2K|T Chain T, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin Variant X(Triple.Glu)bt.D2
pdb|1V2L|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.D1
pdb|1V2M|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.A1
Length = 223
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 44/95 (46%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC K + D + + EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHCY-KSGIQVRLGEDNINVV-----------EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS Y DI L++L S + V + L
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLNSRVASISL 105
Score = 32.0 bits (71), Expect = 0.56, Method: Compositional matrix adjust.
Identities = 38/150 (25%), Positives = 59/150 (39%), Gaps = 23/150 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS Y DI
Sbjct: 30 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSETYNNDIM 86
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S + V + L P A G + GWG ++ S + LK
Sbjct: 87 LIKLKSAASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 139
Query: 332 MPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
PI+S S S + FCAG+
Sbjct: 140 APILSDS----SCKSASSFIITSNMFCAGY 165
>pdb|3PMJ|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLB|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLP|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PM3|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 44/95 (46%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + V+ EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVV------------EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS Y DI L++L S + V + L
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLNSRVASISL 105
Score = 32.0 bits (71), Expect = 0.53, Method: Compositional matrix adjust.
Identities = 38/150 (25%), Positives = 59/150 (39%), Gaps = 23/150 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS Y DI
Sbjct: 30 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSETYNNDIM 86
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S + V + L P A G + GWG ++ S + LK
Sbjct: 87 LIKLKSAASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 139
Query: 332 MPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
PI+S S S + FCAG+
Sbjct: 140 APILSDS----SCKSASSFIITSNMFCAGY 165
>pdb|1V2N|T Chain T, Potent Factor Xa Inhibitor In Complex With Bovine Trypsin
Variant X(99175190)BT
Length = 223
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 44/95 (46%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + V+ EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVV------------EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS Y DI L++L S + V + L
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLNSRVASISL 105
Score = 32.0 bits (71), Expect = 0.51, Method: Compositional matrix adjust.
Identities = 38/150 (25%), Positives = 59/150 (39%), Gaps = 23/150 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS Y DI
Sbjct: 30 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSETYNNDIM 86
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S + V + L P A G + GWG ++ S + LK
Sbjct: 87 LIKLKSAASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 139
Query: 332 MPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
PI+S S S + FCAG+
Sbjct: 140 APILSDS----SCKSASSFIITSNMFCAGY 165
>pdb|2FI5|E Chain E, Crystal Structure Of A Bpti Variant (Cys38->ser) In
Complex With Trypsin
pdb|2FTM|A Chain A, Crystal Structure Of Trypsin Complexed With The Bpti
Variant (Tyr35- >gly)
Length = 224
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 41/153 (26%), Positives = 63/153 (41%), Gaps = 28/153 (18%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS+ DI
Sbjct: 30 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSNTLNNDIM 86
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGT---VIGWGYDENDRVS--EELK 328
L++L S L D A + L GT + GWG ++ S + LK
Sbjct: 87 LIKLKSAAS---------LXDSRVASISLPTSCASAGTQCLISGWGNTKSSGTSYPDVLK 137
Query: 329 MAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
PI+S C + P Q TS+ FCAG+
Sbjct: 138 CLKAPILSDSSCKSAYP---GQITSN-MFCAGY 166
Score = 36.2 bits (82), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 24/82 (29%), Positives = 43/82 (52%), Gaps = 12/82 (14%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC Y + + LG+ + + EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHC-----YKSGIQ-----VRLGEDNINVV--EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSS 128
++P++NS+ DI L++L S
Sbjct: 71 IVHPSYNSNTLNNDIMLIKLKS 92
>pdb|1ZZZ|A Chain A, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
Length = 237
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 35/143 (24%), Positives = 61/143 (42%), Gaps = 15/143 (10%)
Query: 221 IDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIALLQLSSD 280
+ +A + + + + D + V + F + ++P++NS+ DI L++L S
Sbjct: 50 VSAAHCYKSGIQVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSNTLNNDIMLIKLKSA 107
Query: 281 VDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAIMPIVSHQ 338
+ V + L P A G + GWG ++ S + LK PI+S
Sbjct: 108 ASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDS 160
Query: 339 QCLWSNPQFFSQFTSDETFCAGF 361
C + P Q TS+ FCAG+
Sbjct: 161 SCKSAYP---GQITSN-MFCAGY 179
Score = 37.7 bits (86), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 46/95 (48%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + LG+ + + EG Q +
Sbjct: 37 HFCGGSLINSQWVVSAAHCYK----------SGIQVRLGEDNINVV--EGNEQFISASKS 84
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS+ DI L++L S + V + L
Sbjct: 85 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISL 119
>pdb|1OPH|B Chain B, Non-Covalent Complex Between Alpha-1-Pi-Pittsburgh And
S195a Trypsin
Length = 243
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 40/150 (26%), Positives = 63/150 (42%), Gaps = 23/150 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS+ DI
Sbjct: 50 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSNTLNNDIM 106
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S + V + L P A G + GWG ++ S + LK
Sbjct: 107 LIKLKSAASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 159
Query: 332 MPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
PI+S C + P Q TS+ FCAG+
Sbjct: 160 APILSDSSCKSAYP---GQITSN-MFCAGY 185
Score = 37.7 bits (86), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 47/95 (49%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC Y + + LG+ + + EG Q +
Sbjct: 43 HFCGGSLINSQWVVSAAHC-----YKSGIQ-----VRLGEDNINVV--EGNEQFISASKS 90
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS+ DI L++L S + V + L
Sbjct: 91 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISL 125
>pdb|2TLD|E Chain E, Crystal Structure Of An Engineered Subtilisin Inhibitor
Complexed With Bovine Trypsin
Length = 220
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 40/151 (26%), Positives = 62/151 (41%), Gaps = 23/151 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS+ DI
Sbjct: 30 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSNTLNNDIM 86
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S + V + L P A G + GWG ++ S + LK
Sbjct: 87 LIKLKSAASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 139
Query: 332 MPIVSHQQCLWSNPQFFSQFTSDETFCAGFR 362
PI+S C + P Q TS+ FCAG
Sbjct: 140 APILSDSSCKSAYP---GQITSN-MFCAGLE 166
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 47/95 (49%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC Y + + LG+ + + EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHC-----YKSGIQ-----VRLGEDNINVV--EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS+ DI L++L S + V + L
Sbjct: 71 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISL 105
>pdb|1F0T|A Chain A, Bovine Trypsin Complexed With Rpr131247
pdb|1F0U|A Chain A, Bovine Trypsin Complexed With Rpr128515
pdb|1EZX|C Chain C, Crystal Structure Of A Serpin:protease Complex
pdb|1LQE|A Chain A, Crystal Structure Of Trypsin In Complex With 79.
pdb|1UTN|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTO|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-ray Structures And Association Constant Measurements
pdb|1UTP|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTQ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|2BY5|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY6|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY7|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY8|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY9|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BYA|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
Length = 243
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 40/150 (26%), Positives = 63/150 (42%), Gaps = 23/150 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS+ DI
Sbjct: 50 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSNTLNNDIM 106
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S + V + L P A G + GWG ++ S + LK
Sbjct: 107 LIKLKSAASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 159
Query: 332 MPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
PI+S C + P Q TS+ FCAG+
Sbjct: 160 APILSDSSCKSAYP---GQITSN-MFCAGY 185
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 47/95 (49%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC Y + + LG+ + + EG Q +
Sbjct: 43 HFCGGSLINSQWVVSAAHC-----YKSGIQ-----VRLGEDNINVV--EGNEQFISASKS 90
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS+ DI L++L S + V + L
Sbjct: 91 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISL 125
>pdb|1H9H|E Chain E, Complex Of Eeti-Ii With Porcine Trypsin
Length = 231
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/117 (28%), Positives = 54/117 (46%), Gaps = 17/117 (14%)
Query: 26 TARGQWPWHVALYRTEGINLSYVC-GGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYL 84
+A P+ V+L S+ C GGSL++ +V++AAHC K + + L
Sbjct: 8 SAANSIPYQVSLNSG-----SHFCSGGSLINSQWVVSAAHCSYK---------SRIQVRL 53
Query: 85 GKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
G+++ EG Q ++ +P FN + DI L++LSS + V V L
Sbjct: 54 GEHNIDVL--EGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSL 108
Score = 33.9 bits (76), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 30/114 (26%), Positives = 48/114 (42%), Gaps = 13/114 (11%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P FN + DI L++LSS + V V L P +A
Sbjct: 67 FINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSL------PRSCAAAGTECS 120
Query: 311 TVIGWGYDENDRVS--EELKMAI-MPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
+ GWG ++ S L+ ++ P++S C S P Q T + C GF
Sbjct: 121 LISGWGNTKSSGSSYPSLLQCSLKAPVLSDSSCKSSYP---GQITGN-MICVGF 170
>pdb|3V0X|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 43/95 (45%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + V+ EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVV------------EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS Y DI L++L S V + L
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLXSRVASISL 105
Score = 31.6 bits (70), Expect = 0.75, Method: Compositional matrix adjust.
Identities = 31/124 (25%), Positives = 49/124 (39%), Gaps = 19/124 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS Y DI
Sbjct: 30 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSETYNNDIM 86
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S V + L P A G + GWG ++ S + LK
Sbjct: 87 LIKLKSAASLXSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 139
Query: 332 MPIV 335
PI+
Sbjct: 140 APIL 143
>pdb|2FI4|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser) In
Complex With Trypsin
pdb|2FTL|E Chain E, Crystal Structure Of Trypsin Complexed With Bpti At 100k
Length = 223
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 40/150 (26%), Positives = 62/150 (41%), Gaps = 23/150 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS+ DI
Sbjct: 30 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSNTLNNDIM 86
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S V + L P A G + GWG ++ S + LK
Sbjct: 87 LIKLKSAASLXSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 139
Query: 332 MPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
PI+S C + P Q TS+ FCAG+
Sbjct: 140 APILSDSSCKSAYP---GQITSN-MFCAGY 165
Score = 37.4 bits (85), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 46/95 (48%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC Y + + LG+ + + EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHC-----YKSGIQ-----VRLGEDNINVV--EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS+ DI L++L S V + L
Sbjct: 71 IVHPSYNSNTLNNDIMLIKLKSAASLXSRVASISL 105
>pdb|3H7T|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
pdb|3H7T|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
Length = 235
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 34/132 (25%), Positives = 60/132 (45%), Gaps = 25/132 (18%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G+K+ + PW V + ++ CGGS+++ N+VITAA CV D SD +
Sbjct: 4 GKKSDITKEPWAVGVL----VDEKPFCGGSILTANFVITAAQCV-----DGTKPSDISIH 54
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLW 142
Y Y + + V K++ V +P +NY A+++ P+ L
Sbjct: 55 YGSSYRTTKGT---SVMAKKIYIVRYHPLTMQNNY----AVIETE---------MPIKLD 98
Query: 143 DDSTAPLQLSAV 154
D +T ++L ++
Sbjct: 99 DKTTKKIELPSL 110
>pdb|3PLK|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 44/95 (46%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + + V+ EG Q +
Sbjct: 23 HFCGGSLLNSQWVVSAAHCYKSGIQVRLGEDNINVV------------EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS Y DI L++L S + V + L
Sbjct: 71 IVHPSYNSETYNNDIMLIKLKSAASLNSRVASISL 105
Score = 32.0 bits (71), Expect = 0.57, Method: Compositional matrix adjust.
Identities = 33/143 (23%), Positives = 57/143 (39%), Gaps = 15/143 (10%)
Query: 221 IDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIALLQLSSD 280
+ +A + + + + D + V + F + ++P++NS Y DI L++L S
Sbjct: 36 VSAAHCYKSGIQVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSETYNNDIMLIKLKSA 93
Query: 281 VDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAIMPIVSHQ 338
+ V + L P A G + GWG ++ S + LK PI+S
Sbjct: 94 ASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDS 146
Query: 339 QCLWSNPQFFSQFTSDETFCAGF 361
S S + FCAG+
Sbjct: 147 ----SCKSASSFIITSNMFCAGY 165
>pdb|2D8W|A Chain A, Structure Of Hyper-Vil-Trypsin
Length = 223
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 35/142 (24%), Positives = 60/142 (42%), Gaps = 15/142 (10%)
Query: 221 IDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIALLQLSSD 280
+ +A + + + + D + V + F + ++P++NS+ DI L++L S
Sbjct: 36 VSAAHCXKSGIQVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSNTLNNDIMLIKLKSA 93
Query: 281 VDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAIMPIVSHQ 338
+ V + L P A G + GWG ++ S + LK PI+S
Sbjct: 94 ASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSXPDVLKCLKAPILSDS 146
Query: 339 QCLWSNPQFFSQFTSDETFCAG 360
C + P Q TS+ FCAG
Sbjct: 147 SCKSAYP---GQITSN-MFCAG 164
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 44/95 (46%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC K + D + + EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHC-XKSGIQVRLGEDNINVV-----------EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS+ DI L++L S + V + L
Sbjct: 71 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISL 105
>pdb|2AIP|A Chain A, Crystal Structure Of Native Protein C Activator From The
Venom Of Copperhead Snake Agkistrodon Contortrix
Contortrix
pdb|2AIQ|A Chain A, Crystal Structure Of Benzamidine-Inhibited Protein C
Activator From The Venom Of Copperhead Snake Agkistrodon
Contortrix Contortrix
Length = 231
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 47/94 (50%), Gaps = 11/94 (11%)
Query: 48 VCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRVH 107
+CGG+L++ +V+TA HC D + IYLG H + ++ ++ ++
Sbjct: 24 LCGGTLINQEWVLTARHC----------DRGNMRIYLG-MHNLKVLNKDALRRFPKEKYF 72
Query: 108 IYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
T N + + DI L++L+ V S ++ P+ L
Sbjct: 73 CLNTRNDTIWDKDIMLIRLNRPVRNSAHIAPLSL 106
>pdb|2FMJ|A Chain A, 220-Loop Mutant Of Streptomyces Griseus Trypsin
Length = 222
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 65/243 (26%), Positives = 103/243 (42%), Gaps = 43/243 (17%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
V G + A+G++P+ V LS CGG+L + + V+TAAHCV+ + + +
Sbjct: 1 VVGGTRAAQGEFPFMV--------RLSMGCGGALYAQDIVLTAAHCVSGSGNNTSITATG 52
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
V+ L Q S V++ +V + P +N + D AL++L+ ++ +P
Sbjct: 53 GVVDL------QSSSAVKVRSTKVLQA---PGYNGTGK--DWALIKLAQPIN-----QPT 96
Query: 140 CLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARD--GLRVCDTK 197
+TA Q + N + G + + + VS R G + +
Sbjct: 97 LKIATTTAYNQGTFTVAGWGANREGGSQQRYLLKANVPF---VSDAACRSAYGNELVANE 153
Query: 198 HYVVFTDVANV--CNGDSGGGMVFKIDSA--WYLRGIVS--ITVARDGLRVCDTKHYVVF 251
D V C GDSGG M F+ D+A W GIVS AR G Y V+
Sbjct: 154 EICAGYDTGGVDTCQGDSGGPM-FRKDNADEWIQVGIVSWGEGCARKG-------KYGVY 205
Query: 252 TDV 254
T+V
Sbjct: 206 TEV 208
>pdb|4D9Q|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9Q|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 28/97 (28%), Positives = 43/97 (44%), Gaps = 8/97 (8%)
Query: 43 INLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQ 102
+N ++CGG LV+ +V++AAHC+ K + + LG + Q E +
Sbjct: 20 VNGEHLCGGVLVAEQWVLSAAHCLEDAADGK------VQVLLGAHSLSQ--PEPSKRLYD 71
Query: 103 VKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
V R +P D+ LLQLS VRP+
Sbjct: 72 VLRAVPHPDSRPDTIDHDLLLLQLSEKATLGPAVRPL 108
>pdb|1BQY|A Chain A, Plasminogen Activator (tsv-pa) From Snake Venom
pdb|1BQY|B Chain B, Plasminogen Activator (tsv-pa) From Snake Venom
Length = 234
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 26/103 (25%), Positives = 50/103 (48%), Gaps = 17/103 (16%)
Query: 35 VALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSD 94
V L+ + G ++CGG+L++ ++V+TAAHC DS+ + G + + ++
Sbjct: 16 VVLFNSNG----FLCGGTLINQDWVVTAAHC----------DSNNFQLLFGVHSKKILNE 61
Query: 95 EGGVQNKQVKRVHIYPTFNSSNYL-GDIALLQLSSDVDYSMYV 136
+ Q + K P + + DI L++L S V S ++
Sbjct: 62 D--EQTRDPKEKFFCPNRKKDDEVDKDIMLIKLDSSVSNSEHI 102
>pdb|1KYN|B Chain B, Cathepsin-G
pdb|1KYN|A Chain A, Cathepsin-G
Length = 235
Score = 38.1 bits (87), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 25/79 (31%), Positives = 37/79 (46%), Gaps = 12/79 (15%)
Query: 49 CGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRVHI 108
CGG LV ++V+TAAHC + + LG ++ + E Q+ +R
Sbjct: 29 CGGFLVREDFVLTAAHCW----------GSNINVTLGAHNIQR--RENTQQHITARRAIR 76
Query: 109 YPTFNSSNYLGDIALLQLS 127
+P +N DI LLQLS
Sbjct: 77 HPQYNQRTIQNDIMLLQLS 95
Score = 32.7 bits (73), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 44/177 (24%), Positives = 75/177 (42%), Gaps = 25/177 (14%)
Query: 196 TKHYVVFTDVANVCNGDSGGGMVFKID---SAWYLRGI-VSITV-ARDGLRVCDTKHYVV 250
++ Y+ + + + GG + + D +A + G +++T+ A + R +T+ ++
Sbjct: 11 SRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHCWGSNINVTLGAHNIQRRENTQQHIT 70
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEG-RD 309
+R +P +N DI LLQLS V + V PV L A EG R
Sbjct: 71 ---ARRAIRHPQYNQRTIQNDIMLLQLSRRVRRNRNVNPVAL---------PRAQEGLRP 118
Query: 310 G---TVIGWGYDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFRN 363
G TV GWG R ++ L+ + + +QCL + F + C G R
Sbjct: 119 GTLCTVAGWGRVSMRRGTDTLREVQLRVQRDRQCL----RIFGSYDPRRQICVGDRR 171
>pdb|2PSX|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin
pdb|2PSY|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin And Zinc
Length = 227
Score = 38.1 bits (87), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 27/108 (25%), Positives = 45/108 (41%), Gaps = 14/108 (12%)
Query: 32 PWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQ 91
PW AL CG LV +++TAAHC K + LG Y
Sbjct: 13 PWQAALLLRPN---QLYCGAVLVHPQWLLTAAHCRKK----------VFRVRLGHYSLSP 59
Query: 92 FSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
+ G + VK + +P ++ + D+ L++L+ + + VRP+
Sbjct: 60 VYESGQQMFQGVKSI-PHPGYSHPGHSNDLMLIKLNRRIRPTKDVRPI 106
>pdb|1AU8|A Chain A, Human Cathepsin G
pdb|1T32|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|1CGH|A Chain A, Human Cathepsin G
Length = 224
Score = 38.1 bits (87), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 25/79 (31%), Positives = 37/79 (46%), Gaps = 12/79 (15%)
Query: 49 CGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRVHI 108
CGG LV ++V+TAAHC + + LG ++ + E Q+ +R
Sbjct: 29 CGGFLVREDFVLTAAHCW----------GSNINVTLGAHNIQR--RENTQQHITARRAIR 76
Query: 109 YPTFNSSNYLGDIALLQLS 127
+P +N DI LLQLS
Sbjct: 77 HPQYNQRTIQNDIMLLQLS 95
Score = 32.7 bits (73), Expect = 0.33, Method: Compositional matrix adjust.
Identities = 44/177 (24%), Positives = 75/177 (42%), Gaps = 25/177 (14%)
Query: 196 TKHYVVFTDVANVCNGDSGGGMVFKID---SAWYLRGI-VSITV-ARDGLRVCDTKHYVV 250
++ Y+ + + + GG + + D +A + G +++T+ A + R +T+ ++
Sbjct: 11 SRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHCWGSNINVTLGAHNIQRRENTQQHIT 70
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEG-RD 309
+R +P +N DI LLQLS V + V PV L A EG R
Sbjct: 71 ---ARRAIRHPQYNQRTIQNDIMLLQLSRRVRRNRNVNPVAL---------PRAQEGLRP 118
Query: 310 G---TVIGWGYDENDRVSEELKMAIMPIVSHQQCLWSNPQFFSQFTSDETFCAGFRN 363
G TV GWG R ++ L+ + + +QCL + F + C G R
Sbjct: 119 GTLCTVAGWGRVSMRRGTDTLREVQLRVQRDRQCL----RIFGSYDPRRQICVGDRR 171
>pdb|4E7N|A Chain A, Crystal Structure Of Ahv_tl-I, A Glycosylated Snake-Venom
Thrombin- Like Enzyme From Agkistrodon Halys
Length = 238
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 29/102 (28%), Positives = 46/102 (45%), Gaps = 13/102 (12%)
Query: 35 VALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSD 94
VALY + L CGG+L++ +V+TAAHC D I LG H + +
Sbjct: 16 VALYTSRSRTL--FCGGTLINQEWVLTAAHC----------DRKNFRIKLG-MHSKKVPN 62
Query: 95 EGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYV 136
E ++ + N + + DI L++L S V S ++
Sbjct: 63 EDEQTRVPKEKFFCLSSKNYTLWDKDIMLIRLDSPVKNSKHI 104
>pdb|1V2Q|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Sswi)bt.B4
Length = 223
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 47/95 (49%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC Y + + LG+ + + EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHC-----YKSGIQ-----VRLGEDNINVV--EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS+ DI L++L S + V + L
Sbjct: 71 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISL 105
Score = 30.0 bits (66), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 37/150 (24%), Positives = 59/150 (39%), Gaps = 23/150 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS+ DI
Sbjct: 30 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSNTLNNDIM 86
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S + V + L P A G + GWG ++ S + LK
Sbjct: 87 LIKLKSAASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 139
Query: 332 MPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
PI+S S S + FCAG+
Sbjct: 140 APILSDS----SCKSASSWIITSNMFCAGY 165
>pdb|1V2J|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssri)
Bt.C1
pdb|1V2R|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssri)bt.B4
Length = 223
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 47/95 (49%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC Y + + LG+ + + EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHC-----YKSGIQ-----VRLGEDNINVV--EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS+ DI L++L S + V + L
Sbjct: 71 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISL 105
Score = 31.6 bits (70), Expect = 0.70, Method: Compositional matrix adjust.
Identities = 37/150 (24%), Positives = 60/150 (40%), Gaps = 23/150 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS+ DI
Sbjct: 30 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSNTLNNDIM 86
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S + V + L P A G + GWG ++ S + LK
Sbjct: 87 LIKLKSAASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 139
Query: 332 MPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
PI+S S S+ + FCAG+
Sbjct: 140 APILSDS----SCKSASSRIITSNMFCAGY 165
>pdb|1V2U|T Chain T, Benzamidine In Complex With Bovine Trypsin Varinat X(Ssai)
Bt.D1
pdb|1V2V|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssai)
Bt.C1
pdb|1V2W|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssai)bt.B4
Length = 223
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 47/95 (49%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC Y + + LG+ + + EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHC-----YKSGIQ-----VRLGEDNINVV--EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS+ DI L++L S + V + L
Sbjct: 71 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISL 105
Score = 31.2 bits (69), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 37/150 (24%), Positives = 59/150 (39%), Gaps = 23/150 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS+ DI
Sbjct: 30 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSNTLNNDIM 86
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S + V + L P A G + GWG ++ S + LK
Sbjct: 87 LIKLKSAASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 139
Query: 332 MPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
PI+S S S + FCAG+
Sbjct: 140 APILSDS----SCKSASSAIITSNMFCAGY 165
>pdb|1V2S|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Ssfi.Glu)bt.D1
pdb|1V2T|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(ssfi.glu)bt.b4
Length = 223
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 44/95 (46%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC K + D + + EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHCY-KSGIQVRLGEDNINVV-----------EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS+ DI L++L S + V + L
Sbjct: 71 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISL 105
Score = 29.6 bits (65), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 37/150 (24%), Positives = 59/150 (39%), Gaps = 23/150 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS+ DI
Sbjct: 30 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSNTLNNDIM 86
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S + V + L P A G + GWG ++ S + LK
Sbjct: 87 LIKLKSAASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 139
Query: 332 MPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
PI+S S S + FCAG+
Sbjct: 140 APILSDS----SCKSASSFIITSNMFCAGY 165
>pdb|1HJ9|A Chain A, Atomic Resolution Structures Of Trypsin Provide Insight
Into Structural Radiation Damage
Length = 223
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 47/95 (49%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC Y + + LG+ + + EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHC-----YKSGIQ-----VRLGEDNINVV--EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS+ DI L++L S + V + L
Sbjct: 71 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISL 105
Score = 37.0 bits (84), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 39/148 (26%), Positives = 61/148 (41%), Gaps = 23/148 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS+ DI
Sbjct: 30 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSNTLNNDIM 86
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S + V + L P A G + GWG ++ S + LK
Sbjct: 87 LIKLKSAASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 139
Query: 332 MPIVSHQQCLWSNPQFFSQFTSDETFCA 359
PI+S C + P Q TS+ FCA
Sbjct: 140 APILSDSSCKSAYP---GQITSN-MFCA 163
>pdb|1V2O|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.B4
pdb|1V2P|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.A4
Length = 223
Score = 37.4 bits (85), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 44/95 (46%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC K + D + + EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHCY-KSGIQVRLGEDNINVV-----------EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++NS+ DI L++L S + V + L
Sbjct: 71 IVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISL 105
Score = 30.4 bits (67), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 37/150 (24%), Positives = 59/150 (39%), Gaps = 23/150 (15%)
Query: 221 IDSAW-------YLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIYPTFNSSNYLGDIA 273
I+S W Y GI + + D + V + F + ++P++NS+ DI
Sbjct: 30 INSQWVVSAAHCYKSGI-QVRLGEDNINVVEGNEQ--FISASKSIVHPSYNSNTLNNDIM 86
Query: 274 LLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDGTVIGWGYDENDRVS--EELKMAI 331
L++L S + V + L P A G + GWG ++ S + LK
Sbjct: 87 LIKLKSAASLNSRVASISL------PTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLK 139
Query: 332 MPIVSHQQCLWSNPQFFSQFTSDETFCAGF 361
PI+S S S + FCAG+
Sbjct: 140 APILSDS----SCKSASSYIITSNMFCAGY 165
>pdb|2RA3|A Chain A, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
pdb|2RA3|B Chain B, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
Length = 224
Score = 37.4 bits (85), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 26/102 (25%), Positives = 48/102 (47%), Gaps = 15/102 (14%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++A HC + + + LG+++ EG Q ++
Sbjct: 23 HFCGGSLINEQWVVSAGHCYKSR----------IQVRLGEHNIEVL--EGNEQFINAAKI 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAP 148
+P ++ DI L++LSS + +V + L TAP
Sbjct: 71 IRHPQYDRKTLNNDIMLIKLSSRAVINAHVSTISL---PTAP 109
>pdb|2ZCH|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|2ZCK|P Chain P, Crystal Structure Of A Ternary Complex Between Psa, A
Substrat-Acyl Intermediate And An Activating Antibody
pdb|2ZCL|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|3QUM|P Chain P, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
pdb|3QUM|Q Chain Q, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
Length = 237
Score = 37.4 bits (85), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 36/126 (28%), Positives = 53/126 (42%), Gaps = 27/126 (21%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVI 82
G + + PW V L + G VCGG LV +V+TAAHC+ K VI
Sbjct: 4 GWECEKHSQPWQV-LVASRG---RAVCGGVLVHPQWVLTAAHCIRNKS----------VI 49
Query: 83 YLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSS-----------NYLGDIALLQLSSDVD 131
LG++ D G Q QV +P ++ S + D+ LL+LS +
Sbjct: 50 LLGRHSLFHPEDTG--QVFQVSHSFPHPLYDMSLLKNRFLRPGDDSSHDLMLLRLSEPAE 107
Query: 132 YSMYVR 137
+ V+
Sbjct: 108 LTDAVK 113
>pdb|2BDG|A Chain A, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDG|B Chain B, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDH|A Chain A, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|B Chain B, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|C Chain C, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|D Chain D, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDI|A Chain A, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|B Chain B, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|C Chain C, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|D Chain D, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|E Chain E, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|F Chain F, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|G Chain G, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|H Chain H, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|I Chain I, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|J Chain J, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|K Chain K, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|L Chain L, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|M Chain M, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|N Chain N, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|O Chain O, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|P Chain P, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
Length = 223
Score = 37.0 bits (84), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 52/227 (22%), Positives = 83/227 (36%), Gaps = 35/227 (15%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G+ + PW AL + C G LV +V++AAHC ++
Sbjct: 1 IINGEDCSPHSQPWQAALVMENEL----FCSGVLVHPQWVLSAAHCF----------QNS 46
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPV 139
I LG H + E G Q + +P +N D+ L++L V S +R +
Sbjct: 47 YTIGLG-LHSLEADQEPGSQMVEASLSVRHPEYNRPLLANDLMLIKLDESVSESDTIRSI 105
Query: 140 CLWDDSTAPLQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVAR--DGLRVCDTK 197
+ V G G G + + + + ++ D L
Sbjct: 106 SIASQCPTAGNSCLVSGW----GLLANGRMPTVLQCVNVSVVSEEVCSKLYDPLY----- 156
Query: 198 HYVVF-----TDVANVCNGDSGGGMVFKIDSAWYLRGIVSITVARDG 239
H +F D + CNGDSGG ++ YL+G+VS A G
Sbjct: 157 HPSMFCAGGGQDQKDSCNGDSGGPLICN----GYLQGLVSFGKAPCG 199
>pdb|1B0F|A Chain A, Crystal Structure Of Human Neutrophil Elastase With Mdl
101, 146
Length = 218
Score = 36.6 bits (83), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 30/118 (25%), Positives = 56/118 (47%), Gaps = 13/118 (11%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G++ WP+ V+L G + CG +L++ N+V++AAHCV +
Sbjct: 1 IVGGRRARPHAWPFMVSLQLAGG----HFCGATLIAPNFVMSAAHCVANV------NVRA 50
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVR 137
+ + LG ++ + E Q V+R+ ++ N L DI +LQL+ + V+
Sbjct: 51 VRVVLGAHNLSR--REPTRQVFAVQRI-FEDGYDPVNLLNDIVILQLNGSATINANVQ 105
>pdb|1TRN|A Chain A, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
pdb|1TRN|B Chain B, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
Length = 224
Score = 36.2 bits (82), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 26/102 (25%), Positives = 47/102 (46%), Gaps = 15/102 (14%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++A HC + + + LG+++ EG Q ++
Sbjct: 23 HFCGGSLINEQWVVSAGHCYKSR----------IQVRLGEHNIEVL--EGNEQFINAAKI 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAP 148
+P ++ DI L++LSS + V + L TAP
Sbjct: 71 IRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISL---PTAP 109
>pdb|1AFQ|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|3RU4|E Chain E, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 96
Score = 36.2 bits (82), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 23/59 (38%), Positives = 28/59 (47%), Gaps = 5/59 (8%)
Query: 152 SAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVANVCN 210
+ G S C GDSGG +V K + AW L GIVS G C T V+ V + N
Sbjct: 34 AGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSW-----GSSTCSTSTPGVYARVTALVN 87
Score = 32.3 bits (72), Expect = 0.43, Method: Compositional matrix adjust.
Identities = 20/46 (43%), Positives = 23/46 (50%), Gaps = 5/46 (10%)
Query: 209 CNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDV 254
C GDSGG +V K + AW L GIVS G C T V+ V
Sbjct: 42 CMGDSGGPLVCKKNGAWTLVGIVSW-----GSSTCSTSTPGVYARV 82
>pdb|1MTN|C Chain C, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|G Chain G, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|C Chain C, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|H Chain H, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|C Chain C, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|H Chain H, Bovine Chymotrypsin Complexed To Bpti
pdb|1VGC|C Chain C, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|C Chain C, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|C Chain C, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|C Chain C, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|C Chain C, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|C Chain C, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|E Chain E, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|F Chain F, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|C Chain C, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|G Chain G, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|C Chain C, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|G Chain G, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|G Chain G, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|G Chain G, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|G Chain G, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|G Chain G, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|G Chain G, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|G Chain G, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|G Chain G, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|C Chain C, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|G Chain G, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|C Chain C, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|G Chain G, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|C Chain C, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|G Chain G, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|G Chain G, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|C Chain C, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|C Chain C, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|C Chain C, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|C Chain C, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|C Chain C, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
Length = 97
Score = 36.2 bits (82), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 23/59 (38%), Positives = 28/59 (47%), Gaps = 5/59 (8%)
Query: 152 SAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVANVCN 210
+ G S C GDSGG +V K + AW L GIVS G C T V+ V + N
Sbjct: 35 AGASGVSSCMGDSGGPLVCKKNGAWTLVGIVSW-----GSSTCSTSTPGVYARVTALVN 88
Score = 32.3 bits (72), Expect = 0.44, Method: Compositional matrix adjust.
Identities = 20/46 (43%), Positives = 23/46 (50%), Gaps = 5/46 (10%)
Query: 209 CNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDV 254
C GDSGG +V K + AW L GIVS G C T V+ V
Sbjct: 43 CMGDSGGPLVCKKNGAWTLVGIVSW-----GSSTCSTSTPGVYARV 83
>pdb|1M9U|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|B Chain B, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|C Chain C, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
Length = 241
Score = 36.2 bits (82), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 32/124 (25%), Positives = 59/124 (47%), Gaps = 12/124 (9%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
V G + G++PW ++ R G + S+ CG SL+S ++A+HCV V +
Sbjct: 1 VIGGTNASPGEFPWQLSQQRQSG-SWSHSCGASLLSSTSALSASHCVDG------VLPNN 53
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTF--NSSNYLGDIALLQLSSDVDYSMYVR 137
+ + G + Q SD G Q V ++ + +++Y DIA+L L++ + ++
Sbjct: 54 IRVIAGLWQQ---SDTSGTQTANVDSYTMHENYGAGTASYSNDIAILHLATSISLGGNIQ 110
Query: 138 PVCL 141
L
Sbjct: 111 AAVL 114
>pdb|1PPF|E Chain E, X-Ray Crystal Structure Of The Complex Of Human Leukocyte
Elastase (Pmn Elastase) And The Third Domain Of The
Turkey Ovomucoid Inhibitor
Length = 218
Score = 36.2 bits (82), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 30/118 (25%), Positives = 56/118 (47%), Gaps = 13/118 (11%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G++ WP+ V+L G + CG +L++ N+V++AAHCV +
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGG----HFCGATLIAPNFVMSAAHCVANV------NVRA 50
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVR 137
+ + LG ++ + E Q V+R+ ++ N L DI +LQL+ + V+
Sbjct: 51 VRVVLGAHNLSR--REPTRQVFAVQRI-FENGYDPVNLLNDIVILQLNGSATINANVQ 105
>pdb|1HNE|E Chain E, Structure Of Human Neutrophil Elastase In Complex With A
Peptide Chloromethyl Ketone Inhibitor At 1.84-Angstroms
Resolution
Length = 218
Score = 36.2 bits (82), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 30/118 (25%), Positives = 56/118 (47%), Gaps = 13/118 (11%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G++ WP+ V+L G + CG +L++ N+V++AAHCV +
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGG----HFCGATLIAPNFVMSAAHCVANV------NVRA 50
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVR 137
+ + LG ++ + E Q V+R+ ++ N L DI +LQL+ + V+
Sbjct: 51 VRVVLGAHNLSR--REPTRQVFAVQRI-FEDGYDPVNLLNDIVILQLNGSATINANVQ 105
>pdb|2RG3|A Chain A, Covalent Complex Structure Of Elastase
Length = 218
Score = 36.2 bits (82), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 30/118 (25%), Positives = 56/118 (47%), Gaps = 13/118 (11%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G++ WP+ V+L G + CG +L++ N+V++AAHCV +
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGG----HFCGATLIAPNFVMSAAHCVANV------NVRA 50
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVR 137
+ + LG ++ + E Q V+R+ ++ N L DI +LQL+ + V+
Sbjct: 51 VRVVLGAHNLSR--REPTRQVFAVQRI-FENGYDPVNLLNDIVILQLNGSATINANVQ 105
>pdb|1PPG|E Chain E, The Refined 2.3 Angstroms Crystal Structure Of Human
Leukocyte Elastase In A Complex With A Valine
Chloromethyl Ketone Inhibitor
pdb|1H1B|A Chain A, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|1H1B|B Chain B, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|2Z7F|E Chain E, Crystal Structure Of The Complex Of Human Neutrophil
Elastase With 12SLPI
pdb|3Q76|A Chain A, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q76|B Chain B, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q77|A Chain A, Structure Of Human Neutrophil Elastase In Complex With A
Dihydropyrimidone Inhibitor
Length = 218
Score = 35.8 bits (81), Expect = 0.034, Method: Compositional matrix adjust.
Identities = 30/118 (25%), Positives = 56/118 (47%), Gaps = 13/118 (11%)
Query: 20 VTYGQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDT 79
+ G++ WP+ V+L G + CG +L++ N+V++AAHCV +
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGG----HFCGATLIAPNFVMSAAHCVANV------NVRA 50
Query: 80 LVIYLGKYHQHQFSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVR 137
+ + LG ++ + E Q V+R+ ++ N L DI +LQL+ + V+
Sbjct: 51 VRVVLGAHNLSR--REPTRQVFAVQRI-FENGYDPVNLLNDIVILQLNGSATINANVQ 105
>pdb|3S69|A Chain A, Crystal Structure Of Saxthrombin
Length = 234
Score = 35.0 bits (79), Expect = 0.057, Method: Compositional matrix adjust.
Identities = 27/103 (26%), Positives = 48/103 (46%), Gaps = 17/103 (16%)
Query: 35 VALYRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSD 94
VA + + G + C G+L++ +V+TAAHC D+ + LG + + ++
Sbjct: 16 VAFFNSTG----FFCSGTLINEEWVLTAAHC----------DNTNFQMKLGVHSKKVLNE 61
Query: 95 EGGVQNKQVKRVHIYPTFNSSNYL-GDIALLQLSSDVDYSMYV 136
+ Q + K I P + L DI L++L S V S ++
Sbjct: 62 D--EQTRNPKEKFICPNKKNDEVLDKDIMLIKLDSRVSNSEHI 102
>pdb|1KDQ|B Chain B, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 99
Score = 35.0 bits (79), Expect = 0.058, Method: Compositional matrix adjust.
Identities = 21/57 (36%), Positives = 27/57 (47%), Gaps = 5/57 (8%)
Query: 149 LQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDV 205
+ + G C GDSGG +V + D W L GIVS G VC T V++ V
Sbjct: 34 MTCAGASGVDSCMGDSGGPLVCQKDGVWTLAGIVSW-----GSGVCSTSTPAVYSRV 85
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 20/52 (38%), Positives = 26/52 (50%), Gaps = 5/52 (9%)
Query: 209 CNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIY 260
C GDSGG +V + D W L GIVS G VC T V++ V + +
Sbjct: 45 CMGDSGGPLVCQKDGVWTLAGIVSW-----GSGVCSTSTPAVYSRVTALMPW 91
>pdb|3QK1|A Chain A, Crystal Structure Of Enterokinase-Like Trypsin Variant
Length = 229
Score = 35.0 bits (79), Expect = 0.060, Method: Compositional matrix adjust.
Identities = 24/95 (25%), Positives = 44/95 (46%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL++ +V++AAHC + + LG+ + + EG Q +
Sbjct: 23 HFCGGSLINSQWVVSAAHCYK----------SGIQVRLGEDNINVV--EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P++N DI L++L S + V + L
Sbjct: 71 IVHPSYNKRRKNNDIMLIKLKSAASLNSRVASISL 105
>pdb|1MZA|A Chain A, Crystal Structure Of Human Pro-Granzyme K
pdb|1MZD|A Chain A, Crystal Structure Of Human Pro-Granzyme K
Length = 240
Score = 34.7 bits (78), Expect = 0.084, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 44/92 (47%), Gaps = 9/92 (9%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFS-DEGGVQNKQVKR 105
+VCGG L+ +V+TAAHC + + K + + LG H S +E Q ++K+
Sbjct: 26 HVCGGVLIDPQWVLTAAHCQYR--FTK---GQSPTVVLG---AHSLSKNEASKQTLEIKK 77
Query: 106 VHIYPTFNSSNYLGDIALLQLSSDVDYSMYVR 137
+ S DI L++L + + +V+
Sbjct: 78 FIPFSRVTSDPQSNDIMLVKLQTAAKLNKHVK 109
>pdb|1NTP|A Chain A, Use Of The Neutron Diffraction HD EXCHANGE TECHNIQUE TO
Determine The Conformational Dynamics Of Trypsin
Length = 223
Score = 34.7 bits (78), Expect = 0.096, Method: Compositional matrix adjust.
Identities = 24/95 (25%), Positives = 44/95 (46%), Gaps = 12/95 (12%)
Query: 47 YVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQFSDEGGVQNKQVKRV 106
+ CGGSL+ +V++AAHC + + LG+ + + EG Q +
Sbjct: 23 HFCGGSLIDSQWVVSAAHCYK----------SGIQVRLGEDNINVV--EGNEQFISASKS 70
Query: 107 HIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCL 141
++P+++S+ DI L++L S V + L
Sbjct: 71 IVHPSYDSNTLNNDIMLIKLKSAASLDSRVASISL 105
>pdb|2JET|C Chain C, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 99
Score = 33.9 bits (76), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 21/57 (36%), Positives = 27/57 (47%), Gaps = 5/57 (8%)
Query: 149 LQLSAVEGTSVCNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDV 205
+ + G C GDSGG +V + D W L GIVS G VC T V++ V
Sbjct: 34 MTCAGASGVDSCMGDSGGPLVCQKDGVWTLAGIVSW-----GSGVCSTSTPGVYSRV 85
Score = 32.7 bits (73), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 20/52 (38%), Positives = 26/52 (50%), Gaps = 5/52 (9%)
Query: 209 CNGDSGGGMVFKIDSAWYLRGIVSITVARDGLRVCDTKHYVVFTDVKRVHIY 260
C GDSGG +V + D W L GIVS G VC T V++ V + +
Sbjct: 45 CMGDSGGPLVCQKDGVWTLAGIVSW-----GSGVCSTSTPGVYSRVTALMPW 91
>pdb|1DJ3|A Chain A, Structures Of Adenylosuccinate Synthetase From Triticum
Aestivum And Arabidopsis Thaliana
pdb|1DJ3|B Chain B, Structures Of Adenylosuccinate Synthetase From Triticum
Aestivum And Arabidopsis Thaliana
Length = 442
Score = 31.6 bits (70), Expect = 0.69, Method: Compositional matrix adjust.
Identities = 18/55 (32%), Positives = 27/55 (49%), Gaps = 4/55 (7%)
Query: 183 SITVARDGLRVCDTKHYVVFTDVANVCNGDSGGGMVFKIDSAWYLRGIVSITVAR 237
S V R+GLRVCD +H F D +V D+ + + Y +G++ V R
Sbjct: 156 SSKVTRNGLRVCDLRHMDTFGDKLDVLFEDAAA----RFEGFKYSKGMLKEEVER 206
>pdb|1EPT|A Chain A, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
Length = 43
Score = 29.6 bits (65), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 16/43 (37%), Positives = 24/43 (55%), Gaps = 5/43 (11%)
Query: 23 GQKTARGQWPWHVALYRTEGINLSYVCGGSLVSVNYVITAAHC 65
G A P+ V+L S+ CGGSL++ +V++AAHC
Sbjct: 4 GYTCAANSIPYQVSLNSG-----SHFCGGSLINSQWVVSAAHC 41
>pdb|2HNT|F Chain F, Crystallographic Structure Of Human Gamma-Thrombin
pdb|1BHX|F Chain F, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|C Chain C, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
Length = 105
Score = 29.6 bits (65), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 26/77 (33%), Positives = 35/77 (45%), Gaps = 17/77 (22%)
Query: 119 GDIALLQLSSDVDYSMYVRPVCLWDDST----------APLQLSAVEGTSVCNGDSGGGM 168
G ++LQ+ V+ + RPVC DST A + + C GDSGG
Sbjct: 1 GQPSVLQV---VNLPIVERPVC--KDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPF 55
Query: 169 VFK--IDSAWYLRGIVS 183
V K ++ WY GIVS
Sbjct: 56 VMKSPFNNRWYQMGIVS 72
Score = 28.5 bits (62), Expect = 6.2, Method: Compositional matrix adjust.
Identities = 14/29 (48%), Positives = 17/29 (58%), Gaps = 2/29 (6%)
Query: 206 ANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+ C GDSGG V K ++ WY GIVS
Sbjct: 44 GDACEGDSGGPFVMKSPFNNRWYQMGIVS 72
>pdb|2PKS|C Chain C, Thrombin In Complex With Inhibitor
pdb|3PO1|C Chain C, Thrombin In Complex With Benzothiazole Guanidine
Length = 102
Score = 29.6 bits (65), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 26/77 (33%), Positives = 35/77 (45%), Gaps = 17/77 (22%)
Query: 119 GDIALLQLSSDVDYSMYVRPVCLWDDST----------APLQLSAVEGTSVCNGDSGGGM 168
G ++LQ+ V+ + RPVC DST A + + C GDSGG
Sbjct: 1 GQPSVLQV---VNLPIVERPVC--KDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPF 55
Query: 169 VFK--IDSAWYLRGIVS 183
V K ++ WY GIVS
Sbjct: 56 VMKSPFNNRWYQMGIVS 72
Score = 28.5 bits (62), Expect = 6.2, Method: Compositional matrix adjust.
Identities = 14/29 (48%), Positives = 17/29 (58%), Gaps = 2/29 (6%)
Query: 206 ANVCNGDSGGGMVFK--IDSAWYLRGIVS 232
+ C GDSGG V K ++ WY GIVS
Sbjct: 44 GDACEGDSGGPFVMKSPFNNRWYQMGIVS 72
>pdb|1SI5|H Chain H, Protease-Like Domain From 2-Chain Hepatocyte Growth Factor
Length = 240
Score = 29.3 bits (64), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 32/122 (26%), Positives = 54/122 (44%), Gaps = 19/122 (15%)
Query: 33 WHVAL-YRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQ 91
W V+L YR + ++CGGSL+ ++V+TA C + D +LG + H
Sbjct: 13 WMVSLRYRNK-----HICGGSLIKESWVLTARQCFPSR------DLKDYEAWLGIHDVHG 61
Query: 92 FSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWD-DSTAPLQ 150
DE Q V ++ P + D+ L++L+ +V + L + ST P +
Sbjct: 62 RGDEKCKQVLNVSQLVYGPEGS------DLVLMKLARPAVLDDFVSTIDLPNYGSTIPEK 115
Query: 151 LS 152
S
Sbjct: 116 TS 117
>pdb|1SHY|A Chain A, The Crystal Structure Of Hgf Beta-Chain In Complex With
The Sema Domain Of The Met Receptor
Length = 234
Score = 29.3 bits (64), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 32/122 (26%), Positives = 54/122 (44%), Gaps = 19/122 (15%)
Query: 33 WHVAL-YRTEGINLSYVCGGSLVSVNYVITAAHCVTKKPYDKPVDSDTLVIYLGKYHQHQ 91
W V+L YR + ++CGGSL+ ++V+TA C + D +LG + H
Sbjct: 13 WMVSLRYRNK-----HICGGSLIKESWVLTARQCFPSR------DLKDYEAWLGIHDVHG 61
Query: 92 FSDEGGVQNKQVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWD-DSTAPLQ 150
DE Q V ++ P + D+ L++L+ +V + L + ST P +
Sbjct: 62 RGDEKCKQVLNVSQLVYGPEGS------DLVLMKLARPAVLDDFVSTIDLPNYGSTIPEK 115
Query: 151 LS 152
S
Sbjct: 116 TS 117
>pdb|1EPT|B Chain B, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
Length = 82
Score = 28.5 bits (62), Expect = 5.6, Method: Composition-based stats.
Identities = 19/66 (28%), Positives = 30/66 (45%), Gaps = 7/66 (10%)
Query: 251 FTDVKRVHIYPTFNSSNYLGDIALLQLSSDVDYSMYVRPVCLWDDSTAPLQLSAVEGRDG 310
F + ++ +P FN + DI L++LSS + V V L P +A G +
Sbjct: 21 FINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSL------PRSCAAA-GTEC 73
Query: 311 TVIGWG 316
+ GWG
Sbjct: 74 LISGWG 79
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.321 0.137 0.434
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 11,401,859
Number of Sequences: 62578
Number of extensions: 488430
Number of successful extensions: 2544
Number of sequences better than 100.0: 353
Number of HSP's better than 100.0 without gapping: 336
Number of HSP's successfully gapped in prelim test: 17
Number of HSP's that attempted gapping in prelim test: 1095
Number of HSP's gapped (non-prelim): 963
length of query: 363
length of database: 14,973,337
effective HSP length: 100
effective length of query: 263
effective length of database: 8,715,537
effective search space: 2292186231
effective search space used: 2292186231
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.9 bits)
S2: 52 (24.6 bits)